1	Thrombosis	NNP	ORGANIZATION	Thrombosis	nn	2	SENT_1	[p1l6t160r345b212],
2	Research	NNP	ORGANIZATION	Research	_	0	SENT_1	[p1l374t160r635b212],
3	(	CD	NUMBER	(	num	4	SENT_1	[p1l668t160r849b225],
4	2007	CD	DATE	2007	dep	2	SENT_1	[p1l668t160r849b225],
5	)	NN	O	)	dep	2	SENT_1	[p1l668t160r849b225],
6	119	CD	NUMBER	119	num	5	SENT_1	[p1l885t160r1012b223],
7	,	,	O	,	_	0	SENT_1	[p1l885t160r1012b223],
8	355-360	CD	NUMBER	355-360	appos	5	SENT_1	[p1l1046t160r1321b212],

1	x	CC	O	x	cc	2	SENT_2	[p1l201t672r218b682],
2	L	NN	O	l	nsubj	7	SENT_2	[p1l123t694r149b705],
3	f	FW	O	f	dep	2	SENT_2	[p1l190t689r209b708],
4	1	CD	NUMBER	1	dep	2	SENT_2	[p1l110t650r112b658],
5	’	SYM	O	’	dep	7	SENT_2	[p1l116t646r125b659],
6	-	:	O	-	_	0	SENT_2	[p1l116t646r125b659],
7	,	,	O	,	_	0	SENT_2	[p1l116t646r125b659],
8	.	.	O	.	_	0	SENT_2	[p1l116t646r125b659],

1	--	:	O	--	_	0	SENT_3	[p1l105t657r128b669],
2	,1	NN	O	,1	_	0	SENT_3	[p1l105t657r128b669],
3	,	,	O	,	_	0	SENT_3	[p1l105t657r128b669],
4	H	NN	O	h	appos	2	SENT_3	[p1l115t665r131b680],

1	REGULAR	JJ	O	regular	amod	2	SENT_4	[p1l13t979r423b1055],
2	ARTICLE	NN	O	article	_	0	SENT_4	[p1l457t979r822b1055],

1	Genetic	JJ	O	genetic	amod	2	SENT_5	[p1l12t1213r613b1339],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_5	[p1l716t1210r1891b1372],
3	of	IN	O	of	_	0	SENT_5	[p1l1988t1211r2146b1338],
4	P2Y12	NN	O	p2y12	prep_of	2	SENT_5	[p1l17t1416r503b1571],
5	,	,	O	,	_	0	SENT_5	[p1l17t1416r503b1571],
6	PZY1	NN	O	pzy1	conj_and	4	SENT_5	[p1l581t1416r923b1569],
7	and	CC	O	and	_	0	SENT_5	[p1l1000t1413r1275b1542],
8	GP	NN	O	gp	prep_of	2	SENT_5	[p1l1338t1416r1539b1542],
9	Illa	NN	PERSON	illum	dep	2	SENT_5	[p1l1607t1418r1820b1542],
10	and	CC	O	and	_	0	SENT_5	[p1l1878t1412r2153b1542],
11	clopidogrel	NN	O	clopidogrel	conj_and	9	SENT_5	[p1l10t1616r882b1778],

1	TI-IROMBOSIS	NN	O	ti-irombosis	_	0	SENT_6	[p1l1170t2103r2129b2208],

1	RESEARCH	NN	O	research	_	0	SENT_7	[p1l1293t2322r2015b2425],

1	intl.elsevierhealth.com/journals/thre	RB	O	intl.elsevierhealth.com/journals/thre	_	0	SENT_8	[p1l809t2645r2152b2721],
2	the	DT	O	the	det	5	SENT_8	[p1l19t2903r320b3054],
3	platelet	NN	O	platelet	nn	5	SENT_8	[p1l440t2902r1150b3094],
4	receptors	NNS	O	receptor	nn	5	SENT_8	[p1l1271t2917r2147b3094],
5	response	NN	O	response	dep	6	SENT_8	[p1l7t3184r818b3333],
6	to	TO	O	to	dep	1	SENT_8	[p1l886t3157r1069b3293],
7	aspirin	NN	O	aspirin	pobj	6	SENT_8	[p1l1137t3146r1747b3333],
8	and	CC	O	and	advmod	7	SENT_8	[p1l1821t3142r2144b3293],

1	Eli	NNP	PERSON	Eli	nn	3	SENT_9	[p1l100t3420r159b3464],
2	I.	NNP	PERSON	I.	nn	3	SENT_9	[p1l186t3421r213b3465],
3	Lev	NNP	PERSON	Lev	dep	37	SENT_9	[p1l242t3421r334b3464],
4	3	CD	NUMBER	3	num	3	SENT_9	[p1l348t3416r385b3474],
5	,	,	O	,	_	0	SENT_9	[p1l348t3416r385b3474],
6	Rajnikant	NNP	PERSON	Rajnikant	nn	8	SENT_9	[p1l414t3420r664b3475],
7	T.	NNP	PERSON	T.	nn	8	SENT_9	[p1l685t3421r729b3465],
8	Patela	NNP	PERSON	Patela	appos	3	SENT_9	[p1l759t3416r941b3474],
9	,	,	O	,	_	0	SENT_9	[p1l759t3416r941b3474],
10	Sasidhar	NNP	PERSON	Sasidhar	nn	11	SENT_9	[p1l968t3420r1191b3464],
11	Guthikonda	NNP	PERSON	Guthikonda	appos	3	SENT_9	[p1l1213t3420r1518b3464],
12	3	CD	NUMBER	3	num	11	SENT_9	[p1l1533t3416r1570b3474],
13	,	,	O	,	_	0	SENT_9	[p1l1533t3416r1570b3474],
14	David	NNP	PERSON	David	nn	15	SENT_9	[p1l1599t3420r1743b3464],
15	Lopez	NNP	PERSON	Lopez	poss	17	SENT_9	[p1l1769t3421r1925b3476],
16	'	POS	O	'	_	0	SENT_9	[p1l1941t3408r1979b3474],
17	°	NN	O	°	appos	3	SENT_9	[p1l1941t3408r1979b3474],
18	,	,	O	,	_	0	SENT_9	[p1l1941t3408r1979b3474],
19	Paul	NNP	PERSON	Paul	nn	21	SENT_9	[p1l100t3486r208b3531],
20	F.	NNP	PERSON	F.	nn	21	SENT_9	[p1l233t3488r272b3532],
21	Bray	NNP	PERSON	Bray	poss	23	SENT_9	[p1l301t3488r416b3542],
22	'	POS	O	'	_	0	SENT_9	[p1l431t3475r469b3541],
23	°	NN	O	°	appos	17	SENT_9	[p1l431t3475r469b3541],
24	,	,	O	,	_	0	SENT_9	[p1l431t3475r469b3541],
25	Neal	NNP	PERSON	Neal	nn	30	SENT_9	[p1l498t3486r612b3531],
26	S.	NNP	PERSON	S.	nn	30	SENT_9	[p1l635t3487r678b3532],
27	Kleiman	NNP	PERSON	Kleiman	nn	30	SENT_9	[p1l708t3486r918b3531],
28	a	DT	O	a	det	30	SENT_9	[p1l934t3483r995b3511],
29	’	NN	O	’	nn	30	SENT_9	[p1l934t3483r995b3511],
30	*	NN	O	*	appos	3	SENT_9	[p1l934t3483r995b3511],
31	'	''	O	'	_	0	SENT_9	[p1l97t3617r112b3632],
32	3	CD	NUMBER	3	dep	37	SENT_9	[p1l97t3617r112b3632],
33	The	DT	O	the	det	37	SENT_9	[p1l128t3620r194b3651],
34	Methodist	NNP	O	Methodist	nn	37	SENT_9	[p1l208t3620r393b3651],
35	DeBakey	NNP	O	DeBakey	nn	37	SENT_9	[p1l408t3620r564b3659],
36	Heart	NNP	ORGANIZATION	Heart	nn	37	SENT_9	[p1l577t3620r681b3651],
37	Center	NNP	ORGANIZATION	Center	dep	77	SENT_9	[p1l698t3620r826b3657],
38	,	,	O	,	_	0	SENT_9	[p1l698t3620r826b3657],
39	The	DT	O	the	det	41	SENT_9	[p1l847t3620r913b3651],
40	Methodist	NNP	ORGANIZATION	Methodist	nn	41	SENT_9	[p1l927t3620r1112b3651],
41	Hospital	NNP	ORGANIZATION	Hospital	dep	77	SENT_9	[p1l1128t3620r1278b3659],
42	and	CC	O	and	_	0	SENT_9	[p1l1294t3620r1361b3651],
43	Baylor	NNP	ORGANIZATION	Baylor	nn	44	SENT_9	[p1l1376t3620r1492b3659],
44	College	NNP	ORGANIZATION	College	dep	77	SENT_9	[p1l1508t3620r1643b3659],
45	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1658t3620r1698b3659],
46	Medicine	NNP	ORGANIZATION	Medicine	nn	48	SENT_9	[p1l1709t3620r1885b3657],
47	,	,	O	,	_	0	SENT_9	[p1l1709t3620r1885b3657],
48	Section	NNP	ORGANIZATION	Section	prep_of	37	SENT_9	[p1l98t3669r231b3701],
49	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l247t3669r287b3709],
50	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	48	SENT_9	[p1l301t3669r501b3709],
51	,	,	O	,	_	0	SENT_9	[p1l301t3669r501b3709],
52	6565	CD	NUMBER	6565	dep	50	SENT_9	[p1l522t3670r606b3701],
53	Fannin	NNP	LOCATION	Fannin	nn	54	SENT_9	[p1l621t3669r742b3701],
54	St.	NNP	LOCATION	St.	dep	52	SENT_9	[p1l759t3669r909b3701],
55	/	:	O	/	punct	52	SENT_9	[p1l759t3669r909b3701],
56	Mail	NNP	O	Mail	nn	58	SENT_9	[p1l759t3669r909b3701],
57	Station	NNP	O	Station	nn	58	SENT_9	[p1l926t3669r1056b3701],
58	F-1090	NN	O	f-1090	dep	52	SENT_9	[p1l1072t3669r1205b3707],
59	,	,	O	,	_	0	SENT_9	[p1l1072t3669r1205b3707],
60	Houston	NNP	LOCATION	Houston	appos	58	SENT_9	[p1l1225t3670r1384b3707],
61	,	,	O	,	_	0	SENT_9	[p1l1225t3670r1384b3707],
62	TX	NNP	LOCATION	TX	appos	58	SENT_9	[p1l1406t3670r1452b3701],
63	77030	CD	NUMBER	77030	num	62	SENT_9	[p1l1466t3669r1582b3707],
64	,	,	O	,	_	0	SENT_9	[p1l1466t3669r1582b3707],
65	United	NNP	LOCATION	United	nn	70	SENT_9	[p1l1603t3669r1727b3701],
66	States	NNP	LOCATION	States	nn	70	SENT_9	[p1l1741t3669r1854b3701],
67	b	NN	O	b	nn	70	SENT_9	[p1l98t3710r113b3731],
68	Thrombosis	NNP	ORGANIZATION	Thrombosis	nn	70	SENT_9	[p1l129t3718r337b3750],
69	Research	NNP	ORGANIZATION	Research	nn	70	SENT_9	[p1l351t3718r514b3750],
70	Section	NNP	ORGANIZATION	Section	appos	58	SENT_9	[p1l531t3719r675b3756],
71	,	,	O	,	_	0	SENT_9	[p1l531t3719r675b3756],
72	Department	NNP	ORGANIZATION	Department	appos	58	SENT_9	[p1l695t3719r916b3758],
73	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l931t3718r971b3758],
74	Medicine	NNP	ORGANIZATION	Medicine	prep_of	72	SENT_9	[p1l982t3718r1158b3756],
75	,	,	O	,	_	0	SENT_9	[p1l982t3718r1158b3756],
76	Baylor	NNP	ORGANIZATION	Baylor	nn	77	SENT_9	[p1l1178t3718r1295b3758],
77	College	NNP	ORGANIZATION	College	dep	86	SENT_9	[p1l1311t3718r1445b3758],
78	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1461t3718r1501b3758],
79	Medicine	NNP	ORGANIZATION	Medicine	nn	83	SENT_9	[p1l1512t3718r1688b3756],
80	,	,	O	,	_	0	SENT_9	[p1l1512t3718r1688b3756],
81	Houston	NNP	LOCATION	Houston	appos	83	SENT_9	[p1l1708t3719r1867b3756],
82	,	,	O	,	_	0	SENT_9	[p1l1708t3719r1867b3756],
83	TX	NNP	LOCATION	TX	prep_of	77	SENT_9	[p1l99t3769r153b3806],
84	,	,	O	,	_	0	SENT_9	[p1l99t3769r153b3806],
85	United	NNP	LOCATION	United	nn	86	SENT_9	[p1l175t3768r297b3800],
86	States	NNPS	LOCATION	States	_	0	SENT_9	[p1l312t3768r425b3800],

1	Received	VBN	O	receive	_	0	SENT_10	[p2l99t68r243b97],
2	17	CD	DATE	17	dobj	1	SENT_10	[p2l261t68r296b96],
3	December	NNP	DATE	December	tmod	1	SENT_10	[p2l311t68r476b97],
4	2005	CD	DATE	2005	num	3	SENT_10	[p2l489t68r576b103],
5	;	:	O	;	_	0	SENT_10	[p2l489t68r576b103],
6	received	VBN	O	receive	parataxis	1	SENT_10	[p2l595t68r733b97],
7	in	IN	O	in	_	0	SENT_10	[p2l749t69r776b96],
8	revised	JJ	O	revised	amod	9	SENT_10	[p2l793t68r908b97],
9	form	NN	O	form	prep_in	6	SENT_10	[p2l923t68r999b97],
10	17	CD	DATE	17	num	9	SENT_10	[p2l1017t69r1052b96],
11	December	NNP	DATE	December	tmod	9	SENT_10	[p2l1067t68r1232b97],
12	2005	CD	DATE	2005	num	11	SENT_10	[p2l1245t68r1332b103],
13	;	:	O	;	_	0	SENT_10	[p2l1245t68r1332b103],
14	accepted	VBN	O	accept	parataxis	1	SENT_10	[p2l1349t68r1498b104],
15	15	CD	DATE	15	dobj	14	SENT_10	[p2l1517t69r1550b97],
16	February	NNP	DATE	February	tmod	15	SENT_10	[p2l1567t68r1711b104],
17	2006	CD	DATE	2006	num	16	SENT_10	[p2l1725t68r1801b97],
18	Available	JJ	O	available	amod	15	SENT_10	[p2l96t114r245b142],
19	online	NN	O	online	prep	15	SENT_10	[p2l260t114r360b142],
20	6	CD	DATE	6	dep	19	SENT_10	[p2l375t114r391b142],
21	March	NNP	DATE	March	tmod	14	SENT_10	[p2l405t114r502b142],
22	2006	CD	DATE	2006	num	21	SENT_10	[p2l517t114r593b142],

1	KEYWORDS	NNS	O	keyword	dep	10	SENT_11	[p2l119t259r327b291],
2	Abstract	JJ	O	abstract	amod	3	SENT_11	[p2l669t262r812b291],
3	Platelets	NNS	O	platelet	dep	1	SENT_11	[p2l119t307r273b342],
4	;	:	O	;	_	0	SENT_11	[p2l119t307r273b342],
5	Polymorphism	NN	O	polymorphism	dep	1	SENT_11	[p2l119t352r356b388],
6	;	:	O	;	_	0	SENT_11	[p2l119t352r356b388],
7	Introduction	NN	O	introduction	dep	5	SENT_11	[p2l670t352r886b381],
8	:	:	O	:	_	0	SENT_11	[p2l670t352r886b381],
9	There	EX	O	there	expl	10	SENT_11	[p2l907t352r1002b381],
10	is	VBZ	O	be	_	0	SENT_11	[p2l1022t353r1045b381],
11	wide	JJ	O	wide	amod	12	SENT_11	[p2l1064t352r1142b381],
12	variability	NN	O	variability	nsubj	10	SENT_11	[p2l1161t352r1328b388],
13	in	IN	O	in	_	0	SENT_11	[p2l1347t353r1375b380],
14	the	DT	O	the	det	15	SENT_11	[p2l1396t352r1449b381],
15	responses	NNS	O	response	prep_in	12	SENT_11	[p2l1470t360r1627b388],
16	of	IN	O	of	_	0	SENT_11	[p2l1646t352r1679b381],
17	individual	JJ	O	individual	amod	18	SENT_11	[p2l1698t352r1857b381],
18	patients	NNS	O	patient	prep_of	15	SENT_11	[p2l1878t353r2011b388],
19	to	TO	O	to	_	0	SENT_11	[p2l2030t355r2063b381],
20	Aspirin	NNP	O	Aspirin	prep_to	18	SENT_11	[p2l116t397r239b433],
21	;	:	O	;	_	0	SENT_11	[p2l116t397r239b433],
22	aspirin	NN	O	aspirin	dep	12	SENT_11	[p2l670t398r777b433],
23	and	CC	O	and	_	0	SENT_11	[p2l801t397r858b426],
24	clopidogrel	NN	O	clopidogrel	dep	12	SENT_11	[p2l881t397r1074b433],
25	.	.	O	.	_	0	SENT_11	[p2l881t397r1074b433],

1	Polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_12	[p2l1101t397r1342b433],
2	of	IN	O	of	_	0	SENT_12	[p2l1364t397r1397b426],
3	several	JJ	O	several	amod	5	SENT_12	[p2l1418t397r1533b426],
4	platelet	NN	O	platelet	nn	5	SENT_12	[p2l1557t397r1686b433],
5	receptors	NNS	O	receptor	prep_of	1	SENT_12	[p2l1709t400r1864b433],
6	have	VBP	O	have	aux	8	SENT_12	[p2l1886t397r1962b426],
7	been	VBN	O	be	cop	8	SENT_12	[p2l1985t397r2062b426],
8	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_12	[p2l118t442r304b478],
9	related	JJ	O	related	amod	8	SENT_12	[p2l671t442r787b471],
10	to	TO	O	to	_	0	SENT_12	[p2l802t445r835b471],
11	increased	VBN	O	increase	amod	13	SENT_12	[p2l848t442r1004b471],
12	platelet	NN	O	platelet	nn	13	SENT_12	[p2l1020t442r1149b478],
13	aggregation	NN	O	aggregation	prep_to	9	SENT_12	[p2l1162t443r1365b478],
14	.	.	O	.	_	0	SENT_12	[p2l1162t443r1365b478],

1	We	PRP	O	we	nsubj	3	SENT_13	[p2l1381t443r1430b471],
2	therefore	RB	O	therefore	advmod	3	SENT_13	[p2l1444t442r1599b471],
3	aimed	VBD	O	aim	_	0	SENT_13	[p2l1613t442r1711b471],
4	to	TO	O	to	aux	5	SENT_13	[p2l1726t445r1759b471],
5	evaluate	VB	O	evaluate	xcomp	3	SENT_13	[p2l1772t442r1913b471],
6	whether	IN	O	whether	complm	10	SENT_13	[p2l1926t442r2064b471],
7	these	DT	O	these	det	8	SENT_13	[p2l670t487r758b516],
8	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_13	[p2l774t487r1017b523],
9	are	VBP	O	be	cop	10	SENT_13	[p2l1032t495r1084b516],
10	related	JJ	O	related	ccomp	5	SENT_13	[p2l1099t487r1215b516],
11	to	TO	O	to	_	0	SENT_13	[p2l1231t490r1264b516],
12	altered	JJ	O	altered	amod	13	SENT_13	[p2l1279t487r1396b516],
13	response	NN	O	response	prep_to	10	SENT_13	[p2l1413t495r1554b523],
14	to	TO	O	to	_	0	SENT_13	[p2l1569t490r1602b516],
15	aspirin	NN	O	aspirin	prep_to	10	SENT_13	[p2l1616t488r1723b523],
16	or	CC	O	or	_	0	SENT_13	[p2l1739t495r1772b516],
17	clopidogrel	NN	O	clopidogrel	prep_to	10	SENT_13	[p2l1785t487r1978b523],
18	.	.	O	.	_	0	SENT_13	[p2l1785t487r1978b523],

1	Materials	NNPS	O	Materials	_	0	SENT_14	[p2l669t532r829b561],
2	and	CC	O	and	_	0	SENT_14	[p2l854t532r916b561],
3	methods	NNS	O	method	conj_and	1	SENT_14	[p2l940t532r1096b561],
4	:	:	O	:	_	0	SENT_14	[p2l940t532r1096b561],
5	Patients	NNS	O	patient	dep	1	SENT_14	[p2l1125t533r1260b561],
6	(	VBP	O	(	rcmod	5	SENT_14	[p2l1288t533r1422b568],
7	n	NN	O	n	nsubj	11	SENT_14	[p2l1288t533r1422b568],
8	=	JJ	O	=	amod	7	SENT_14	[p2l1288t533r1422b568],
9	120	CD	NUMBER	120	number	10	SENT_14	[p2l1288t533r1422b568],
10	)	CD	NUMBER	)	dep	8	SENT_14	[p2l1288t533r1422b568],
11	undergoing	VBG	O	undergo	dep	6	SENT_14	[p2l1451t532r1636b568],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_14	[p2l1664t535r1890b568],
13	coronary	JJ	O	coronary	amod	14	SENT_14	[p2l1916t540r2064b568],
14	intervention	NN	O	intervention	dobj	11	SENT_14	[p2l670t578r871b606],
15	who	WP	O	who	nsubj	16	SENT_14	[p2l888t578r955b607],
16	received	VBD	O	receive	rcmod	14	SENT_14	[p2l973t578r1111b606],
17	aspirin	NN	O	aspirin	nsubjpass	24	SENT_14	[p2l1129t578r1236b614],
18	for	IN	O	for	_	0	SENT_14	[p2l1254t578r1301b606],
19	21week	NN	O	21week	prep_for	17	SENT_14	[p2l1317t578r1458b607],
20	but	CC	O	but	_	0	SENT_14	[p2l1475t578r1527b607],
21	not	RB	O	not	_	0	SENT_14	[p2l1545t581r1597b606],
22	clopidogrel	NN	O	clopidogrel	prep_for	17	SENT_14	[p2l1613t578r1795b614],
23	were	VBD	O	be	auxpass	24	SENT_14	[p2l1812t586r1893b607],
24	included	VBN	O	include	ccomp	16	SENT_14	[p2l1910t578r2059b606],
25	.	.	O	.	_	0	SENT_14	[p2l1910t578r2059b606],

1	Blood	NN	O	blood	nn	2	SENT_15	[p2l671t623r759b652],
2	samples	NNS	O	sample	nsubjpass	4	SENT_15	[p2l773t623r903b659],
3	were	VBD	O	be	auxpass	4	SENT_15	[p2l914t631r996b652],
4	drawn	VBN	O	draw	_	0	SENT_15	[p2l1008t623r1107b652],
5	at	IN	O	at	_	0	SENT_15	[p2l1122t626r1154b652],
6	baseline	NN	O	baseline	prep_at	4	SENT_15	[p2l1167t623r1301b652],
7	and	CC	O	and	_	0	SENT_15	[p2l1314t623r1371b652],
8	20	CD	NUMBER	20	number	9	SENT_15	[p2l1385t623r1511b652],
9	—	CD	NUMBER	—	num	10	SENT_15	[p2l1385t623r1511b652],
10	24h	NN	O	24h	prep_at	4	SENT_15	[p2l1385t623r1511b652],
11	after	IN	O	after	_	0	SENT_15	[p2l1525t623r1606b652],
12	a	DT	O	a	det	15	SENT_15	[p2l1618t631r1635b652],
13	300-mg	JJ	O	300-mg	amod	15	SENT_15	[p2l1649t623r1767b659],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_15	[p2l1780t623r1963b659],
15	dose	NN	O	dose	prep_after	4	SENT_15	[p2l1976t623r2059b652],
16	.	.	O	.	_	0	SENT_15	[p2l1976t623r2059b652],

1	Aspirin	NN	O	aspirin	nn	2	SENT_16	[p2l669t668r780b704],
2	insensitivity	NN	O	insensitivity	nsubjpass	4	SENT_16	[p2l794t669r991b704],
3	was	VBD	O	be	auxpass	4	SENT_16	[p2l1002t676r1063b697],
4	defined	VBN	O	define	_	0	SENT_16	[p2l1076t668r1199b697],
5	as	IN	O	as	_	0	SENT_16	[p2l1213t676r1245b697],
6	5uM	NN	O	5um	nn	8	SENT_16	[p2l1259t669r1326b704],
7	ADP-induced	JJ	O	adp-induced	amod	8	SENT_16	[p2l1337t668r1544b697],
8	aggregation	NN	O	aggregation	prep_as	4	SENT_16	[p2l1558t669r1750b704],
9	270	CD	PERCENT	270	num	10	SENT_16	[p2l1765t668r1856b697],
10	%	NN	PERCENT	%	dep	8	SENT_16	[p2l1765t668r1856b697],
11	and	CC	O	and	_	0	SENT_16	[p2l1869t668r1926b697],
12	0.5	CD	NUMBER	0.5	num	13	SENT_16	[p2l1940t668r2060b704],
13	mg	NN	O	mg	prep_as	4	SENT_16	[p2l1940t668r2060b704],
14	/	:	O	/	punct	18	SENT_16	[p2l1940t668r2060b704],
15	mL	NN	O	ml	nn	18	SENT_16	[p2l671t715r719b742],
16	arachidonic	JJ	O	arachidonic	amod	18	SENT_16	[p2l744t714r937b742],
17	acid-induced	JJ	O	acid-induced	amod	18	SENT_16	[p2l964t714r1177b742],
18	aggregation	NN	O	aggregation	dep	13	SENT_16	[p2l1205t714r1400b750],
19	220	CD	PERCENT	220	num	20	SENT_16	[p2l1428t714r1530b743],
20	%	NN	PERCENT	%	dep	18	SENT_16	[p2l1428t714r1530b743],
21	.	.	O	.	_	0	SENT_16	[p2l1428t714r1530b743],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_17	[p2l1560t714r1749b750],
2	insensitivity	NN	O	insensitivity	nsubjpass	4	SENT_17	[p2l1776t714r1977b750],
3	was	VBD	O	be	auxpass	4	SENT_17	[p2l2002t722r2063b743],
4	defined	VBN	O	define	_	0	SENT_17	[p2l670t759r793b788],
5	as	IN	O	as	_	0	SENT_17	[p2l812t767r845b788],
6	baseline	NN	O	baseline	prep_as	4	SENT_17	[p2l863t759r997b788],
7	minus	CC	O	minus	prep	6	SENT_17	[p2l1016t760r1110b788],
8	post-treatment	JJ	O	post-treatment	amod	9	SENT_17	[p2l1129t762r1379b795],
9	aggregation	NN	O	aggregation	dep	7	SENT_17	[p2l1397t760r1589b795],
10	510	CD	PERCENT	510	num	11	SENT_17	[p2l1607t759r1693b788],
11	%	NN	PERCENT	%	npadvmod	4	SENT_17	[p2l1607t759r1693b788],
12	in	IN	O	in	_	0	SENT_17	[p2l1711t760r1738b787],
13	response	NN	O	response	prep_in	4	SENT_17	[p2l1759t767r1900b795],
14	to	TO	O	to	_	0	SENT_17	[p2l1919t762r1951b788],
15	5	CD	NUMBER	5	prep_to	4	SENT_17	[p2l1970t760r1986b788],
16	and	CC	O	and	_	0	SENT_17	[p2l2005t759r2062b788],
17	20uM	NN	O	20um	nn	18	SENT_17	[p2l670t804r758b840],
18	ADP	NN	O	adp	conj_and	15	SENT_17	[p2l770t804r837b833],
19	.	.	O	.	_	0	SENT_17	[p2l770t804r837b833],

1	PlA	NN	O	plum	nn	2	SENT_18	[p2l856t804r907b833],
2	polymorphism	NN	O	polymorphism	nsubjpass	24	SENT_18	[p2l921t804r1149b840],
3	of	IN	O	of	_	0	SENT_18	[p2l1164t804r1197b833],
4	glycoprotein	NN	O	glycoprotein	nn	5	SENT_18	[p2l1210t804r1413b840],
5	Illa	NN	PERSON	illum	prep_of	2	SENT_18	[p2l1430t805r1486b839],
6	,	,	O	,	_	0	SENT_18	[p2l1430t805r1486b839],
7	T744C	NN	O	t744c	nn	8	SENT_18	[p2l1503t804r1603b833],
8	polymorphism	NN	O	polymorphism	prep_of	2	SENT_18	[p2l1619t804r1846b840],
9	of	IN	O	of	_	0	SENT_18	[p2l1861t804r1894b833],
10	the	DT	O	the	det	12	SENT_18	[p2l1907t804r1960b833],
11	P2Y12	NN	O	p2y12	nn	12	SENT_18	[p2l1976t804r2063b839],
12	gene	NN	O	gene	prep_of	8	SENT_18	[p2l670t857r748b886],
13	and	CC	O	and	_	0	SENT_18	[p2l774t850r832b878],
14	the	DT	O	the	det	15	SENT_18	[p2l859t850r913b878],
15	1622A	NN	O	1622a	conj_and	5	SENT_18	[p2l941t850r1091b879],
16	>	JJR	O	>	amod	18	SENT_18	[p2l941t850r1091b879],
17	G	NN	O	g	nn	18	SENT_18	[p2l941t850r1091b879],
18	polymorphism	NN	O	polymorphism	dep	15	SENT_18	[p2l1120t850r1349b886],
19	of	IN	O	of	_	0	SENT_18	[p2l1376t850r1409b878],
20	the	DT	O	the	det	22	SENT_18	[p2l1435t850r1488b878],
21	P2Y1	NN	O	p2y1	nn	22	SENT_18	[p2l1516t850r1585b884],
22	gene	NN	O	gene	prep_of	18	SENT_18	[p2l1615t857r1693b886],
23	were	VBD	O	be	auxpass	24	SENT_18	[p2l1718t858r1800b879],
24	genotyped	VBN	O	genotype	_	0	SENT_18	[p2l1826t850r1998b886],
25	by	IN	O	by	_	0	SENT_18	[p2l2027t850r2064b886],
26	polymerase	NN	O	polymerase	nn	28	SENT_18	[p2l671t895r857b931],
27	chain	NN	O	chain	nn	28	SENT_18	[p2l872t895r958b924],
28	reaction	NN	O	reaction	agent	24	SENT_18	[p2l975t896r1119b924],
29	.	.	O	.	_	0	SENT_18	[p2l975t896r1119b924],

1	Results	NNS	O	result	_	0	SENT_19	[p2l670t940r798b969],
2	:	:	O	:	_	0	SENT_19	[p2l670t940r798b969],
3	There	EX	O	there	expl	4	SENT_19	[p2l820t940r916b969],
4	were	VBD	O	be	dep	1	SENT_19	[p2l936t948r1017b969],
5	no	DT	O	no	det	6	SENT_19	[p2l1039t948r1076b969],
6	differences	NNS	O	difference	nsubj	4	SENT_19	[p2l1097t940r1282b969],
7	in	IN	O	in	_	0	SENT_19	[p2l1303t941r1330b968],
8	polymorphism	NN	O	polymorphism	nn	9	SENT_19	[p2l1353t940r1580b976],
9	frequencies	NNS	O	frequency	prep_in	6	SENT_19	[p2l1602t940r1794b976],
10	between	IN	O	between	_	0	SENT_19	[p2l1816t940r1955b969],
11	druginsensitive	JJ	O	druginsensitive	prep_between	9	SENT_19	[p2l1977t940r2061b976, p2l670t985r843b1014],
12	vs.	CC	O	vs.	prep	11	SENT_19	[p2l856t993r898b1013],
13	drug-sensitive	JJ	O	drug-sensitive	amod	14	SENT_19	[p2l916t985r1145b1021],
14	patients	NNS	O	patient	dep	12	SENT_19	[p2l1161t985r1303b1021],
15	.	.	O	.	_	0	SENT_19	[p2l1161t985r1303b1021],

1	There	EX	O	there	expl	2	SENT_20	[p2l1319t985r1415b1013],
2	were	VBD	O	be	_	0	SENT_20	[p2l1428t993r1509b1014],
3	also	RB	O	also	advmod	2	SENT_20	[p2l1523t985r1586b1013],
4	no	DT	O	no	det	6	SENT_20	[p2l1601t993r1638b1013],
5	significant	JJ	O	significant	amod	6	SENT_20	[p2l1652t985r1822b1021],
6	differences	NNS	O	difference	nsubj	2	SENT_20	[p2l1836t985r2020b1013],
7	in	IN	O	in	prep	2	SENT_20	[p2l2034t985r2062b1013],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_21	[p2l146t1113r359b1139],
2	:	:	O	:	_	0	SENT_21	[p2l146t1113r359b1139],
3	PCI	NN	O	pcus	dep	1	SENT_21	[p2l375t1113r428b1144],
4	,	,	O	,	_	0	SENT_21	[p2l375t1113r428b1144],
5	percutaneous	JJ	O	percutaneous	amod	7	SENT_21	[p2l443t1115r638b1145],
6	coronary	JJ	O	coronary	amod	7	SENT_21	[p2l648t1120r776b1145],
7	intervention	NN	O	intervention	appos	3	SENT_21	[p2l786t1113r975b1144],
8	;	:	O	;	_	0	SENT_21	[p2l786t1113r975b1144],
9	GP	NN	O	gp	dep	3	SENT_21	[p2l988t1113r1030b1144],
10	,	,	O	,	_	0	SENT_21	[p2l988t1113r1030b1144],
11	glycoprotein	NN	O	glycoprotein	appos	9	SENT_21	[p2l1043t1113r1234b1145],
12	;	:	O	;	_	0	SENT_21	[p2l1043t1113r1234b1145],
13	AA	NNP	O	AA	dep	3	SENT_21	[p2l1246t1113r1294b1144],
14	,	,	O	,	_	0	SENT_21	[p2l1246t1113r1294b1144],
15	arachidonic	JJ	O	arachidonic	amod	16	SENT_21	[p2l1307t1113r1476b1138],
16	acid	NN	O	acid	appos	13	SENT_21	[p2l1486t1113r1555b1144],
17	;	:	O	;	_	0	SENT_21	[p2l1486t1113r1555b1144],
18	MFI	NNP	ORGANIZATION	MFI	nsubj	20	SENT_21	[p2l1567t1113r1626b1144],
19	,	,	O	,	_	0	SENT_21	[p2l1567t1113r1626b1144],
20	mean	VB	O	mean	dep	3	SENT_21	[p2l1640t1120r1717b1138],
21	fluorescence	NN	O	fluorescence	nn	22	SENT_21	[p2l1728t1113r1914b1138],
22	intensity	NN	O	intensity	dobj	20	SENT_21	[p2l1925t1113r2060b1145],
23	;	:	O	;	_	0	SENT_21	[p2l1925t1113r2060b1145],

1	ADP	NN	O	adp	_	0	SENT_22	[p2l96t1154r156b1185],
2	,	,	O	,	_	0	SENT_22	[p2l96t1154r156b1185],
3	adenosine	NN	LOCATION	adenosine	nn	4	SENT_22	[p2l172t1154r317b1180],
4	diphosphate	NN	O	diphosphate	appos	1	SENT_22	[p2l330t1154r516b1186],
5	.	.	O	.	_	0	SENT_22	[p2l330t1154r516b1186],

1	*	NN	O	*	_	0	SENT_23	[p2l126t1196r136b1206],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_23	[p2l147t1195r355b1227],
3	author	NN	O	author	dobj	2	SENT_23	[p2l368t1195r467b1221],
4	.	.	O	.	_	0	SENT_23	[p2l368t1195r467b1221],

1	Tel.	NNP	O	Tel.	_	0	SENT_24	[p2l482t1195r545b1221],
2	:	:	O	:	_	0	SENT_24	[p2l482t1195r545b1221],
3	+1	CD	NUMBER	+1	number	4	SENT_24	[p2l562t1196r589b1220],
4	713 7904952	CD	NUMBER	713 7904952	dep	1	SENT_24	[p2l669t1195r798b1226],[p2l607t1195r655b1221],
5	;	:	O	;	_	0	SENT_24	[p2l669t1195r798b1226],
6	fax	NN	O	fax	dep	4	SENT_24	[p2l813t1195r866b1221],
7	:	:	O	:	_	0	SENT_24	[p2l813t1195r866b1221],
8	+1	CD	NUMBER	+1	number	9	SENT_24	[p2l883t1196r910b1220],
9	713 7931352	CD	NUMBER	713 7931352	dep	6	SENT_24	[p2l991t1195r1119b1221],[p2l928t1195r977b1220],
10	.	.	O	.	_	0	SENT_24	[p2l991t1195r1119b1221],

1	E-mail	NN	O	e-mail	nn	2	SENT_25	[p2l147t1236r240b1262],
2	addresses	NNS	O	address	_	0	SENT_25	[p2l252t1236r403b1262],
3	:	:	O	:	_	0	SENT_25	[p2l252t1236r403b1262],
4	elev@tmh.tmc.edu	NNS	O	elev@tmh.tmc.edu	dep	2	SENT_25	[p2l419t1236r697b1263],
5	(	CD	NUMBER	(	num	7	SENT_25	[p2l713t1237r769b1268],
6	E.	NNP	O	E.	nn	7	SENT_25	[p2l713t1237r769b1268],
7	|	NNP	O	|	dep	4	SENT_25	[p2l713t1237r769b1268],
8	.	.	O	.	_	0	SENT_25	[p2l713t1237r769b1268],

1	Lev	NN	MISC	lev	nn	2	SENT_26	[p2l786t1237r853b1268],
2	)	NN	O	)	_	0	SENT_26	[p2l786t1237r853b1268],
3	,	,	O	,	_	0	SENT_26	[p2l786t1237r853b1268],
4	patel@bcm.tmc.edu	NN	O	patel@bcm.tmc.edu	appos	2	SENT_26	[p2l868t1236r1162b1268],
5	(	CD	NUMBER	(	num	4	SENT_26	[p2l1178t1237r1240b1268],
6	R.	NNP	O	R.	poss	8	SENT_26	[p2l1178t1237r1240b1268],
7	'	POS	O	'	_	0	SENT_26	[p2l1178t1237r1240b1268],
8	l'	NN	O	l'	dep	4	SENT_26	[p2l1178t1237r1240b1268],
9	.	.	O	.	_	0	SENT_26	[p2l1178t1237r1240b1268],

1	Patel	NNP	PERSON	Patel	nn	2	SENT_27	[p2l1257t1236r1349b1268],
2	)	NNP	O	)	_	0	SENT_27	[p2l1257t1236r1349b1268],
3	,	,	O	,	_	0	SENT_27	[p2l1257t1236r1349b1268],
4	guthikon@bcm.tmc.edu	FW	O	guthikon@bcm.tmc.edu	nn	8	SENT_27	[p2l1362t1236r1708b1268],
5	(	FW	O	(	nn	8	SENT_27	[p2l1724t1236r1757b1268],
6	S.	FW	PERSON	s.	nn	8	SENT_27	[p2l1724t1236r1757b1268],
7	Guthikonda	FW	PERSON	guthikonda	nn	8	SENT_27	[p2l1773t1236r1959b1268],
8	)	FW	O	)	appos	2	SENT_27	[p2l1773t1236r1959b1268],
9	,	,	O	,	_	0	SENT_27	[p2l1773t1236r1959b1268],

1	dlopez@bcm.tmc.edu	NN	O	dlopez@bcm.tmc.edu	_	0	SENT_28	[p2l97t1278r414b1310],
2	(	CD	NUMBER	(	num	5	SENT_28	[p2l429t1278r467b1310],
3	D.	NNP	PERSON	D.	nn	5	SENT_28	[p2l429t1278r467b1310],
4	Lopez	NNP	PERSON	Lopez	nn	5	SENT_28	[p2l484t1279r586b1310],
5	)	NN	O	)	dep	1	SENT_28	[p2l484t1279r586b1310],
6	,	,	O	,	_	0	SENT_28	[p2l484t1279r586b1310],
7	pbray@bcm.tmc.edu	NN	O	pbray@bcm.tmc.edu	appos	5	SENT_28	[p2l601t1278r902b1310],
8	(	CD	NUMBER	(	num	11	SENT_28	[p2l917t1278r970b1310],
9	P.F.	NNP	PERSON	P.F.	nn	11	SENT_28	[p2l917t1278r970b1310],
10	Bray	NNP	PERSON	Bray	nn	11	SENT_28	[p2l987t1278r1069b1310],
11	)	NN	O	)	dep	1	SENT_28	[p2l987t1278r1069b1310],
12	,	,	O	,	_	0	SENT_28	[p2l987t1278r1069b1310],
13	nkleiman@bcm.tmc.edu	NN	O	nkleiman@bcm.tmc.edu	appos	11	SENT_28	[p2l1083t1278r1436b1305],
14	(	CD	NUMBER	(	num	13	SENT_28	[p2l1451t1278r1518b1310],
15	N.S.	NNP	PERSON	N.S.	nn	16	SENT_28	[p2l1451t1278r1518b1310],
16	Kleiman	NNP	PERSON	Kleiman	dep	1	SENT_28	[p2l1535t1278r1671b1310],
17	)	NN	O	)	dep	16	SENT_28	[p2l1535t1278r1671b1310],
18	.	.	O	.	_	0	SENT_28	[p2l1535t1278r1671b1310],

1	0049-3848	CD	DURATION	0049-3848	nsubj	5	SENT_29	[p2l97t1352r260b1377],
2	/	:	O	/	punct	3	SENT_29	[p2l97t1352r260b1377],
3	S	NN	O	s	dep	1	SENT_29	[p2l265t1350r279b1381],
4	-	:	O	-	_	0	SENT_29	[p2l294t1365r302b1369],
5	see	VB	O	see	_	0	SENT_29	[p2l316t1359r363b1377],
6	front	JJ	O	front	amod	7	SENT_29	[p2l376t1352r448b1377],
7	matter	NN	O	matter	dobj	5	SENT_29	[p2l461t1354r561b1377],
8	©	CD	NUMBER	©	num	11	SENT_29	[p2l573t1354r596b1378],
9	2006	CD	DATE	2006	num	11	SENT_29	[p2l609t1352r676b1378],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_29	[p2l690t1352r803b1377],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_29	[p2l816t1352r870b1377],
12	.	.	O	.	_	0	SENT_29	[p2l816t1352r870b1377],

1	All	DT	O	all	det	2	SENT_30	[p2l885t1352r922b1377],
2	rights	NNS	O	rights	nsubj	3	SENT_30	[p2l936t1352r1017b1384],
3	reserved	VBN	O	reserve	_	0	SENT_30	[p2l1030t1352r1164b1377],
4	.	.	O	.	_	0	SENT_30	[p2l1030t1352r1164b1377],

1	doi	FW	O	doi	nsubj	5	SENT_31	[p2l97t1393r633b1425],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_31	[p2l97t1393r633b1425],
3	/	:	O	/	punct	4	SENT_31	[p2l97t1393r633b1425],
4	j.	NN	O	j.	dep	1	SENT_31	[p2l97t1393r633b1425],
5	thromres	VBZ	O	thromre	_	0	SENT_31	[p2l97t1393r633b1425],
6	.2006.02.006	CD	NUMBER	.2006.02.006	number	7	SENT_31	[p2l97t1393r633b1425],
7	356	CD	NUMBER	356	dobj	5	SENT_31	[p2l99t1444r160b1476],
8	E.	NNP	O	E.	nn	9	SENT_31	[p2l1810t1445r1866b1476],
9	|	NNP	O	|	dep	7	SENT_31	[p2l1810t1445r1866b1476],
10	.	.	O	.	_	0	SENT_31	[p2l1810t1445r1866b1476],

1	Lev	NNP	O	Lev	_	0	SENT_32	[p2l1888t1445r1948b1476],
2	et	FW	O	et	nn	3	SENT_32	[p2l1963t1447r2000b1476],
3	al.	FW	O	al.	dep	1	SENT_32	[p2l2017t1444r2059b1476],
4	.	.	O	.	_	0	SENT_32	[p2l2017t1444r2059b1476],

1	response	NN	O	response	nsubj	22	SENT_33	[p2l672t1568r815b1596],
2	to	TO	O	to	_	0	SENT_33	[p2l841t1563r874b1589],
3	aspirin	NN	O	aspirin	nn	4	SENT_33	[p2l900t1561r1009b1596],
4	(	NN	O	(	prep_to	1	SENT_33	[p2l1038t1560r1188b1596],
5	assessed	VBN	O	assess	partmod	4	SENT_33	[p2l1038t1560r1188b1596],
6	by	IN	O	by	_	0	SENT_33	[p2l1216t1560r1253b1596],
7	arachidonic	JJ	O	arachidonic	amod	10	SENT_33	[p2l1279t1560r1470b1589],
8	acid-induced	JJ	O	acid-induced	amod	10	SENT_33	[p2l1497t1560r1709b1589],
9	aggregation	NN	O	aggregation	nn	10	SENT_33	[p2l1737t1561r1944b1596],
10	)	NN	O	)	agent	5	SENT_33	[p2l1737t1561r1944b1596],
11	or	CC	O	or	_	0	SENT_33	[p2l1971t1568r2005b1589],
12	to	TO	O	to	_	0	SENT_33	[p2l2030t1563r2063b1589],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_33	[p2l670t1606r853b1642],
14	(	NN	O	(	conj_or	4	SENT_33	[p2l880t1606r1027b1642],
15	assessed	VBN	O	assess	partmod	14	SENT_33	[p2l880t1606r1027b1642],
16	by	IN	O	by	_	0	SENT_33	[p2l1054t1606r1091b1642],
17	ADP-induced	JJ	O	adp-induced	amod	18	SENT_33	[p2l1113t1606r1320b1634],
18	aggregation	NN	O	aggregation	agent	15	SENT_33	[p2l1346t1606r1538b1642],
19	or	CC	O	or	_	0	SENT_33	[p2l1563t1614r1596b1634],
20	activation	NN	O	activation	nn	21	SENT_33	[p2l1620t1606r1783b1634],
21	markers	NNS	O	marker	conj_or	18	SENT_33	[p2l1809t1606r1951b1642],
22	)	VBP	O	)	_	0	SENT_33	[p2l1809t1606r1951b1642],
23	when	WRB	O	when	advmod	26	SENT_33	[p2l1976t1606r2062b1635],
24	patients	NNS	O	patient	nsubjpass	26	SENT_33	[p2l671t1651r804b1687],
25	were	VBD	O	be	auxpass	26	SENT_33	[p2l819t1658r900b1680],
26	grouped	VBN	O	group	advcl	22	SENT_33	[p2l917t1651r1048b1687],
27	according	VBG	O	accord	_	0	SENT_33	[p2l1065t1651r1223b1687],
28	to	TO	O	to	prepc_according_to	26	SENT_33	[p2l1240t1654r1272b1679],
29	genotype	NN	O	genotype	pobj	26	SENT_33	[p2l1289t1654r1449b1687],
30	.	.	O	.	_	0	SENT_33	[p2l1289t1654r1449b1687],

1	The	DT	O	the	det	3	SENT_34	[p2l1468t1651r1529b1679],
2	only	JJ	O	only	amod	3	SENT_34	[p2l1545t1651r1613b1687],
3	trend	NN	O	trend	nsubj	7	SENT_34	[p2l1629t1651r1716b1679],
4	observed	VBN	O	observe	partmod	3	SENT_34	[p2l1733t1651r1879b1680],
5	was	VBD	O	be	cop	7	SENT_34	[p2l1895t1658r1956b1679],
6	lower	JJR	O	lower	amod	7	SENT_34	[p2l1973t1651r2064b1680],
7	reduction	NN	O	reduction	dep	16	SENT_34	[p2l672t1696r826b1725],
8	in	IN	O	in	_	0	SENT_34	[p2l842t1697r870b1725],
9	PAC-1	NN	O	pac-1	nn	10	SENT_34	[p2l887t1697r971b1725],
10	binding	NN	O	binding	prep_in	7	SENT_34	[p2l992t1696r1111b1732],
11	following	VBG	O	follow	_	0	SENT_34	[p2l1125t1696r1275b1732],
12	clopidogrel	NN	O	clopidogrel	prep_following	10	SENT_34	[p2l1290t1696r1472b1732],
13	in	IN	O	in	_	0	SENT_34	[p2l1487t1697r1515b1725],
14	PlA2	NN	O	pla2	nn	15	SENT_34	[p2l1532t1696r1596b1731],
15	carriers	NNS	O	carrier	prep_in	12	SENT_34	[p2l1611t1697r1735b1725],
16	(	VBP	O	(	_	0	SENT_34	[p2l1752t1696r1933b1732],
17	P	NN	O	p	nsubj	18	SENT_34	[p2l1752t1696r1933b1732],
18	=	JJ	O	=	xcomp	16	SENT_34	[p2l1752t1696r1933b1732],
19	0.065	CD	NUMBER	0.065	num	20	SENT_34	[p2l1752t1696r1933b1732],
20	)	NN	O	)	nsubj	16	SENT_34	[p2l1752t1696r1933b1732],
21	.	.	O	.	_	0	SENT_34	[p2l1752t1696r1933b1732],

1	Conclusions	NNS	O	conclusion	_	0	SENT_35	[p2l672t1742r873b1771],
2	:	:	O	:	_	0	SENT_35	[p2l672t1742r873b1771],
3	We	PRP	O	we	nsubj	6	SENT_35	[p2l888t1743r937b1771],
4	did	VBD	O	do	aux	6	SENT_35	[p2l952t1742r1000b1770],
5	not	RB	O	not	neg	6	SENT_35	[p2l1017t1744r1069b1770],
6	find	VB	O	find	dep	1	SENT_35	[p2l1083t1742r1145b1770],
7	an	DT	O	a	det	8	SENT_35	[p2l1161t1750r1197b1770],
8	association	NN	O	association	dobj	6	SENT_35	[p2l1213t1742r1392b1770],
9	between	IN	O	between	_	0	SENT_35	[p2l1408t1742r1548b1771],
10	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_35	[p2l1565t1742r1808b1778],
11	in	IN	O	in	_	0	SENT_35	[p2l1823t1742r1850b1770],
12	the	DT	O	the	det	16	SENT_35	[p2l1866t1742r1919b1770],
13	platelet	NN	O	platelet	nn	16	SENT_35	[p2l1934t1742r2063b1778],
14	receptors	NNS	O	receptor	nn	16	SENT_35	[p2l672t1790r826b1823],
15	GP	NN	O	gp	nn	16	SENT_35	[p2l844t1787r887b1816],
16	Illa	NN	O	illum	prep_in	10	SENT_35	[p2l907t1788r963b1821],
17	,	,	O	,	_	0	SENT_35	[p2l907t1788r963b1821],
18	P2Y12	NN	O	p2y12	conj_or	16	SENT_35	[p2l986t1787r1073b1822],
19	or	CC	O	or	_	0	SENT_35	[p2l1091t1795r1124b1816],
20	PZY1	NN	O	pzy1	prep_in	10	SENT_35	[p2l1142t1787r1211b1822],
21	and	CC	O	and	_	0	SENT_35	[p2l1233t1787r1290b1816],
22	response	NN	O	response	conj_and	20	SENT_35	[p2l1310t1795r1452b1823],
23	to	TO	O	to	_	0	SENT_35	[p2l1470t1790r1502b1816],
24	aspirin	NN	O	aspirin	prep_to	6	SENT_35	[p2l1520t1788r1627b1823],
25	or	CC	O	or	_	0	SENT_35	[p2l1646t1795r1680b1816],
26	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_35	[p2l1697t1787r1879b1823],
27	in	IN	O	in	_	0	SENT_35	[p2l1898t1788r1925b1815],
28	cardiac	JJ	O	cardiac	amod	29	SENT_35	[p2l1944t1787r2063b1816],
29	patients	NNS	O	patient	prep_in	6	SENT_35	[p2l671t1833r814b1868],
30	.	.	O	.	_	0	SENT_35	[p2l671t1833r814b1868],

1	These	DT	O	these	det	2	SENT_36	[p2l837t1832r933b1861],
2	findings	NNS	O	finding	nsubjpass	17	SENT_36	[p2l953t1832r1081b1868],
3	suggest	VBP	O	suggest	_	0	SENT_36	[p2l1101t1835r1221b1868],
4	that	IN	O	that	complm	13	SENT_36	[p2l1241t1832r1309b1861],
5	the	DT	O	the	det	6	SENT_36	[p2l1329t1832r1382b1861],
6	variability	NN	O	variability	nsubj	13	SENT_36	[p2l1402t1832r1569b1868],
7	in	IN	O	in	_	0	SENT_36	[p2l1589t1833r1616b1861],
8	response	NN	O	response	prep_in	6	SENT_36	[p2l1639t1840r1781b1868],
9	to	TO	O	to	_	0	SENT_36	[p2l1802t1835r1834b1861],
10	anti-platelet	JJ	O	anti-platelet	amod	11	SENT_36	[p2l1855t1832r2063b1868],
11	drugs	NNS	O	drug	prep_to	8	SENT_36	[p2l670t1878r757b1914],
12	is	VBZ	O	be	cop	13	SENT_36	[p2l772t1878r795b1906],
13	multi-factorial	JJ	O	multi-factorial	ccomp	3	SENT_36	[p2l810t1878r1049b1906],
14	and	CC	O	and	_	0	SENT_36	[p2l1064t1878r1121b1906],
15	is	VBZ	O	be	auxpass	17	SENT_36	[p2l1137t1878r1160b1906],
16	not	RB	O	not	neg	17	SENT_36	[p2l1175t1881r1227b1906],
17	caused	VBN	O	cause	conj_and	3	SENT_36	[p2l1241t1878r1352b1906],
18	only	RB	O	only	advmod	17	SENT_36	[p2l1367t1878r1436b1914],
19	by	IN	O	by	_	0	SENT_36	[p2l1450t1878r1487b1914],
20	single	JJ	O	single	amod	22	SENT_36	[p2l1501t1878r1594b1914],
21	gene	NN	O	gene	nn	22	SENT_36	[p2l1609t1885r1686b1914],
22	mutations	NNS	O	mutation	agent	17	SENT_36	[p2l1701t1878r1874b1906],
23	.	.	O	.	_	0	SENT_36	[p2l1701t1878r1874b1906],

1	©	RB	O	©	advmod	2	SENT_37	[p2l670t1925r697b1952],
2	2006	CD	DATE	2006	_	0	SENT_37	[p2l711t1923r786b1952],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_37	[p2l802t1923r929b1952],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_37	[p2l944t1923r1005b1952],
5	.	.	O	.	_	0	SENT_37	[p2l944t1923r1005b1952],

1	All	DT	O	all	det	2	SENT_38	[p2l1022t1923r1064b1952],
2	rights	NNS	O	rights	nsubj	3	SENT_38	[p2l1080t1923r1170b1959],
3	reserved	VBN	O	reserve	_	0	SENT_38	[p2l1186t1923r1336b1952],
4	.	.	O	.	_	0	SENT_38	[p2l1186t1923r1336b1952],

1	Aspirin	NN	O	aspirin	nsubj	7	SENT_39	[p2l7t2166r294b2255],
2	and	CC	O	and	_	0	SENT_39	[p2l364t2165r510b2237],
3	clopidogrel	NN	O	clopidogrel	conj_and	1	SENT_39	[p2l580t2165r1054b2255],
4	have	VBP	O	have	aux	7	SENT_39	[p2l1124t2165r1318b2237],
5	become	VBN	O	become	cop	7	SENT_39	[p2l1388t2165r1714b2237],
6	standard	JJ	O	standard	amod	7	SENT_39	[p2l1781t2165r2146b2237],
7	therapy	NN	O	therapy	_	0	SENT_39	[p2l10t2278r329b2368],
8	in	IN	O	in	_	0	SENT_39	[p2l365t2280r433b2349],
9	patients	NNS	O	patient	prep_in	7	SENT_39	[p2l476t2280r810b2368],
10	undergoing	VBG	O	undergo	partmod	9	SENT_39	[p2l850t2278r1306b2368],
11	percutaneous	JJ	O	percutaneous	amod	13	SENT_39	[p2l1345t2285r1901b2368],
12	coronary	JJ	O	coronary	amod	13	SENT_39	[p2l1938t2297r2144b2349, p2l12t2410r188b2479],
13	intervention	NN	O	intervention	dobj	10	SENT_39	[p2l243t2392r749b2461],
14	with	IN	O	with	_	0	SENT_39	[p2l806t2391r984b2461],
15	stenting	VBG	O	stent	prepc_with	10	SENT_39	[p2l1043t2392r1376b2479],
16	as	RB	O	as	_	0	SENT_39	[p2l1432t2410r1513b2461],
17	well	RB	O	well	_	0	SENT_39	[p2l1566t2391r1737b2461],
18	as	IN	O	as	_	0	SENT_39	[p2l1795t2410r1876b2461],
19	many	JJ	O	many	amod	20	SENT_39	[p2l1933t2410r2151b2479],
20	patients	NNS	O	patient	conj_and	7	SENT_39	[p2l12t2505r346b2593],
21	with	IN	O	with	_	0	SENT_39	[p2l381t2503r559b2575],
22	acute	JJ	O	acute	amod	24	SENT_39	[p2l600t2510r828b2575],
23	coronary	JJ	O	coronary	amod	24	SENT_39	[p2l866t2523r1228b2593],
24	syndromes	NNS	O	syndrome	prep_with	20	SENT_39	[p2l1262t2503r1722b2593],
25	.	.	O	.	_	0	SENT_39	[p2l1262t2503r1722b2593],

1	However	RB	O	however	advmod	4	SENT_40	[p2l1771t2505r2141b2590],
2	,	,	O	,	_	0	SENT_40	[p2l1771t2505r2141b2590],
3	there	EX	O	there	expl	4	SENT_40	[p2l10t2616r253b2686],
4	is	VBZ	O	be	dep	18	SENT_40	[p2l329t2617r393b2686],
5	considerable	JJ	O	considerable	amod	6	SENT_40	[p2l468t2616r1053b2686],
6	heterogeneity	NN	O	heterogeneity	nsubj	4	SENT_40	[p2l1131t2616r1778b2704],
7	in	IN	O	in	_	0	SENT_40	[p2l1852t2617r1926b2685],
8	the	DT	O	the	det	9	SENT_40	[p2l2005t2616r2150b2686],
9	responses	NNS	O	response	prep_in	6	SENT_40	[p2l13t2748r408b2818],
10	of	IN	O	of	_	0	SENT_40	[p2l457t2728r540b2800],
11	individual	JJ	O	individual	amod	12	SENT_40	[p2l586t2728r988b2800],
12	patients	NNS	O	patient	prep_of	9	SENT_40	[p2l1042t2730r1376b2818],
13	to	TO	O	to	_	0	SENT_40	[p2l1425t2735r1507b2800],
14	each	DT	O	each	prep_to	12	SENT_40	[p2l1556t2728r1745b2800],
15	of	IN	O	of	_	0	SENT_40	[p2l1798t2728r1880b2800],
16	these	DT	O	these	det	17	SENT_40	[p2l1927t2728r2149b2800],
17	drugs	NNS	O	drug	prep_of	14	SENT_40	[p2l9t2841r229b2931],
18	[	VBP	O	[	_	0	SENT_40	[p2l288t2841r538b2931],
19	1	CD	NUMBER	1	num	20	SENT_40	[p2l288t2841r538b2931],
20	—	CD	NUMBER	—	dobj	18	SENT_40	[p2l288t2841r538b2931],
21	4	CD	NUMBER	4	num	22	SENT_40	[p2l288t2841r538b2931],
22	]	NN	O	]	nsubj	18	SENT_40	[p2l288t2841r538b2931],
23	.	.	O	.	_	0	SENT_40	[p2l288t2841r538b2931],

1	It	PRP	O	it	nsubjpass	3	SENT_41	[p2l606t2843r658b2912],
2	is	VBZ	O	be	auxpass	3	SENT_41	[p2l712t2843r771b2912],
3	estimated	VBN	O	estimate	dep	10	SENT_41	[p2l824t2841r1235b2912],
4	that	IN	O	that	_	0	SENT_41	[p2l1292t2841r1461b2912],
5	adequate	JJ	O	adequate	amod	7	SENT_41	[p2l1515t2841r1902b2931],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_41	[p2l1957t2843r2144b2912, p2l12t2954r341b3042],
7	effects	NNS	O	effect	prep_that	3	SENT_41	[p2l407t2954r696b3024],
8	are	VBP	O	be	auxpass	10	SENT_41	[p2l762t2973r893b3024],
9	not	RB	O	not	neg	10	SENT_41	[p2l962t2961r1094b3024],
10	achieved	VBN	O	achieve	_	0	SENT_41	[p2l1160t2954r1527b3024],
11	in	IN	O	in	_	0	SENT_41	[p2l1597t2955r1666b3023],
12	5	CD	PERCENT	5	number	13	SENT_41	[p2l1738t2955r2004b3024],
13	—	CD	PERCENT	—	prep_in	10	SENT_41	[p2l1738t2955r2004b3024],
14	45	CD	PERCENT	45	num	15	SENT_41	[p2l1738t2955r2004b3024],
15	%	NN	PERCENT	%	dobj	10	SENT_41	[p2l1738t2955r2004b3024],
16	of	IN	O	of	_	0	SENT_41	[p2l2069t2954r2152b3024],
17	patients	NNS	O	patient	prep_of	15	SENT_41	[p2l12t3068r346b3156],
18	taking	VBG	O	take	partmod	17	SENT_41	[p2l374t3066r626b3156],
19	aspirin	NN	O	aspirin	dobj	18	SENT_41	[p2l655t3068r925b3156],
20	and	CC	O	and	_	0	SENT_41	[p2l956t3066r1099b3138],
21	4	CD	PERCENT	4	number	22	SENT_41	[p2l1129t3067r1397b3138],
22	—	CD	PERCENT	—	conj_and	19	SENT_41	[p2l1129t3067r1397b3138],
23	30	CD	PERCENT	30	number	24	SENT_41	[p2l1129t3067r1397b3138],
24	%	NN	PERCENT	%	amod	22	SENT_41	[p2l1129t3067r1397b3138],
25	of	IN	O	of	_	0	SENT_41	[p2l1425t3066r1508b3138],
26	patients	NNS	O	patient	prep_of	22	SENT_41	[p2l1535t3068r1869b3156],
27	taking	VBG	O	take	xcomp	10	SENT_41	[p2l1897t3066r2149b3156],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_41	[p2l9t3179r469b3269],
29	[	NN	O	[	dobj	27	SENT_41	[p2l504t3179r562b3269],
30	1	CD	NUMBER	1	num	29	SENT_41	[p2l504t3179r562b3269],
31	,3	CD	NUMBER	,3	num	34	SENT_41	[p2l586t3179r838b3269],
32	—	NN	O	—	nn	34	SENT_41	[p2l586t3179r838b3269],
33	6	CD	NUMBER	6	num	34	SENT_41	[p2l586t3179r838b3269],
34	]	NN	O	]	nsubjpass	10	SENT_41	[p2l586t3179r838b3269],
35	.	.	O	.	_	0	SENT_41	[p2l586t3179r838b3269],

1	Several	JJ	O	several	amod	2	SENT_42	[p2l875t3179r1174b3251],
2	mechanisms	NNS	O	mechanism	nsubjpass	5	SENT_42	[p2l1206t3179r1702b3250],
3	have	VBP	O	have	aux	5	SENT_42	[p2l1733t3179r1922b3250],
4	been	VBN	O	be	auxpass	5	SENT_42	[p2l1952t3179r2146b3250],
5	proposed	VBN	O	propose	dep	19	SENT_42	[p2l12t3292r387b3380],
6	for	IN	O	for	_	0	SENT_42	[p2l456t3292r576b3362],
7	this	DT	O	this	det	9	SENT_42	[p2l640t3292r789b3362],
8	wide	JJ	O	wide	amod	9	SENT_42	[p2l853t3292r1051b3362],
9	variability	NN	O	variability	prep_for	5	SENT_42	[p2l1115t3292r1545b3380],
10	in	IN	O	in	_	0	SENT_42	[p2l1609t3293r1679b3361],
11	response	NN	O	response	prep_in	9	SENT_42	[p2l1752t3311r2142b3380],
12	,	,	O	,	_	0	SENT_42	[p2l1752t3311r2142b3380],
13	including	VBG	O	include	_	0	SENT_42	[p2l10t3404r383b3494],
14	polymorphisms	NNS	O	polymorphism	prep_including	9	SENT_42	[p2l418t3404r1033b3494],
15	in	IN	O	in	_	0	SENT_42	[p2l1065t3406r1134b3475],
16	platelet	NN	O	platelet	nn	18	SENT_42	[p2l1173t3404r1497b3494],
17	receptor	NN	O	receptor	nn	18	SENT_42	[p2l1533t3411r1887b3494],
18	genes	NNS	O	gene	prep_in	14	SENT_42	[p2l1917t3422r2149b3494],
19	[	VBP	O	[	_	0	SENT_42	[p2l15t3517r231b3605, p2l126t3629r694b3719],
20	7,8	CD	NUMBER	7,8	dobj	19	SENT_42	[p2l15t3517r231b3605, p2l126t3629r694b3719],
21	]	CD	NUMBER	]	num	22	SENT_42	[p2l15t3517r231b3605, p2l126t3629r694b3719],
22	Polymorphism	NN	O	polymorphism	nsubj	19	SENT_42	[p2l15t3517r231b3605, p2l126t3629r694b3719],

1	of	IN	O	of	dep	16	SENT_43	[p2l750t3629r833b3701],
2	the	DT	O	the	det	3	SENT_43	[p2l883t3629r1016b3701],
3	Pl	NN	O	pl	pobj	1	SENT_43	[p2l1072t3629r1142b3701],
4	(	CD	NUMBER	(	num	5	SENT_43	[p2l1202t3630r1489b3719],
5	A1/A2	NN	O	a1/a2	dep	11	SENT_43	[p2l1202t3630r1489b3719],
6	)	CD	NUMBER	)	num	8	SENT_43	[p2l1202t3630r1489b3719],
7	gene-encoding	JJ	O	gene-encoding	amod	8	SENT_43	[p2l1545t3629r2149b3719],
8	glycoprotein	NN	O	glycoprotein	dep	5	SENT_43	[p3l10t18r522b108],
9	(	CD	NUMBER	(	num	10	SENT_43	[p3l561t19r730b107],
10	GP	NN	O	gp	dep	11	SENT_43	[p3l561t19r730b107],
11	)	CD	NUMBER	)	dep	3	SENT_43	[p3l561t19r730b107],
12	Illa	NNP	PERSON	Illa	dep	11	SENT_43	[p3l768t20r909b105],
13	,	,	O	,	_	0	SENT_43	[p3l768t20r909b105],
14	has	VBZ	O	have	aux	16	SENT_43	[p3l950t18r1080b89],
15	been	VBN	O	be	auxpass	16	SENT_43	[p3l1112t18r1305b89],
16	associated	VBN	O	associate	_	0	SENT_43	[p3l1338t18r1766b89],
17	with	IN	O	with	_	0	SENT_43	[p3l1796t18r1974b89],
18	low	JJ	O	low	amod	19	SENT_43	[p3l2011t18r2151b89],
19	response	NN	O	response	prep_with	16	SENT_43	[p3l13t150r370b219],
20	to	TO	O	to	_	0	SENT_43	[p3l420t138r501b201],
21	aspirin	NN	O	aspirin	prep_to	16	SENT_43	[p3l551t132r822b219],
22	[	CD	NUMBER	[	num	21	SENT_43	[p3l879t131r1178b219],
23	9	CD	NUMBER	9	num	26	SENT_43	[p3l879t131r1178b219],
24	—	NN	O	—	nn	26	SENT_43	[p3l879t131r1178b219],
25	12	CD	NUMBER	12	num	26	SENT_43	[p3l879t131r1178b219],
26	]	NN	O	]	nsubjpass	16	SENT_43	[p3l879t131r1178b219],
27	.	.	O	.	_	0	SENT_43	[p3l879t131r1178b219],

1	However	RB	O	however	advmod	4	SENT_44	[p3l1240t133r1610b217],
2	,	,	O	,	_	0	SENT_44	[p3l1240t133r1610b217],
3	controversy	NN	O	controversy	nsubj	4	SENT_44	[p3l1667t138r2151b219],
4	exists	VBZ	O	exist	_	0	SENT_44	[p3l9t244r242b313],
5	over	IN	O	over	_	0	SENT_44	[p3l306t261r488b313],
6	which	WDT	O	which	dobj	9	SENT_44	[p3l549t242r787b313],
7	allele	NN	O	allele	nsubjpass	9	SENT_44	[p3l856t242r1084b313],
8	is	VBZ	O	be	auxpass	9	SENT_44	[p3l1149t244r1208b313],
9	associated	VBN	O	associate	prepc_over	4	SENT_44	[p3l1274t242r1702b313],
10	with	IN	O	with	_	0	SENT_44	[p3l1768t242r1947b313],
11	the	DT	O	the	det	13	SENT_44	[p3l2015t242r2149b313],
12	reduced	VBN	O	reduce	amod	13	SENT_44	[p3l13t355r340b426],
13	response	NN	O	response	prep_with	9	SENT_44	[p3l389t374r746b445],
14	to	TO	O	to	_	0	SENT_44	[p3l786t362r868b426],
15	aspirin	NN	O	aspirin	prep_to	13	SENT_44	[p3l909t357r1208b445],
16	.	.	O	.	_	0	SENT_44	[p3l909t357r1208b445],

1	While	IN	O	while	mark	4	SENT_45	[p3l1255t355r1487b426],
2	several	JJ	O	several	amod	3	SENT_45	[p3l1528t355r1820b427],
3	studies	NNS	O	study	nsubj	4	SENT_45	[p3l1862t355r2150b426],
4	reported	VBD	O	report	advcl	27	SENT_45	[p3l13t468r367b556],
5	that	IN	O	that	complm	14	SENT_45	[p3l406t468r575b538],
6	carriers	NNS	O	carrier	nsubj	14	SENT_45	[p3l609t469r923b538],
7	of	IN	O	of	_	0	SENT_45	[p3l957t468r1039b538],
8	the	DT	O	the	det	9	SENT_45	[p3l1071t468r1204b538],
9	HA	NNP	O	HA	prep_of	6	SENT_45	[p3l1243t468r1404b553],
10	;	:	O	;	_	0	SENT_45	[p3l1243t468r1404b553],
11	allele	NN	O	allele	dep	9	SENT_45	[p3l1440t468r1667b538],
12	were	VBD	O	be	cop	14	SENT_45	[p3l1700t487r1905b538],
13	more	RBR	O	more	advmod	14	SENT_45	[p3l1942t487r2149b538],
14	likely	JJ	O	likely	ccomp	4	SENT_45	[p3l13t580r232b670],
15	to	TO	O	to	aux	16	SENT_45	[p3l283t587r365b652],
16	have	VB	O	have	xcomp	14	SENT_45	[p3l420t580r610b652],
17	an	DT	O	a	det	19	SENT_45	[p3l663t600r754b652],
18	inadequate	JJ	O	inadequate	amod	19	SENT_45	[p3l810t580r1275b670],
19	response	NN	O	response	dobj	16	SENT_45	[p3l1331t600r1688b670],
20	to	TO	O	to	_	0	SENT_45	[p3l1741t588r1823b652],
21	aspirin	NN	O	aspirin	prep_to	16	SENT_45	[p3l1876t582r2146b670],
22	[	CD	NUMBER	[	num	21	SENT_45	[p3l15t693r281b781],
23	9,10	CD	NUMBER	9,10	num	24	SENT_45	[p3l15t693r281b781],
24	]	NN	O	]	dep	21	SENT_45	[p3l15t693r281b781],
25	,	,	O	,	_	0	SENT_45	[p3l15t693r281b781],
26	others	NNS	O	other	nsubj	27	SENT_45	[p3l331t693r588b763],
27	found	VBD	O	find	_	0	SENT_45	[p3l630t693r859b763],
28	that	IN	O	that	complm	35	SENT_45	[p3l905t693r1074b763],
29	patients	NNS	O	patient	nsubj	35	SENT_45	[p3l1118t694r1452b781],
30	homozygous	JJ	O	homozygous	amod	29	SENT_45	[p3l1496t693r1992b781],
31	for	IN	O	for	_	0	SENT_45	[p3l2033t693r2151b763],
32	the	DT	O	the	det	34	SENT_45	[p3l10t805r143b877],
33	PlA1	NN	O	pla1	nn	34	SENT_45	[p3l183t805r336b892],
34	allele	NN	O	allele	prep_for	30	SENT_45	[p3l382t805r609b877],
35	appeared	VBD	O	appear	ccomp	27	SENT_45	[p3l645t805r1029b895],
36	to	TO	O	to	aux	39	SENT_45	[p3l1069t812r1150b877],
37	be	VB	O	be	cop	39	SENT_45	[p3l1189t805r1284b877],
38	less	RBR	O	less	advmod	39	SENT_45	[p3l1323t805r1468b877],
39	sensitive	JJ	O	sensitive	xcomp	35	SENT_45	[p3l1503t807r1862b877],
40	to	TO	O	to	_	0	SENT_45	[p3l1898t812r1980b877],
41	the	DT	O	the	det	45	SENT_45	[p3l2016t805r2149b877],
42	drug	NN	O	drug	nn	45	SENT_45	[p3l9t918r191b1008],
43	[	NN	O	[	nn	45	SENT_45	[p3l250t918r432b1008],
44	11	CD	NUMBER	11	num	45	SENT_45	[p3l250t918r432b1008],
45	]	NN	O	]	prep_to	39	SENT_45	[p3l250t918r432b1008],
46	.	.	O	.	_	0	SENT_45	[p3l250t918r432b1008],

1	In	FW	O	in	nn	2	SENT_46	[p3l499t920r561b989],
2	vitro	FW	O	vitro	amod	3	SENT_46	[p3l615t920r809b989],
3	studies	NNS	O	study	nsubj	4	SENT_46	[p3l862t918r1150b989],
4	showed	VBD	O	show	_	0	SENT_46	[p3l1202t918r1505b989],
5	that	IN	O	that	complm	14	SENT_46	[p3l1563t918r1731b989],
6	platelets	NNS	O	platelet	nsubj	14	SENT_46	[p3l1787t918r2150b1008],
7	from	IN	O	from	_	0	SENT_46	[p3l9t1031r200b1101],
8	subjects	NNS	O	subject	prep_from	6	SENT_46	[p3l238t1031r580b1119],
9	heterozygous	JJ	O	heterozygous	amod	8	SENT_46	[p3l619t1031r1163b1119],
10	for	IN	O	for	_	0	SENT_46	[p3l1199t1031r1317b1101],
11	the	DT	O	the	det	13	SENT_46	[p3l1352t1031r1485b1101],
12	PlA	NN	O	plum	nn	13	SENT_46	[p3l1524t1031r1652b1101],
13	alleles	NNS	O	allele	prep_for	9	SENT_46	[p3l1687t1031r1952b1101],
14	[	VBP	O	[	ccomp	4	SENT_46	[p3l1993t1031r2142b1119],
15	12	CD	NUMBER	12	num	16	SENT_46	[p3l1993t1031r2142b1119],
16	]	CD	NUMBER	]	dobj	14	SENT_46	[p3l1993t1031r2142b1119],
17	or	CC	O	or	_	0	SENT_46	[p3l9t1163r93b1215],
18	from	IN	O	from	_	0	SENT_46	[p3l123t1143r313b1215],
19	any	DT	O	any	det	20	SENT_46	[p3l349t1163r492b1233],
20	carriers	NNS	O	carrier	prep_from	37	SENT_46	[p3l522t1145r836b1215],
21	of	IN	O	of	_	0	SENT_46	[p3l868t1143r951b1215],
22	the	DT	O	the	det	31	SENT_46	[p3l980t1143r1114b1215],
23	HA	NNP	O	HA	nn	31	SENT_46	[p3l1150t1143r1312b1230],
24	;	:	O	;	_	0	SENT_46	[p3l1150t1143r1312b1230],
25	allele	NN	O	allele	nn	27	SENT_46	[p3l1346t1143r1573b1215],
26	(	CD	NUMBER	(	num	27	SENT_46	[p3l1611t1144r1867b1233],
27	A1/A2	NN	O	a1/a2	dep	31	SENT_46	[p3l1611t1144r1867b1233],
28	or	CC	O	or	_	0	SENT_46	[p3l1900t1163r1984b1215],
29	A2	NN	O	a2	dep	31	SENT_46	[p3l2011t1144r2143b1230],
30	/	:	O	/	punct	27	SENT_46	[p3l2011t1144r2143b1230],
31	A2	NN	O	a2	prep_of	20	SENT_46	[p3l7t1257r127b1346],
32	)	CD	NUMBER	)	number	33	SENT_46	[p3l7t1257r127b1346],
33	[	CD	NUMBER	[	dep	31	SENT_46	[p3l173t1256r322b1346],
34	13	CD	NUMBER	13	num	35	SENT_46	[p3l173t1256r322b1346],
35	]	NN	O	]	dep	33	SENT_46	[p3l173t1256r322b1346],
36	had	VBD	O	have	aux	37	SENT_46	[p3l368t1256r509b1327],
37	increased	VBN	O	increase	conj_or	14	SENT_46	[p3l550t1256r941b1327],
38	sensitivity	NN	O	sensitivity	dobj	37	SENT_46	[p3l981t1258r1401b1346],
39	to	TO	O	to	_	0	SENT_46	[p3l1436t1263r1518b1327],
40	aspirin	NN	O	aspirin	prep_to	37	SENT_46	[p3l1555t1258r1853b1346],
41	.	.	O	.	_	0	SENT_46	[p3l1555t1258r1853b1346],

1	Clopidogrel	NN	O	clopidogrel	nsubj	2	SENT_47	[p3l123t1369r592b1457],
2	inhibits	VBZ	O	inhibit	_	0	SENT_47	[p3l632t1369r934b1439],
3	the	DT	O	the	det	7	SENT_47	[p3l973t1369r1106b1439],
4	purinergic	JJ	O	purinergic	amod	7	SENT_47	[p3l1147t1370r1563b1457],
5	ADP	NN	O	adp	nn	7	SENT_47	[p3l1599t1370r1759b1438],
6	receptor	NN	O	receptor	nn	7	SENT_47	[p3l1798t1376r2152b1457],
7	P2Y12	NN	O	p2y12	dobj	2	SENT_47	[p3l13t1482r266b1568],
8	.	.	O	.	_	0	SENT_47	[p3l13t1482r266b1568],

1	ADP	NN	ORGANIZATION	adp	nsubj	2	SENT_48	[p3l340t1482r505b1552],
2	activates	VBZ	O	activate	_	0	SENT_48	[p3l570t1483r958b1553],
3	platelets	NNS	O	platelet	dobj	2	SENT_48	[p3l1029t1481r1405b1571],
4	through	IN	O	through	_	0	SENT_48	[p3l1473t1481r1798b1571],
5	two	CD	NUMBER	two	num	8	SENT_48	[p3l1870t1489r2024b1553],
6	G	NN	O	g	nn	8	SENT_48	[p3l2093t1482r2146b1553],
7	protein-coupled	JJ	O	protein-coupled	amod	8	SENT_48	[p3l12t1594r670b1682],
8	receptors	NNS	O	receptor	prep_through	2	SENT_48	[p3l737t1601r1151b1682],
9	:	:	O	:	_	0	SENT_48	[p3l737t1601r1151b1682],
10	PZY1	NN	O	pzy1	dep	8	SENT_48	[p3l1223t1595r1395b1679],
11	and	CC	O	and	_	0	SENT_48	[p3l1465t1594r1608b1664],
12	P2Y12	NN	O	p2y12	conj_and	10	SENT_48	[p3l1675t1595r1893b1679],
13	[	CD	NUMBER	[	number	14	SENT_48	[p3l1959t1594r2141b1682],
14	14	CD	NUMBER	14	num	15	SENT_48	[p3l1959t1594r2141b1682],
15	]	NN	O	]	dep	10	SENT_48	[p3l1959t1594r2141b1682],
16	.	.	O	.	_	0	SENT_48	[p3l1959t1594r2141b1682],

1	Stimulation	NN	O	stimulation	nsubj	6	SENT_49	[p3l10t1706r481b1778],
2	of	IN	O	of	_	0	SENT_49	[p3l517t1706r600b1778],
3	the	DT	O	the	det	5	SENT_49	[p3l631t1706r765b1778],
4	PZY1	NN	O	pzy1	nn	5	SENT_49	[p3l803t1707r975b1793],
5	receptor	NN	O	receptor	prep_of	1	SENT_49	[p3l1023t1714r1376b1796],
6	results	VBZ	O	result	_	0	SENT_49	[p3l1412t1706r1681b1778],
7	in	IN	O	in	_	0	SENT_49	[p3l1716t1708r1784b1777],
8	platelet	NN	O	platelet	nn	10	SENT_49	[p3l1824t1706r2149b1796],
9	conformational	JJ	O	conformational	amod	10	SENT_49	[p3l9t1820r640b1891],
10	change	NN	O	change	prep_in	6	SENT_49	[p3l672t1820r963b1910],
11	and	CC	O	and	_	0	SENT_49	[p3l995t1820r1138b1891],
12	weak	JJ	O	weak	amod	15	SENT_49	[p3l1172t1820r1388b1891],
13	transient	JJ	O	transient	amod	15	SENT_49	[p3l1418t1821r1790b1891],
14	platelet	NN	O	platelet	nn	15	SENT_49	[p3l1824t1820r2150b1910],
15	aggregation	NN	O	aggregation	prep_in	6	SENT_49	[p3l10t1933r523b2020],
16	,	,	O	,	_	0	SENT_49	[p3l10t1933r523b2020],
17	while	IN	O	while	mark	22	SENT_49	[p3l587t1932r836b2018],
18	,	,	O	,	_	0	SENT_49	[p3l587t1932r836b2018],
19	activation	NN	O	activation	nsubj	22	SENT_49	[p3l904t1933r1314b2002],
20	of	IN	O	of	_	0	SENT_49	[p3l1377t1932r1459b2002],
21	P2Y12	NN	O	p2y12	prep_of	19	SENT_49	[p3l1518t1933r1736b2017],
22	leads	VBZ	O	lead	advcl	6	SENT_49	[p3l1800t1932r2009b2002],
23	to	TO	O	to	_	0	SENT_49	[p3l2068t1939r2150b2002],
24	sustained	JJ	O	sustained	amod	26	SENT_49	[p3l9t2044r400b2116],
25	platelet	NN	O	platelet	nn	26	SENT_49	[p3l473t2044r804b2134],
26	aggregation	NN	O	aggregation	prep_to	22	SENT_49	[p3l870t2046r1362b2134],
27	[	CD	NUMBER	[	number	28	SENT_49	[p3l1438t2044r1623b2134],
28	14	CD	NUMBER	14	num	29	SENT_49	[p3l1438t2044r1623b2134],
29	]	NN	O	]	dep	26	SENT_49	[p3l1438t2044r1623b2134],
30	.	.	O	.	_	0	SENT_49	[p3l1438t2044r1623b2134],

1	In	IN	O	in	_	0	SENT_50	[p3l1702t2046r1767b2115],
2	healthy	JJ	O	healthy	amod	3	SENT_50	[p3l1839t2044r2151b2134],
3	subjects	NNS	O	subject	prep_in	12	SENT_50	[p3l9t2157r351b2247],
4	a	DT	O	a	det	5	SENT_50	[p3l402t2176r445b2228],
5	haplotype	NN	O	haplotype	nsubjpass	12	SENT_50	[p3l500t2157r908b2247],
6	of	IN	O	of	_	0	SENT_50	[p3l959t2157r1042b2228],
7	the	DT	O	the	det	10	SENT_50	[p3l1090t2157r1223b2228],
8	P2Y12	NN	O	p2y12	nn	10	SENT_50	[p3l1278t2158r1496b2243],
9	receptor	NN	O	receptor	nn	10	SENT_50	[p3l1551t2164r1905b2247],
10	gene	NN	O	gene	prep_of	5	SENT_50	[p3l1955t2174r2149b2247],
11	was	VBD	O	be	auxpass	12	SENT_50	[p3l7t2289r161b2340],
12	associated	VBN	O	associate	_	0	SENT_50	[p3l223t2270r650b2340],
13	with	IN	O	with	_	0	SENT_50	[p3l713t2270r891b2340],
14	the	DT	O	the	det	15	SENT_50	[p3l957t2270r1091b2340],
15	extent	NN	O	extent	prep_with	12	SENT_50	[p3l1153t2277r1423b2340],
16	of	IN	O	of	_	0	SENT_50	[p3l1484t2270r1567b2340],
17	ADP-induced	JJ	O	adp-induced	amod	19	SENT_50	[p3l1623t2270r2145b2340],
18	platelet	NN	O	platelet	nn	19	SENT_50	[p3l12t2382r340b2470],
19	aggregation	NN	O	aggregation	prep_of	15	SENT_50	[p3l407t2383r895b2470],
20	[	CD	NUMBER	[	number	21	SENT_50	[p3l970t2382r1154b2470],
21	15	CD	NUMBER	15	num	22	SENT_50	[p3l970t2382r1154b2470],
22	]	NN	O	]	dep	19	SENT_50	[p3l970t2382r1154b2470],
23	.	.	O	.	_	0	SENT_50	[p3l970t2382r1154b2470],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_51	[p3l1232t2382r1781b2468],
2	,	,	O	,	_	0	SENT_51	[p3l1232t2382r1781b2468],
3	the	DT	O	the	det	5	SENT_51	[p3l1856t2382r1990b2452],
4	H2	NN	O	h2	nn	5	SENT_51	[p3l2060t2383r2149b2467],
5	haplotype	NN	O	haplotype	nsubj	8	SENT_51	[p3l12t2494r426b2582],
6	was	VBD	O	be	cop	8	SENT_51	[p3l491t2513r646b2564],
7	more	RBR	O	more	advmod	8	SENT_51	[p3l715t2513r924b2564],
8	frequent	JJ	O	frequent	_	0	SENT_51	[p3l989t2494r1354b2582],
9	in	IN	O	in	_	0	SENT_51	[p3l1421t2495r1490b2563],
10	patients	NNS	O	patient	prep_in	8	SENT_51	[p3l1562t2495r1902b2582],
11	with	IN	O	with	_	0	SENT_51	[p3l1965t2494r2146b2564],
12	peripheral	JJ	O	peripheral	amod	14	SENT_51	[p3l12t2606r436b2696],
13	arterial	JJ	O	arterial	amod	14	SENT_51	[p3l474t2606r780b2678],
14	disease	NN	O	disease	prep_with	10	SENT_51	[p3l817t2606r1116b2678],
15	than	IN	O	than	dep	8	SENT_51	[p3l1152t2606r1332b2678],
16	in	IN	O	in	_	0	SENT_51	[p3l1371t2608r1440b2677],
17	control	JJ	O	control	amod	18	SENT_51	[p3l1479t2606r1771b2678],
18	subjects	NNS	O	subject	prep_in	8	SENT_51	[p3l1808t2606r2149b2696],
19	[	JJ	O	[	amod	18	SENT_51	[p3l16t2719r197b2809],
20	16	CD	NUMBER	16	num	21	SENT_51	[p3l16t2719r197b2809],
21	]	NN	O	]	dep	19	SENT_51	[p3l16t2719r197b2809],
22	.	.	O	.	_	0	SENT_51	[p3l16t2719r197b2809],

1	However	RB	O	however	advmod	4	SENT_52	[p3l238t2721r608b2806],
2	,	,	O	,	_	0	SENT_52	[p3l238t2721r608b2806],
3	there	EX	O	there	expl	4	SENT_52	[p3l646t2719r867b2790],
4	is	VBZ	O	be	_	0	SENT_52	[p3l896t2721r955b2790],
5	currently	RB	DATE	currently	advmod	4	SENT_52	[p3l984t2719r1363b2809],
6	no	DT	O	no	det	7	SENT_52	[p3l1394t2738r1486b2790],
7	data	NNS	O	datum	nsubj	4	SENT_52	[p3l1516t2719r1697b2790],
8	to	TO	O	to	aux	9	SENT_52	[p3l1728t2726r1809b2790],
9	support	VB	O	support	infmod	7	SENT_52	[p3l1838t2726r2150b2809],
10	an	DT	O	a	det	11	SENT_52	[p3l10t2851r101b2902],
11	association	NN	O	association	dobj	9	SENT_52	[p3l143t2833r594b2902],
12	between	IN	O	between	_	0	SENT_52	[p3l639t2832r991b2902],
13	this	DT	O	this	det	14	SENT_52	[p3l1032t2832r1179b2902],
14	haplotype	NN	O	haplotype	prep_between	11	SENT_52	[p3l1219t2832r1627b2920],
15	and	CC	O	and	_	0	SENT_52	[p3l1666t2832r1809b2902],
16	altered	JJ	O	altered	amod	17	SENT_52	[p3l1850t2832r2146b2902],
17	response	NN	O	response	prep_between	11	SENT_52	[p3l13t2964r370b3034],
18	to	TO	O	to	_	0	SENT_52	[p3l411t2952r492b3016],
19	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_52	[p3l532t2944r1019b3034],
20	.	.	O	.	_	0	SENT_52	[p3l532t2944r1019b3034],

1	A	DT	O	a	det	2	SENT_53	[p3l1064t2945r1120b3015],
2	dimorphism	NN	O	dimorphism	nsubjpass	11	SENT_53	[p3l1157t2944r1635b3034],
3	in	IN	O	in	_	0	SENT_53	[p3l1678t2946r1747b3015],
4	the	DT	O	the	det	6	SENT_53	[p3l1790t2944r1923b3016],
5	PZY1	NN	O	pzy1	nn	6	SENT_53	[p3l1967t2945r2139b3031],
6	gene	NN	O	gene	prep_in	2	SENT_53	[p3l10t3075r204b3147],
7	has	VBZ	O	have	aux	11	SENT_53	[p3l260t3057r390b3128],
8	also	RB	O	also	advmod	11	SENT_53	[p3l442t3057r601b3128],
9	been	VBN	O	be	auxpass	11	SENT_53	[p3l656t3057r850b3128],
10	recently	RB	DATE	recently	advmod	11	SENT_53	[p3l910t3057r1249b3147],
11	associated	VBN	O	associate	_	0	SENT_53	[p3l1301t3057r1727b3128],
12	with	IN	O	with	_	0	SENT_53	[p3l1781t3057r1959b3129],
13	the	DT	O	the	det	14	SENT_53	[p3l2016t3057r2149b3128],
14	degree	NN	O	degree	prep_with	11	SENT_53	[p3l9t3170r293b3258],
15	of	IN	O	of	_	0	SENT_53	[p3l358t3170r441b3240],
16	platelet	NN	O	platelet	nn	17	SENT_53	[p3l505t3170r830b3258],
17	reactivity	NN	O	reactivity	prep_of	14	SENT_53	[p3l899t3171r1295b3258],
18	to	TO	O	to	_	0	SENT_53	[p3l1359t3177r1441b3240],
19	ADP	NN	ORGANIZATION	adp	prep_to	11	SENT_53	[p3l1503t3171r1664b3239],
20	in	IN	O	in	_	0	SENT_53	[p3l1726t3171r1794b3239],
21	normal	JJ	O	normal	amod	22	SENT_53	[p3l1865t3170r2148b3240],
22	subjects	NNS	O	subject	prep_in	19	SENT_53	[p3l9t3282r351b3370],
23	[	VBP	O	[	dep	22	SENT_53	[p3l397t3282r578b3370],
24	17	CD	NUMBER	17	num	25	SENT_53	[p3l397t3282r578b3370],
25	]	CD	NUMBER	]	dobj	23	SENT_53	[p3l397t3282r578b3370],
26	.	.	O	.	_	0	SENT_53	[p3l397t3282r578b3370],

1	It	PRP	O	it	nsubj	3	SENT_54	[p3l631t3283r684b3352],
2	is	VBZ	O	be	cop	3	SENT_54	[p3l724t3283r782b3352],
3	possible	JJ	O	possible	_	0	SENT_54	[p3l825t3282r1151b3370],
4	that	IN	O	that	complm	14	SENT_54	[p3l1191t3282r1360b3352],
5	mutations	NNS	O	mutation	nsubj	14	SENT_54	[p3l1402t3283r1811b3352],
6	conferring	VBG	O	confer	partmod	5	SENT_54	[p3l1851t3282r2144b3352, p3l13t3395r165b3482],
7	increased	VBN	O	increase	amod	8	SENT_54	[p3l199t3394r591b3464],
8	function	NN	O	function	dobj	6	SENT_54	[p3l627t3394r967b3464],
9	of	IN	O	of	_	0	SENT_54	[p3l1003t3394r1086b3464],
10	the	DT	O	the	det	12	SENT_54	[p3l1116t3394r1249b3464],
11	PZY1	NN	O	pzy1	nn	12	SENT_54	[p3l1286t3395r1458b3479],
12	gene	NN	O	gene	prep_of	8	SENT_54	[p3l1502t3411r1696b3482],
13	may	MD	O	may	aux	14	SENT_54	[p3l1733t3413r1899b3482],
14	allow	VB	O	allow	ccomp	3	SENT_54	[p3l1931t3394r2151b3464],
15	an	DT	O	a	det	17	SENT_54	[p3l9t3526r100b3578],
16	“	NN	O	“	nn	17	SENT_54	[p3l133t3513r489b3596],
17	escape	NN	O	escape	dobj	14	SENT_54	[p3l133t3513r489b3596],
18	”	CD	NUMBER	”	num	17	SENT_54	[p3l133t3513r489b3596],
19	from	IN	O	from	_	0	SENT_54	[p3l516t3506r706b3578],
20	P2Y12	NN	O	p2y12	nn	21	SENT_54	[p3l742t3507r960b3593],
21	blockade	NN	O	blockade	prep_from	14	SENT_54	[p3l993t3506r1360b3578],
22	by	IN	O	by	_	0	SENT_54	[p3l1392t3506r1484b3596],
23	clopidogrel	NN	O	clopidogrel	prep_by	14	SENT_54	[p3l1512t3506r1972b3596],
24	and	CC	O	and	_	0	SENT_54	[p3l2003t3506r2146b3578],
25	therefore	RB	O	therefore	advmod	14	SENT_54	[p3l9t3619r402b3690],
26	be	VB	O	be	auxpass	27	SENT_54	[p3l452t3619r547b3691],
27	associated	VBN	O	associate	conj_and	14	SENT_54	[p3l594t3619r1021b3690],
28	with	IN	O	with	_	0	SENT_54	[p3l1069t3619r1248b3691],
29	the	DT	O	the	det	30	SENT_54	[p3l1298t3619r1432b3690],
30	response	NN	O	response	prep_with	27	SENT_54	[p3l1482t3638r1839b3709],
31	to	TO	O	to	_	0	SENT_54	[p3l1887t3626r1968b3690],
32	the	DT	O	the	det	33	SENT_54	[p3l2016t3619r2150b3690],
33	drug	NN	O	drug	prep_to	27	SENT_54	[p4l9t18r216b106],
34	.	.	O	.	_	0	SENT_54	[p4l9t18r216b106],

1	Interestingly	RB	O	interestingly	advmod	14	SENT_55	[p4l289t18r819b106],
2	,	,	O	,	_	0	SENT_55	[p4l289t18r819b106],
3	a	DT	O	a	det	6	SENT_55	[p4l887t37r929b88],
4	single	JJ	O	single	amod	6	SENT_55	[p4l989t18r1224b106],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_55	[p4l1286t18r1721b88],
6	polymorphism	NN	O	polymorphism	nsubjpass	14	SENT_55	[p4l1783t18r2145b106, p4l12t130r244b220],
7	in	IN	O	in	_	0	SENT_55	[p4l275t132r344b201],
8	the	DT	O	the	det	10	SENT_55	[p4l373t130r507b202],
9	PZY1	NN	O	pzy1	nn	10	SENT_55	[p4l537t131r709b217],
10	gene	NN	O	gene	prep_in	6	SENT_55	[p4l746t148r940b220],
11	has	VBZ	O	have	aux	14	SENT_55	[p4l969t130r1099b202],
12	recently	RB	DATE	recently	advmod	14	SENT_55	[p4l1129t130r1468b220],
13	been	VBN	O	be	auxpass	14	SENT_55	[p4l1495t130r1689b202],
14	associated	VBN	O	associate	_	0	SENT_55	[p4l1720t130r2146b202],
15	with	IN	O	with	_	0	SENT_55	[p4l7t243r185b313],
16	aspirin	NN	O	aspirin	nn	18	SENT_55	[p4l222t244r491b331],
17	“	CD	NUMBER	“	num	18	SENT_55	[p4l528t244r1021b313],
18	resistance	NN	O	resistance	prep_with	14	SENT_55	[p4l528t244r1021b313],
19	”	CD	NUMBER	”	num	18	SENT_55	[p4l528t244r1021b313],
20	[	CD	NUMBER	[	number	21	SENT_55	[p4l1057t243r1238b331],
21	18	CD	NUMBER	18	num	22	SENT_55	[p4l1057t243r1238b331],
22	]	NN	O	]	dep	14	SENT_55	[p4l1057t243r1238b331],
23	.	.	O	.	_	0	SENT_55	[p4l1057t243r1238b331],

1	The	DT	O	the	det	3	SENT_56	[p4l1277t243r1431b313],
2	possible	JJ	O	possible	amod	3	SENT_56	[p4l1466t243r1791b331],
3	association	NN	O	association	nsubjpass	14	SENT_56	[p4l1825t244r2145b313, p4l9t357r166b427],
4	of	IN	O	of	_	0	SENT_56	[p4l203t355r286b427],
5	PZY1	NN	O	pzy1	nn	6	SENT_56	[p4l321t356r494b442],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_56	[p4l542t355r1156b445],
7	with	IN	O	with	_	0	SENT_56	[p4l1188t355r1367b427],
8	response	NN	O	response	prep_with	6	SENT_56	[p4l1409t375r1765b445],
9	to	TO	O	to	_	0	SENT_56	[p4l1801t362r1883b427],
10	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_56	[p4l1918t355r2144b445, p4l9t468r267b558],
11	has	VBZ	O	have	aux	14	SENT_56	[p4l302t468r431b539],
12	not	RB	O	not	neg	14	SENT_56	[p4l464t475r595b539],
13	been	VBN	O	be	auxpass	14	SENT_56	[p4l628t468r821b539],
14	evaluated	VBN	O	evaluate	_	0	SENT_56	[p4l856t468r1262b539],
15	to	TO	O	to	_	0	SENT_56	[p4l1297t475r1379b539],
16	date	NN	O	date	prep_to	14	SENT_56	[p4l1409t468r1618b539],
17	.	.	O	.	_	0	SENT_56	[p4l1409t468r1618b539],

1	Accordingly	RB	O	accordingly	advmod	5	SENT_57	[p4l119t581r616b669],
2	,	,	O	,	_	0	SENT_57	[p4l119t581r616b669],
3	our	PRP$	O	we	poss	4	SENT_57	[p4l677t600r811b651],
4	aim	NN	O	aim	nsubj	5	SENT_57	[p4l862t582r1006b651],
5	was	VBD	O	be	_	0	SENT_57	[p4l1058t600r1212b651],
6	to	TO	O	to	aux	7	SENT_57	[p4l1264t587r1346b651],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_57	[p4l1398t581r1754b651],
8	whether	IN	O	whether	complm	24	SENT_57	[p4l1805t581r2151b651],
9	polymorphisms	NNS	O	polymorphism	nsubjpass	24	SENT_57	[p4l12t693r626b783],
10	in	IN	O	in	_	0	SENT_57	[p4l653t695r722b764],
11	the	DT	O	the	det	12	SENT_57	[p4l754t693r887b765],
12	genes	NNS	O	gene	prep_in	9	SENT_57	[p4l916t711r1148b783],
13	encoding	VBG	O	encode	partmod	12	SENT_57	[p4l1176t693r1546b783],
14	for	IN	O	for	_	0	SENT_57	[p4l1573t693r1692b765],
15	GP	NN	O	gp	nn	16	SENT_57	[p4l1717t694r1826b765],
16	Illa	NN	PERSON	illum	prep_for	13	SENT_57	[p4l1859t695r1974b765],
17	and	CC	O	and	_	0	SENT_57	[p4l2003t693r2146b765],
18	the	DT	O	the	det	22	SENT_57	[p4l9t806r143b877],
19	P2Y12	NN	O	p2y12	nn	22	SENT_57	[p4l193t807r410b892],
20	and	CC	O	and	_	0	SENT_57	[p4l457t806r600b877],
21	PZY1	NN	O	pzy1	conj_and	19	SENT_57	[p4l652t807r825b892],
22	receptors	NNS	O	receptor	prep_for	13	SENT_57	[p4l883t813r1273b896],
23	are	VBP	O	be	auxpass	24	SENT_57	[p4l1318t825r1448b877],
24	associated	VBN	O	associate	ccomp	7	SENT_57	[p4l1494t806r1921b877],
25	with	IN	O	with	_	0	SENT_57	[p4l1968t806r2146b878],
26	the	DT	O	the	det	27	SENT_57	[p4l9t919r143b989],
27	response	NN	O	response	prep_with	24	SENT_57	[p4l184t938r540b1007],
28	to	TO	O	to	_	0	SENT_57	[p4l578t926r660b989],
29	aspirin	NN	O	aspirin	prep_to	27	SENT_57	[p4l697t920r966b1007],
30	and	CC	O	and	_	0	SENT_57	[p4l1007t919r1150b989],
31	to	TO	O	to	_	0	SENT_57	[p4l1190t926r1272b989],
32	clopidogrel	NN	O	clopidogrel	prep_to	27	SENT_57	[p4l1309t919r1796b1007],
33	.	.	O	.	_	0	SENT_57	[p4l1309t919r1796b1007],

1	Materials	NNPS	O	Materials	_	0	SENT_58	[p4l7t1177r479b1263],
2	and	CC	O	and	_	0	SENT_58	[p4l523t1177r705b1263],
3	methods	NNS	O	method	conj_and	1	SENT_58	[p4l755t1177r1193b1263],

1	Patients	NNS	O	patient	_	0	SENT_59	[p4l13t1430r390b1507],

1	We	PRP	O	we	nsubj	2	SENT_60	[p4l7t1663r131b1732],
2	enrolled	VBD	O	enrol	_	0	SENT_60	[p4l186t1661r525b1732],
3	120	CD	NUMBER	120	num	4	SENT_60	[p4l591t1662r726b1732],
4	patients	NNS	O	patient	dobj	2	SENT_60	[p4l786t1663r1119b1751],
5	scheduled	VBN	O	schedule	partmod	4	SENT_60	[p4l1176t1661r1586b1732],
6	for	IN	O	for	_	0	SENT_60	[p4l1646t1661r1764b1732],
7	elective	JJ	O	elective	amod	10	SENT_60	[p4l1818t1661r2150b1732],
8	percutaneous	JJ	O	percutaneous	amod	10	SENT_60	[p4l12t1781r597b1864],
9	coronary	JJ	O	coronary	amod	10	SENT_60	[p4l666t1793r1046b1864],
10	intervention	NN	O	intervention	prep_for	5	SENT_60	[p4l1114t1775r1651b1845],
11	(	CD	NUMBER	(	num	13	SENT_60	[p4l1730t1775r1960b1864],
12	PCI	NN	O	pcus	nn	13	SENT_60	[p4l1730t1775r1960b1864],
13	)	NN	O	)	dep	10	SENT_60	[p4l1730t1775r1960b1864],
14	.	.	O	.	_	0	SENT_60	[p4l1730t1775r1960b1864],

1	All	DT	O	all	det	2	SENT_61	[p4l2036t1774r2148b1845],
2	patients	NNS	O	patient	nsubj	17	SENT_61	[p4l12t1888r346b1975],
3	had	VBD	O	have	aux	4	SENT_61	[p4l394t1887r535b1957],
4	received	VBN	O	receive	dep	27	SENT_61	[p4l587t1887r936b1957],
5	aspirin	NN	O	aspirin	nn	7	SENT_61	[p4l985t1888r1254b1975],
6	81-325	CD	NUMBER	81-325	num	7	SENT_61	[p4l1305t1887r1610b1957],
7	mg	NN	O	mg	dobj	4	SENT_61	[p4l1630t1904r1746b1975],
8	daily	RB	SET	daily	advmod	4	SENT_61	[p4l1792t1887r1990b1975],
9	for	IN	O	for	_	0	SENT_61	[p4l2034t1887r2152b1957],
10	21week	CD	NUMBER	21week	prep_for	4	SENT_61	[p4l11t1998r366b2069],
11	before	IN	O	before	_	0	SENT_61	[p4l420t1998r686b2069],
12	the	DT	O	the	det	13	SENT_61	[p4l740t1998r874b2069],
13	PCI	NN	O	pcus	prep_before	4	SENT_61	[p4l932t1999r1051b2069],
14	and	CC	O	and	_	0	SENT_61	[p4l1110t1998r1253b2069],
15	had	VBD	O	have	aux	17	SENT_61	[p4l1313t1998r1453b2069],
16	not	RB	O	not	neg	17	SENT_61	[p4l1513t2005r1644b2069],
17	received	VBN	O	receive	conj_and	4	SENT_61	[p4l1701t1998r2049b2069],
18	a	DT	O	a	det	19	SENT_61	[p4l2106t2017r2149b2069],
19	thienopyridine	NN	O	thienopyridine	dobj	17	SENT_61	[p4l9t2111r612b2201],
20	or	CC	O	or	_	0	SENT_61	[p4l655t2130r740b2182],
21	GP	NN	O	gp	nn	24	SENT_61	[p4l781t2112r889b2183],
22	|	CD	NUMBER	|	num	24	SENT_61	[p4l938t2111r1204b2182],
23	|	NN	O	|	nn	24	SENT_61	[p4l938t2111r1204b2182],
24	b	NN	O	b	conj_or	19	SENT_61	[p4l938t2111r1204b2182],
25	/	:	O	/	punct	27	SENT_61	[p4l938t2111r1204b2182],
26	|	CD	NUMBER	|	num	27	SENT_61	[p4l938t2111r1204b2182],
27	|	CD	NUMBER	|	_	0	SENT_61	[p4l938t2111r1204b2182],
28	|	VBD	O	|	dep	27	SENT_61	[p4l938t2111r1204b2182],
29	a	DT	O	a	det	30	SENT_61	[p4l938t2111r1204b2182],
30	inhibitor	NN	O	inhibitor	dobj	28	SENT_61	[p4l1248t2111r1603b2182],
31	in	IN	O	in	_	0	SENT_61	[p4l1644t2113r1712b2182],
32	the	DT	DATE	the	det	33	SENT_61	[p4l1759t2111r1892b2182],
33	week	NN	DATE	week	prep_in	28	SENT_61	[p4l1933t2111r2152b2182],
34	prior	RB	O	prior	_	0	SENT_61	[p4l12t2225r207b2312],
35	to	TO	O	to	_	0	SENT_61	[p4l243t2231r325b2294],
36	enrollment	NN	O	enrollment	prep_prior_to	28	SENT_61	[p4l361t2224r842b2294],
37	.	.	O	.	_	0	SENT_61	[p4l361t2224r842b2294],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_62	[p4l892t2225r1221b2294],
2	were	VBD	O	be	auxpass	3	SENT_62	[p4l1256t2243r1461b2294],
3	enrolled	VBN	O	enrol	_	0	SENT_62	[p4l1498t2224r1836b2294],
4	if	IN	O	if	mark	7	SENT_62	[p4l1877t2224r1935b2293],
5	they	PRP	O	they	nsubjpass	7	SENT_62	[p4l1969t2224r2152b2312],
6	were	VBD	O	be	auxpass	7	SENT_62	[p4l7t2356r212b2408],
7	planned	VBN	O	plan	advcl	3	SENT_62	[p4l272t2336r594b2426],
8	to	TO	O	to	aux	9	SENT_62	[p4l656t2343r738b2408],
9	receive	VB	O	receive	xcomp	7	SENT_62	[p4l799t2338r1098b2408],
10	bivalirudin	NN	O	bivalirudin	dobj	9	SENT_62	[p4l1158t2336r1592b2408],
11	rather	RB	O	rather	advmod	10	SENT_62	[p4l1656t2336r1911b2408],
12	than	IN	O	than	_	0	SENT_62	[p4l1967t2336r2146b2408],
13	heparin	NN	O	heparin	prep_than	10	SENT_62	[p4l12t2449r318b2539],
14	and	CC	O	and	_	0	SENT_62	[p4l371t2449r514b2520],
15	a	DT	O	a	det	19	SENT_62	[p4l568t2468r611b2520],
16	GP	NN	O	gp	nn	19	SENT_62	[p4l662t2450r770b2520],
17	|	CD	NUMBER	|	num	19	SENT_62	[p4l827t2449r1093b2520],
18	|	NN	O	|	nn	19	SENT_62	[p4l827t2449r1093b2520],
19	b	NN	O	b	prep_than	10	SENT_62	[p4l827t2449r1093b2520],
20	/	:	O	/	punct	23	SENT_62	[p4l827t2449r1093b2520],
21	|	CD	NUMBER	|	num	22	SENT_62	[p4l827t2449r1093b2520],
22	|	CD	NUMBER	|	nsubj	23	SENT_62	[p4l827t2449r1093b2520],
23	|	VBD	O	|	dep	10	SENT_62	[p4l827t2449r1093b2520],
24	a	DT	O	a	det	25	SENT_62	[p4l827t2449r1093b2520],
25	inhibitor	NN	O	inhibitor	dobj	23	SENT_62	[p4l1145t2449r1499b2520],
26	during	IN	O	during	_	0	SENT_62	[p4l1547t2449r1805b2539],
27	PCI	NNP	O	PCI	prep_during	23	SENT_62	[p4l1859t2450r2010b2536],
28	,	,	O	,	_	0	SENT_62	[p4l1859t2450r2010b2536],
29	as	IN	O	as	mark	33	SENT_62	[p4l2069t2468r2150b2520],
30	bivalirudin	NN	O	bivalirudin	nsubj	33	SENT_62	[p4l12t2562r445b2634],
31	does	VBZ	O	do	aux	33	SENT_62	[p4l506t2562r691b2633],
32	not	RB	O	not	neg	33	SENT_62	[p4l751t2569r881b2633],
33	affect	VB	O	affect	advcl	23	SENT_62	[p4l939t2562r1185b2633],
34	ADP-induced	JJ	MISC	adp-induced	amod	36	SENT_62	[p4l1239t2562r1761b2633],
35	platelet	NN	O	platelet	nn	36	SENT_62	[p4l1824t2562r2150b2652],
36	aggregation	NN	O	aggregation	dobj	33	SENT_62	[p4l9t2677r496b2765],
37	[	CD	NUMBER	[	number	38	SENT_62	[p4l571t2675r753b2765],
38	19	CD	NUMBER	19	num	39	SENT_62	[p4l571t2675r753b2765],
39	]	NN	O	]	dep	10	SENT_62	[p4l571t2675r753b2765],
40	.	.	O	.	_	0	SENT_62	[p4l571t2675r753b2765],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_63	[p4l831t2675r1209b2746],
2	criteria	NNS	O	criterion	nsubj	6	SENT_63	[p4l1277t2676r1583b2746],
3	were	VBD	O	be	cop	6	SENT_63	[p4l1647t2694r1853b2746],
4	acute	JJ	O	acute	amod	6	SENT_63	[p4l1919t2682r2150b2746],
5	myocardial	JJ	O	myocardial	amod	6	SENT_63	[p4l12t2788r463b2876],
6	infarction	NN	O	infarction	_	0	SENT_63	[p4l520t2788r920b2858],
7	within	IN	O	within	_	0	SENT_63	[p4l976t2788r1233b2858],
8	1week	NN	O	1week	prep_within	6	SENT_63	[p4l1297t2788r1589b2874],
9	,	,	O	,	_	0	SENT_63	[p4l1297t2788r1589b2874],
10	any	DT	O	any	det	11	SENT_63	[p4l1654t2807r1796b2876],
11	contraindications	NNS	O	contraindication	appos	6	SENT_63	[p4l1850t2795r2145b2858, p4l9t2900r457b2972],
12	to	TO	O	to	_	0	SENT_63	[p4l515t2907r597b2972],
13	aspirin	NN	O	aspirin	prep_to	11	SENT_63	[p4l654t2902r954b2990],
14	,	,	O	,	_	0	SENT_63	[p4l654t2902r954b2990],
15	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_63	[p4l1019t2900r1479b2990],
16	or	CC	O	or	_	0	SENT_63	[p4l1537t2920r1621b2972],
17	bivalirudin	NN	O	bivalirudin	conj_or	13	SENT_63	[p4l1678t2900r2141b2987],
18	,	,	O	,	_	0	SENT_63	[p4l1678t2900r2141b2987],
19	thrombocytopenia	NN	O	thrombocytopenia	nn	20	SENT_63	[p4l9t3014r767b3104],
20	(	NN	O	(	appos	6	SENT_63	[p4l826t2996r1790b3104],
21	<	JJR	O	<	npadvmod	24	SENT_63	[p4l826t2996r1790b3104],
22	1O0	CD	NUMBER	1o0	npadvmod	23	SENT_63	[p4l826t2996r1790b3104],
23	>	JJR	O	>	amod	21	SENT_63	[p4l826t2996r1790b3104],
24	<	JJR	O	<	amod	20	SENT_63	[p4l826t2996r1790b3104],
25	103cells/mm3	CD	NUMBER	103cells/mm3	num	26	SENT_63	[p4l826t2996r1790b3104],
26	)	NN	O	)	dep	20	SENT_63	[p4l826t2996r1790b3104],
27	,	,	O	,	_	0	SENT_63	[p4l826t2996r1790b3104],
28	anemia	NN	O	anemia	nn	30	SENT_63	[p4l1850t3016r2149b3085],
29	(	CD	NUMBER	(	num	30	SENT_63	[p4l15t3126r1045b3214],
30	hemoglobin	NN	O	hemoglobin	dep	31	SENT_63	[p4l15t3126r1045b3214],
31	<	JJR	O	<	appos	6	SENT_63	[p4l15t3126r1045b3214],
32	10gm/dl	CD	NUMBER	10gm/dl	num	33	SENT_63	[p4l15t3126r1045b3214],
33	)	NN	O	)	dep	31	SENT_63	[p4l15t3126r1045b3214],
34	,	,	O	,	_	0	SENT_63	[p4l15t3126r1045b3214],
35	renal	JJ	O	renal	amod	38	SENT_63	[p4l1124t3126r1335b3196],
36	failure	NN	O	failure	nn	38	SENT_63	[p4l1402t3126r1682b3196],
37	(	NN	O	(	nn	38	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
38	creatinine	NN	O	creatinine	appos	6	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
39	>	JJR	O	>	amod	49	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
40	2.5	CD	NUMBER	2.5	dep	39	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
41	mg/dL	NN	O	mg/dl	num	45	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
42	)	CD	NUMBER	)	num	41	SENT_63	[p4l1755t3127r2146b3214, p4l12t3238r640b3328],
43	or	CC	O	or	_	0	SENT_63	[p4l710t3258r795b3310],
44	prothrombin	NN	O	prothrombin	conj_or	41	SENT_63	[p4l863t3238r1384b3328],
45	time	NN	O	time	npadvmod	46	SENT_63	[p4l1455t3240r1645b3310],
46	>	JJR	O	>	amod	49	SENT_63	[p4l1711t3240r2150b3310],
47	1.5	CD	NUMBER	1.5	num	48	SENT_63	[p4l1711t3240r2150b3310],
48	times	NNS	O	time	dep	46	SENT_63	[p4l1711t3240r2150b3310],
49	control	NN	O	control	dep	38	SENT_63	[p4l8t3351r328b3421],
50	.	.	O	.	_	0	SENT_63	[p4l8t3351r328b3421],

1	This	DT	O	this	det	2	SENT_64	[p4l119t3463r286b3534],
2	study	NN	O	study	nsubjpass	4	SENT_64	[p4l332t3463r552b3553],
3	was	VBD	O	be	auxpass	4	SENT_64	[p4l594t3482r747b3535],
4	approved	VBN	O	approve	_	0	SENT_64	[p4l794t3463r1174b3553],
5	by	IN	O	by	_	0	SENT_64	[p4l1226t3463r1318b3553],
6	the	DT	O	the	det	9	SENT_64	[p4l1362t3463r1496b3534],
7	lnvestigational	JJ	O	lnvestigational	amod	9	SENT_64	[p4l1547t3463r2148b3553],
8	Review	NNP	ORGANIZATION	Review	nn	9	SENT_64	[p4l13t3577r301b3647],
9	Board	NNP	ORGANIZATION	Board	agent	4	SENT_64	[p4l355t3576r583b3647],
10	of	IN	O	of	_	0	SENT_64	[p4l637t3576r720b3647],
11	the	DT	O	the	det	13	SENT_64	[p4l769t3576r902b3647],
12	Baylor	NNP	ORGANIZATION	Baylor	nn	13	SENT_64	[p4l957t3576r1213b3666],
13	College	NNP	ORGANIZATION	College	prep_of	9	SENT_64	[p4l1263t3576r1566b3666],
14	of	IN	ORGANIZATION	of	_	0	SENT_64	[p4l1619t3576r1701b3647],
15	Medicine	NNP	ORGANIZATION	Medicine	prep_of	13	SENT_64	[p4l1747t3576r2142b3663],
16	,	,	O	,	_	0	SENT_64	[p4l1747t3576r2142b3663],
17	Houston	NNP	LOCATION	Houston	nn	19	SENT_64	[p4l13t3690r368b3774],
18	,	,	O	,	_	0	SENT_64	[p4l13t3690r368b3774],
19	Texas	NNP	LOCATION	Texas	appos	15	SENT_64	[p4l401t3690r652b3774],
20	;	:	O	;	_	0	SENT_64	[p4l401t3690r652b3774],
21	all	DT	O	all	det	22	SENT_64	[p4l689t3689r786b3759],
22	patients	NNS	O	patient	nsubj	23	SENT_64	[p4l817t3690r1152b3777],
23	gave	VBD	O	give	parataxis	4	SENT_64	[p4l1180t3706r1367b3777],
24	informed	VBN	O	inform	amod	25	SENT_64	[p4l1395t3689r1766b3759],
25	consent	NN	O	consent	dobj	23	SENT_64	[p4l1796t3695r2140b3759],
26	.	.	O	.	_	0	SENT_64	[p4l1796t3695r2140b3759],

1	All	DT	O	all	det	2	SENT_65	[p5l6t19r113b91],
2	patients	NNS	O	patient	nsubj	3	SENT_65	[p5l141t21r475b109],
3	underwent	VBD	O	undergo	_	0	SENT_65	[p5l501t19r944b91],
4	coronary	JJ	O	coronary	amod	6	SENT_65	[p5l968t39r1330b109],
5	stent	NN	O	stent	nn	6	SENT_65	[p5l1352t26r1561b91],
6	implantation	NN	O	implantation	dobj	3	SENT_65	[p5l1585t19r2141b109],
7	.	.	O	.	_	0	SENT_65	[p5l1585t19r2141b109],

1	Medications	NNS	MISC	medication	_	0	SENT_66	[p5l7t275r570b353],

1	Immediately	RB	O	immediately	advmod	7	SENT_67	[p5l14t508r528b598],
2	following	VBG	O	follow	_	0	SENT_67	[p5l557t508r936b598],
3	the	DT	O	the	det	4	SENT_67	[p5l968t508r1102b579],
4	PCI	NN	O	pcus	prep_following	7	SENT_67	[p5l1138t509r1258b580],
5	all	DT	O	all	det	6	SENT_67	[p5l1295t508r1392b579],
6	patients	NNS	O	patient	nsubj	7	SENT_67	[p5l1429t510r1763b598],
7	received	VBD	O	receive	_	0	SENT_67	[p5l1798t508r2146b580],
8	300	CD	NUMBER	300	num	9	SENT_67	[p5l11t621r151b690],
9	mg	NN	O	mg	dobj	7	SENT_67	[p5l169t637r285b708],
10	of	IN	O	of	_	0	SENT_67	[p5l325t620r407b690],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_67	[p5l443t620r904b708],
12	and	CC	O	and	_	0	SENT_67	[p5l946t620r1089b690],
13	325	CD	NUMBER	325	num	14	SENT_67	[p5l1134t621r1271b690],
14	mg	NN	O	mg	dobj	7	SENT_67	[p5l1291t637r1407b708],
15	of	IN	O	of	_	0	SENT_67	[p5l1447t620r1530b690],
16	oral	JJ	O	oral	amod	17	SENT_67	[p5l1566t620r1722b690],
17	aspirin	NN	O	aspirin	prep_of	14	SENT_67	[p5l1764t621r2034b708],
18	in	IN	O	in	_	0	SENT_67	[p5l2078t621r2146b689],
19	the	DT	O	the	det	21	SENT_67	[p5l9t732r143b802],
20	catheterization	NN	O	catheterization	nn	21	SENT_67	[p5l183t732r819b802],
21	laboratory	NN	O	laboratory	prep_in	7	SENT_67	[p5l866t732r1293b820],
22	under	IN	O	under	_	0	SENT_67	[p5l1334t732r1570b802],
23	direct	JJ	O	direct	amod	24	SENT_67	[p5l1609t732r1852b802],
24	supervision	NN	O	supervision	prep_under	7	SENT_67	[p5l1892t751r2145b820, p5l7t844r267b913],
25	.	.	O	.	_	0	SENT_67	[p5l1892t751r2145b820, p5l7t844r267b913],

1	These	DT	O	these	det	2	SENT_68	[p5l324t843r566b913],
2	dosages	NNS	O	dosage	nsubjpass	4	SENT_68	[p5l617t843r936b931],
3	were	VBD	O	be	auxpass	4	SENT_68	[p5l984t862r1189b913],
4	followed	VBN	O	follow	_	0	SENT_68	[p5l1240t843r1594b913],
5	by	IN	O	by	_	0	SENT_68	[p5l1652t843r1744b931],
6	75	CD	NUMBER	75	num	7	SENT_68	[p5l1793t844r1883b913],
7	mg	NN	O	mg	agent	4	SENT_68	[p5l1903t860r2019b931],
8	of	IN	O	of	prep	7	SENT_68	[p5l2070t843r2153b913],

1	Genetic	JJ	O	genetic	amod	2	SENT_69	[p5l98t1007r239b1038],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_69	[p5l256t1006r527b1046],
3	of	IN	O	of	_	0	SENT_69	[p5l543t1006r580b1038],
4	the	DT	O	the	det	6	SENT_69	[p5l594t1006r653b1038],
5	platelet	NN	O	platelet	nn	6	SENT_69	[p5l671t1006r814b1046],
6	receptors	NNS	O	receptor	prep_of	2	SENT_69	[p5l832t1009r1004b1046],
7	P2Y12	NN	O	p2y12	nn	12	SENT_69	[p5l1021t1006r1129b1045],
8	,	,	O	,	_	0	SENT_69	[p5l1021t1006r1129b1045],
9	PZY1	NN	O	pzy1	nn	12	SENT_69	[p5l1151t1007r1221b1045],
10	and	CC	O	and	_	0	SENT_69	[p5l1242t1006r1305b1038],
11	GP	NN	O	gp	nn	12	SENT_69	[p5l1323t1007r1371b1038],
12	Illa	NN	PERSON	illum	dep	2	SENT_69	[p5l1389t1007r1435b1045],
13	357	CD	NUMBER	357	dep	12	SENT_69	[p5l2001t1006r2063b1038],

1	clopidogrel	NN	O	clopidogrel	_	0	SENT_70	[p5l9t1210r478b1300],
2	daily	RB	SET	daily	advmod	1	SENT_70	[p5l545t1210r747b1300],
3	for	IN	O	for	_	0	SENT_70	[p5l811t1210r931b1282],
4	23months	NNS	O	23month	prep_for	1	SENT_70	[p5l997t1210r1441b1282],
5	and	CC	O	and	_	0	SENT_70	[p5l1508t1210r1653b1282],
6	325mg	NN	O	325mg	prep_for	1	SENT_70	[p5l1725t1211r2002b1300],
7	of	IN	O	of	_	0	SENT_70	[p5l2068t1210r2152b1282],
8	aspirin	NN	O	aspirin	prep_of	1	SENT_70	[p5l10t1324r280b1413],
9	daily	JJ	SET	daily	amod	8	SENT_70	[p5l333t1323r531b1413],
10	thereafter	RB	O	thereafter	advmod	8	SENT_70	[p5l579t1323r1023b1394],
11	.	.	O	.	_	0	SENT_70	[p5l579t1323r1023b1394],

1	During	IN	O	during	_	0	SENT_71	[p5l1084t1324r1345b1413],
2	the	DT	O	the	det	3	SENT_71	[p5l1395t1323r1529b1394],
3	procedure	NN	O	procedure	prep_during	6	SENT_71	[p5l1582t1323r1999b1413],
4	all	DT	O	all	det	5	SENT_71	[p5l2050t1323r2148b1394],
5	patients	NNS	O	patient	nsubj	6	SENT_71	[p5l12t1437r358b1524],
6	received	VBD	O	receive	_	0	SENT_71	[p5l430t1436r790b1506],
7	intravenous	JJ	O	intravenous	amod	8	SENT_71	[p5l862t1437r1361b1506],
8	bivalirudin	NN	O	bivalirudin	dobj	6	SENT_71	[p5l1432t1436r1882b1506],
9	at	IN	O	at	_	0	SENT_71	[p5l1954t1443r2037b1506],
10	a	DT	O	a	det	12	SENT_71	[p5l2105t1455r2148b1506],
11	loading	VBG	O	load	amod	12	SENT_71	[p5l13t1548r307b1638],
12	dose	NN	O	dose	prep_at	6	SENT_71	[p5l344t1548r529b1620],
13	of	IN	O	of	_	0	SENT_71	[p5l565t1548r647b1620],
14	0.75	CD	NUMBER	0.75	num	15	SENT_71	[p5l681t1549r855b1620],
15	mg	NN	O	mg	prep_of	12	SENT_71	[p5l875t1550r1034b1638],
16	/	:	O	/	punct	17	SENT_71	[p5l875t1550r1034b1638],
17	kg	NN	O	kg	dep	6	SENT_71	[p5l1048t1548r1135b1638],
18	followed	VBN	O	follow	partmod	17	SENT_71	[p5l1172t1548r1525b1620],
19	by	IN	O	by	_	0	SENT_71	[p5l1568t1548r1660b1638],
20	an	DT	O	a	det	21	SENT_71	[p5l1695t1568r1786b1620],
21	infusion	NN	O	infusion	agent	18	SENT_71	[p5l1827t1548r2145b1620],
22	of	IN	O	of	_	0	SENT_71	[p5l9t1661r91b1732],
23	1.75	CD	NUMBER	1.75	num	24	SENT_71	[p5l130t1663r298b1732],
24	mg/kg/h	NN	O	mg/kg/h	prep_of	21	SENT_71	[p5l319t1661r676b1751],
25	until	IN	O	until	_	0	SENT_71	[p5l718t1661r902b1732],
26	PCI	NN	O	pcus	nn	27	SENT_71	[p5l944t1662r1063b1732],
27	completion	NN	O	completion	prep_until	6	SENT_71	[p5l1105t1661r1595b1751],
28	.	.	O	.	_	0	SENT_71	[p5l1105t1661r1595b1751],

1	Blood	NN	O	blood	nn	2	SENT_72	[p5l14t1917r269b1996],
2	sampling	NN	O	sampling	_	0	SENT_72	[p5l311t1917r726b2016],

1	Two	CD	NUMBER	two	num	3	SENT_73	[p5l7t2152r165b2221],
2	blood	NN	O	blood	nn	3	SENT_73	[p5l221t2150r441b2221],
3	samples	NNS	O	sample	nsubjpass	5	SENT_73	[p5l497t2150r824b2240],
4	were	VBD	O	be	auxpass	5	SENT_73	[p5l875t2169r1080b2221],
5	collected	VBN	O	collect	_	0	SENT_73	[p5l1133t2150r1513b2221],
6	in	IN	O	in	_	0	SENT_73	[p5l1571t2151r1639b2221],
7	tubes	NNS	O	tube	prep_in	5	SENT_73	[p5l1696t2150r1919b2221],
8	containing	VBG	O	contain	partmod	7	SENT_73	[p5l1972t2169r2143b2221, p5l9t2265r296b2353],
9	3.2	CD	PERCENT	3.2	num	10	SENT_73	[p5l365t2264r549b2334],
10	%	NN	PERCENT	%	dobj	8	SENT_73	[p5l365t2264r549b2334],
11	citrate	NN	O	citrate	dep	10	SENT_73	[p5l615t2265r924b2334],
12	.	.	O	.	_	0	SENT_73	[p5l615t2265r924b2334],

1	The	DT	O	the	det	2	SENT_74	[p5l997t2263r1152b2334],
2	tubes	NNS	O	tube	nsubj	3	SENT_74	[p5l1218t2263r1445b2334],
3	were	VBD	O	be	_	0	SENT_74	[p5l1508t2282r1716b2334],
4	filled	VBN	O	fill	dep	3	SENT_74	[p5l1782t2263r1997b2334],
5	to	TO	O	to	_	0	SENT_74	[p5l2066t2270r2149b2334],
6	capacity	NN	O	capacity	prep_to	4	SENT_74	[p5l9t2377r358b2464],
7	and	CC	O	and	_	0	SENT_74	[p5l385t2376r528b2446],
8	then	RB	O	then	advmod	9	SENT_74	[p5l559t2376r741b2446],
9	gently	RB	O	gently	advmod	10	SENT_74	[p5l773t2376r1029b2464],
10	mixed	JJ	O	mixed	dep	3	SENT_74	[p5l1058t2376r1329b2446],
11	.	.	O	.	_	0	SENT_74	[p5l1058t2376r1329b2446],

1	The	DT	O	the	det	7	SENT_75	[p5l1364t2376r1517b2446],
2	first	JJ	ORDINAL	first	amod	7	SENT_75	[p5l1545t2376r1712b2446],
3	(	NN	O	(	nn	7	SENT_75	[p5l1745t2376r2144b2464],
4	baseline	NN	O	baseline	nn	7	SENT_75	[p5l1745t2376r2144b2464],
5	)	CD	NUMBER	)	num	7	SENT_75	[p5l1745t2376r2144b2464],
6	blood	NN	O	blood	nn	7	SENT_75	[p5l12t2488r233b2560],
7	sample	NN	O	sample	nsubjpass	9	SENT_75	[p5l280t2488r569b2578],
8	was	VBD	O	be	auxpass	9	SENT_75	[p5l611t2508r764b2560],
9	obtained	VBN	O	obtain	_	0	SENT_75	[p5l808t2488r1168b2560],
10	in	IN	O	in	_	0	SENT_75	[p5l1216t2490r1285b2559],
11	the	DT	O	the	det	13	SENT_75	[p5l1333t2488r1466b2560],
12	catheterization	NN	O	catheterization	nn	13	SENT_75	[p5l1509t2488r2145b2560],
13	laboratory	NN	O	laboratory	prep_in	9	SENT_75	[p5l13t2601r453b2691],
14	,	,	O	,	_	0	SENT_75	[p5l13t2601r453b2691],
15	prior	RB	O	prior	_	0	SENT_75	[p5l499t2603r694b2691],
16	to	TO	O	to	_	0	SENT_75	[p5l726t2608r808b2672],
17	the	DT	O	the	det	21	SENT_75	[p5l843t2601r976b2672],
18	PCI	NN	O	pcus	nn	21	SENT_75	[p5l1015t2602r1134b2673],
19	and	CC	O	and	_	0	SENT_75	[p5l1174t2601r1317b2672],
20	clopidogrel	NN	O	clopidogrel	conj_and	18	SENT_75	[p5l1355t2601r1815b2691],
21	loading	NN	O	loading	prep_prior_to	9	SENT_75	[p5l1854t2601r2149b2691],
22	and	CC	O	and	_	0	SENT_75	[p5l10t2714r152b2784],
23	the	DT	O	the	det	25	SENT_75	[p5l192t2714r326b2784],
24	second	JJ	ORDINAL	second	amod	25	SENT_75	[p5l361t2714r640b2784],
25	sample	NN	O	sample	nsubjpass	27	SENT_75	[p5l679t2714r969b2802],
26	was	VBD	O	be	auxpass	27	SENT_75	[p5l1002t2733r1155b2784],
27	obtained	VBN	O	obtain	conj_and	9	SENT_75	[p5l1190t2714r1551b2784],
28	20	CD	NUMBER	20	number	29	SENT_75	[p5l1590t2714r1907b2784],
29	—	CD	NUMBER	—	num	30	SENT_75	[p5l1590t2714r1907b2784],
30	24h	NN	O	24h	dobj	27	SENT_75	[p5l1590t2714r1907b2784],
31	after	IN	O	after	_	0	SENT_75	[p5l1947t2714r2151b2784],
32	the	DT	O	the	det	33	SENT_75	[p5l9t2826r143b2896],
33	PCI	NN	O	pcus	prep_after	27	SENT_75	[p5l177t2826r327b2896],
34	.	.	O	.	_	0	SENT_75	[p5l177t2826r327b2896],

1	Blood	NN	O	blood	nn	2	SENT_76	[p5l369t2826r590b2896],
2	samples	NNS	O	sample	nsubjpass	4	SENT_76	[p5l623t2826r949b2914],
3	were	VBD	O	be	auxpass	4	SENT_76	[p5l977t2845r1182b2896],
4	processed	VBN	O	process	_	0	SENT_76	[p5l1214t2826r1616b2914],
5	within	IN	O	within	_	0	SENT_76	[p5l1647t2826r1903b2896],
6	1	CD	NUMBER	1	num	7	SENT_76	[p5l1941t2827r1965b2895],
7	h	NN	O	h	prep_within	4	SENT_76	[p5l1997t2826r2037b2895],
8	of	IN	O	of	_	0	SENT_76	[p5l2069t2826r2152b2896],
9	blood	NN	O	blood	nn	10	SENT_76	[p5l12t2937r233b3008],
10	collection	NN	O	collection	prep_of	7	SENT_76	[p5l272t2937r706b3008],
11	.	.	O	.	_	0	SENT_76	[p5l272t2937r706b3008],

1	Platelet	NN	O	platelet	nn	2	SENT_77	[p5l14t3178r380b3257],
2	aggregation	NN	O	aggregation	_	0	SENT_77	[p5l419t3180r968b3277],

1	Turbidimetric	JJ	MISC	turbidimetric	amod	3	SENT_78	[p5l7t3411r565b3482],
2	platelet	NN	O	platelet	nn	3	SENT_78	[p5l614t3411r939b3501],
3	aggregation	NN	O	aggregation	nsubjpass	5	SENT_78	[p5l985t3413r1468b3501],
4	was	VBD	O	be	auxpass	5	SENT_78	[p5l1514t3430r1667b3482],
5	performed	VBN	O	perform	_	0	SENT_78	[p5l1716t3411r2145b3501],
6	in	IN	O	in	_	0	SENT_78	[p5l9t3525r81b3594],
7	platelet-rich	JJ	O	platelet-rich	amod	8	SENT_78	[p5l155t3523r695b3613],
8	plasma	NN	O	plasma	prep_in	5	SENT_78	[p5l770t3523r1063b3613],
9	with	IN	O	with	_	0	SENT_78	[p5l1131t3523r1315b3594],
10	a	DT	O	a	det	12	SENT_78	[p5l1388t3542r1430b3594],
11	platelet	NN	O	platelet	nn	12	SENT_78	[p5l1503t3523r1842b3613],
12	count	NN	O	count	prep_with	5	SENT_78	[p5l1910t3530r2149b3594],
13	adjusted	VBN	O	adjust	partmod	12	SENT_78	[p5l10t3635r365b3725],
14	to	TO	O	to	_	0	SENT_78	[p5l413t3642r495b3706],
15	250	CD	NUMBER	250	num	16	SENT_78	[p5l540t3617r1179b3706],
16	>	JJR	O	>	prep_to	13	SENT_78	[p5l540t3617r1179b3706],
17	<	JJR	O	<	amod	18	SENT_78	[p5l540t3617r1179b3706],
18	1O3/mm3	NN	O	1o3/mm3	dep	16	SENT_78	[p5l540t3617r1179b3706],
19	.	.	O	.	_	0	SENT_78	[p5l540t3617r1179b3706],

1	Platelets	NNS	O	platelet	nsubjpass	3	SENT_79	[p5l1236t3635r1598b3706],
2	were	VBD	O	be	auxpass	3	SENT_79	[p5l1640t3654r1845b3706],
3	stimulated	VBN	O	stimulate	_	0	SENT_79	[p5l1890t3637r2143b3706, p6l13t19r221b89],

1	with	IN	O	with	dep	20	SENT_80	[p6l290t19r471b89],
2	O.	NNP	O	O.	nn	3	SENT_80	[p6l541t19r985b107],
3	5mg/mL	NNP	O	5mg/mL	pobj	1	SENT_80	[p6l541t19r985b107],
4	(	CD	NUMBER	(	number	5	SENT_80	[p6l1055t19r1590b107],
5	1.6	CD	NUMBER	1.6	dep	3	SENT_80	[p6l1055t19r1590b107],
6	mmol/L	NN	O	mmol/l	nn	12	SENT_80	[p6l1055t19r1590b107],
7	)	JJ	O	)	amod	12	SENT_80	[p6l1055t19r1590b107],
8	arachidonic	JJ	O	arachidonic	amod	12	SENT_80	[p6l1661t19r2148b89],
9	acid	NN	O	acid	nn	12	SENT_80	[p6l10t131r174b203],
10	(	CD	NUMBER	(	num	12	SENT_80	[p6l226t132r390b221],
11	AA	NN	O	aa	nn	12	SENT_80	[p6l226t132r390b221],
12	)	NN	O	)	dep	5	SENT_80	[p6l226t132r390b221],
13	and	CC	O	and	_	0	SENT_80	[p6l436t131r579b203],
14	with	IN	O	with	conj_and	1	SENT_80	[p6l623t131r802b203],
15	5	CD	NUMBER	5	pobj	14	SENT_80	[p6l850t133r889b203],
16	and	CC	O	and	_	0	SENT_80	[p6l934t131r1077b203],
17	20umol	CD	NUMBER	20umol	pobj	14	SENT_80	[p6l1122t131r1472b220],
18	/	:	O	/	punct	20	SENT_80	[p6l1122t131r1472b220],
19	L	NN	O	l	nn	20	SENT_80	[p6l1488t133r1528b202],
20	ADP	NN	O	adp	_	0	SENT_80	[p6l1566t132r1736b203],
21	.	.	O	.	_	0	SENT_80	[p6l1566t132r1736b203],

1	Aggregation	NN	O	aggregation	nsubjpass	3	SENT_81	[p6l1785t132r2143b221, p6l9t245r166b315],
2	was	VBD	O	be	auxpass	3	SENT_81	[p6l210t263r362b315],
3	performed	VBN	O	perform	_	0	SENT_81	[p6l408t244r838b334],
4	with	IN	O	with	_	0	SENT_81	[p6l881t244r1059b315],
5	a	DT	O	a	det	9	SENT_81	[p6l1105t263r1148b315],
6	BioData	NNP	MISC	BioData	nn	9	SENT_81	[p6l1195t245r1508b315],
7	PAP-4	NN	MISC	pap-4	nn	9	SENT_81	[p6l1555t245r1779b315],
8	platelet	NN	O	platelet	nn	9	SENT_81	[p6l1824t244r2149b334],
9	aggregometer	NN	O	aggregometer	prep_with	3	SENT_81	[p6l10t364r588b445],
10	(	CD	NUMBER	(	num	12	SENT_81	[p6l641t358r986b445],
11	BioData	NNP	ORGANIZATION	BioData	nn	12	SENT_81	[p6l641t358r986b445],
12	Corp.	NNP	ORGANIZATION	Corp.	dep	3	SENT_81	[p6l1037t357r1286b445],
13	,	,	O	,	_	0	SENT_81	[p6l1037t357r1286b445],
14	Horsham	NNP	ORGANIZATION	Horsham	appos	12	SENT_81	[p6l1349t357r1728b442],
15	,	,	O	,	_	0	SENT_81	[p6l1349t357r1728b442],
16	PA	NN	LOCATION	pa	nn	17	SENT_81	[p6l1790t358r1939b445],
17	)	NN	O	)	appos	12	SENT_81	[p6l1790t358r1939b445],
18	.	.	O	.	_	0	SENT_81	[p6l1790t358r1939b445],

1	The	DT	O	the	det	2	SENT_82	[p6l1995t357r2148b427],
2	extent	NN	O	extent	nsubjpass	6	SENT_82	[p6l9t476r279b541],
3	of	IN	O	of	_	0	SENT_82	[p6l318t469r400b541],
4	aggregation	NN	O	aggregation	prep_of	2	SENT_82	[p6l437t471r920b559],
5	was	VBD	O	be	auxpass	6	SENT_82	[p6l961t489r1114b541],
6	defined	VBN	O	define	_	0	SENT_82	[p6l1154t469r1463b541],
7	as	IN	O	as	mark	14	SENT_82	[p6l1506t489r1587b541],
8	the	DT	O	the	det	10	SENT_82	[p6l1626t469r1760b541],
9	maximal	JJ	O	maximal	amod	10	SENT_82	[p6l1803t469r2147b541],
10	amount	NN	O	amount	nsubj	14	SENT_82	[p6l10t589r321b653],
11	of	IN	O	of	_	0	SENT_82	[p6l360t582r443b653],
12	light	JJ	O	light	amod	13	SENT_82	[p6l484t582r665b672],
13	transmission	NN	O	transmission	prep_of	10	SENT_82	[p6l706t584r1215b653],
14	reached	VBD	O	reach	advcl	6	SENT_82	[p6l1262t582r1588b653],
15	:6	CD	NUMBER	:6	num	16	SENT_82	[p6l1629t583r1739b653],
16	min	NN	DURATION	min	dobj	14	SENT_82	[p6l1758t584r1902b653],
17	after	IN	O	after	_	0	SENT_82	[p6l1947t582r2151b653],
18	addition	NN	O	addition	prep_after	14	SENT_82	[p6l10t695r345b766],
19	of	IN	O	of	_	0	SENT_82	[p6l389t695r471b766],
20	the	DT	O	the	det	21	SENT_82	[p6l509t695r642b766],
21	agonist	NN	O	agonist	prep_of	18	SENT_82	[p6l683t697r1002b785],
22	,	,	O	,	_	0	SENT_82	[p6l683t697r1002b785],
23	with	IN	O	with	_	0	SENT_82	[p6l1049t695r1226b767],
24	platelet-poor	JJ	O	platelet-poor	amod	25	SENT_82	[p6l1273t695r1824b785],
25	plasma	NN	O	plasma	prep_with	14	SENT_82	[p6l1864t695r2148b785],
26	used	VBN	O	use	partmod	25	SENT_82	[p6l12t807r192b877],
27	as	IN	O	as	_	0	SENT_82	[p6l232t826r313b877],
28	a	DT	O	a	det	29	SENT_82	[p6l350t826r393b877],
29	reference	NN	O	reference	prep_as	26	SENT_82	[p6l433t807r858b877],
30	.	.	O	.	_	0	SENT_82	[p6l433t807r858b877],

1	Platelet	NN	O	platelet	nn	2	SENT_83	[p6l14t1047r379b1126],
2	activation	NN	O	activation	_	0	SENT_83	[p6l419t1050r888b1126],

1	Platelet	NN	O	platelet	nn	2	SENT_84	[p6l13t1281r337b1351],
2	activation	NN	O	activation	nsubjpass	4	SENT_84	[p6l398t1282r809b1351],
3	was	VBD	O	be	auxpass	4	SENT_84	[p6l870t1300r1024b1351],
4	determined	VBN	O	determine	dep	18	SENT_84	[p6l1085t1281r1562b1351],
5	by	IN	O	by	_	0	SENT_84	[p6l1629t1281r1721b1369],
6	assessing	VBG	O	assess	agent	4	SENT_84	[p6l1780t1282r2149b1369],
7	platelet	NN	O	platelet	nn	9	SENT_84	[p6l12t1393r337b1483],
8	surface	NN	O	surface	nn	9	SENT_84	[p6l374t1393r674b1465],
9	expression	NN	O	expression	dobj	6	SENT_84	[p6l713t1395r1144b1483],
10	of	IN	O	of	_	0	SENT_84	[p6l1184t1393r1267b1465],
11	activated	VBN	O	activate	amod	12	SENT_84	[p6l1302t1393r1688b1465],
12	GP	NN	O	gp	prep_of	9	SENT_84	[p6l1729t1394r1837b1465],
13	|	CD	NUMBER	|	num	15	SENT_84	[p6l1881t1393r2147b1465],
14	|	NN	O	|	nn	15	SENT_84	[p6l1881t1393r2147b1465],
15	b	NN	O	b	dep	12	SENT_84	[p6l1881t1393r2147b1465],
16	/	:	O	/	punct	18	SENT_84	[p6l1881t1393r2147b1465],
17	|	CD	NUMBER	|	num	18	SENT_84	[p6l1881t1393r2147b1465],
18	|	CD	NUMBER	|	_	0	SENT_84	[p6l1881t1393r2147b1465],
19	|	VBD	O	|	dep	18	SENT_84	[p6l1881t1393r2147b1465],
20	a	DT	O	a	det	21	SENT_84	[p6l1881t1393r2147b1465],
21	receptors	NNS	O	receptor	dobj	19	SENT_84	[p6l13t1513r402b1596],
22	and	CC	O	and	_	0	SENT_84	[p6l446t1506r590b1577],
23	P-selectin	NN	O	p-selectin	conj_and	21	SENT_84	[p6l641t1506r1043b1577],
24	in	IN	O	in	_	0	SENT_84	[p6l1090t1508r1159b1577],
25	response	NN	O	response	prep_in	21	SENT_84	[p6l1210t1525r1568b1596],
26	to	TO	O	to	_	0	SENT_84	[p6l1612t1513r1694b1577],
27	ADP	NN	ORGANIZATION	adp	nn	28	SENT_84	[p6l1735t1507r1896b1577],
28	stimulation	NN	O	stimulation	prep_to	19	SENT_84	[p6l1941t1508r2144b1577, p6l11t1619r322b1705],
29	,	,	O	,	_	0	SENT_84	[p6l1941t1508r2144b1577, p6l11t1619r322b1705],
30	using	VBG	O	use	partmod	19	SENT_84	[p6l397t1620r601b1707],
31	flow	NN	O	flow	nn	32	SENT_84	[p6l664t1619r843b1689],
32	cytometry	NN	O	cytometry	dobj	30	SENT_84	[p6l904t1626r1329b1707],
33	as	IN	O	as	mark	35	SENT_84	[p6l1391t1638r1472b1689],
34	previously	RB	DATE	previously	advmod	35	SENT_84	[p6l1537t1619r1955b1707],
35	described	VBN	O	describe	advcl	19	SENT_84	[p6l2017t1619r2144b1689, p6l9t1731r304b1803],
36	[	RB	O	[	advmod	35	SENT_84	[p6l379t1731r562b1821],
37	20	CD	NUMBER	20	num	38	SENT_84	[p6l379t1731r562b1821],
38	]	NN	O	]	dobj	35	SENT_84	[p6l379t1731r562b1821],
39	.	.	O	.	_	0	SENT_84	[p6l379t1731r562b1821],

1	Briefly	RB	O	briefly	advmod	14	SENT_85	[p6l640t1731r924b1821],
2	,	,	O	,	_	0	SENT_85	[p6l640t1731r924b1821],
3	GP	NN	O	gp	nn	6	SENT_85	[p6l998t1732r1106b1803],
4	|	CD	NUMBER	|	num	6	SENT_85	[p6l1179t1731r1448b1803],
5	|	NN	O	|	nn	6	SENT_85	[p6l1179t1731r1448b1803],
6	b	NN	O	b	nsubjpass	14	SENT_85	[p6l1179t1731r1448b1803],
7	/	:	O	/	punct	10	SENT_85	[p6l1179t1731r1448b1803],
8	|	CD	NUMBER	|	num	9	SENT_85	[p6l1179t1731r1448b1803],
9	|	CD	NUMBER	|	nsubj	10	SENT_85	[p6l1179t1731r1448b1803],
10	|	VBD	O	|	dep	6	SENT_85	[p6l1179t1731r1448b1803],
11	a	DT	O	a	det	12	SENT_85	[p6l1179t1731r1448b1803],
12	activation	NN	O	activation	dobj	10	SENT_85	[p6l1514t1733r1928b1803],
13	was	VBD	O	be	auxpass	14	SENT_85	[p6l1994t1751r2149b1803],
14	assessed	VBN	O	assess	_	0	SENT_85	[p6l10t1844r353b1914],
15	using	VBG	O	use	xcomp	14	SENT_85	[p6l413t1845r617b1932],
16	a	DT	O	a	det	19	SENT_85	[p6l672t1863r714b1914],
17	FITC-conjugated	JJ	O	fitc-conjugated	amod	19	SENT_85	[p6l772t1844r1448b1932],
18	PAC-1	NN	O	pac-1	nn	19	SENT_85	[p6l1508t1845r1722b1914],
19	antibody	NN	O	antibody	dobj	15	SENT_85	[p6l1790t1844r2151b1932],
20	(	CD	NUMBER	(	amod	19	SENT_85	[p6l15t1958r333b2046],
21	Becton	NNP	PERSON	Becton	nn	22	SENT_85	[p6l15t1958r333b2046],
22	Dickinson	NNP	PERSON	Dickinson	dep	20	SENT_85	[p6l408t1956r832b2043],
23	,	,	O	,	_	0	SENT_85	[p6l408t1956r832b2043],
24	San	NNP	LOCATION	San	nn	25	SENT_85	[p6l909t1957r1048b2028],
25	Jose	NNP	LOCATION	Jose	appos	22	SENT_85	[p6l1118t1958r1329b2043],
26	,	,	O	,	_	0	SENT_85	[p6l1118t1958r1329b2043],
27	CA	NNP	LOCATION	CA	appos	22	SENT_85	[p6l1406t1957r1545b2046],
28	)	CD	NUMBER	)	num	27	SENT_85	[p6l1406t1957r1545b2046],
29	which	WDT	O	which	nsubj	30	SENT_85	[p6l1614t1956r1858b2028],
30	binds	VBZ	O	bind	rcmod	27	SENT_85	[p6l1932t1956r2149b2028],
31	directly	RB	O	directly	advmod	30	SENT_85	[p6l9t2069r329b2159],
32	to	TO	O	to	_	0	SENT_85	[p6l361t2076r443b2140],
33	the	DT	O	the	det	37	SENT_85	[p6l477t2069r610b2140],
34	activated	VBN	O	activate	amod	37	SENT_85	[p6l645t2069r1031b2140],
35	GP	NN	O	gp	nn	37	SENT_85	[p6l1069t2070r1177b2140],
36	IIb/IIIa	NN	O	iib/iiia	nn	37	SENT_85	[p6l1217t2069r1483b2140],
37	receptor	NN	O	receptor	prep_to	30	SENT_85	[p6l1521t2076r1886b2159],
38	,	,	O	,	_	0	SENT_85	[p6l1521t2076r1886b2159],
39	while	IN	O	while	mark	43	SENT_85	[p6l1926t2069r2148b2140],
40	P-selectin	NN	MISC	p-selectin	nn	41	SENT_85	[p6l13t2182r415b2252],
41	expression	NN	O	expression	nsubjpass	43	SENT_85	[p6l465t2183r896b2270],
42	was	VBD	O	be	auxpass	43	SENT_85	[p6l943t2201r1097b2252],
43	determined	VBN	O	determine	advcl	14	SENT_85	[p6l1143t2182r1620b2252],
44	using	VBG	O	use	xcomp	43	SENT_85	[p6l1673t2183r1877b2270],
45	an	DT	O	a	det	52	SENT_85	[p6l1925t2201r2016b2252],
46	RPhycoerythrin-conjugated	JJ	MISC	rphycoerythrin-conjugated	amod	47	SENT_85	[p6l2070t2183r2144b2251, p6l13t2294r1083b2384],
47	monoclonal	JJ	O	monoclonal	amod	52	SENT_85	[p6l1155t2294r1626b2366],
48	anti-CD62P	JJ	O	anti-cd62p	amod	52	SENT_85	[p6l1692t2295r2148b2366],
49	antibody	NN	O	antibody	nn	52	SENT_85	[p6l10t2407r380b2497],
50	(	NN	O	(	nn	52	SENT_85	[p6l451t2409r587b2496],
51	BD	NN	PERSON	bd	nn	52	SENT_85	[p6l451t2409r587b2496],
52	Pharmingen	NN	PERSON	pharmingen	dobj	44	SENT_85	[p6l658t2407r1179b2497],
53	,	,	O	,	_	0	SENT_85	[p6l658t2407r1179b2497],
54	San	NNP	LOCATION	San	nn	55	SENT_85	[p6l1255t2408r1394b2479],
55	Jose	NNP	LOCATION	Jose	appos	52	SENT_85	[p6l1463t2409r1674b2494],
56	,	,	O	,	_	0	SENT_85	[p6l1463t2409r1674b2494],
57	CA	NNP	LOCATION	CA	nn	58	SENT_85	[p6l1750t2408r1919b2497],
58	)	NNP	O	)	appos	55	SENT_85	[p6l1750t2408r1919b2497],
59	.	.	O	.	_	0	SENT_85	[p6l1750t2408r1919b2497],

1	The	DT	O	the	det	4	SENT_86	[p6l1993t2407r2149b2478],
2	whole-blood	JJ	O	whole-blood	amod	4	SENT_86	[p6l7t2520r535b2590],
3	citrate	NN	O	citrate	nn	4	SENT_86	[p6l607t2521r897b2590],
4	mixture	NN	O	mixture	nsubjpass	35	SENT_86	[p6l969t2521r1299b2590],
5	was	VBD	O	be	auxpass	6	SENT_86	[p6l1366t2539r1523b2590],
6	diluted	VBN	O	dilute	_	0	SENT_86	[p6l1591t2520r1892b2590],
7	with	IN	O	with	mark	9	SENT_86	[p6l1961t2520r2145b2590],
8	Tyrodes	NNS	MISC	tyrode	nsubj	9	SENT_86	[p6l7t2632r320b2722],
9	buffer	VBP	O	buffer	advcl	6	SENT_86	[p6l377t2632r630b2704],
10	(	CD	NUMBER	(	number	11	SENT_86	[p6l688t2633r1098b2722],
11	137.0	CD	NUMBER	137.0	num	13	SENT_86	[p6l688t2633r1098b2722],
12	mM	NN	O	mm	nn	13	SENT_86	[p6l688t2633r1098b2722],
13	NaCl	NN	O	nacl	dobj	9	SENT_86	[p6l1154t2632r1363b2719],
14	,	,	O	,	_	0	SENT_86	[p6l1154t2632r1363b2719],
15	0.4	CD	NUMBER	0.4	num	17	SENT_86	[p6l1426t2633r1709b2704],
16	mM	NN	O	mm	nn	17	SENT_86	[p6l1426t2633r1709b2704],
17	NaH2PO4	NN	O	nah2po4	appos	13	SENT_86	[p6l1765t2633r2141b2719],
18	,	,	O	,	_	0	SENT_86	[p6l1765t2633r2141b2719],
19	11.9	CD	NUMBER	11.9	num	21	SENT_86	[p6l15t2746r349b2815],
20	mM	NN	O	mm	nn	21	SENT_86	[p6l15t2746r349b2815],
21	NaHCO3	NN	O	nahco3	appos	17	SENT_86	[p6l419t2746r772b2831],
22	,	,	O	,	_	0	SENT_86	[p6l419t2746r772b2831],
23	2.9	CD	NUMBER	2.9	num	25	SENT_86	[p6l847t2746r1137b2815],
24	mM	NN	O	mm	nn	25	SENT_86	[p6l847t2746r1137b2815],
25	KCl	NN	O	kcl	appos	17	SENT_86	[p6l1207t2745r1366b2831],
26	,	,	O	,	_	0	SENT_86	[p6l1207t2745r1366b2831],
27	5.5	CD	NUMBER	5.5	num	29	SENT_86	[p6l1446t2746r1732b2815],
28	mM	NN	O	mm	nn	29	SENT_86	[p6l1446t2746r1732b2815],
29	glucose	NN	O	glucose	appos	17	SENT_86	[p6l1798t2745r2141b2833],
30	,	,	O	,	_	0	SENT_86	[p6l1798t2745r2141b2833],
31	pH7	NN	O	ph7	nn	33	SENT_86	[p6l12t2858r339b2947],
32	.35	CD	NUMBER	.35	num	33	SENT_86	[p6l12t2858r339b2947],
33	)	NN	O	)	appos	17	SENT_86	[p6l12t2858r339b2947],
34	and	CC	O	and	_	0	SENT_86	[p6l386t2857r529b2929],
35	stimulated	VBN	O	stimulate	conj_and	6	SENT_86	[p6l576t2857r1013b2929],
36	with	IN	O	with	_	0	SENT_86	[p6l1058t2857r1236b2929],
37	10umol/L	NN	O	10umol/l	nn	38	SENT_86	[p6l1288t2857r1689b2946],
38	ADP	NN	O	adp	prep_with	35	SENT_86	[p6l1726t2858r1887b2928],
39	(	CD	NUMBER	(	num	42	SENT_86	[p6l1937t2857r2148b2947],
40	final	JJ	O	final	amod	42	SENT_86	[p6l1937t2857r2148b2947],
41	concentration	NN	O	concentration	nn	42	SENT_86	[p6l9t2973r618b3060],
42	)	NN	O	)	dobj	6	SENT_86	[p6l9t2973r618b3060],
43	for	IN	O	for	_	0	SENT_86	[p6l670t2971r788b3042],
44	5min	NN	O	5min	prep_for	6	SENT_86	[p6l837t2973r1068b3042],
45	.	.	O	.	_	0	SENT_86	[p6l837t2973r1068b3042],

1	The	DT	O	the	det	3	SENT_87	[p6l1123t2971r1276b3042],
2	corresponding	JJ	O	corresponding	amod	3	SENT_87	[p6l1325t2971r1907b3061],
3	antibody	NN	O	antibody	nsubjpass	8	SENT_87	[p6l1956t2973r2143b3042, p6l12t3083r206b3171],
4	was	VBD	O	be	auxpass	6	SENT_87	[p6l246t3102r399b3153],
5	then	RB	O	then	advmod	6	SENT_87	[p6l444t3083r626b3153],
6	added	VBN	O	add	_	0	SENT_87	[p6l673t3083r921b3153],
7	and	CC	O	and	_	0	SENT_87	[p6l969t3083r1112b3153],
8	incubated	VBN	O	incubate	conj_and	6	SENT_87	[p6l1160t3083r1567b3153],
9	for	IN	O	for	_	0	SENT_87	[p6l1615t3083r1733b3153],
10	20min	NN	O	20min	prep_for	6	SENT_87	[p6l1774t3084r2029b3153],
11	in	IN	O	in	_	0	SENT_87	[p6l2077t3084r2145b3152],
12	the	DT	O	the	det	16	SENT_87	[p6l9t3195r143b3267],
13	dark	JJ	O	dark	amod	16	SENT_87	[p6l190t3195r371b3267],
14	at	IN	O	at	_	0	SENT_87	[p6l416t3203r497b3267],
15	room	NN	O	room	prep_at	13	SENT_87	[p6l546t3215r748b3267],
16	temperature	NN	O	temperature	prep_in	10	SENT_87	[p6l799t3202r1348b3285],
17	.	.	O	.	_	0	SENT_87	[p6l799t3202r1348b3285],

1	Following	VBG	O	follow	_	0	SENT_88	[p6l1408t3195r1796b3285],
2	incubation	NN	O	incubation	prep_following	13	SENT_88	[p6l1844t3195r2144b3267, p6l9t3310r194b3395],
3	,	,	O	,	_	0	SENT_88	[p6l1844t3195r2144b3267, p6l9t3310r194b3395],
4	1mL	NN	O	1ml	nsubjpass	13	SENT_88	[p6l249t3310r423b3379],
5	of	IN	O	of	_	0	SENT_88	[p6l460t3308r543b3379],
6	phosphate-buffered	JJ	O	phosphate-buffered	amod	7	SENT_88	[p6l582t3308r1399b3398],
7	saline	NN	O	saline	prep_of	4	SENT_88	[p6l1441t3308r1678b3380],
8	containing	VBG	O	contain	partmod	7	SENT_88	[p6l1718t3310r2148b3398],
9	1	CD	PERCENT	1	number	10	SENT_88	[p6l15t3422r109b3491],
10	%	NN	PERCENT	%	amod	11	SENT_88	[p6l15t3422r109b3491],
11	paraformaldehyde	NN	O	paraformaldehyde	dobj	8	SENT_88	[p6l155t3421r912b3509],
12	was	VBD	O	be	auxpass	13	SENT_88	[p6l953t3440r1106b3491],
13	added	VBN	O	add	_	0	SENT_88	[p6l1150t3421r1397b3491],
14	for	IN	O	for	_	0	SENT_88	[p6l1444t3421r1562b3491],
15	fixation	NN	O	fixation	prep_for	13	SENT_88	[p6l1603t3421r1946b3491],
16	.	.	O	.	_	0	SENT_88	[p6l1603t3421r1946b3491],

1	The	DT	O	the	det	2	SENT_89	[p6l1995t3421r2148b3491],
2	samples	NNS	O	sample	nsubjpass	4	SENT_89	[p6l9t3533r336b3621],
3	were	VBD	O	be	auxpass	4	SENT_89	[p6l365t3552r570b3603],
4	analyzed	VBN	O	analyze	_	0	SENT_89	[p6l602t3533r964b3621],
5	with	IN	O	with	_	0	SENT_89	[p6l996t3533r1174b3603],
6	a	DT	O	a	det	10	SENT_89	[p6l1210t3552r1253b3603],
7	Coulter	NNP	O	Coulter	nn	10	SENT_89	[p6l1285t3533r1591b3603],
8	Epics	NNPS	O	Epics	nn	10	SENT_89	[p6l1624t3534r1827b3621],
9	XL	NNP	O	XL	nn	10	SENT_89	[p6l1856t3534r1955b3602],
10	MCL	NN	O	mcl	nn	11	SENT_89	[p6l1982t3533r2151b3603],
11	flow	NN	O	flow	prep_with	4	SENT_89	[p6l9t3645r187b3715],
12	cytometer	NN	O	cytometer	nn	14	SENT_89	[p6l213t3652r643b3733],
13	(	CD	NUMBER	(	num	14	SENT_89	[p6l675t3645r1431b3733],
14	Beckman-Coulter	NNP	O	Beckman-Coulter	dep	11	SENT_89	[p6l675t3645r1431b3733],
15	,	,	O	,	_	0	SENT_89	[p6l675t3645r1431b3733],
16	Miami	NNP	LOCATION	Miami	appos	11	SENT_89	[p6l1465t3646r1734b3731],
17	,	,	O	,	_	0	SENT_89	[p6l1465t3646r1734b3731],
18	FL	NN	O	fl	nn	19	SENT_89	[p6l1775t3647r1922b3733],
19	)	NN	O	)	appos	16	SENT_89	[p6l1775t3647r1922b3733],
20	.	.	O	.	_	0	SENT_89	[p6l1775t3647r1922b3733],

1	Nonstimulated	JJ	O	nonstimulated	_	0	SENT_90	[p6l1963t3647r2144b3715, p7l9t19r448b91],

1	samples	NNS	O	sample	nsubj	2	SENT_91	[p7l512t19r839b109],
2	served	VBD	O	serve	_	0	SENT_91	[p7l899t19r1163b91],
3	as	IN	O	as	_	0	SENT_91	[p7l1228t39r1309b91],
4	negative	JJ	O	negative	amod	5	SENT_91	[p7l1373t21r1724b109],
5	controls	NNS	O	control	prep_as	2	SENT_91	[p7l1784t19r2140b91],
6	.	.	O	.	_	0	SENT_91	[p7l1784t19r2140b91],

1	Both	DT	O	both	preconj	3	SENT_92	[p7l13t132r192b203],
2	PAC-1	NN	O	pac-1	nn	3	SENT_92	[p7l241t133r455b204],
3	binding	NN	O	binding	nsubjpass	7	SENT_92	[p7l514t132r812b222],
4	and	CC	O	and	_	0	SENT_92	[p7l855t132r998b203],
5	P-selectin	NN	O	p-selectin	conj_and	3	SENT_92	[p7l1047t132r1449b203],
6	were	VBD	O	be	auxpass	7	SENT_92	[p7l1492t151r1697b203],
7	expressed	VBN	O	express	_	0	SENT_92	[p7l1739t132r2145b222],
8	as	IN	O	as	_	0	SENT_92	[p7l10t264r91b315],
9	log	NN	O	log	nn	15	SENT_92	[p7l151t245r266b333],
10	mean	NN	O	mean	nn	15	SENT_92	[p7l326t264r543b315],
11	fluorescence	NN	O	fluorescence	nn	15	SENT_92	[p7l603t245r1130b315],
12	intensity	NN	O	intensity	nn	15	SENT_92	[p7l1188t246r1548b333],
13	(	CD	NUMBER	(	num	15	SENT_92	[p7l1609t247r1804b333],
14	MFI	NNP	ORGANIZATION	MFI	nn	15	SENT_92	[p7l1609t247r1804b333],
15	)	NN	O	)	prep_as	7	SENT_92	[p7l1609t247r1804b333],
16	and	CC	O	and	_	0	SENT_92	[p7l1865t245r2008b315],
17	as	IN	O	as	amod	19	SENT_92	[p7l2068t264r2149b315],
18	percent	JJ	O	percent	amod	19	SENT_92	[p7l12t364r329b447],
19	change	NN	O	change	prep_as	7	SENT_92	[p7l358t357r648b447],
20	in	IN	O	in	_	0	SENT_92	[p7l678t359r747b428],
21	MFI	NNP	ORGANIZATION	MFI	prep_in	19	SENT_92	[p7l776t359r909b429],
22	from	IN	O	from	_	0	SENT_92	[p7l944t357r1134b429],
23	baseline	NN	O	baseline	prep_from	7	SENT_92	[p7l1169t357r1506b429],
24	to	TO	O	to	_	0	SENT_92	[p7l1535t364r1617b429],
25	the	DT	O	the	det	27	SENT_92	[p7l1647t357r1780b429],
26	post-PCI	JJ	O	post-pci	amod	27	SENT_92	[p7l1813t358r2144b447],
27	sample	NN	O	sample	prep_to	7	SENT_92	[p7l9t470r324b560],
28	.	.	O	.	_	0	SENT_92	[p7l9t470r324b560],

1	Genotyping	VBG	O	genotype	_	0	SENT_93	[p7l10t727r550b824],

1	The	DT	O	the	det	3	SENT_94	[p7l7t958r161b1029],
2	PlA	NN	O	plum	nn	3	SENT_94	[p7l231t958r361b1029],
3	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_94	[p7l427t958r1006b1048],
4	of	IN	O	of	_	0	SENT_94	[p7l1075t958r1158b1029],
5	glycoprotein	NN	O	glycoprotein	nn	6	SENT_94	[p7l1221t958r1740b1048],
6	Illa	NN	PERSON	illum	prep_of	3	SENT_94	[p7l1813t960r1930b1029],
7	was	VBD	O	be	auxpass	8	SENT_94	[p7l1994t977r2150b1029],
8	genotyped	VBN	O	genotype	_	0	SENT_94	[p7l10t1071r439b1161],
9	by	IN	O	by	_	0	SENT_94	[p7l484t1071r576b1161],
10	real	JJ	O	real	amod	17	SENT_94	[p7l617t1071r771b1142],
11	time	NN	O	time	nn	17	SENT_94	[p7l811t1073r998b1142],
12	polymerase	NN	O	polymerase	nn	17	SENT_94	[p7l1040t1071r1510b1161],
13	chain	NN	O	chain	nn	17	SENT_94	[p7l1549t1071r1764b1142],
14	reaction	NN	O	reaction	nn	17	SENT_94	[p7l1810t1073r2145b1142],
15	(	CD	NUMBER	(	num	17	SENT_94	[p7l15t1185r231b1272],
16	PCR	NN	O	pcr	nn	17	SENT_94	[p7l15t1185r231b1272],
17	)	NN	O	)	agent	8	SENT_94	[p7l15t1185r231b1272],
18	[	CD	NUMBER	[	number	19	SENT_94	[p7l268t1184r417b1272],
19	11	CD	NUMBER	11	num	20	SENT_94	[p7l268t1184r417b1272],
20	]	NN	O	]	dep	17	SENT_94	[p7l268t1184r417b1272],
21	using	VBG	O	use	partmod	17	SENT_94	[p7l453t1185r659b1272],
22	ABI	NNP	O	ABI	nn	23	SENT_94	[p7l684t1185r809b1253],
23	PRISM	NNP	O	PRISM	nsubj	26	SENT_94	[p7l846t1185r1081b1254],
24	7700	CD	NUMBER	7700	num	26	SENT_94	[p7l1108t1185r1299b1254],
25	Sequence	NN	O	sequence	nn	26	SENT_94	[p7l1327t1185r1719b1272],
26	Detection	NN	O	detection	xcomp	21	SENT_94	[p7l1751t1185r2145b1254],
27	System	NNP	O	System	nn	32	SENT_94	[p7l10t1297r295b1386],
28	(	NNP	O	(	nn	32	SENT_94	[p7l346t1296r681b1386],
29	Applied	NNP	O	Applied	nn	32	SENT_94	[p7l346t1296r681b1386],
30	Biosystems	NNP	O	Biosystems	nn	32	SENT_94	[p7l731t1298r1175b1386],
31	Foster	NNP	O	Foster	nn	32	SENT_94	[p7l1220t1298r1474b1368],
32	City	NNP	O	City	dep	26	SENT_94	[p7l1514t1297r1690b1386],
33	,	,	O	,	_	0	SENT_94	[p7l1514t1297r1690b1386],
34	CA	NNP	LOCATION	CA	nn	35	SENT_94	[p7l1740t1297r1905b1386],
35	)	NNP	O	)	appos	26	SENT_94	[p7l1740t1297r1905b1386],
36	.	.	O	.	_	0	SENT_94	[p7l1740t1297r1905b1386],

1	Genotyping	NN	O	genotyping	nsubjpass	12	SENT_95	[p7l1956t1297r2144b1368, p7l9t1411r314b1499],
2	of	IN	O	of	_	0	SENT_95	[p7l365t1409r447b1480],
3	the	DT	O	the	det	5	SENT_95	[p7l495t1409r629b1480],
4	T744C	NN	O	t744c	nn	5	SENT_95	[p7l677t1410r930b1481],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_95	[p7l985t1409r1558b1499],
6	of	IN	O	of	_	0	SENT_95	[p7l1611t1409r1694b1480],
7	the	DT	O	the	det	10	SENT_95	[p7l1742t1409r1876b1480],
8	P2Y12	NN	O	p2y12	nn	10	SENT_95	[p7l1930t1410r2149b1495],
9	receptor	NN	O	receptor	nn	10	SENT_95	[p7l13t1529r367b1610],
10	gene	NN	O	gene	prep_of	5	SENT_95	[p7l405t1539r599b1610],
11	was	VBD	O	be	auxpass	12	SENT_95	[p7l636t1541r790b1592],
12	performed	VBN	O	perform	_	0	SENT_95	[p7l831t1522r1261b1610],
13	with	IN	O	with	_	0	SENT_95	[p7l1301t1522r1479b1592],
14	a	DT	O	a	det	16	SENT_95	[p7l1522t1541r1565b1592],
15	PCR	NN	O	pcr	nn	16	SENT_95	[p7l1608t1523r1764b1592],
16	method	NN	O	method	prep_with	12	SENT_95	[p7l1804t1522r2141b1608],
17	,	,	O	,	_	0	SENT_95	[p7l1804t1522r2141b1608],
18	as	IN	O	as	mark	20	SENT_95	[p7l10t1653r91b1704],
19	previously	RB	DATE	previously	advmod	20	SENT_95	[p7l144t1634r561b1722],
20	described	VBN	O	describe	dep	16	SENT_95	[p7l610t1634r1006b1704],
21	[	CD	NUMBER	[	number	22	SENT_95	[p7l1065t1634r1247b1722],
22	15	CD	NUMBER	15	num	23	SENT_95	[p7l1065t1634r1247b1722],
23	]	NN	O	]	dobj	20	SENT_95	[p7l1065t1634r1247b1722],
24	.	.	O	.	_	0	SENT_95	[p7l1065t1634r1247b1722],

1	The	DT	O	the	det	3	SENT_96	[p7l1303t1634r1456b1704],
2	C	NN	O	c	nn	3	SENT_96	[p7l1507t1634r1556b1704],
3	allele	NN	O	allele	nsubj	10	SENT_96	[p7l1607t1634r1835b1704],
4	of	IN	O	of	_	0	SENT_96	[p7l1886t1634r1968b1704],
5	the	DT	O	the	det	7	SENT_96	[p7l2015t1634r2149b1704],
6	T744C	NN	O	t744c	nn	7	SENT_96	[p7l7t1747r260b1818],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_96	[p7l305t1746r878b1836],
8	is	VBZ	O	be	cop	10	SENT_96	[p7l923t1748r981b1817],
9	a	DT	O	a	det	10	SENT_96	[p7l1022t1765r1064b1817],
10	constituent	NN	O	constituent	_	0	SENT_96	[p7l1106t1748r1577b1817],
11	of	IN	O	of	_	0	SENT_96	[p7l1617t1746r1700b1817],
12	the	DT	O	the	det	14	SENT_96	[p7l1738t1746r1872b1817],
13	minor	JJ	O	minor	amod	14	SENT_96	[p7l1915t1748r2152b1817],
14	haplotype	NN	O	haplotype	prep_of	10	SENT_96	[p7l12t1859r420b1949],
15	of	IN	O	of	_	0	SENT_96	[p7l484t1859r567b1930],
16	the	DT	O	the	det	17	SENT_96	[p7l627t1859r761b1930],
17	P2Y12	NN	O	p2y12	prep_of	14	SENT_96	[p7l828t1860r1046b1945],
18	previously	RB	DATE	previously	advmod	19	SENT_96	[p7l1114t1859r1531b1949],
19	described	VBN	O	describe	partmod	17	SENT_96	[p7l1594t1859r1989b1930],
20	by	IN	O	by	_	0	SENT_96	[p7l2059t1859r2151b1949],
21	Fontana	NNP	PERSON	Fontana	agent	19	SENT_96	[p7l13t1974r339b2043],
22	et	FW	O	et	nn	24	SENT_96	[p7l383t1979r466b2043],
23	al.	FW	O	al.	nn	24	SENT_96	[p7l509t1972r605b2043],
24	[	FW	O	[	dobj	19	SENT_96	[p7l662t1972r976b2062],
25	15,16	CD	NUMBER	15,16	num	26	SENT_96	[p7l662t1972r976b2062],
26	]	NN	O	]	dep	10	SENT_96	[p7l662t1972r976b2062],
27	.	.	O	.	_	0	SENT_96	[p7l662t1972r976b2062],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_97	[p7l1030t1974r1360b2043],
2	were	VBD	O	be	auxpass	3	SENT_97	[p7l1399t1991r1604b2043],
3	divided	VBN	O	divide	_	0	SENT_97	[p7l1646t1972r1944b2044],
4	into	IN	O	into	_	0	SENT_97	[p7l1990t1974r2149b2043],
5	2	CD	NUMBER	2	num	6	SENT_97	[p7l9t2086r52b2154],
6	groups	NNS	O	group	prep_into	3	SENT_97	[p7l97t2102r366b2173],
7	according	VBG	O	accord	_	0	SENT_97	[p7l409t2085r808b2173],
8	to	TO	O	to	prepc_according_to	3	SENT_97	[p7l852t2092r934b2155],
9	the	DT	O	the	det	10	SENT_97	[p7l978t2085r1111b2155],
10	presence	NN	O	presence	pobj	3	SENT_97	[p7l1158t2104r1526b2173],
11	or	CC	O	or	_	0	SENT_97	[p7l1569t2104r1653b2155],
12	absence	NN	O	absence	conj_or	10	SENT_97	[p7l1695t2085r2025b2155],
13	of	IN	O	of	_	0	SENT_97	[p7l2070t2085r2152b2155],
14	the	DT	O	the	det	16	SENT_97	[p7l10t2197r143b2269],
15	C	NN	O	c	nn	16	SENT_97	[p7l201t2198r251b2269],
16	allele	NN	O	allele	prep_of	10	SENT_97	[p7l309t2197r563b2269],
17	:	:	O	:	_	0	SENT_97	[p7l309t2197r563b2269],
18	carriers	NNS	O	carrier	nsubj	19	SENT_97	[p7l629t2199r942b2269],
19	(	VBP	O	(	parataxis	3	SENT_97	[p7l1005t2198r1141b2287],
20	CT	NN	O	ct	nn	21	SENT_97	[p7l1005t2198r1141b2287],
21	heterozygotes	NNS	O	heterozygote	dobj	19	SENT_97	[p7l1199t2197r1781b2287],
22	and	CC	O	and	_	0	SENT_97	[p7l1839t2197r1981b2269],
23	CC	NN	O	cc	nn	25	SENT_97	[p7l2043t2198r2148b2269],
24	homozygotes	NNS	O	homozygote	nn	25	SENT_97	[p7l13t2310r577b2400],
25	)	NN	O	)	conj_and	21	SENT_97	[p7l13t2310r577b2400],
26	and	CC	O	and	_	0	SENT_97	[p7l634t2310r777b2381],
27	non-carriers	JJ	O	non-carriers	amod	30	SENT_97	[p7l837t2312r1334b2381],
28	(	NN	O	(	nn	30	SENT_97	[p7l1393t2312r1527b2400],
29	TT	NN	O	tt	nn	30	SENT_97	[p7l1393t2312r1527b2400],
30	homozygotes	NNS	O	homozygote	dobj	19	SENT_97	[p7l1581t2310r2145b2400],
31	)	CD	NUMBER	)	dep	30	SENT_97	[p7l1581t2310r2145b2400],
32	of	IN	O	of	_	0	SENT_97	[p7l9t2423r92b2493],
33	the	DT	O	the	det	35	SENT_97	[p7l125t2423r259b2493],
34	C	NN	O	c	nn	35	SENT_97	[p7l295t2424r344b2493],
35	allele	NN	O	allele	prep_of	31	SENT_97	[p7l381t2423r634b2493],
36	.	.	O	.	_	0	SENT_97	[p7l381t2423r634b2493],

1	The	DT	O	the	det	2	SENT_98	[p7l676t2423r830b2493],
2	1622A	NN	O	1622a	nsubj	5	SENT_98	[p7l871t2424r1247b2493],
3	>	JJR	O	>	amod	5	SENT_98	[p7l871t2424r1247b2493],
4	G	NN	O	g	nn	5	SENT_98	[p7l871t2424r1247b2493],
5	polymorphism	NN	O	polymorphism	_	0	SENT_98	[p7l1288t2423r1861b2511],
6	of	IN	O	of	_	0	SENT_98	[p7l1900t2423r1982b2493],
7	the	DT	O	the	det	10	SENT_98	[p7l2015t2423r2149b2493],
8	PZY1	NN	O	pzy1	nn	10	SENT_98	[p7l13t2535r185b2620],
9	gene	NN	O	gene	nn	10	SENT_98	[p7l230t2552r425b2623],
10	[	NN	O	[	prep_of	5	SENT_98	[p7l465t2535r614b2623],
11	17	CD	NUMBER	17	num	12	SENT_98	[p7l465t2535r614b2623],
12	]	NN	O	]	nsubjpass	14	SENT_98	[p7l465t2535r614b2623],
13	was	VBD	O	be	auxpass	14	SENT_98	[p7l654t2554r807b2605],
14	detected	VBN	O	detect	rcmod	5	SENT_98	[p7l842t2535r1211b2605],
15	with	IN	O	with	_	0	SENT_98	[p7l1247t2535r1425b2605],
16	the	DT	O	the	det	17	SENT_98	[p7l1463t2535r1596b2605],
17	use	NN	O	use	prep_with	14	SENT_98	[p7l1634t2554r1765b2605],
18	of	IN	O	of	_	0	SENT_98	[p7l1800t2535r1883b2605],
19	a	DT	O	a	det	20	SENT_98	[p7l1914t2554r1957b2605],
20	PCR	NN	O	pcr	prep_of	17	SENT_98	[p7l1996t2535r2152b2605],
21	with	IN	O	with	_	0	SENT_98	[p7l7t2647r186b2719],
22	sense	NN	O	sense	prep_with	20	SENT_98	[p7l255t2666r479b2718],
23	(	CD	NUMBER	(	number	24	SENT_98	[p7l551t2648r1932b2737],
24	5	CD	NUMBER	5	num	22	SENT_98	[p7l551t2648r1932b2737],
25	’	SYM	O	’	dep	20	SENT_98	[p7l551t2648r1932b2737],
26	-	:	O	-	_	0	SENT_98	[p7l551t2648r1932b2737],
27	CGAGTACCTGCGAAGTTATT-3	NN	O	cgagtacctgcgaagttatt-3	nn	29	SENT_98	[p7l551t2648r1932b2737],
28	’	CD	NUMBER	’	num	29	SENT_98	[p7l551t2648r1932b2737],
29	)	NN	O	)	dep	20	SENT_98	[p7l551t2648r1932b2737],
30	and	CC	O	and	_	0	SENT_98	[p7l2002t2647r2145b2718],
31	antisense	JJ	O	antisense	amod	32	SENT_98	[p7l10t2760r396b2829],
32	(	NN	O	(	dep	20	SENT_98	[p7l468t2760r1768b2847],
33	5	CD	NUMBER	5	dep	5	SENT_98	[p7l468t2760r1768b2847],
34	’	SYM	O	’	dep	42	SENT_98	[p7l468t2760r1768b2847],
35	-	:	O	-	_	0	SENT_98	[p7l468t2760r1768b2847],
36	TTGCTGGGGTCTGAAAATCA	NN	O	ttgctggggtctgaaaatca	nn	38	SENT_98	[p7l468t2760r1768b2847],
37	)	NN	O	)	nn	38	SENT_98	[p7l468t2760r1768b2847],
38	primers	NNS	O	primer	npadvmod	42	SENT_98	[p7l1839t2760r2150b2848],
39	and	CC	O	and	_	0	SENT_98	[p7l10t2872r153b2943],
40	subsequent	JJ	O	subsequent	amod	41	SENT_98	[p7l195t2872r661b2962],
41	digestion	NN	O	digestion	npadvmod	42	SENT_98	[p7l699t2872r1069b2962],
42	of	IN	O	of	dep	33	SENT_98	[p7l1110t2872r1193b2943],
43	PCR	NN	O	pcr	nn	44	SENT_98	[p7l1232t2873r1387b2944],
44	product	NN	O	product	pobj	42	SENT_98	[p7l1426t2872r1743b2962],
45	with	IN	O	with	_	0	SENT_98	[p7l1779t2872r1956b2944],
46	BC	NN	O	bc	prep_with	44	SENT_98	[p7l1999t2872r2118b2943],
47	!	.	O	!	_	0	SENT_98	[p7l1999t2872r2118b2943],

1	I	PRP	O	I	_	0	SENT_99	[p7l2134t2874r2144b2943],
2	restriction	NN	O	restriction	nn	3	SENT_99	[p7l13t2986r446b3055],
3	enzyme	NN	O	enzyme	dep	1	SENT_99	[p7l515t3004r862b3073],
4	.	.	O	.	_	0	SENT_99	[p7l515t3004r862b3073],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_100	[p7l941t2986r1275b3055],
2	were	VBD	O	be	auxpass	3	SENT_100	[p7l1339t3004r1547b3055],
3	divided	VBN	O	divide	_	0	SENT_100	[p7l1614t2985r1917b3055],
4	into	IN	O	into	_	0	SENT_100	[p7l1987t2986r2149b3055],
5	2groups	NNS	O	2group	prep_into	3	SENT_100	[p7l9t3098r362b3187],
6	:	:	O	:	_	0	SENT_100	[p7l9t3098r362b3187],
7	carriers	NNS	O	carrier	dep	14	SENT_100	[p7l405t3099r718b3169],
8	of	IN	O	of	_	0	SENT_100	[p7l751t3097r834b3169],
9	the	DT	O	the	det	11	SENT_100	[p7l864t3097r998b3169],
10	G	NN	O	g	nn	11	SENT_100	[p7l1032t3098r1086b3169],
11	allele	NN	O	allele	prep_of	7	SENT_100	[p7l1123t3097r1350b3169],
12	(	CD	NUMBER	(	num	14	SENT_100	[p7l1390t3098r1528b3187],
13	AG	NNP	O	AG	nn	14	SENT_100	[p7l1390t3098r1528b3187],
14	heterozygotes	NNS	O	heterozygote	conj_and	3	SENT_100	[p7l1567t3097r2149b3187],
15	and	CC	O	and	_	0	SENT_100	[p7l10t3210r153b3281],
16	GG	NNS	O	gg	nn	17	SENT_100	[p7l199t3211r316b3282],
17	homozygotes	NNS	O	homozygote	dep	18	SENT_100	[p7l365t3210r930b3300],
18	)	NN	O	)	conj_and	3	SENT_100	[p7l365t3210r930b3300],
19	and	CC	O	and	_	0	SENT_100	[p7l977t3210r1120b3281],
20	non-carriers	JJ	O	non-carriers	amod	23	SENT_100	[p7l1169t3212r1667b3281],
21	(	NN	O	(	nn	23	SENT_100	[p7l1715t3211r1851b3300],
22	AA	NN	O	aa	nn	23	SENT_100	[p7l1715t3211r1851b3300],
23	homozygotes	NNS	O	homozygote	dep	24	SENT_100	[p7l1894t3210r2144b3281, p7l8t3325r348b3411],
24	)	CD	NUMBER	)	conj_and	3	SENT_100	[p7l1894t3210r2144b3281, p7l8t3325r348b3411],
25	of	IN	O	of	_	0	SENT_100	[p7l388t3323r471b3393],
26	the	DT	O	the	det	28	SENT_100	[p7l504t3323r638b3393],
27	G	NN	O	g	nn	28	SENT_100	[p7l675t3324r729b3393],
28	allele	NN	O	allele	prep_of	24	SENT_100	[p7l769t3323r1024b3393],
29	.	.	O	.	_	0	SENT_100	[p7l769t3323r1024b3393],

1	Definitions	NNS	O	definition	_	0	SENT_101	[p7l14t3578r521b3656],

1	Aspirin	NN	O	aspirin	nn	2	SENT_102	[p8l7t85r285b172],
2	insensitivity	NN	O	insensitivity	nsubjpass	4	SENT_102	[p8l330t85r828b172],
3	was	VBD	O	be	auxpass	4	SENT_102	[p8l864t103r1018b154],
4	defined	VBN	O	define	_	0	SENT_102	[p8l1058t84r1367b154],
5	as	IN	O	as	_	0	SENT_102	[p8l1412t103r1494b154],
6	0.5	CD	NUMBER	0.5	num	7	SENT_102	[p8l1534t84r1971b172],
7	mg/mL	NN	O	mg/ml	prep_as	4	SENT_102	[p8l1534t84r1971b172],
8	AAinduced	JJ	O	aainduced	amod	10	SENT_102	[p8l2007t85r2144b153, p8l10t196r331b268],
9	platelet	NN	O	platelet	nn	10	SENT_102	[p8l391t196r716b286],
10	aggregation	NN	O	aggregation	dep	7	SENT_102	[p8l769t198r1252b286],
11	220	CD	PERCENT	220	num	12	SENT_102	[p8l1311t197r1539b268],
12	%	NN	PERCENT	%	dep	7	SENT_102	[p8l1311t197r1539b268],
13	and	CC	O	and	_	0	SENT_102	[p8l1595t196r1737b268],
14	5umol	NN	O	5umol	prep_as	4	SENT_102	[p8l1797t196r2095b285],
15	/	:	O	/	punct	16	SENT_102	[p8l1797t196r2095b285],
16	L	NN	O	l	dep	14	SENT_102	[p8l2111t198r2151b267],
17	ADP-induced	JJ	O	adp-induced	amod	19	SENT_102	[p8l7t309r529b380],
18	platelet	NN	O	platelet	nn	19	SENT_102	[p8l572t309r897b399],
19	aggregation	NN	O	aggregation	dep	16	SENT_102	[p8l934t311r1417b399],
20	270	CD	PERCENT	270	num	21	SENT_102	[p8l1458t310r1688b380],
21	%	NN	PERCENT	%	dep	19	SENT_102	[p8l1458t310r1688b380],
22	[	CD	NUMBER	[	number	23	SENT_102	[p8l1730t309r1862b399],
23	5	CD	NUMBER	5	num	21	SENT_102	[p8l1730t309r1862b399],
24	]	NN	O	]	dep	14	SENT_102	[p8l1730t309r1862b399],
25	.	.	O	.	_	0	SENT_102	[p8l1730t309r1862b399],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_103	[p8l1908t309r2144b399, p8l10t422r268b512],
2	insensitivity	NN	O	insensitivity	nsubjpass	4	SENT_103	[p8l334t424r833b512],
3	was	VBD	O	be	auxpass	4	SENT_103	[p8l894t441r1047b494],
4	defined	VBN	O	define	_	0	SENT_103	[p8l1113t422r1422b493],
5	as	IN	O	as	_	0	SENT_103	[p8l1492t441r1573b493],
6	an	DT	O	a	det	8	SENT_103	[p8l1639t441r1730b493],
7	absolute	JJ	O	absolute	amod	8	SENT_103	[p8l1798t422r2148b493],
8	difference	NN	O	difference	prep_as	4	SENT_103	[p8l10t536r464b607],
9	between	IN	O	between	_	0	SENT_103	[p8l537t536r907b607],
10	baseline	NN	O	baseline	nn	11	SENT_103	[p8l983t536r1340b607],
11	aggregation	NN	O	aggregation	prep_between	8	SENT_103	[p8l1411t537r1923b626],
12	and	CC	O	and	_	0	SENT_103	[p8l1998t536r2146b607],
13	post-treatment	JJ	O	post-treatment	amod	14	SENT_103	[p8l12t654r643b736],
14	aggregation	NN	O	aggregation	conj_and	11	SENT_103	[p8l701t649r1185b736],
15	310	CD	PERCENT	310	num	16	SENT_103	[p8l1243t648r1460b718],
16	%	NN	PERCENT	%	dep	4	SENT_103	[p8l1243t648r1460b718],
17	in	IN	O	in	_	0	SENT_103	[p8l1518t649r1587b717],
18	response	NN	O	response	prep_in	4	SENT_103	[p8l1652t667r2009b736],
19	to	TO	O	to	_	0	SENT_103	[p8l2067t654r2149b718],
20	both	DT	O	both	preconj	21	SENT_103	[p8l13t760r191b832],
21	5	CD	NUMBER	5	prep_to	18	SENT_103	[p8l234t762r272b832],
22	and	CC	O	and	_	0	SENT_103	[p8l313t760r456b832],
23	20umol	CD	NUMBER	20umol	conj_and	21	SENT_103	[p8l495t760r845b849],
24	/	:	O	/	punct	26	SENT_103	[p8l495t760r845b849],
25	L	NN	O	l	nn	26	SENT_103	[p8l860t762r900b831],
26	ADP	NN	O	adp	dep	4	SENT_103	[p8l933t761r1094b831],
27	[	CD	NUMBER	[	number	28	SENT_103	[p8l1137t760r1269b850],
28	3	CD	NUMBER	3	dep	26	SENT_103	[p8l1137t760r1269b850],
29	]	NN	O	]	dep	28	SENT_103	[p8l1137t760r1269b850],
30	.	.	O	.	_	0	SENT_103	[p8l1137t760r1269b850],

1	Statistical	JJ	O	statistical	amod	2	SENT_104	[p8l10t1016r477b1095],
2	analysis	NN	O	analysis	_	0	SENT_104	[p8l517t1016r885b1115],

1	Continuous	JJ	O	continuous	amod	2	SENT_105	[p8l10t1250r466b1321],
2	variables	NNS	O	variable	nsubjpass	4	SENT_105	[p8l494t1249r867b1320],
3	are	VBP	O	be	auxpass	4	SENT_105	[p8l898t1268r1028b1320],
4	presented	VBN	O	present	_	0	SENT_105	[p8l1062t1249r1470b1339],
5	as	IN	O	as	_	0	SENT_105	[p8l1505t1268r1586b1320],
6	mean	JJ	O	mean	amod	15	SENT_105	[p8l1619t1268r1836b1320],
7	i	FW	O	i	nn	9	SENT_105	[p8l1864t1258r1919b1324],
8	stanstandard	FW	O	stanstandard	nn	9	SENT_105	[p8l1945t1256r2144b1320, p8l21t1362r377b1432],
9	deviation	NN	O	deviation	nn	15	SENT_105	[p8l415t1362r796b1432],
10	(	CD	NUMBER	(	num	12	SENT_105	[p8l839t1363r1064b1450],
11	S.D.	NNP	LOCATION	S.D.	nn	12	SENT_105	[p8l839t1363r1064b1450],
12	)	NN	O	)	dep	9	SENT_105	[p8l839t1363r1064b1450],
13	and	CC	O	and	_	0	SENT_105	[p8l1103t1362r1246b1432],
14	categorical	JJ	O	categorical	nn	15	SENT_105	[p8l1283t1362r1743b1450],
15	variables	NNS	O	variable	prep_as	4	SENT_105	[p8l1777t1362r2150b1432],
16	as	IN	O	as	_	0	SENT_105	[p8l10t1493r91b1544],
17	frequencies	NNS	O	frequency	prep_as	4	SENT_105	[p8l140t1474r623b1562],
18	and	CC	O	and	_	0	SENT_105	[p8l673t1474r816b1544],
19	percentages	NNS	O	percentage	prep_as	4	SENT_105	[p8l871t1480r1399b1562],
20	.	.	O	.	_	0	SENT_105	[p8l871t1480r1399b1562],

1	The	DT	O	the	det	2	SENT_106	[p8l1454t1474r1607b1544],
2	response	NN	O	response	nsubjpass	6	SENT_106	[p8l1660t1493r2017b1562],
3	to	TO	O	to	_	0	SENT_106	[p8l2067t1480r2149b1544],
4	aspirin	NN	O	aspirin	prep_to	2	SENT_106	[p8l10t1587r280b1674],
5	was	VBD	O	be	auxpass	6	SENT_106	[p8l347t1605r500b1656],
6	evaluated	VBN	O	evaluate	_	0	SENT_106	[p8l565t1586r973b1656],
7	by	IN	O	by	_	0	SENT_106	[p8l1044t1586r1136b1674],
8	the	DT	O	the	det	9	SENT_106	[p8l1200t1586r1334b1656],
9	level	NN	O	level	agent	6	SENT_106	[p8l1403t1586r1597b1656],
10	of	IN	O	of	_	0	SENT_106	[p8l1663t1586r1745b1656],
11	baseline	NN	O	baseline	nn	13	SENT_106	[p8l1811t1586r2149b1656],
12	platelet	NN	O	platelet	nn	13	SENT_106	[p8l13t1698r338b1788],
13	aggregation	NN	O	aggregation	prep_of	9	SENT_106	[p8l392t1700r875b1788],
14	in	IN	O	in	_	0	SENT_106	[p8l934t1700r1002b1769],
15	response	NN	O	response	prep_in	13	SENT_106	[p8l1064t1718r1420b1788],
16	to	TO	O	to	_	0	SENT_106	[p8l1476t1706r1557b1770],
17	AA	NN	O	aa	prep_to	6	SENT_106	[p8l1610t1699r1720b1769],
18	and	CC	O	and	_	0	SENT_106	[p8l1772t1698r1916b1770],
19	ADP	NN	O	adp	conj_and	17	SENT_106	[p8l1971t1699r2140b1770],
20	.	.	O	.	_	0	SENT_106	[p8l1971t1699r2140b1770],

1	The	DT	O	the	det	2	SENT_107	[p8l7t1811r160b1882],
2	response	NN	O	response	nsubjpass	6	SENT_107	[p8l208t1830r565b1901],
3	to	TO	O	to	_	0	SENT_107	[p8l610t1818r692b1882],
4	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_107	[p8l735t1811r1195b1901],
5	was	VBD	O	be	auxpass	6	SENT_107	[p8l1239t1830r1392b1882],
6	expressed	VBN	O	express	_	0	SENT_107	[p8l1435t1811r1842b1901],
7	as	IN	O	as	_	0	SENT_107	[p8l1890t1830r1971b1882],
8	the	DT	O	the	det	9	SENT_107	[p8l2015t1811r2149b1882],
9	change	NN	O	change	prep_as	6	SENT_107	[p8l9t1924r316b2012],
10	in	IN	O	in	_	0	SENT_107	[p8l389t1925r460b1993],
11	platelet	NN	O	platelet	nn	12	SENT_107	[p8l538t1924r887b2012],
12	aggregation	NN	O	aggregation	prep_in	9	SENT_107	[p8l958t1925r1475b2012],
13	or	CC	O	or	_	0	SENT_107	[p8l1549t1943r1637b1994],
14	activation	NN	O	activation	nn	15	SENT_107	[p8l1706t1925r2146b1994],
15	markers	NNS	O	marker	conj_or	12	SENT_107	[p8l13t2036r339b2108],
16	from	IN	O	from	_	0	SENT_107	[p8l377t2036r568b2108],
17	baseline	NN	O	baseline	prep_from	6	SENT_107	[p8l613t2036r949b2108],
18	to	TO	O	to	_	0	SENT_107	[p8l989t2043r1071b2108],
19	the	DT	O	the	det	21	SENT_107	[p8l1110t2036r1244b2108],
20	post-treatment	JJ	O	post-treatment	amod	21	SENT_107	[p8l1286t2043r1917b2126],
21	sample	NN	O	sample	prep_to	6	SENT_107	[p8l1956t2056r2144b2108, p8l13t2149r162b2239],
22	.	.	O	.	_	0	SENT_107	[p8l1956t2056r2144b2108, p8l13t2149r162b2239],

1	Comparisons	NNS	O	comparison	nsubjpass	6	SENT_108	[p8l237t2150r762b2239],
2	between	IN	O	between	_	0	SENT_108	[p8l831t2149r1187b2221],
3	continuous	JJ	O	continuous	amod	4	SENT_108	[p8l1256t2151r1709b2220],
4	variables	NNS	O	variable	prep_between	1	SENT_108	[p8l1771t2149r2150b2221],
5	were	VBD	O	be	auxpass	6	SENT_108	[p8l7t2281r212b2332],
6	performed	VBN	O	perform	_	0	SENT_108	[p8l268t2262r698b2350],
7	using	VBG	O	use	xcomp	6	SENT_108	[p8l756t2263r961b2350],
8	unpaired	JJ	O	unpaired	amod	9	SENT_108	[p8l1017t2262r1375b2350],
9	Student	NN	O	student	poss	11	SENT_108	[p8l1432t2262r1823b2332],
10	’s	POS	O	’s	_	0	SENT_108	[p8l1432t2262r1823b2332],
11	t-tests	NNS	O	t-test	dobj	7	SENT_108	[p8l1881t2268r2150b2332],
12	as	IN	O	as	mark	16	SENT_108	[p8l10t2394r91b2446],
13	these	DT	O	these	nsubjpass	16	SENT_108	[p8l128t2374r350b2446],
14	were	VBD	O	be	auxpass	16	SENT_108	[p8l385t2394r590b2446],
15	normally	RB	O	normally	advmod	16	SENT_108	[p8l630t2374r989b2464],
16	distributed	VBN	O	distribute	advcl	7	SENT_108	[p8l1025t2374r1505b2461],
17	,	,	O	,	_	0	SENT_108	[p8l1025t2374r1505b2461],
18	as	IN	O	as	mark	19	SENT_108	[p8l1551t2394r1632b2446],
19	determined	VBN	O	determine	advcl	16	SENT_108	[p8l1669t2374r2146b2446],
20	by	IN	O	by	_	0	SENT_108	[p8l12t2487r105b2575],
21	the	DT	O	the	det	22	SENT_108	[p8l161t2487r294b2557],
22	Shapiro	NNP	PERSON	Shapiro	prep_by	19	SENT_108	[p8l354t2487r909b2575],
23	.	.	O	.	_	0	SENT_108	[p8l354t2487r909b2575],

1	—	NN	O	—	_	0	SENT_109	[p8l354t2487r909b2575],
2	.	.	O	.	_	0	SENT_109	[p8l354t2487r909b2575],

1	Wilk	NNP	PERSON	Wilk	nsubj	2	SENT_110	[p8l354t2487r909b2575],
2	test	NN	O	test	_	0	SENT_110	[p8l965t2493r1147b2557],
3	.	.	O	.	_	0	SENT_110	[p8l965t2493r1147b2557],

1	Comparisons	NNS	O	comparison	_	0	SENT_111	[p8l1216t2488r1734b2575],
2	between	IN	O	between	prep	1	SENT_111	[p8l1794t2487r2146b2557],

1	358	CD	NUMBER	358	_	0	SENT_112	[p8l98t2650r159b2682],
2	E.	NNP	O	E.	nn	3	SENT_112	[p8l1810t2651r1866b2682],
3	|	NNP	O	|	dep	1	SENT_112	[p8l1810t2651r1866b2682],
4	.	.	O	.	_	0	SENT_112	[p8l1810t2651r1866b2682],

1	Lev	NNP	O	Lev	_	0	SENT_113	[p8l1888t2651r1948b2682],
2	et	FW	O	et	nn	3	SENT_113	[p8l1963t2653r2000b2682],
3	al.	FW	O	al.	dep	1	SENT_113	[p8l2016t2650r2059b2682],
4	.	.	O	.	_	0	SENT_113	[p8l2016t2650r2059b2682],

1	Table	NNP	O	Table	_	0	SENT_114	[p8l121t2772r212b2801],
2	1	CD	NUMBER	1	num	4	SENT_114	[p8l230t2773r241b2801],
3	Patient	NN	O	patient	nn	4	SENT_114	[p8l300t2773r415b2801],
4	characteristics	NNS	O	characteristic	dep	1	SENT_114	[p8l430t2772r671b2801],
5	Characteristic	JJ	O	characteristic	amod	7	SENT_114	[p8l122t2832r326b2858],
6	Total	JJ	O	total	amod	7	SENT_114	[p8l503t2832r575b2857],
7	group	NN	O	group	dep	4	SENT_114	[p8l588t2838r670b2864],
8	Aspirin-insensitive	JJ	MISC	aspirin-insensitive	amod	9	SENT_114	[p8l734t2832r1001b2864],
9	Aspirin-sensitive	JJ	MISC	aspirin-sensitive	amod	7	SENT_114	[p8l1053t2832r1293b2864],
10	Clopidogrel-insensitive	JJ	MISC	clopidogrel-insensitive	amod	11	SENT_114	[p8l1346t2832r1680b2864],
11	Clopidogrel-sensitive	JJ	MISC	clopidogrel-sensitive	amod	7	SENT_114	[p8l1733t2832r2039b2864],

1	Age	NNP	O	Age	nn	3	SENT_115	[p8l6t2964r150b3048],
2	(	CD	NUMBER	(	num	3	SENT_115	[p8l189t2964r451b3048],
3	years	NNS	NUMBER	year	nsubj	4	SENT_115	[p8l189t2964r451b3048],
4	)	VBP	O	)	_	0	SENT_115	[p8l189t2964r451b3048],
5	65.5	CD	NUMBER	65.5	dobj	4	SENT_115	[p8l1091t2964r1257b3031],
6	i	FW	O	i	dep	5	SENT_115	[p8l1281t2971r1335b3034],
7	10.9	CD	NUMBER	10.9	number	8	SENT_115	[p8l1365t2963r1527b3031],
8	67.2	CD	NUMBER	67.2	dep	6	SENT_115	[p8l1718t2963r1885b3031],
9	i	FW	O	i	dep	8	SENT_115	[p8l1910t2971r1963b3034],
10	10.6	CD	NUMBER	10.6	num	11	SENT_115	[p8l1992t2963r2154b3031],
11	Women	NNS	O	woman	dep	18	SENT_115	[p8l6t3075r292b3142],
12	38	CD	PERCENT	38	dep	11	SENT_115	[p8l1093t3075r1179b3142],
13	(	CD	PERCENT	(	number	14	SENT_115	[p8l1219t3075r1499b3159],
14	31.7	CD	PERCENT	31.7	num	15	SENT_115	[p8l1219t3075r1499b3159],
15	%	NN	PERCENT	%	dep	12	SENT_115	[p8l1219t3075r1499b3159],
16	)	CD	NUMBER	)	dep	18	SENT_115	[p8l1219t3075r1499b3159],
17	7	CD	PERCENT	7	num	18	SENT_115	[p8l1718t3075r1762b3140],
18	(	NN	PERCENT	(	dep	25	SENT_115	[p8l1800t3075r2115b3159],
19	58.3	CD	PERCENT	58.3	num	20	SENT_115	[p8l1800t3075r2115b3159],
20	%	NN	PERCENT	%	dep	18	SENT_115	[p8l1800t3075r2115b3159],
21	)	CD	NUMBER	)	number	22	SENT_115	[p8l1800t3075r2115b3159],
22	*	CD	NUMBER	*	num	23	SENT_115	[p8l1800t3075r2115b3159],
23	BMI	NN	O	bmus	dep	20	SENT_115	[p8l12t3185r138b3252],
24	(	CD	NUMBER	(	num	25	SENT_115	[p8l182t3166r480b3269],
25	kg/m2	NN	O	kg/m2	dep	36	SENT_115	[p8l182t3166r480b3269],
26	)	CD	NUMBER	)	number	27	SENT_115	[p8l182t3166r480b3269],
27	29.9	CD	NUMBER	29.9	dep	25	SENT_115	[p8l1090t3185r1335b3256],
28	:	:	O	:	_	0	SENT_115	[p8l1090t3185r1335b3256],
29	5.3	CD	NUMBER	5.3	num	30	SENT_115	[p8l1363t3185r1478b3252],
30	3o	NN	O	3o	dep	27	SENT_115	[p8l1720t3185r2107b3256],
31	.9:7.2	CD	NUMBER	.9:7.2	num	32	SENT_115	[p8l1720t3185r2107b3256],
32	Diabetes	NNP	O	Diabetes	dep	30	SENT_115	[p8l11t3296r349b3364],
33	39	CD	PERCENT	39	num	32	SENT_115	[p8l1093t3296r1178b3364],
34	(	CD	PERCENT	(	num	36	SENT_115	[p8l1219t3296r1499b3381],
35	32.5	CD	PERCENT	32.5	num	36	SENT_115	[p8l1219t3296r1499b3381],
36	%	NN	PERCENT	%	dep	43	SENT_115	[p8l1219t3296r1499b3381],
37	)	CD	NUMBER	)	number	38	SENT_115	[p8l1219t3296r1499b3381],
38	6	CD	NUMBER	6	num	39	SENT_115	[p8l1718t3297r1759b3364],
39	(	NN	O	(	dep	36	SENT_115	[p8l1800t3296r2000b3381],
40	50	CD	PERCENT	50	number	41	SENT_115	[p8l1800t3296r2000b3381],
41	%	NN	PERCENT	%	amod	39	SENT_115	[p8l1800t3296r2000b3381],
42	)	CD	NUMBER	)	num	43	SENT_115	[p8l1800t3296r2000b3381],
43	Hypertension	NN	O	hypertension	dep	50	SENT_115	[p8l11t3408r526b3492],
44	101	CD	PERCENT	101	number	45	SENT_115	[p8l1051t3408r1168b3475],
45	(	CD	PERCENT	(	dep	43	SENT_115	[p8l1222t3408r1500b3492],
46	84.2	CD	PERCENT	84.2	num	47	SENT_115	[p8l1222t3408r1500b3492],
47	%	NN	PERCENT	%	dep	45	SENT_115	[p8l1222t3408r1500b3492],
48	)	CD	NUMBER	)	number	49	SENT_115	[p8l1222t3408r1500b3492],
49	10	CD	NUMBER	10	num	50	SENT_115	[p8l1679t3408r1762b3475],
50	(	NN	O	(	dep	54	SENT_115	[p8l1802t3408r2081b3492],
51	83.3	CD	PERCENT	83.3	num	52	SENT_115	[p8l1802t3408r2081b3492],
52	%	NN	PERCENT	%	dep	50	SENT_115	[p8l1802t3408r2081b3492],
53	)	CD	NUMBER	)	num	54	SENT_115	[p8l1802t3408r2081b3492],
54	Hyperlipidemia	NN	ORGANIZATION	hyperlipidemia	dep	61	SENT_115	[p8l11t3517r609b3602],
55	86	CD	PERCENT	86	number	56	SENT_115	[p8l1091t3518r1179b3585],
56	(	CD	PERCENT	(	dep	54	SENT_115	[p8l1219t3518r1499b3602],
57	71.7	CD	PERCENT	71.7	num	58	SENT_115	[p8l1219t3518r1499b3602],
58	%	NN	PERCENT	%	dep	56	SENT_115	[p8l1219t3518r1499b3602],
59	)	CD	NUMBER	)	number	60	SENT_115	[p8l1219t3518r1499b3602],
60	10	CD	NUMBER	10	num	61	SENT_115	[p8l1679t3518r1762b3585],
61	(	NN	O	(	dep	65	SENT_115	[p8l1802t3518r2081b3602],
62	83.3	CD	PERCENT	83.3	num	63	SENT_115	[p8l1802t3518r2081b3602],
63	%	NN	PERCENT	%	dep	61	SENT_115	[p8l1802t3518r2081b3602],
64	)	CD	NUMBER	)	num	65	SENT_115	[p8l1802t3518r2081b3602],
65	Smoking	NN	O	smoking	dep	72	SENT_115	[p8l9t3628r333b3713],
66	39	CD	PERCENT	39	number	67	SENT_115	[p8l1093t3629r1178b3696],
67	(	CD	PERCENT	(	dep	65	SENT_115	[p8l1219t3629r1499b3713],
68	32.5	CD	PERCENT	32.5	num	69	SENT_115	[p8l1219t3629r1499b3713],
69	%	NN	PERCENT	%	dep	67	SENT_115	[p8l1219t3629r1499b3713],
70	)	CD	NUMBER	)	number	71	SENT_115	[p8l1219t3629r1499b3713],
71	4	CD	NUMBER	4	num	72	SENT_115	[p8l1716t3630r1761b3696],
72	(	NN	O	(	dep	75	SENT_115	[p8l1800t3629r2080b3713],
73	33.3	CD	PERCENT	33.3	num	74	SENT_115	[p8l1800t3629r2080b3713],
74	%	NN	PERCENT	%	dep	72	SENT_115	[p8l1800t3629r2080b3713],
75	)	CD	NUMBER	)	dep	4	SENT_115	[p8l1800t3629r2080b3713],

1	Prior	RB	O	prior	advmod	3	SENT_116	[p9l11t21r194b88],
2	MI	NNP	O	MI	pobj	1	SENT_116	[p9l224t21r305b88],
3	23	CD	PERCENT	23	_	0	SENT_116	[p9l1090t21r1176b88],
4	(	CD	PERCENT	(	number	5	SENT_116	[p9l1219t21r1499b105],
5	19.2	CD	PERCENT	19.2	dep	6	SENT_116	[p9l1219t21r1499b105],
6	%	NN	PERCENT	%	dep	3	SENT_116	[p9l1219t21r1499b105],
7	)	CD	NUMBER	)	num	9	SENT_116	[p9l1219t21r1499b105],
8	Prior	JJ	O	prior	amod	9	SENT_116	[p9l12t131r194b198],
9	CABG	NN	O	cabg	dep	3	SENT_116	[p9l227t131r435b198],
10	24	CD	PERCENT	24	number	11	SENT_116	[p9l1090t131r1180b197],
11	(	CD	PERCENT	(	amod	9	SENT_116	[p9l1219t131r1419b215],
12	20	CD	PERCENT	20	num	13	SENT_116	[p9l1219t131r1419b215],
13	%	NN	PERCENT	%	dep	11	SENT_116	[p9l1219t131r1419b215],
14	)	CD	NUMBER	)	num	15	SENT_116	[p9l1219t131r1419b215],
15	Race	NN	O	race	dep	9	SENT_116	[p9l13t242r195b308],

1	Caucasian	JJ	MISC	caucasian	amod	2	SENT_117	[p9l98t353r487b421],
2	76	CD	PERCENT	76	_	0	SENT_117	[p9l1091t353r1179b421],
3	(	CD	PERCENT	(	number	4	SENT_117	[p9l1219t353r1499b437],
4	63.3	CD	PERCENT	63.3	num	5	SENT_117	[p9l1219t353r1499b437],
5	%	NN	PERCENT	%	dep	2	SENT_117	[p9l1219t353r1499b437],
6	)	CD	NUMBER	)	num	7	SENT_117	[p9l1219t353r1499b437],
7	African-Amer	NNP	O	African-Amer	dep	5	SENT_117	[p9l95t463r634b531],
8	.	.	O	.	_	0	SENT_117	[p9l95t463r634b531],

1	4	CD	PERCENT	4	dep	7	SENT_118	[p9l1134t465r1179b530],
2	(	CD	PERCENT	(	num	4	SENT_118	[p9l1218t464r1450b548],
3	3.3	CD	PERCENT	3.3	num	4	SENT_118	[p9l1218t464r1450b548],
4	%	NN	PERCENT	%	dep	1	SENT_118	[p9l1218t464r1450b548],
5	)	CD	NUMBER	)	dep	7	SENT_118	[p9l1218t464r1450b548],
6	Hispanic	JJ	MISC	hispanic	amod	7	SENT_118	[p9l101t575r427b659],
7	origin	NN	O	origin	dep	14	SENT_118	[p9l462t575r681b659],
8	29	CD	PERCENT	29	num	9	SENT_118	[p9l1090t575r1178b642],
9	(	CD	PERCENT	(	dep	7	SENT_118	[p9l1219t575r1499b659],
10	24.2	CD	PERCENT	24.2	number	11	SENT_118	[p9l1219t575r1499b659],
11	%	NN	PERCENT	%	amod	9	SENT_118	[p9l1219t575r1499b659],
12	)	CD	NUMBER	)	num	14	SENT_118	[p9l1219t575r1499b659],
13	Asian	JJ	MISC	asian	amod	14	SENT_118	[p9l95t686r299b753],
14	origin	NN	O	origin	dep	19	SENT_118	[p9l337t687r556b770],
15	11	CD	PERCENT	11	dep	14	SENT_118	[p9l1096t687r1166b753],
16	(	CD	PERCENT	(	number	17	SENT_118	[p9l1219t686r1451b770],
17	9.2	CD	PERCENT	9.2	num	18	SENT_118	[p9l1219t686r1451b770],
18	%	NN	PERCENT	%	dep	15	SENT_118	[p9l1219t686r1451b770],
19	)	CD	NUMBER	)	_	0	SENT_118	[p9l1219t686r1451b770],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_119	[p9l12t797r439b882],
2	data	NNS	O	datum	_	0	SENT_119	[p9l471t797r644b864],

1	Hemoglobin	NN	O	hemoglobin	nn	3	SENT_120	[p9l101t907r562b992],
2	(	NN	O	(	nn	3	SENT_120	[p9l604t907r843b992],
3	g/dL	NN	O	g/dl	nsubj	9	SENT_120	[p9l604t907r843b992],
4	)	CD	NUMBER	)	num	8	SENT_120	[p9l604t907r843b992],
5	13.7	CD	NUMBER	13.7	num	8	SENT_120	[p9l1096t908r1480b979],
6	i1	NN	O	i1	nn	8	SENT_120	[p9l1096t908r1480b979],
7	.5	CD	NUMBER	.5	num	8	SENT_120	[p9l1096t908r1480b979],
8	Platelets	NNS	O	platelet	dep	3	SENT_120	[p9l101t1018r447b1087],
9	(	VBP	O	(	_	0	SENT_120	[p9l486t1002r898b1104],
10	103/mm3	CD	NUMBER	103/mm3	dobj	9	SENT_120	[p9l486t1002r898b1104],
11	)	CD	NUMBER	)	number	12	SENT_120	[p9l486t1002r898b1104],
12	208.4	CD	NUMBER	208.4	num	13	SENT_120	[p9l1045t1020r1262b1087],
13	¢	NN	O	¢	dep	10	SENT_120	[p9l1284t1028r1337b1091],
14	62	CD	NUMBER	62	num	15	SENT_120	[p9l1361t1020r1449b1088],
15	Creatinine	NN	O	creatinine	dep	20	SENT_120	[p9l98t1131r510b1199],
16	(	CD	NUMBER	(	num	17	SENT_120	[p9l550t1131r862b1216],
17	mg/dL	NN	O	mg/dl	dep	15	SENT_120	[p9l550t1131r862b1216],
18	)	NN	O	)	dep	20	SENT_120	[p9l550t1131r862b1216],
19	1.1	CD	NUMBER	1.1	num	18	SENT_120	[p9l1142t1132r1244b1198],
20	i	FW	O	i	dep	10	SENT_120	[p9l1280t1139r1333b1202],
21	0.4	CD	NUMBER	0.4	dep	20	SENT_120	[p9l1357t1131r1481b1198],

1	Baseline	NN	O	baseline	nn	2	SENT_121	[p9l11t1241r334b1309],
2	medications	NNS	O	medication	_	0	SENT_121	[p9l371t1241r846b1309],

1	12.7	CD	NUMBER	12.7	num	3	SENT_122	[p9l1724t908r2141b979],
2	i1	NN	O	i1	nn	3	SENT_122	[p9l1724t908r2141b979],
3	.3	NN	NUMBER	.3	_	0	SENT_122	[p9l1724t908r2141b979],
4	*	CD	NUMBER	*	dep	3	SENT_122	[p9l1724t908r2141b979],

1	236.94	CD	NUMBER	236.94	_	0	SENT_123	[p9l1673t1020r1964b1091],
2	;	:	O	;	_	0	SENT_123	[p9l1673t1020r1964b1091],
3	71	CD	NUMBER	71	number	4	SENT_123	[p9l1989t1021r2063b1086],
4	1.2	CD	NUMBER	1.2	num	6	SENT_123	[p9l1768t1131r2108b1202],
5	iO	NN	O	io	nn	6	SENT_123	[p9l1768t1131r2108b1202],
6	.4	NN	NUMBER	.4	dep	1	SENT_123	[p9l1768t1131r2108b1202],

1	o	NN	O	o	dep	10	SENT_124	[p9l1720t1354r1762b1421],
2	(	CD	PERCENT	(	number	3	SENT_124	[p9l1802t1354r2081b1438],
3	83.3	CD	PERCENT	83.3	num	4	SENT_124	[p9l1802t1354r2081b1438],
4	%	NN	PERCENT	%	dep	1	SENT_124	[p9l1802t1354r2081b1438],
5	)	CD	NUMBER	)	number	6	SENT_124	[p9l1802t1354r2081b1438],
6	8	CD	PERCENT	8	num	7	SENT_124	[p9l1718t1465r1759b1533],
7	(	NN	PERCENT	(	dep	4	SENT_124	[p9l1800t1465r2080b1549],
8	67.7	CD	PERCENT	67.7	num	9	SENT_124	[p9l1800t1465r2080b1549],
9	%	NN	PERCENT	%	dep	10	SENT_124	[p9l1800t1465r2080b1549],
10	)	CD	NUMBER	)	dep	17	SENT_124	[p9l1800t1465r2080b1549],
11	4	CD	NUMBER	4	num	12	SENT_124	[p9l1716t1577r1761b1643],
12	(	NN	O	(	dep	10	SENT_124	[p9l1800t1576r2080b1660],
13	33.3	CD	PERCENT	33.3	num	14	SENT_124	[p9l1800t1576r2080b1660],
14	%	NN	PERCENT	%	dep	12	SENT_124	[p9l1800t1576r2080b1660],
15	)	CD	NUMBER	)	number	16	SENT_124	[p9l1800t1576r2080b1660],
16	65.9	CD	NUMBER	65.9	num	14	SENT_124	[p9l1749t1682r1973b1748],
17	i	FW	O	i	dep	25	SENT_124	[p9l1749t1682r1973b1748],
18	11.3	CD	NUMBER	11.3	number	19	SENT_124	[p9l2000t1682r2148b1744],
19	26	CD	NUMBER	26	num	20	SENT_124	[p9l1706t1787r1788b1849],
20	(	NN	O	(	dep	17	SENT_124	[p9l1824t1787r2082b1865],
21	28.6	CD	PERCENT	28.6	num	22	SENT_124	[p9l1824t1787r2082b1865],
22	%	NN	PERCENT	%	dep	20	SENT_124	[p9l1824t1787r2082b1865],
23	)	CD	NUMBER	)	number	24	SENT_124	[p9l1824t1787r2082b1865],
24	29.4	CD	NUMBER	29.4	num	22	SENT_124	[p9l1748t1889r1973b1954],
25	i	FW	O	i	_	0	SENT_124	[p9l1748t1889r1973b1954],
26	5	CD	PERCENT	5	number	27	SENT_124	[p9l1998t1889r2032b1950],
27	31.9	CD	PERCENT	31.9	num	28	SENT_124	[p9l1852t1992r2055b2055],
28	%	NN	PERCENT	%	dep	25	SENT_124	[p9l1852t1992r2055b2055],
29	77	CD	PERCENT	77	number	30	SENT_124	[p9l1706t2096r1789b2157],
30	84.6	CD	PERCENT	84.6	dep	31	SENT_124	[p9l1850t2096r2055b2158],
31	%	NN	PERCENT	%	dep	28	SENT_124	[p9l1850t2096r2055b2158],

1	Statins	NNS	O	statin	dep	101	SENT_125	[p9l98t1354r364b1422],
2	86	CD	PERCENT	86	dep	101	SENT_125	[p9l1091t1354r1179b1422],
3	(	CD	PERCENT	(	dep	101	SENT_125	[p9l1219t1354r1499b1438],
4	71.7	CD	PERCENT	71.7	dep	101	SENT_125	[p9l1219t1354r1499b1438],
5	%	NN	PERCENT	%	dep	101	SENT_125	[p9l1219t1354r1499b1438],
6	)	CD	NUMBER	)	dep	101	SENT_125	[p9l1219t1354r1499b1438],
7	Beta-blockers	NNS	O	beta-blocker	dep	101	SENT_125	[p9l101t1465r640b1533],
8	67	CD	PERCENT	67	dep	101	SENT_125	[p9l1091t1465r1181b1533],
9	(	CD	PERCENT	(	dep	101	SENT_125	[p9l1219t1465r1499b1549],
10	55.8	CD	PERCENT	55.8	dep	101	SENT_125	[p9l1219t1465r1499b1549],
11	%	NN	PERCENT	%	dep	101	SENT_125	[p9l1219t1465r1499b1549],
12	)	CD	NUMBER	)	dep	101	SENT_125	[p9l1219t1465r1499b1549],
13	ACEI/ARB	NN	O	acei/arb	dep	101	SENT_125	[p9l95t1576r472b1644],
14	45	CD	PERCENT	45	dep	101	SENT_125	[p9l1089t1577r1177b1644],
15	(	CD	PERCENT	(	dep	101	SENT_125	[p9l1219t1576r1499b1660],
16	37.5	CD	PERCENT	37.5	dep	101	SENT_125	[p9l1219t1576r1499b1660],
17	%	NN	PERCENT	%	dep	101	SENT_125	[p9l1219t1576r1499b1660],
18	)	CD	NUMBER	)	dep	101	SENT_125	[p9l1219t1576r1499b1660],
19	65.3	CD	NUMBER	65.3	dep	101	SENT_125	[p9l51t1682r203b1744],
20	i	FW	O	i	dep	101	SENT_125	[p9l227t1690r276b1748],
21	10.6	CD	NUMBER	10.6	dep	101	SENT_125	[p9l304t1682r453b1744],
22	64.3	CD	NUMBER	64.3	dep	101	SENT_125	[p9l781t1682r934b1744],
23	i	FW	O	i	dep	101	SENT_125	[p9l957t1690r1006b1748],
24	10.1	CD	NUMBER	10.1	dep	101	SENT_125	[p9l1034t1682r1171b1744],
25	31	CD	NUMBER	31	dep	101	SENT_125	[p9l11t1787r78b1849],
26	(	NN	O	(	dep	101	SENT_125	[p9l128t1787r418b1865],
27	28.7	CD	PERCENT	28.7	dep	101	SENT_125	[p9l128t1787r418b1865],
28	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t1787r418b1865],
29	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t1787r418b1865],
30	*	CD	NUMBER	*	dep	101	SENT_125	[p9l128t1787r418b1865],
31	12	CD	NUMBER	12	dep	101	SENT_125	[p9l744t1787r819b1848],
32	(	NN	O	(	dep	101	SENT_125	[p9l858t1787r1116b1865],
33	41.4	CD	PERCENT	41.4	dep	101	SENT_125	[p9l858t1787r1116b1865],
34	%	NN	PERCENT	%	dep	101	SENT_125	[p9l858t1787r1116b1865],
35	)	CD	NUMBER	)	dep	101	SENT_125	[p9l858t1787r1116b1865],
36	29.8	CD	NUMBER	29.8	dep	101	SENT_125	[p9l50t1889r205b1951],
37	i	FW	O	i	dep	101	SENT_125	[p9l227t1896r276b1954],
38	5	CD	NUMBER	5	dep	101	SENT_125	[p9l301t1889r335b1950],
39	31.3	CD	NUMBER	31.3	dep	101	SENT_125	[p9l783t1889r934b1950],
40	i	FW	O	i	dep	101	SENT_125	[p9l957t1896r1006b1954],
41	6	CD	PERCENT	6	dep	101	SENT_125	[p9l1029t1889r1067b1951],
42	33	CD	PERCENT	33	dep	101	SENT_125	[p9l11t1992r88b2055],
43	(	NN	PERCENT	(	dep	101	SENT_125	[p9l128t1992r385b2071],
44	30.6	CD	PERCENT	30.6	dep	101	SENT_125	[p9l128t1992r385b2071],
45	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t1992r385b2071],
46	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t1992r385b2071],
47	10	CD	NUMBER	10	dep	101	SENT_125	[p9l744t1992r821b2055],
48	(	NN	O	(	dep	101	SENT_125	[p9l858t1992r1116b2071],
49	34.5	CD	PERCENT	34.5	dep	101	SENT_125	[p9l858t1992r1116b2071],
50	%	NN	PERCENT	%	dep	101	SENT_125	[p9l858t1992r1116b2071],
51	)	CD	PERCENT	)	dep	101	SENT_125	[p9l858t1992r1116b2071],
52	91	CD	PERCENT	91	dep	101	SENT_125	[p9l9t2096r78b2158],
53	(	NN	PERCENT	(	dep	101	SENT_125	[p9l128t2096r385b2174],
54	84.3	CD	PERCENT	84.3	dep	101	SENT_125	[p9l128t2096r385b2174],
55	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t2096r385b2174],
56	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t2096r385b2174],
57	24	CD	NUMBER	24	dep	101	SENT_125	[p9l739t2096r822b2157],
58	(	NN	O	(	dep	101	SENT_125	[p9l858t2096r1116b2174],
59	82.8	CD	PERCENT	82.8	dep	101	SENT_125	[p9l858t2096r1116b2174],
60	%	NN	PERCENT	%	dep	101	SENT_125	[p9l858t2096r1116b2174],
61	)	CD	NUMBER	)	dep	101	SENT_125	[p9l858t2096r1116b2174],
62	76	CD	NUMBER	76	dep	101	SENT_125	[p9l9t2198r90b2260],
63	(	NN	O	(	dep	101	SENT_125	[p9l128t2198r385b2276],
64	70.4	CD	PERCENT	70.4	dep	101	SENT_125	[p9l128t2198r385b2276],
65	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t2198r385b2276],
66	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t2198r385b2276],
67	21	CD	NUMBER	21	dep	101	SENT_125	[p9l739t2198r808b2260],
68	(	NN	O	(	dep	101	SENT_125	[p9l858t2198r1116b2276],
69	72.4	CD	PERCENT	72.4	dep	101	SENT_125	[p9l858t2198r1116b2276],
70	%	NN	PERCENT	%	dep	101	SENT_125	[p9l858t2198r1116b2276],
71	)	CD	NUMBER	)	dep	101	SENT_125	[p9l858t2198r1116b2276],
72	35	CD	NUMBER	35	dep	101	SENT_125	[p9l11t2301r89b2363],
73	(	NN	O	(	dep	101	SENT_125	[p9l128t2301r385b2379],
74	32.4	CD	PERCENT	32.4	dep	101	SENT_125	[p9l128t2301r385b2379],
75	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t2301r385b2379],
76	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t2301r385b2379],
77	8	CD	PERCENT	8	dep	101	SENT_125	[p9l782t2301r819b2363],
78	(	NN	PERCENT	(	dep	101	SENT_125	[p9l856t2301r1114b2379],
79	27.6	CD	PERCENT	27.6	dep	101	SENT_125	[p9l856t2301r1114b2379],
80	%	NN	PERCENT	%	dep	101	SENT_125	[p9l856t2301r1114b2379],
81	)	CD	NUMBER	)	dep	101	SENT_125	[p9l856t2301r1114b2379],
82	21	CD	NUMBER	21	dep	101	SENT_125	[p9l8t2405r78b2466],
83	(	NN	O	(	dep	101	SENT_125	[p9l128t2405r385b2483],
84	19.4	CD	PERCENT	19.4	dep	101	SENT_125	[p9l128t2405r385b2483],
85	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t2405r385b2483],
86	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t2405r385b2483],
87	7	CD	NUMBER	7	dep	101	SENT_125	[p9l781t2405r821b2466],
88	(	NN	O	(	dep	101	SENT_125	[p9l856t2405r1114b2483],
89	24.1	CD	PERCENT	24.1	dep	101	SENT_125	[p9l856t2405r1114b2483],
90	%	NN	PERCENT	%	dep	101	SENT_125	[p9l856t2405r1114b2483],
91	)	CD	NUMBER	)	dep	101	SENT_125	[p9l856t2405r1114b2483],
92	22	CD	NUMBER	22	dep	101	SENT_125	[p9l8t2507r90b2569],
93	(	NN	O	(	dep	101	SENT_125	[p9l128t2507r385b2585],
94	20.4	CD	PERCENT	20.4	dep	101	SENT_125	[p9l128t2507r385b2585],
95	%	NN	PERCENT	%	dep	101	SENT_125	[p9l128t2507r385b2585],
96	)	CD	NUMBER	)	dep	101	SENT_125	[p9l128t2507r385b2585],
97	6	CD	NUMBER	6	dep	101	SENT_125	[p9l781t2507r819b2569],
98	(	NN	O	(	dep	101	SENT_125	[p9l856t2507r1114b2585],
99	20.7	CD	PERCENT	20.7	dep	101	SENT_125	[p9l856t2507r1114b2585],
100	%	NN	PERCENT	%	dep	101	SENT_125	[p9l856t2507r1114b2585],
101	)	CD	NUMBER	)	_	0	SENT_125	[p9l856t2507r1114b2585],

1	13.9	CD	NUMBER	13.9	num	2	SENT_126	[p9l56t3232r440b3297],
2	i1	NN	O	i1	dep	14	SENT_126	[p9l56t3232r440b3297],
3	.6	CD	NUMBER	.6	num	4	SENT_126	[p9l56t3232r440b3297],
4	*	NN	O	*	dep	2	SENT_126	[p9l56t3232r440b3297],
5	13.6	CD	NUMBER	13.6	num	6	SENT_126	[p9l786t3232r1140b3297],
6	i1	NN	O	i1	dep	4	SENT_126	[p9l786t3232r1140b3297],
7	.8	CD	NUMBER	.8	number	8	SENT_126	[p9l786t3232r1140b3297],
8	204.8	CD	NUMBER	204.8	dep	6	SENT_126	[p9l8t3335r380b3400],
9	i62	NN	O	i62	dep	14	SENT_126	[p9l8t3335r380b3400],
10	218.4	CD	NUMBER	218.4	num	9	SENT_126	[p9l739t3335r1113b3400],
11	i64	NN	O	i64	nn	14	SENT_126	[p9l739t3335r1113b3400],
12	1.1	CD	NUMBER	1.1	num	14	SENT_126	[p9l97t3438r406b3503],
13	i0	NN	O	i0	nn	14	SENT_126	[p9l97t3438r406b3503],
14	.3	NN	NUMBER	.3	_	0	SENT_126	[p9l97t3438r406b3503],
15	1.14303	CD	NUMBER	1.14303	dep	14	SENT_126	[p9l828t3438r1136b3503],

1	13.8	CD	NUMBER	13.8	num	2	SENT_127	[p9l1753t3232r2106b3297],
2	i1	NN	O	i1	_	0	SENT_127	[p9l1753t3232r2106b3297],
3	.5	CD	NUMBER	.5	number	4	SENT_127	[p9l1753t3232r2106b3297],
4	204.9	CD	NUMBER	204.9	num	5	SENT_127	[p9l1706t3335r2152b3400],
5	i62	NN	O	i62	dep	2	SENT_127	[p9l1706t3335r2152b3400],
6	.8	CD	NUMBER	.8	number	7	SENT_127	[p9l1706t3335r2152b3400],
7	1.2	CD	NUMBER	1.2	num	9	SENT_127	[p9l1794t3438r2103b3503],
8	iO	NN	O	io	nn	9	SENT_127	[p9l1794t3438r2103b3503],
9	.3	NN	NUMBER	.3	dep	5	SENT_127	[p9l1794t3438r2103b3503],

1	59	CD	PERCENT	59	_	0	SENT_128	[p10l12t19r90b82],
2	(	CD	PERCENT	(	number	3	SENT_128	[p10l128t19r385b97],
3	54.6	CD	PERCENT	54.6	num	4	SENT_128	[p10l128t19r385b97],
4	%	NN	PERCENT	%	dep	1	SENT_128	[p10l128t19r385b97],
5	)	CD	NUMBER	)	number	6	SENT_128	[p10l128t19r385b97],
6	20	CD	NUMBER	20	num	7	SENT_128	[p10l739t19r821b82],
7	(	NN	O	(	dep	4	SENT_128	[p10l858t19r1042b97],
8	69	CD	PERCENT	69	num	9	SENT_128	[p10l858t19r1042b97],
9	%	NN	PERCENT	%	dep	1	SENT_128	[p10l858t19r1042b97],
10	)	CD	NUMBER	)	number	11	SENT_128	[p10l858t19r1042b97],
11	47	CD	NUMBER	47	num	12	SENT_128	[p10l1704t20r1789b81],
12	(	NN	O	(	dep	9	SENT_128	[p10l1824t19r2082b97],
13	51.6	CD	PERCENT	51.6	num	14	SENT_128	[p10l1824t19r2082b97],
14	%	NN	PERCENT	%	dep	1	SENT_128	[p10l1824t19r2082b97],
15	)	CD	NUMBER	)	number	16	SENT_128	[p10l1824t19r2082b97],
16	41	CD	NUMBER	41	num	17	SENT_128	[p10l7t123r78b184],
17	(	NN	O	(	dep	14	SENT_128	[p10l128t122r311b200],
18	38	CD	PERCENT	38	num	19	SENT_128	[p10l128t122r311b200],
19	%	NN	PERCENT	%	dep	1	SENT_128	[p10l128t122r311b200],
20	)	CD	NUMBER	)	number	21	SENT_128	[p10l128t122r311b200],
21	7	CD	NUMBER	7	num	22	SENT_128	[p10l781t123r821b184],
22	(	NN	O	(	dep	19	SENT_128	[p10l856t122r1114b200],
23	24.1	CD	PERCENT	24.1	num	24	SENT_128	[p10l856t122r1114b200],
24	%	NN	PERCENT	%	dep	1	SENT_128	[p10l856t122r1114b200],
25	)	CD	NUMBER	)	number	26	SENT_128	[p10l856t122r1114b200],
26	38	CD	NUMBER	38	num	27	SENT_128	[p10l1708t122r1788b185],
27	(	NN	O	(	dep	24	SENT_128	[p10l1824t122r2082b200],
28	41.8	CD	PERCENT	41.8	num	29	SENT_128	[p10l1824t122r2082b200],
29	%	NN	PERCENT	%	dep	1	SENT_128	[p10l1824t122r2082b200],
30	)	CD	NUMBER	)	num	32	SENT_128	[p10l1824t122r2082b200],
31	MB	NN	O	mb	nn	32	SENT_128	[p10l121t233r268b265],
32	|	NN	O	|	dep	29	SENT_128	[p10l121t233r268b265],
33	=	JJ	O	=	amod	55	SENT_128	[p10l121t233r268b265],
34	body	NN	O	body	nn	55	SENT_128	[p10l121t233r268b265],
35	mass	NN	O	mass	nn	55	SENT_128	[p10l288t240r357b258],
36	index	NN	O	index	nn	55	SENT_128	[p10l377t233r465b264],
37	,	,	O	,	_	0	SENT_128	[p10l377t233r465b264],
38	M	NN	O	m	dep	55	SENT_128	[p10l488t233r706b265],
39	|	NN	O	|	nn	55	SENT_128	[p10l488t233r706b265],
40	=	JJ	O	=	amod	55	SENT_128	[p10l488t233r706b265],
41	myocardial	JJ	O	myocardial	amod	55	SENT_128	[p10l488t233r706b265],
42	infarction	NN	O	infarction	nn	55	SENT_128	[p10l727t233r878b264],
43	,	,	O	,	_	0	SENT_128	[p10l727t233r878b264],
44	CABG	NN	O	cabg	nn	55	SENT_128	[p10l902t233r1134b265],
45	=	JJ	O	=	amod	55	SENT_128	[p10l902t233r1134b265],
46	coronary	JJ	O	coronary	amod	55	SENT_128	[p10l902t233r1134b265],
47	artery	NN	O	artery	nn	55	SENT_128	[p10l1154t235r1243b265],
48	bypass	NN	O	bypass	nn	55	SENT_128	[p10l1264t233r1358b265],
49	graft	NN	O	graft	nn	55	SENT_128	[p10l1379t233r1458b265],
50	,	,	O	,	_	0	SENT_128	[p10l1379t233r1458b265],
51	ACEI	NN	O	aceus	nn	55	SENT_128	[p10l1480t233r1906b265],
52	=	JJ	O	=	amod	55	SENT_128	[p10l1480t233r1906b265],
53	angiotensin-converting	JJ	O	angiotensin-converting	amod	55	SENT_128	[p10l1480t233r1906b265],
54	enzyme	NN	O	enzyme	nn	55	SENT_128	[p10l1927t240r2038b265],
55	inhibitors	NNS	O	inhibitor	dep	1	SENT_128	[p10l122t279r268b310],
56	,	,	O	,	_	0	SENT_128	[p10l122t279r268b310],
57	ARB	NN	O	arb	appos	55	SENT_128	[p10l283t279r531b311],
58	=	JJ	O	=	amod	61	SENT_128	[p10l283t279r531b311],
59	angiotensin	NN	O	angiotensin	nn	61	SENT_128	[p10l283t279r531b311],
60	receptor	NN	O	receptor	nn	61	SENT_128	[p10l546t281r671b311],
61	blockers	NNS	O	blocker	dep	1	SENT_128	[p10l683t279r812b310],
62	,	,	O	,	_	0	SENT_128	[p10l683t279r812b310],
63	African-Amer	NNP	O	African-Amer	appos	61	SENT_128	[p10l827t279r1025b304],
64	.	.	O	.	_	0	SENT_128	[p10l827t279r1025b304],

1	=	JJ	O	=	amod	2	SENT_129	[p10l1035t279r1317b305],
2	African-American	JJ	MISC	african-american	_	0	SENT_129	[p10l1035t279r1317b305],
3	.	.	O	.	_	0	SENT_129	[p10l1035t279r1317b305],

1	*	NN	O	*	nn	2	SENT_130	[p10l117t334r140b358],
2	P	NN	O	p	_	0	SENT_130	[p10l182t334r450b390],
3	<	JJR	O	<	dep	2	SENT_130	[p10l182t334r450b390],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_130	[p10l182t334r450b390],
5	.	.	O	.	_	0	SENT_130	[p10l182t334r450b390],

1	categorical	JJ	O	categorical	amod	2	SENT_131	[p10l9t560r470b649],
2	variables	NNS	O	variable	nsubjpass	4	SENT_131	[p10l529t560r903b631],
3	were	VBD	O	be	auxpass	4	SENT_131	[p10l960t579r1165b631],
4	performed	VBN	O	perform	_	0	SENT_131	[p10l1228t560r1658b649],
5	using	VBG	O	use	xcomp	4	SENT_131	[p10l1724t561r1929b649],
6	Chisquare	NNP	O	Chisquare	poss	11	SENT_131	[p10l1990t560r2148b631, p10l9t692r282b762],
7	or	CC	O	or	_	0	SENT_131	[p10l318t692r402b744],
8	Fisher	NNP	PERSON	Fisher	poss	11	SENT_131	[p10l440t672r755b744],
9	’s	POS	O	’s	_	0	SENT_131	[p10l440t672r755b744],
10	Exact	JJ	O	exact	amod	11	SENT_131	[p10l795t674r1017b744],
11	Tests	NNS	O	test	dobj	5	SENT_131	[p10l1050t674r1280b759],
12	,	,	O	,	_	0	SENT_131	[p10l1050t674r1280b759],
13	as	IN	O	as	_	0	SENT_131	[p10l1326t692r1406b744],
14	appropriate	JJ	O	appropriate	prep_as	5	SENT_131	[p10l1444t674r1956b762],
15	.	.	O	.	_	0	SENT_131	[p10l1444t674r1956b762],

1	The	DT	O	the	det	3	SENT_132	[p10l1999t672r2153b744],
2	X2	NN	O	x2	nn	3	SENT_132	[p10l9t766r92b874],
3	test	NN	O	test	nsubjpass	6	SENT_132	[p10l151t791r308b855],
4	was	VBD	O	be	auxpass	6	SENT_132	[p10l364t804r517b855],
5	also	RB	O	also	advmod	6	SENT_132	[p10l575t784r733b855],
6	used	VBN	O	use	_	0	SENT_132	[p10l793t784r974b855],
7	to	TO	O	to	aux	8	SENT_132	[p10l1035t791r1117b855],
8	compare	VB	O	compare	xcomp	6	SENT_132	[p10l1174t804r1531b874],
9	the	DT	O	the	det	11	SENT_132	[p10l1590t784r1723b855],
10	observed	VBN	O	observe	amod	11	SENT_132	[p10l1781t784r2149b855],
11	allele	NN	O	allele	dobj	8	SENT_132	[p10l10t899r239b970],
12	and	CC	O	and	_	0	SENT_132	[p10l285t899r428b970],
13	genotype	NN	O	genotype	nn	14	SENT_132	[p10l480t906r859b988],
14	frequencies	NNS	O	frequency	conj_and	11	SENT_132	[p10l907t899r1391b988],
15	with	IN	O	with	_	0	SENT_132	[p10l1434t899r1613b970],
16	the	DT	O	the	det	19	SENT_132	[p10l1663t899r1797b970],
17	HardyWeinberg	NN	O	hardyweinberg	nn	19	SENT_132	[p10l1848t899r2151b988, p10l7t1011r398b1101],
18	equilibrium	NN	O	equilibrium	nn	19	SENT_132	[p10l463t1011r936b1101],
19	prediction	NN	O	prediction	prep_with	8	SENT_132	[p10l1008t1011r1458b1101],
20	.	.	O	.	_	0	SENT_132	[p10l1008t1011r1458b1101],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_133	[p10l1529t1011r1883b1101],
2	were	VBD	O	be	auxpass	3	SENT_133	[p10l1946t1031r2153b1083],
3	performed	VBN	O	perform	_	0	SENT_133	[p10l12t1125r443b1214],
4	using	VBG	O	use	xcomp	3	SENT_133	[p10l504t1126r710b1214],
5	SPSS	NNP	ORGANIZATION	SPSS	dobj	4	SENT_133	[p10l766t1125r947b1196],
6	version	NN	O	version	dep	12	SENT_133	[p10l1001t1126r1294b1196],
7	11	CD	NUMBER	11	num	9	SENT_133	[p10l1359t1126r1431b1195],
8	statistical	JJ	O	statistical	amod	9	SENT_133	[p10l1501t1125r1907b1196],
9	software	NN	O	software	dep	6	SENT_133	[p10l1964t1125r2148b1196, p10l7t1257r217b1309],
10	(	CD	NUMBER	(	dep	12	SENT_133	[p10l293t1238r512b1327],
11	SPSS	NNP	ORGANIZATION	SPSS	nn	12	SENT_133	[p10l293t1238r512b1327],
12	Inc.	NNP	ORGANIZATION	Inc.	dep	4	SENT_133	[p10l588t1239r771b1324],
13	,	,	O	,	_	0	SENT_133	[p10l588t1239r771b1324],
14	Chicago	NNP	LOCATION	Chicago	appos	12	SENT_133	[p10l849t1237r1212b1327],
15	,	,	O	,	_	0	SENT_133	[p10l849t1237r1212b1327],
16	IL	NN	LOCATION	il	nn	17	SENT_133	[p10l1295t1239r1424b1327],
17	)	NN	O	)	appos	12	SENT_133	[p10l1295t1239r1424b1327],
18	,	,	O	,	_	0	SENT_133	[p10l1295t1239r1424b1327],
19	and	CC	O	and	_	0	SENT_133	[p10l1503t1237r1650b1309],
20	statistical	JJ	O	statistical	amod	21	SENT_133	[p10l1723t1237r2151b1309],
21	significance	NN	O	significance	nsubjpass	23	SENT_133	[p10l9t1350r498b1440],
22	was	VBD	O	be	auxpass	23	SENT_133	[p10l532t1369r686b1421],
23	set	VBN	O	set	conj_and	3	SENT_133	[p10l723t1357r844b1421],
24	at	IN	O	at	_	0	SENT_133	[p10l880t1357r961b1421],
25	P	NN	O	p	prep_at	23	SENT_133	[p10l997t1351r1332b1421],
26	<	JJR	O	<	dep	27	SENT_133	[p10l997t1351r1332b1421],
27	0.05	CD	NUMBER	0.05	advmod	23	SENT_133	[p10l997t1351r1332b1421],
28	.	.	O	.	_	0	SENT_133	[p10l997t1351r1332b1421],

1	Results	NNS	O	result	_	0	SENT_134	[p10l15t1610r377b1695],

1	12	CD	PERCENT	12	number	2	SENT_135	[p10l15t1851r100b1920],
2	(	CD	PERCENT	(	num	4	SENT_135	[p10l144t1851r352b1939],
3	10	CD	PERCENT	10	num	4	SENT_135	[p10l144t1851r352b1939],
4	%	NN	PERCENT	%	nsubj	20	SENT_135	[p10l144t1851r352b1939],
5	)	CD	NUMBER	)	nsubj	10	SENT_135	[p10l144t1851r352b1939],
6	of	IN	O	of	_	0	SENT_135	[p10l391t1850r474b1921],
7	the	DT	O	the	det	8	SENT_135	[p10l507t1850r641b1921],
8	patients	NNS	O	patient	prep_of	5	SENT_135	[p10l680t1851r1014b1939],
9	were	VBD	O	be	cop	10	SENT_135	[p10l1047t1869r1252b1921],
10	insensitive	JJ	O	insensitive	rcmod	4	SENT_135	[p10l1288t1851r1725b1921],
11	to	TO	O	to	_	0	SENT_135	[p10l1761t1857r1842b1921],
12	aspirin	NN	O	aspirin	prep_to	10	SENT_135	[p10l1879t1851r2150b1939],
13	and	CC	O	and	_	0	SENT_135	[p10l10t1962r153b2034],
14	29	CD	PERCENT	29	num	15	SENT_135	[p10l220t1963r312b2034],
15	(	CD	PERCENT	(	conj_and	12	SENT_135	[p10l383t1963r676b2052],
16	24.2	CD	PERCENT	24.2	number	17	SENT_135	[p10l383t1963r676b2052],
17	%	NN	PERCENT	%	amod	15	SENT_135	[p10l383t1963r676b2052],
18	)	CD	NUMBER	)	tmod	10	SENT_135	[p10l383t1963r676b2052],
19	were	VBD	O	be	cop	20	SENT_135	[p10l740t1982r946b2034],
20	insensitive	JJ	O	insensitive	_	0	SENT_135	[p10l1010t1964r1446b2034],
21	to	TO	O	to	_	0	SENT_135	[p10l1510t1970r1592b2034],
22	clopidogrel	NN	O	clopidogrel	prep_to	20	SENT_135	[p10l1656t1962r2144b2052],
23	.	.	O	.	_	0	SENT_135	[p10l1656t1962r2144b2052],

1	Patient	NN	O	patient	nn	2	SENT_136	[p10l13t2078r306b2147],
2	characteristics	NNS	O	characteristic	nsubjpass	4	SENT_136	[p10l359t2076r969b2147],
3	are	VBP	O	be	auxpass	4	SENT_136	[p10l1023t2095r1153b2147],
4	presented	VBN	O	present	_	0	SENT_136	[p10l1211t2076r1619b2166],
5	in	IN	O	in	_	0	SENT_136	[p10l1677t2078r1746b2146],
6	Table	NNP	O	Table	prep_in	4	SENT_136	[p10l1800t2076r2020b2147],
7	1	CD	NUMBER	1	num	6	SENT_136	[p10l2080t2078r2144b2147],
8	.	.	O	.	_	0	SENT_136	[p10l2080t2078r2144b2147],

1	Aspirin-insensitive	JJ	O	aspirin-insensitive	amod	2	SENT_137	[p10l7t2190r766b2278],
2	patients	NNS	O	patient	nsubj	5	SENT_137	[p10l808t2190r1143b2278],
3	were	VBD	O	be	cop	5	SENT_137	[p10l1179t2208r1385b2260],
4	more	RBR	O	more	advmod	5	SENT_137	[p10l1427t2208r1634b2260],
5	likely	JJ	O	likely	_	0	SENT_137	[p10l1677t2189r1896b2278],
6	to	TO	O	to	aux	8	SENT_137	[p10l1934t2196r2015b2260],
7	be	VB	O	be	cop	8	SENT_137	[p10l2057t2189r2152b2260],
8	women	NNS	O	woman	xcomp	5	SENT_137	[p10l7t2321r301b2373],
9	compared	VBN	O	compare	_	0	SENT_137	[p10l358t2301r764b2391],
10	with	IN	O	with	prepc_compared_with	8	SENT_137	[p10l819t2301r997b2373],
11	aspirin-sensitive	JJ	O	aspirin-sensitive	amod	12	SENT_137	[p10l1055t2303r1727b2391],
12	patients	NNS	O	patient	pobj	8	SENT_137	[p10l1784t2303r2143b2391],
13	.	.	O	.	_	0	SENT_137	[p10l1784t2303r2143b2391],

1	They	PRP	O	they	nsubj	3	SENT_138	[p10l7t2414r209b2504],
2	also	RB	O	also	advmod	3	SENT_138	[p10l269t2414r427b2485],
3	had	VBD	O	have	_	0	SENT_138	[p10l491t2414r632b2485],
4	a	DT	O	a	det	8	SENT_138	[p10l698t2433r740b2485],
5	lower	JJR	O	lower	dep	6	SENT_138	[p10l806t2414r1035b2485],
6	mean	NN	O	mean	amod	8	SENT_138	[p10l1096t2433r1315b2485],
7	hemoglobin	NN	O	hemoglobin	nn	8	SENT_138	[p10l1381t2414r1856b2504],
8	level	NN	O	level	dobj	3	SENT_138	[p10l1924t2414r2144b2501],
9	,	,	O	,	_	0	SENT_138	[p10l1924t2414r2144b2501],
10	possibly	RB	O	possibly	advmod	3	SENT_138	[p10l12t2528r335b2617],
11	because	IN	O	because	_	0	SENT_138	[p10l365t2528r696b2599],
12	of	IN	O	of	_	0	SENT_138	[p10l724t2528r807b2599],
13	the	DT	O	the	det	15	SENT_138	[p10l833t2528r967b2599],
14	higher	JJR	O	higher	amod	15	SENT_138	[p10l1000t2528r1257b2617],
15	proportion	NN	O	proportion	prep_because_of	3	SENT_138	[p10l1286t2529r1717b2617],
16	of	IN	O	of	_	0	SENT_138	[p10l1750t2528r1832b2599],
17	women	NNS	O	woman	prep_of	15	SENT_138	[p10l1856t2547r2149b2599],
18	among	IN	O	among	_	0	SENT_138	[p10l10t2658r280b2730],
19	the	DT	O	the	det	21	SENT_138	[p10l315t2640r449b2712],
20	aspirin-insensitive	JJ	O	aspirin-insensitive	amod	21	SENT_138	[p10l485t2642r1235b2730],
21	patients	NNS	O	patient	prep_among	17	SENT_138	[p10l1272t2642r1632b2730],
22	.	.	O	.	_	0	SENT_138	[p10l1272t2642r1632b2730],

1	There	EX	O	there	expl	2	SENT_139	[p10l1673t2640r1915b2712],
2	were	VBD	O	be	_	0	SENT_139	[p10l1947t2660r2153b2712],
3	no	DT	O	no	det	5	SENT_139	[p10l12t2773r106b2825],
4	significant	JJ	O	significant	amod	5	SENT_139	[p10l140t2754r568b2843],
5	differences	NNS	O	difference	nsubj	2	SENT_139	[p10l603t2754r1069b2825],
6	in	IN	O	in	_	0	SENT_139	[p10l1103t2755r1173b2824],
7	patient	NN	O	patient	nn	8	SENT_139	[p10l1212t2755r1510b2843],
8	characteristics	NNS	O	characteristic	prep_in	5	SENT_139	[p10l1543t2754r2152b2825],

1	Table	NNP	O	Table	_	0	SENT_140	[p10l64t3013r270b3078],
2	2	CD	NUMBER	2	num	4	SENT_140	[p10l307t3014r348b3077],
3	Genotype	NN	O	genotype	nn	4	SENT_140	[p10l466t3014r822b3094],
4	frequencies	NNS	O	frequency	dep	1	SENT_140	[p10l855t3013r1290b3094],
5	between	IN	O	between	_	0	SENT_140	[p10l13t3120r379b3190],
6	clopidogrel-sensitive	JJ	O	clopidogrel-sensitive	prep_between	4	SENT_140	[p10l452t3120r1361b3208],
7	and	CC	O	and	_	0	SENT_140	[p10l1432t3120r1580b3190],
8	-	:	O	-	_	0	SENT_140	[p10l1656t3121r2150b3190],
9	insensitive	JJ	O	insensitive	dep	6	SENT_140	[p10l1656t3121r2150b3190],
10	patients	NNS	O	patient	prep_between	4	SENT_140	[p10l13t3233r372b3320],
11	.	.	O	.	_	0	SENT_140	[p10l13t3233r372b3320],

1	31	CD	PERCENT	31	nsubj	7	SENT_141	[p10l125t3345r201b3415],
2	(	CD	PERCENT	(	number	3	SENT_141	[p10l271t3345r562b3434],
3	25.8	CD	PERCENT	25.8	num	4	SENT_141	[p10l271t3345r562b3434],
4	%	NN	PERCENT	%	dep	1	SENT_141	[p10l271t3345r562b3434],
5	)	CD	NUMBER	)	num	6	SENT_141	[p10l271t3345r562b3434],
6	patients	NNS	O	patient	dep	1	SENT_141	[p10l619t3346r953b3434],
7	carried	VBD	O	carry	_	0	SENT_141	[p10l1002t3344r1292b3415],
8	the	DT	O	the	det	13	SENT_141	[p10l1345t3344r1478b3415],
9	PlA2	NN	O	pla2	nn	13	SENT_141	[p10l1532t3344r1694b3430],
10	allele	NN	O	allele	nn	13	SENT_141	[p10l1745t3344r1972b3415],
11	(	CD	NUMBER	(	number	12	SENT_141	[p10l2028t3345r2148b3434],
12	26	CD	NUMBER	26	num	13	SENT_141	[p10l2028t3345r2148b3434],
13	PlA1/A2	NN	O	pla1/a2	dobj	7	SENT_141	[p10l14t3457r317b3542],
14	and	CC	O	and	_	0	SENT_141	[p10l352t3457r496b3527],
15	5	CD	NUMBER	5	num	17	SENT_141	[p10l536t3458r575b3527],
16	PlA2/A2	NN	O	pla2/a2	nn	17	SENT_141	[p10l616t3457r979b3545],
17	)	NN	O	)	conj_and	13	SENT_141	[p10l616t3457r979b3545],
18	.	.	O	.	_	0	SENT_141	[p10l616t3457r979b3545],

1	33	CD	PERCENT	33	number	2	SENT_142	[p10l1025t3458r1112b3527],
2	(	CD	PERCENT	(	nsubj	7	SENT_142	[p10l1156t3458r1448b3545],
3	27.5	CD	PERCENT	27.5	num	4	SENT_142	[p10l1156t3458r1448b3545],
4	%	NN	PERCENT	%	dep	2	SENT_142	[p10l1156t3458r1448b3545],
5	)	CD	NUMBER	)	num	6	SENT_142	[p10l1156t3458r1448b3545],
6	patients	NNS	O	patient	dep	2	SENT_142	[p10l1489t3458r1823b3545],
7	carried	VBD	O	carry	dep	29	SENT_142	[p10l1857t3457r2147b3527],
8	the	DT	O	the	det	10	SENT_142	[p10l10t3569r144b3641],
9	C	NN	O	c	nn	10	SENT_142	[p10l210t3570r259b3641],
10	allele	NN	O	allele	dobj	7	SENT_142	[p10l325t3569r555b3641],
11	of	IN	O	of	_	0	SENT_142	[p10l620t3569r702b3641],
12	the	DT	O	the	det	17	SENT_142	[p10l765t3569r898b3641],
13	P2Y12	NN	O	p2y12	nn	17	SENT_142	[p10l967t3570r1186b3656],
14	T744C	NN	O	t744c	nn	17	SENT_142	[p10l1249t3570r1503b3641],
15	polymorphism	NN	O	polymorphism	nn	17	SENT_142	[p10l1572t3569r2147b3659],
16	(	NN	O	(	nn	17	SENT_142	[p10l16t3682r260b3770],
17	3OCT	NN	O	3oct	prep_of	10	SENT_142	[p10l16t3682r260b3770],
18	and	CC	O	and	_	0	SENT_142	[p10l297t3682r440b3752],
19	3CC	NN	O	3cc	nn	20	SENT_142	[p10l496t3682r720b3770],
20	)	NN	O	)	conj_and	17	SENT_142	[p10l496t3682r720b3770],
21	,	,	O	,	_	0	SENT_142	[p10l496t3682r720b3770],
22	and	CC	O	and	_	0	SENT_142	[p10l779t3682r922b3752],
23	37	CD	PERCENT	37	number	24	SENT_142	[p10l978t3682r1069b3752],
24	(	CD	PERCENT	(	conj_and	10	SENT_142	[p10l1125t3682r1416b3770],
25	30.8	CD	PERCENT	30.8	num	26	SENT_142	[p10l1125t3682r1416b3770],
26	%	NN	PERCENT	%	tmod	7	SENT_142	[p10l1125t3682r1416b3770],
27	)	CD	NUMBER	)	num	28	SENT_142	[p10l1125t3682r1416b3770],
28	patients	NNS	O	patient	dep	26	SENT_142	[p10l1474t3683r1807b3770],
29	carried	VBD	O	carry	_	0	SENT_142	[p10l1857t3682r2147b3752],
30	the	DT	O	the	det	32	SENT_142	[p11l10t19r144b91],
31	PZY1	NN	O	pzy1	nn	32	SENT_142	[p11l183t20r354b106],
32	1622A	NN	O	1622a	dobj	29	SENT_142	[p11l405t20r780b91],
33	>	JJR	O	>	amod	35	SENT_142	[p11l405t20r780b91],
34	G	NN	O	g	nn	35	SENT_142	[p11l405t20r780b91],
35	polymorphism	NN	O	polymorphism	nsubj	29	SENT_142	[p11l821t19r1394b109],
36	(	NN	O	(	nn	38	SENT_142	[p11l1437t20r1544b109],
37	31	CD	NUMBER	31	num	38	SENT_142	[p11l1437t20r1544b109],
38	AG	NNP	O	AG	dep	35	SENT_142	[p11l1571t20r1683b91],
39	and	CC	O	and	_	0	SENT_142	[p11l1721t19r1864b91],
40	6GG	NNP	O	6GG	dep	35	SENT_142	[p11l1903t20r2141b109],
41	)	CD	NUMBER	)	num	40	SENT_142	[p11l1903t20r2141b109],
42	.	.	O	.	_	0	SENT_142	[p11l1903t20r2141b109],

1	The	DT	O	the	det	3	SENT_143	[p11l7t133r161b204],
2	allele	NN	O	allele	nn	3	SENT_143	[p11l220t133r447b204],
3	frequencies	NNS	O	frequency	nsubj	8	SENT_143	[p11l505t133r988b223],
4	of	IN	O	of	_	0	SENT_143	[p11l1047t133r1129b204],
5	all	PDT	O	all	predet	7	SENT_143	[p11l1184t133r1282b204],
6	the	DT	O	the	det	7	SENT_143	[p11l1342t133r1475b204],
7	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_143	[p11l1536t133r2150b223],
8	were	VBD	O	be	_	0	SENT_143	[p11l8t264r213b315],
9	in	IN	O	in	_	0	SENT_143	[p11l279t246r347b314],
10	Hardy	NNP	LOCATION	Hardy	prep_in	8	SENT_143	[p11l419t245r1115b333],
11	.	.	O	.	_	0	SENT_143	[p11l419t245r1115b333],

1	—	NN	O	—	_	0	SENT_144	[p11l419t245r1115b333],
2	.	.	O	.	_	0	SENT_144	[p11l419t245r1115b333],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_145	[p11l419t245r1115b333],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_145	[p11l1180t245r1679b333],
3	.	.	O	.	_	0	SENT_145	[p11l1180t245r1679b333],

1	Genotype	NN	O	genotype	nn	2	SENT_146	[p11l1753t246r2150b333],
2	frequencies	NNS	O	frequency	nsubj	8	SENT_146	[p11l9t357r492b447],
3	for	IN	O	for	_	0	SENT_146	[p11l526t357r644b429],
4	polymorphisms	NNS	O	polymorphism	prep_for	2	SENT_146	[p11l678t357r1291b447],
5	of	IN	O	of	_	0	SENT_146	[p11l1325t357r1407b429],
6	the	DT	O	the	det	7	SENT_146	[p11l1438t357r1571b429],
7	genes	NNS	O	gene	prep_of	4	SENT_146	[p11l1605t375r1837b447],
8	encoding	VBG	O	encode	_	0	SENT_146	[p11l1870t357r2145b429, p11l10t472r129b560],
9	for	IN	O	for	_	0	SENT_146	[p11l176t470r294b541],
10	GP	NN	O	gp	nn	11	SENT_146	[p11l339t471r447b542],
11	Illa	NN	O	illum	prep_for	8	SENT_146	[p11l501t472r642b557],
12	,	,	O	,	_	0	SENT_146	[p11l501t472r642b557],
13	P2Y12	NN	O	p2y12	nn	14	SENT_146	[p11l700t471r918b556],
14	receptor	NN	O	receptor	appos	11	SENT_146	[p11l970t477r1323b560],
15	and	CC	O	and	_	0	SENT_146	[p11l1369t470r1512b541],
16	PZY1	NN	O	pzy1	nn	17	SENT_146	[p11l1565t471r1737b556],
17	receptor	NN	O	receptor	conj_and	14	SENT_146	[p11l1798t477r2152b560],
18	among	IN	O	among	_	0	SENT_146	[p11l10t600r281b671],
19	aspirin-insensitive	JJ	O	aspirin-insensitive	amod	20	SENT_146	[p11l348t584r1103b671],
20	vs.	NN	O	v.	prep_among	14	SENT_146	[p11l1167t602r1274b653],
21	-	:	O	-	_	0	SENT_146	[p11l1352t584r1744b653],
22	sensitive	JJ	O	sensitive	amod	23	SENT_146	[p11l1352t584r1744b653],
23	patients	NNS	O	patient	dep	14	SENT_146	[p11l1813t584r2150b671],
24	and	CC	O	and	_	0	SENT_146	[p11l10t695r153b767],
25	clopidogrel	NN	O	clopidogrel	npadvmod	27	SENT_146	[p11l210t695r1148b785],
26	—	CD	NUMBER	—	num	25	SENT_146	[p11l210t695r1148b785],
27	insensitive	JJ	O	insensitive	amod	28	SENT_146	[p11l210t695r1148b785],
28	vs.	NN	O	v.	conj_and	23	SENT_146	[p11l1199t715r1305b767],
29	-	:	O	-	_	0	SENT_146	[p11l1370t697r1759b767],
30	sensitive	JJ	O	sensitive	amod	31	SENT_146	[p11l1370t697r1759b767],
31	patients	NNS	O	patient	nsubjpass	33	SENT_146	[p11l1816t697r2150b785],
32	are	VBP	O	be	auxpass	33	SENT_146	[p11l10t827r141b878],
33	shown	VBN	O	show	parataxis	8	SENT_146	[p11l194t808r444b878],
34	in	IN	O	in	_	0	SENT_146	[p11l501t809r570b877],
35	Table	NNP	O	Table	prep_in	33	SENT_146	[p11l623t808r843b878],
36	2	CD	NUMBER	2	num	35	SENT_146	[p11l896t809r966b878],
37	.	.	O	.	_	0	SENT_146	[p11l896t809r966b878],

1	There	EX	O	there	expl	2	SENT_147	[p11l1024t808r1265b878],
2	were	VBD	O	be	_	0	SENT_147	[p11l1316t827r1521b878],
3	no	DT	O	no	det	5	SENT_147	[p11l1576t827r1669b878],
4	significant	JJ	O	significant	amod	5	SENT_147	[p11l1722t808r2150b896],
5	differences	NNS	O	difference	nsubj	2	SENT_147	[p11l10t920r476b992],
6	in	IN	O	in	_	0	SENT_147	[p11l520t922r589b991],
7	the	DT	O	the	det	8	SENT_147	[p11l636t920r769b992],
8	frequencies	NNS	O	frequency	prep_in	5	SENT_147	[p11l812t920r1296b1010],
9	of	IN	O	of	_	0	SENT_147	[p11l1338t920r1420b992],
10	any	DT	O	any	prep_of	8	SENT_147	[p11l1461t940r1603b1010],
11	of	IN	O	of	_	0	SENT_147	[p11l1644t920r1727b992],
12	the	DT	O	the	det	13	SENT_147	[p11l1768t920r1901b992],
13	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_147	[p11l1948t920r2145b1010, p11l13t1034r450b1124],
14	between	IN	O	between	_	0	SENT_147	[p11l491t1034r841b1105],
15	the	DT	O	the	det	17	SENT_147	[p11l883t1034r1016b1105],
16	different	JJ	O	different	amod	17	SENT_147	[p11l1053t1034r1421b1105],
17	groups	NNS	O	group	prep_between	13	SENT_147	[p11l1458t1051r1752b1124],
18	.	.	O	.	_	0	SENT_147	[p11l1458t1051r1752b1124],

1	Table	NNP	O	Table	nsubj	3	SENT_148	[p11l120t1146r358b1216],
2	3	CD	NUMBER	3	num	1	SENT_148	[p11l435t1147r473b1216],
3	presents	VBZ	O	present	_	0	SENT_148	[p11l553t1153r932b1234],
4	the	DT	O	the	det	5	SENT_148	[p11l1005t1146r1148b1216],
5	response	NN	O	response	dobj	3	SENT_148	[p11l1226t1165r1614b1234],
6	to	TO	O	to	_	0	SENT_148	[p11l1688t1153r1775b1216],
7	aspirin	NN	O	aspirin	nn	8	SENT_148	[p11l1849t1147r2147b1234],
8	(	NN	O	(	prep_to	3	SENT_148	[p11l16t1258r388b1348],
9	assessed	VBN	O	assess	partmod	8	SENT_148	[p11l16t1258r388b1348],
10	by	IN	O	by	_	0	SENT_148	[p11l431t1258r522b1348],
11	AA-induced	JJ	O	aa-induced	amod	13	SENT_148	[p11l553t1258r1021b1330],
12	aggregation	NN	O	aggregation	nn	13	SENT_148	[p11l1061t1260r1579b1348],
13	)	NN	O	)	agent	9	SENT_148	[p11l1061t1260r1579b1348],
14	and	CC	O	and	_	0	SENT_148	[p11l1618t1258r1761b1330],
15	to	TO	O	to	_	0	SENT_148	[p11l1801t1266r1883b1330],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_148	[p11l1918t1258r2144b1348, p11l10t1371r268b1461],
17	(	NN	O	(	conj_and	8	SENT_148	[p11l312t1371r746b1461],
18	evaluated	VBN	O	evaluate	partmod	17	SENT_148	[p11l312t1371r746b1461],
19	by	IN	O	by	_	0	SENT_148	[p11l790t1371r882b1461],
20	the	DT	O	the	det	21	SENT_148	[p11l917t1371r1051b1442],
21	change	NN	O	change	agent	18	SENT_148	[p11l1088t1371r1378b1461],
22	in	IN	O	in	_	0	SENT_148	[p11l1416t1373r1485b1442],
23	platelet	NN	O	platelet	nn	24	SENT_148	[p11l1528t1371r1853b1461],
24	aggregation	NN	O	aggregation	prep_in	21	SENT_148	[p11l1890t1389r2144b1461, p11l10t1485r263b1572],
25	and	CC	O	and	_	0	SENT_148	[p11l297t1484r440b1554],
26	activation	NN	O	activation	nn	27	SENT_148	[p11l475t1485r884b1554],
27	markers	NNS	O	marker	prep_in	21	SENT_148	[p11l922t1484r1249b1554],
28	following	VBG	O	follow	_	0	SENT_148	[p11l1279t1484r1657b1572],
29	clopidogrel	NN	O	clopidogrel	nn	31	SENT_148	[p11l1688t1484r2149b1572],
30	treatment	NN	O	treatment	nn	31	SENT_148	[p11l10t1598r463b1686],
31	)	NN	O	)	prep_following	18	SENT_148	[p11l10t1598r463b1686],
32	among	IN	O	among	_	0	SENT_148	[p11l513t1614r781b1686],
33	the	DT	O	the	det	36	SENT_148	[p11l827t1596r961b1668],
34	different	JJ	O	different	amod	36	SENT_148	[p11l1007t1596r1376b1668],
35	genotype	NN	O	genotype	nn	36	SENT_148	[p11l1422t1604r1801b1686],
36	groups	NNS	O	group	prep_among	31	SENT_148	[p11l1847t1614r2141b1686],
37	.	.	O	.	_	0	SENT_148	[p11l1847t1614r2141b1686],

1	The	DT	O	the	det	3	SENT_149	[p11l7t1709r161b1779],
2	only	JJ	O	only	amod	3	SENT_149	[p11l189t1709r361b1797],
3	trend	NN	O	trend	nsubj	8	SENT_149	[p11l388t1709r607b1779],
4	observed	VBN	O	observe	partmod	3	SENT_149	[p11l639t1709r1006b1779],
5	was	VBD	O	be	cop	8	SENT_149	[p11l1036t1728r1189b1779],
6	a	DT	O	a	det	8	SENT_149	[p11l1218t1728r1260b1779],
7	lower	JJR	O	lower	amod	8	SENT_149	[p11l1293t1709r1521b1779],
8	change	NN	O	change	_	0	SENT_149	[p11l1548t1709r1837b1797],
9	in	IN	O	in	_	0	SENT_149	[p11l1867t1710r1936b1778],
10	PACGenotype	NN	O	pacgenotype	prep_in	8	SENT_149	[p11l1972t1710r2145b1779, p11l122t1888r261b1920],

1	As	IN	O	as	dep	4	SENT_150	[p11l584t1888r616b1914],
2	'	''	O	'	_	0	SENT_150	[p11l638t1889r643b1893],
3	in-insensitive	JJ	O	in-insensitive	advmod	1	SENT_150	[p11l658t1889r851b1914],
4	Aspirin-sensitive	JJ	O	aspirin-sensitive	_	0	SENT_150	[p11l953t1888r1193b1920],
5	Clopidogrel-insensitive	JJ	O	clopidogrel-insensitive	dep	4	SENT_150	[p11l1296t1888r1629b1920],
6	Clopidogrel-sensitive	JJ	O	clopidogrel-sensitive	dep	4	SENT_150	[p11l1732t1888r2038b1920],

1	(	NN	O	(	nn	2	SENT_151	[p11l587t1931r636b1961],
2	n	NN	O	n	_	0	SENT_151	[p11l587t1931r636b1961],
3	=	JJ	O	=	amod	2	SENT_151	[p11l587t1931r636b1961],
4	)	CD	NUMBER	)	tmod	3	SENT_151	[p11l679t1930r686b1961],
5	(	CD	NUMBER	(	num	6	SENT_151	[p11l956t1930r1073b1961],
6	n	NN	O	n	dep	2	SENT_151	[p11l956t1930r1073b1961],
7	=	JJ	O	=	quantmod	9	SENT_151	[p11l956t1930r1073b1961],
8	108	CD	NUMBER	108	number	9	SENT_151	[p11l956t1930r1073b1961],
9	)	CD	NUMBER	)	num	19	SENT_151	[p11l956t1930r1073b1961],
10	(	NN	O	(	nn	19	SENT_151	[p11l1298t1930r1397b1961],
11	n	NN	O	n	nn	19	SENT_151	[p11l1298t1930r1397b1961],
12	=	JJ	O	=	amod	19	SENT_151	[p11l1298t1930r1397b1961],
13	29	CD	NUMBER	29	number	14	SENT_151	[p11l1298t1930r1397b1961],
14	)	CD	NUMBER	)	num	19	SENT_151	[p11l1298t1930r1397b1961],
15	(	NN	O	(	nn	19	SENT_151	[p11l1734t1930r1833b1961],
16	n	NN	O	n	nn	19	SENT_151	[p11l1734t1930r1833b1961],
17	=	JJ	O	=	amod	19	SENT_151	[p11l1734t1930r1833b1961],
18	91	CD	NUMBER	91	num	19	SENT_151	[p11l1734t1930r1833b1961],
19	)	NN	O	)	dep	6	SENT_151	[p11l1734t1930r1833b1961],

1	GP	NN	O	gp	nn	4	SENT_152	[p11l122t2008r160b2033],
2	Illa	NN	O	illum	nn	4	SENT_152	[p11l175t2008r216b2033],
3	Pl	NN	O	pl	nn	4	SENT_152	[p11l230t2008r254b2033],
4	A1/A2	NN	O	a1/a2	dep	13	SENT_152	[p11l267t2008r347b2038],
5	or	CC	O	or	_	0	SENT_152	[p11l360t2015r390b2033],
6	A2/A2	NN	O	a2/a2	conj_or	4	SENT_152	[p11l401t2008r482b2038],
7	4	CD	PERCENT	4	number	8	SENT_152	[p11l584t2008r601b2033],
8	(	CD	PERCENT	(	dep	4	SENT_152	[p11l615t2008r718b2039],
9	33.3	CD	PERCENT	33.3	num	10	SENT_152	[p11l615t2008r718b2039],
10	%	NN	PERCENT	%	dep	8	SENT_152	[p11l615t2008r718b2039],
11	)	CD	NUMBER	)	dep	13	SENT_152	[p11l615t2008r718b2039],
12	27	CD	NUMBER	27	num	13	SENT_152	[p11l954t2008r988b2033],
13	(	NN	O	(	dep	20	SENT_152	[p11l1002t2008r1075b2039],
14	25	CD	PERCENT	25	num	15	SENT_152	[p11l1002t2008r1075b2039],
15	%	NN	PERCENT	%	dep	13	SENT_152	[p11l1002t2008r1075b2039],
16	)	CD	NUMBER	)	number	17	SENT_152	[p11l1002t2008r1075b2039],
17	6	CD	NUMBER	6	num	18	SENT_152	[p11l1296t2008r1311b2033],
18	(	NN	O	(	dep	15	SENT_152	[p11l1326t2008r1429b2039],
19	20.7	CD	PERCENT	20.7	num	20	SENT_152	[p11l1326t2008r1429b2039],
20	%	NN	PERCENT	%	dep	25	SENT_152	[p11l1326t2008r1429b2039],
21	)	CD	NUMBER	)	num	23	SENT_152	[p11l1326t2008r1429b2039],
22	25	CD	NUMBER	25	num	23	SENT_152	[p11l1732t2008r1764b2033],
23	(	NN	O	(	dep	20	SENT_152	[p11l1780t2008r1883b2039],
24	27.5	CD	PERCENT	27.5	num	25	SENT_152	[p11l1780t2008r1883b2039],
25	%	NN	PERCENT	%	dep	37	SENT_152	[p11l1780t2008r1883b2039],
26	)	CD	NUMBER	)	num	28	SENT_152	[p11l1780t2008r1883b2039],
27	P2Y12	NN	O	p2y12	nn	28	SENT_152	[p11l123t2049r200b2080],
28	CT	NN	O	ct	dep	25	SENT_152	[p11l213t2049r251b2075],
29	or	CC	O	or	_	0	SENT_152	[p11l259t2056r288b2074],
30	CC	NN	O	cc	conj_or	25	SENT_152	[p11l300t2049r337b2075],
31	4	CD	PERCENT	4	num	30	SENT_152	[p11l584t2049r601b2074],
32	(	CD	PERCENT	(	number	33	SENT_152	[p11l615t2049r718b2081],
33	33.3	CD	PERCENT	33.3	num	34	SENT_152	[p11l615t2049r718b2081],
34	%	NN	PERCENT	%	dep	30	SENT_152	[p11l615t2049r718b2081],
35	)	CD	NUMBER	)	num	37	SENT_152	[p11l615t2049r718b2081],
36	29	CD	NUMBER	29	num	37	SENT_152	[p11l954t2049r987b2074],
37	(	NN	O	(	dep	44	SENT_152	[p11l1002t2049r1105b2081],
38	26.9	CD	PERCENT	26.9	num	39	SENT_152	[p11l1002t2049r1105b2081],
39	%	NN	PERCENT	%	dep	37	SENT_152	[p11l1002t2049r1105b2081],
40	)	CD	NUMBER	)	number	41	SENT_152	[p11l1002t2049r1105b2081],
41	6	CD	NUMBER	6	num	42	SENT_152	[p11l1296t2049r1311b2075],
42	(	NN	O	(	dep	39	SENT_152	[p11l1326t2049r1429b2081],
43	20.7	CD	PERCENT	20.7	num	44	SENT_152	[p11l1326t2049r1429b2081],
44	%	NN	PERCENT	%	dep	52	SENT_152	[p11l1326t2049r1429b2081],
45	)	CD	NUMBER	)	number	46	SENT_152	[p11l1326t2049r1429b2081],
46	27	CD	NUMBER	27	num	47	SENT_152	[p11l1732t2049r1766b2074],
47	(	NN	O	(	dep	44	SENT_152	[p11l1780t2049r1883b2081],
48	29.7	CD	PERCENT	29.7	number	49	SENT_152	[p11l1780t2049r1883b2081],
49	%	NN	PERCENT	%	amod	47	SENT_152	[p11l1780t2049r1883b2081],
50	)	CD	NUMBER	)	num	52	SENT_152	[p11l1780t2049r1883b2081],
51	PZY1	NN	O	pzy1	nn	52	SENT_152	[p11l123t2090r184b2121],
52	AG	NNP	O	AG	dep	56	SENT_152	[p11l199t2090r239b2116],
53	or	CC	O	or	_	0	SENT_152	[p11l252t2097r282b2115],
54	GG	NNS	PERCENT	gg	dep	56	SENT_152	[p11l294t2090r335b2116],
55	3	CD	PERCENT	3	num	56	SENT_152	[p11l586t2090r600b2115],
56	(	NN	PERCENT	(	dep	61	SENT_152	[p11l615t2090r689b2122],
57	25	CD	PERCENT	25	num	58	SENT_152	[p11l615t2090r689b2122],
58	%	NN	PERCENT	%	dep	56	SENT_152	[p11l615t2090r689b2122],
59	)	CD	NUMBER	)	num	61	SENT_152	[p11l615t2090r689b2122],
60	34	CD	NUMBER	34	num	61	SENT_152	[p11l955t2090r988b2115],
61	(	NN	O	(	dep	68	SENT_152	[p11l1002t2090r1105b2122],
62	31.5	CD	PERCENT	31.5	num	63	SENT_152	[p11l1002t2090r1105b2122],
63	%	NN	PERCENT	%	dep	61	SENT_152	[p11l1002t2090r1105b2122],
64	)	CD	NUMBER	)	number	65	SENT_152	[p11l1002t2090r1105b2122],
65	7	CD	PERCENT	7	num	66	SENT_152	[p11l1296t2090r1312b2115],
66	(	NN	PERCENT	(	dep	63	SENT_152	[p11l1326t2090r1429b2122],
67	24.1	CD	PERCENT	24.1	num	68	SENT_152	[p11l1326t2090r1429b2122],
68	%	NN	PERCENT	%	dep	74	SENT_152	[p11l1326t2090r1429b2122],
69	)	CD	NUMBER	)	number	70	SENT_152	[p11l1326t2090r1429b2122],
70	30	CD	NUMBER	30	num	71	SENT_152	[p11l1733t2090r1765b2115],
71	(	NN	O	(	dep	68	SENT_152	[p11l1780t2090r1853b2122],
72	33	CD	PERCENT	33	number	73	SENT_152	[p11l1780t2090r1853b2122],
73	%	NN	PERCENT	%	amod	71	SENT_152	[p11l1780t2090r1853b2122],
74	)	CD	NUMBER	)	_	0	SENT_152	[p11l1780t2090r1853b2122],

1	Genetic	JJ	O	genetic	amod	2	SENT_153	[p11l98t2231r239b2262],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_153	[p11l256t2230r527b2270],
3	of	IN	O	of	_	0	SENT_153	[p11l543t2230r580b2262],
4	the	DT	O	the	det	6	SENT_153	[p11l594t2230r653b2262],
5	platelet	NN	O	platelet	nn	6	SENT_153	[p11l671t2230r814b2270],
6	receptors	NNS	O	receptor	prep_of	2	SENT_153	[p11l832t2233r1004b2270],
7	P2Y12	NN	O	p2y12	nn	12	SENT_153	[p11l1021t2230r1129b2269],
8	,	,	O	,	_	0	SENT_153	[p11l1021t2230r1129b2269],
9	PZY1	NN	O	pzy1	nn	12	SENT_153	[p11l1151t2231r1221b2269],
10	and	CC	O	and	_	0	SENT_153	[p11l1242t2230r1305b2262],
11	GP	NN	O	gp	nn	12	SENT_153	[p11l1323t2231r1371b2262],
12	Illa	NN	PERSON	illum	dep	2	SENT_153	[p11l1389t2231r1435b2269],
13	359	CD	NUMBER	359	dep	12	SENT_153	[p11l2001t2230r2062b2262],

1	Table	NNP	O	Table	_	0	SENT_154	[p11l121t2352r212b2381],
2	3	CD	NUMBER	3	num	3	SENT_154	[p11l228t2353r245b2381],
3	Response	NN	O	response	dep	1	SENT_154	[p11l300t2353r447b2388],
4	to	TO	O	to	_	0	SENT_154	[p11l462t2355r494b2381],
5	aspirin	NN	O	aspirin	prep_to	3	SENT_154	[p11l509t2353r616b2388],
6	and	CC	O	and	_	0	SENT_154	[p11l632t2352r689b2381],
7	to	TO	O	to	_	0	SENT_154	[p11l705t2355r737b2381],
8	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_154	[p11l752t2352r934b2388],
9	among	IN	O	among	_	0	SENT_154	[p11l949t2359r1056b2388],
10	different	JJ	O	different	amod	12	SENT_154	[p11l1071t2352r1217b2381],
11	genotype	NN	O	genotype	nn	12	SENT_154	[p11l1231t2355r1382b2388],
12	groups	NNS	O	group	prep_among	8	SENT_154	[p11l1397t2359r1503b2388],

1	Pl	NN	O	pl	dep	129	SENT_155	[p11l731t2410r756b2435],
2	A1/A1	NN	O	a1/a1	dep	129	SENT_155	[p11l768t2410r845b2441],
3	Pl	NN	O	pl	dep	129	SENT_155	[p11l948t2410r973b2436],
4	A1/A2	NN	O	a1/a2	dep	129	SENT_155	[p11l985t2410r1066b2441],
5	or	CC	O	or	dep	129	SENT_155	[p11l1079t2417r1109b2435],
6	P2Y12	NN	O	p2y12	dep	129	SENT_155	[p11l1200t2410r1277b2441],
7	P2Y12	NN	O	p2y12	dep	129	SENT_155	[p11l1418t2410r1495b2441],
8	CT	NN	O	ct	dep	129	SENT_155	[p11l1508t2410r1546b2436],
9	or	CC	O	or	dep	129	SENT_155	[p11l1553t2417r1583b2435],
10	PZY1	NN	O	pzy1	dep	129	SENT_155	[p11l1651t2410r1712b2441],
11	AA	NN	O	aa	dep	129	SENT_155	[p11l1727t2410r1766b2435],
12	PZY1	NN	O	pzy1	dep	129	SENT_155	[p11l1869t2410r1930b2441],
13	AG	NNP	O	AG	dep	129	SENT_155	[p11l1945t2410r1985b2436],
14	or	CC	O	or	dep	129	SENT_155	[p11l1998t2417r2028b2435],
15	(	CD	NUMBER	(	dep	129	SENT_155	[p11l732t2452r831b2483],
16	n	NN	O	n	dep	129	SENT_155	[p11l732t2452r831b2483],
17	=	JJ	O	=	dep	129	SENT_155	[p11l732t2452r831b2483],
18	89	CD	NUMBER	89	dep	129	SENT_155	[p11l732t2452r831b2483],
19	)	CD	NUMBER	)	dep	129	SENT_155	[p11l732t2452r831b2483],
20	A2/A2	NN	O	a2/a2	dep	129	SENT_155	[p11l946t2452r1027b2482],
21	(	NN	O	(	dep	129	SENT_155	[p11l1042t2452r1141b2483],
22	n	NN	O	n	dep	129	SENT_155	[p11l1042t2452r1141b2483],
23	=	JJ	O	=	dep	129	SENT_155	[p11l1042t2452r1141b2483],
24	31	CD	NUMBER	31	dep	129	SENT_155	[p11l1042t2452r1141b2483],
25	)	CD	NUMBER	)	dep	129	SENT_155	[p11l1042t2452r1141b2483],
26	TT	NN	ORGANIZATION	tt	dep	129	SENT_155	[p11l1198t2452r1236b2476],
27	(	NN	O	(	dep	129	SENT_155	[p11l1250t2452r1349b2483],
28	n	NN	O	n	dep	129	SENT_155	[p11l1250t2452r1349b2483],
29	=	JJ	O	=	dep	129	SENT_155	[p11l1250t2452r1349b2483],
30	87	CD	NUMBER	87	dep	129	SENT_155	[p11l1250t2452r1349b2483],
31	)	CD	NUMBER	)	dep	129	SENT_155	[p11l1250t2452r1349b2483],
32	CC	NN	O	cc	dep	129	SENT_155	[p11l1417t2452r1454b2477],
33	(	NN	O	(	dep	129	SENT_155	[p11l1469t2452r1568b2483],
34	n	NN	O	n	dep	129	SENT_155	[p11l1469t2452r1568b2483],
35	=	JJ	O	=	dep	129	SENT_155	[p11l1469t2452r1568b2483],
36	33	CD	NUMBER	33	dep	129	SENT_155	[p11l1469t2452r1568b2483],
37	)	CD	NUMBER	)	dep	129	SENT_155	[p11l1469t2452r1568b2483],
38	(	NN	O	(	dep	129	SENT_155	[p11l1652t2452r1751b2483],
39	n	NN	O	n	dep	129	SENT_155	[p11l1652t2452r1751b2483],
40	=	JJ	O	=	dep	129	SENT_155	[p11l1652t2452r1751b2483],
41	83	CD	NUMBER	83	dep	129	SENT_155	[p11l1652t2452r1751b2483],
42	)	CD	NUMBER	)	dep	129	SENT_155	[p11l1652t2452r1751b2483],
43	GG	NNS	O	gg	dep	129	SENT_155	[p11l1868t2452r1909b2477],
44	(	CD	NUMBER	(	dep	129	SENT_155	[p11l1925t2452r2024b2483],
45	n	NN	O	n	dep	129	SENT_155	[p11l1925t2452r2024b2483],
46	=	JJ	O	=	dep	129	SENT_155	[p11l1925t2452r2024b2483],
47	37	CD	NUMBER	37	dep	129	SENT_155	[p11l1925t2452r2024b2483],
48	)	CD	NUMBER	)	dep	129	SENT_155	[p11l1925t2452r2024b2483],
49	0.5	CD	NUMBER	0.5	dep	129	SENT_155	[p11l122t2510r326b2542],
50	mg/mLAA	NN	O	mg/mlaa	dep	129	SENT_155	[p11l122t2510r326b2542],
51	a	DT	O	a	dep	129	SENT_155	[p11l338t2517r353b2535],
52	10.8:4.4	CD	NUMBER	10.8:4.4	dep	129	SENT_155	[p11l732t2510r874b2537],
53	11.6:4.3	CD	NUMBER	11.6:4.3	dep	129	SENT_155	[p11l949t2510r1090b2537],
54	10.8:4.3	CD	NUMBER	10.8:4.3	dep	129	SENT_155	[p11l1201t2510r1342b2537],
55	11.5:4.8	CD	NUMBER	11.5:4.8	dep	129	SENT_155	[p11l1419t2510r1560b2537],
56	11.2:4.5	CD	NUMBER	11.2:4.5	dep	129	SENT_155	[p11l1652t2510r1793b2537],
57	10.2:4.1	CD	NUMBER	10.2:4.1	dep	129	SENT_155	[p11l1870t2510r2007b2537],
58	Change	NNP	O	Change	dep	129	SENT_155	[p11l122t2551r228b2583],
59	in	IN	O	in	dep	129	SENT_155	[p11l240t2551r265b2576],
60	5um	JJ	O	5um	dep	129	SENT_155	[p11l280t2551r341b2583],
61	ADP	NN	O	adp	dep	129	SENT_155	[p11l415t2551r472b2576],
62	aggr	NN	O	aggr	dep	129	SENT_155	[p11l484t2557r546b2583],
63	19.9	CD	NUMBER	19.9	dep	129	SENT_155	[p11l732t2551r820b2578],
64	:	:	O	:	_	0	SENT_155	[p11l732t2551r820b2578],
65	12.9	CD	NUMBER	12.9	dep	129	SENT_155	[p11l831t2551r890b2577],
66	19.7	CD	NUMBER	19.7	dep	129	SENT_155	[p11l949t2551r1037b2578],
67	:	:	O	:	_	0	SENT_155	[p11l949t2551r1037b2578],
68	10.3	CD	NUMBER	10.3	dep	129	SENT_155	[p11l1048t2551r1108b2577],
69	19.7	CD	NUMBER	19.7	dep	129	SENT_155	[p11l1201t2551r1289b2578],
70	:	:	O	:	_	0	SENT_155	[p11l1201t2551r1289b2578],
71	12.8	CD	NUMBER	12.8	dep	129	SENT_155	[p11l1300t2551r1360b2577],
72	19.9	CD	NUMBER	19.9	dep	129	SENT_155	[p11l1419t2551r1507b2578],
73	:	:	O	:	_	0	SENT_155	[p11l1419t2551r1507b2578],
74	11.3	CD	NUMBER	11.3	dep	129	SENT_155	[p11l1518t2551r1577b2577],
75	19.9	CD	NUMBER	19.9	dep	129	SENT_155	[p11l1652t2551r1740b2578],
76	:	:	O	:	_	0	SENT_155	[p11l1652t2551r1740b2578],
77	12.4	CD	NUMBER	12.4	dep	129	SENT_155	[p11l1751t2551r1812b2577],
78	19.5	CD	NUMBER	19.5	dep	129	SENT_155	[p11l1870t2551r1958b2578],
79	:	:	O	:	_	0	SENT_155	[p11l1870t2551r1958b2578],
80	12.7	CD	NUMBER	12.7	dep	129	SENT_155	[p11l1969t2551r2030b2577],
81	Change	NNP	O	Change	dep	129	SENT_155	[p11l122t2592r228b2624],
82	in	IN	O	in	dep	129	SENT_155	[p11l240t2593r265b2617],
83	20umol/L	NNP	O	20umol/L	dep	129	SENT_155	[p11l279t2592r422b2624],
84	ADP	NN	O	adp	dep	129	SENT_155	[p11l433t2592r489b2617],
85	aggr	NN	O	aggr	dep	129	SENT_155	[p11l501t2598r563b2624],
86	14.5:10.6	CD	TIME	14.5:10.6	dep	129	SENT_155	[p11l732t2592r891b2619],
87	12.4:7.9	CD	NUMBER	12.4:7.9	dep	129	SENT_155	[p11l949t2592r1091b2619],
88	13.4:10.4	CD	TIME	13.4:10.4	dep	129	SENT_155	[p11l1201t2592r1361b2619],
89	14.5:9.3	CD	NUMBER	14.5:9.3	dep	129	SENT_155	[p11l1419t2592r1559b2619],
90	14.5:10.8	CD	TIME	14.5:10.8	dep	129	SENT_155	[p11l1652t2592r1811b2619],
91	12.6:7.6	CD	NUMBER	12.6:7.6	dep	129	SENT_155	[p11l1870t2592r2011b2619],
92	Change	NNP	O	Change	dep	129	SENT_155	[p11l122t2633r228b2665],
93	in	IN	O	in	dep	129	SENT_155	[p11l240t2633r265b2658],
94	PAC-1	NN	O	pac-1	dep	129	SENT_155	[p11l280t2633r355b2659],
95	binding	NN	O	binding	dep	129	SENT_155	[p11l374t2633r479b2665],
96	(	CD	NUMBER	(	dep	129	SENT_155	[p11l493t2633r563b2665],
97	MFI	NNP	ORGANIZATION	MFI	dep	129	SENT_155	[p11l493t2633r563b2665],
98	)	CD	NUMBER	)	dep	129	SENT_155	[p11l493t2633r563b2665],
99	1.8	CD	NUMBER	1.8	dep	129	SENT_155	[p11l748t2633r819b2660],
100	:	:	O	:	_	0	SENT_155	[p11l748t2633r819b2660],
101	1.2	CD	NUMBER	1.2	dep	129	SENT_155	[p11l830t2633r885b2658],
102	*	CD	NUMBER	*	dep	129	SENT_155	[p11l830t2633r885b2658],
103	1.3	CD	NUMBER	1.3	dep	129	SENT_155	[p11l966t2633r1037b2660],
104	:	:	O	:	_	0	SENT_155	[p11l966t2633r1037b2660],
105	1.1	CD	NUMBER	1.1	dep	129	SENT_155	[p11l1048t2633r1103b2658],
106	*	CD	NUMBER	*	dep	129	SENT_155	[p11l1048t2633r1103b2658],
107	1.7:1.4	CD	NUMBER	1.7:1.4	dep	129	SENT_155	[p11l1218t2633r1343b2660],
108	1.4	CD	NUMBER	1.4	dep	129	SENT_155	[p11l1435t2633r1506b2660],
109	:	:	O	:	_	0	SENT_155	[p11l1435t2633r1506b2660],
110	1.4	CD	NUMBER	1.4	dep	129	SENT_155	[p11l1517t2633r1560b2658],
111	1.55	CD	NUMBER	1.55	dep	129	SENT_155	[p11l1652t2633r1740b2660],
112	:	:	O	:	_	0	SENT_155	[p11l1652t2633r1740b2660],
113	1.5	CD	NUMBER	1.5	dep	129	SENT_155	[p11l1751t2633r1793b2658],
114	1.9:1	CD	NUMBER	1.9:1	dep	129	SENT_155	[p11l1886t2633r1977b2660],
115	Change	NNP	O	Change	dep	129	SENT_155	[p11l122t2674r228b2706],
116	in	IN	O	in	dep	129	SENT_155	[p11l240t2674r265b2699],
117	P-selectin	NN	O	p-selectin	dep	129	SENT_155	[p11l280t2674r421b2700],
118	expression	NN	O	expression	dep	129	SENT_155	[p11l435t2674r587b2706],
119	(	CD	NUMBER	(	dep	129	SENT_155	[p11l603t2675r672b2706],
120	MFI	NNP	ORGANIZATION	MFI	dep	129	SENT_155	[p11l603t2675r672b2706],
121	)	CD	NUMBER	)	dep	129	SENT_155	[p11l603t2675r672b2706],
122	5.5:4.1	CD	NUMBER	5.5:4.1	dep	129	SENT_155	[p11l747t2674r868b2701],
123	5.4:2.4	CD	NUMBER	5.4:2.4	dep	129	SENT_155	[p11l965t2674r1091b2701],
124	5.6:3.7	CD	NUMBER	5.6:3.7	dep	129	SENT_155	[p11l1217t2674r1343b2701],
125	5.2:4.1	CD	NUMBER	5.2:4.1	dep	129	SENT_155	[p11l1434t2674r1555b2701],
126	5.4:4	CD	NUMBER	5.4:4	dep	129	SENT_155	[p11l1668t2674r1765b2701],
127	5.7	CD	NUMBER	5.7	dep	129	SENT_155	[p11l1885t2674r1957b2701],
128	:	:	O	:	_	0	SENT_155	[p11l1885t2674r1957b2701],
129	3.2	CD	NUMBER	3.2	_	0	SENT_155	[p11l1967t2674r2010b2700],

1	Aggr	NN	O	aggr	nn	3	SENT_156	[p11l61t2758r679b2828],
2	=	JJ	O	=	amod	3	SENT_156	[p11l61t2758r679b2828],
3	aggregation	NN	O	aggregation	_	0	SENT_156	[p11l61t2758r679b2828],
4	,	,	O	,	_	0	SENT_156	[p11l61t2758r679b2828],
5	MFI	NN	ORGANIZATION	mfus	appos	3	SENT_156	[p11l713t2759r819b2814],
6	=	JJ	O	=	amod	9	SENT_156	[p11l838t2773r1060b2814],
7	mean	NN	O	mean	nn	9	SENT_156	[p11l838t2773r1060b2814],
8	fluorescence	NN	O	fluorescence	nn	9	SENT_156	[p11l1091t2757r1512b2814],
9	intensity	NN	O	intensity	dep	5	SENT_156	[p11l1542t2759r1840b2828],
10	.	.	O	.	_	0	SENT_156	[p11l1542t2759r1840b2828],

1	*	NN	O	*	nn	2	SENT_157	[p11l115t2853r139b2876],
2	P	NN	O	p	_	0	SENT_157	[p11l180t2852r222b2908],
3	=	JJ	O	=	quantmod	4	SENT_157	[p11l236t2875r268b2893],
4	0.065	CD	NUMBER	0.065	num	2	SENT_157	[p11l282t2852r483b2909],
5	.	.	O	.	_	0	SENT_157	[p11l282t2852r483b2909],

1	1	CD	NUMBER	1	num	3	SENT_158	[p11l14t3081r38b3150],
2	antibody	NN	O	antibody	nn	3	SENT_158	[p11l87t3079r448b3169],
3	binding	NN	O	binding	_	0	SENT_158	[p11l484t3079r782b3169],
4	following	VBG	O	follow	_	0	SENT_158	[p11l817t3079r1196b3169],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_158	[p11l1231t3079r1691b3169],
6	treatment	NN	O	treatment	prep_following	3	SENT_158	[p11l1728t3086r2151b3151],
7	in	IN	O	in	_	0	SENT_158	[p11l9t3194r77b3263],
8	carriers	NNS	O	carrier	prep_in	6	SENT_158	[p11l112t3194r426b3263],
9	of	IN	O	of	_	0	SENT_158	[p11l457t3192r540b3263],
10	the	DT	O	the	det	12	SENT_158	[p11l569t3192r702b3263],
11	PlA2	NN	O	pla2	nn	12	SENT_158	[p11l738t3192r899b3278],
12	allele	NN	O	allele	prep_of	3	SENT_158	[p11l932t3192r1159b3263],
13	compared	VBN	O	compare	_	0	SENT_158	[p11l1191t3192r1598b3282],
14	with	IN	O	with	prepc_compared_with	3	SENT_158	[p11l1630t3192r1809b3263],
15	PlA1/A1	NN	O	pla1/a1	nn	16	SENT_158	[p11l1848t3192r2141b3278],
16	patients	NNS	O	patient	pobj	3	SENT_158	[p11l11t3305r349b3392],
17	(	IN	O	(	_	0	SENT_158	[p11l420t3305r574b3392],
18	1.3	CD	NUMBER	1.3	number	19	SENT_158	[p11l420t3305r574b3392],
19	:1.1	CD	NUMBER	:1.1	prep_(	16	SENT_158	[p11l603t3305r798b3378],
20	vs.	IN	O	vs.	amod	19	SENT_158	[p11l876t3323r983b3374],
21	1.8:1.2	CD	NUMBER	1.8:1.2	num	22	SENT_158	[p11l1064t3305r1419b3378],
22	MFI	NNP	ORGANIZATION	MFI	dep	19	SENT_158	[p11l1485t3306r1652b3390],
23	,	,	O	,	_	0	SENT_158	[p11l1485t3306r1652b3390],
24	P	NN	O	p	appos	22	SENT_158	[p11l1725t3305r2142b3392],
25	=	JJ	O	=	amod	27	SENT_158	[p11l1725t3305r2142b3392],
26	0.065	CD	NUMBER	0.065	tmod	25	SENT_158	[p11l1725t3305r2142b3392],
27	)	NN	O	)	dep	24	SENT_158	[p11l1725t3305r2142b3392],
28	.	.	O	.	_	0	SENT_158	[p11l1725t3305r2142b3392],

1	There	EX	O	there	expl	2	SENT_159	[p11l6t3417r246b3489],
2	were	VBD	O	be	_	0	SENT_159	[p11l294t3437r500b3489],
3	no	DT	O	no	det	5	SENT_159	[p11l552t3437r644b3489],
4	significant	JJ	O	significant	amod	5	SENT_159	[p11l695t3417r1123b3507],
5	differences	NNS	O	difference	nsubj	2	SENT_159	[p11l1172t3417r1639b3489],
6	in	IN	O	in	_	0	SENT_159	[p11l1689t3419r1757b3488],
7	baseline	NN	O	baseline	nn	9	SENT_159	[p11l1813t3417r2151b3489],
8	platelet	NN	O	platelet	nn	9	SENT_159	[p11l11t3531r336b3620],
9	reactivity	NN	O	reactivity	prep_in	5	SENT_159	[p11l367t3532r777b3620],
10	,	,	O	,	_	0	SENT_159	[p11l367t3532r777b3620],
11	assessed	VBN	O	assess	partmod	9	SENT_159	[p11l813t3531r1157b3602],
12	by	IN	O	by	_	0	SENT_159	[p11l1190t3531r1282b3620],
13	PAC-1	NN	O	pac-1	nn	14	SENT_159	[p11l1311t3531r1525b3602],
14	binding	NN	O	binding	agent	11	SENT_159	[p11l1569t3531r1867b3620],
15	and	CC	O	and	_	0	SENT_159	[p11l1896t3531r2039b3602],
16	Pselectin	NN	PERSON	pselectin	agent	11	SENT_159	[p11l2073t3532r2146b3601, p12l8t18r328b90],

1	expression	NN	O	expression	_	0	SENT_160	[p12l383t20r844b108],
2	,	,	O	,	_	0	SENT_160	[p12l383t20r844b108],
3	between	IN	O	between	dep	1	SENT_160	[p12l907t18r1260b90],
4	the	DT	O	the	det	7	SENT_160	[p12l1315t18r1449b90],
5	different	JJ	O	different	amod	7	SENT_160	[p12l1501t18r1871b90],
6	genotype	NN	O	genotype	nn	7	SENT_160	[p12l1923t36r2145b108, p12l8t115r189b198],
7	groups	NNS	O	group	pobj	3	SENT_160	[p12l227t126r521b198],
8	.	.	O	.	_	0	SENT_160	[p12l227t126r521b198],

1	Discussion	NN	O	discussion	_	0	SENT_161	[p12l13t368r534b452],

1	The	DT	O	the	det	3	SENT_162	[p12l6t606r159b678],
2	current	JJ	DATE	current	amod	3	SENT_162	[p12l226t614r534b678],
3	study	NN	O	study	nsubj	4	SENT_162	[p12l599t606r822b696],
4	evaluated	VBD	O	evaluate	_	0	SENT_162	[p12l886t606r1297b678],
5	whether	IN	O	whether	complm	21	SENT_162	[p12l1364t606r1714b678],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	21	SENT_162	[p12l1781t606r2146b696, p12l11t720r285b809],
7	in	IN	O	in	_	0	SENT_162	[p12l333t721r401b790],
8	the	DT	O	the	det	9	SENT_162	[p12l453t720r587b791],
9	genes	NNS	O	gene	prep_in	6	SENT_162	[p12l636t737r867b809],
10	encoding	VBG	O	encode	partmod	9	SENT_162	[p12l915t720r1285b809],
11	for	IN	O	for	_	0	SENT_162	[p12l1332t720r1451b791],
12	GP	NN	O	gp	nn	13	SENT_162	[p12l1497t720r1605b791],
13	Illa	NN	PERSON	illum	prep_for	10	SENT_162	[p12l1659t721r1773b791],
14	and	CC	O	and	_	0	SENT_162	[p12l1823t720r1965b791],
15	the	DT	O	the	det	19	SENT_162	[p12l2017t720r2150b791],
16	P2Y12	NN	O	p2y12	nn	19	SENT_162	[p12l12t833r230b919],
17	and	CC	O	and	_	0	SENT_162	[p12l277t832r419b904],
18	PZY1	NN	O	pzy1	nn	19	SENT_162	[p12l472t833r645b919],
19	receptors	NNS	O	receptor	prep_for	10	SENT_162	[p12l704t840r1093b922],
20	are	VBP	O	be	auxpass	21	SENT_162	[p12l1139t852r1269b904],
21	associated	VBN	O	associate	ccomp	4	SENT_162	[p12l1316t832r1743b904],
22	with	IN	O	with	_	0	SENT_162	[p12l1790t832r1968b904],
23	the	DT	O	the	det	24	SENT_162	[p12l2017t832r2150b904],
24	response	NN	O	response	prep_with	21	SENT_162	[p12l12t965r369b1036],
25	to	TO	O	to	_	0	SENT_162	[p12l417t953r498b1017],
26	aspirin	NN	O	aspirin	prep_to	21	SENT_162	[p12l545t948r815b1036],
27	and	CC	O	and	_	0	SENT_162	[p12l865t946r1008b1017],
28	to	TO	O	to	_	0	SENT_162	[p12l1059t953r1141b1017],
29	clopidogrel	NN	O	clopidogrel	prep_to	21	SENT_162	[p12l1187t946r1648b1036],
30	in	IN	O	in	_	0	SENT_162	[p12l1695t948r1764b1016],
31	patients	NNS	O	patient	prep_in	29	SENT_162	[p12l1817t948r2151b1036],
32	undergoing	VBG	O	undergo	partmod	31	SENT_162	[p12l11t1059r467b1148],
33	elective	JJ	O	elective	amod	34	SENT_162	[p12l502t1059r833b1130],
34	PCI	NN	O	pcus	dobj	32	SENT_162	[p12l872t1060r1022b1130],
35	.	.	O	.	_	0	SENT_162	[p12l872t1060r1022b1130],

1	The	DT	O	the	det	3	SENT_163	[p12l1063t1059r1216b1130],
2	genotype	NN	O	genotype	nn	3	SENT_163	[p12l1252t1066r1632b1148],
3	frequencies	NNS	O	frequency	nsubj	22	SENT_163	[p12l1667t1059r2151b1148],
4	we	PRP	O	we	nsubj	5	SENT_163	[p12l6t1190r124b1241],
5	observed	VBD	O	observe	parataxis	22	SENT_163	[p12l192t1170r568b1241],
6	for	IN	O	for	_	0	SENT_163	[p12l638t1170r758b1241],
7	the	DT	O	the	det	9	SENT_163	[p12l823t1170r959b1241],
8	PlA2	NN	O	pla2	nn	9	SENT_163	[p12l1030t1170r1195b1256],
9	allele	NN	O	allele	prep_for	5	SENT_163	[p12l1264t1170r1525b1256],
10	,	,	O	,	_	0	SENT_163	[p12l1264t1170r1525b1256],
11	P2Y12	NN	O	p2y12	nn	13	SENT_163	[p12l1604t1171r1826b1256],
12	T744C	NN	O	t744c	nn	13	SENT_163	[p12l1892t1171r2150b1241],
13	polymorphism	NN	O	polymorphism	appos	9	SENT_163	[p12l11t1283r585b1373],
14	and	CC	O	and	_	0	SENT_163	[p12l646t1283r789b1354],
15	PZY1	NN	O	pzy1	nn	16	SENT_163	[p12l854t1284r1026b1369],
16	1622A	NN	O	1622a	appos	9	SENT_163	[p12l1100t1284r1476b1355],
17	>	JJR	O	>	amod	19	SENT_163	[p12l1100t1284r1476b1355],
18	G	NN	O	g	nn	19	SENT_163	[p12l1100t1284r1476b1355],
19	polymorphism	NN	O	polymorphism	dep	13	SENT_163	[p12l1539t1283r2143b1373],
20	,	,	O	,	_	0	SENT_163	[p12l1539t1283r2143b1373],
21	were	VBD	O	be	cop	22	SENT_163	[p12l6t1416r211b1468],
22	similar	JJ	O	similar	_	0	SENT_163	[p12l268t1397r546b1468],
23	to	TO	O	to	_	0	SENT_163	[p12l600t1404r682b1468],
24	the	DT	O	the	det	25	SENT_163	[p12l739t1397r873b1468],
25	frequencies	NNS	O	frequency	prep_to	22	SENT_163	[p12l929t1397r1413b1486],
26	reported	VBN	O	report	partmod	25	SENT_163	[p12l1473t1397r1828b1486],
27	in	IN	O	in	_	0	SENT_163	[p12l1888t1398r1957b1467],
28	the	DT	O	the	det	30	SENT_163	[p12l2017t1397r2150b1468],
29	literature	NN	O	literature	nn	30	SENT_163	[p12l12t1509r407b1581],
30	[	NN	O	[	prep_in	26	SENT_163	[p12l447t1509r1062b1599],
31	10,11,15	CD	NUMBER	10,11,15	number	32	SENT_163	[p12l447t1509r1062b1599],
32	—	CD	NUMBER	—	dep	30	SENT_163	[p12l447t1509r1062b1599],
33	17	CD	NUMBER	17	num	34	SENT_163	[p12l447t1509r1062b1599],
34	]	NN	O	]	dep	32	SENT_163	[p12l447t1509r1062b1599],
35	.	.	O	.	_	0	SENT_163	[p12l447t1509r1062b1599],

1	We	PRP	O	we	nsubj	4	SENT_164	[p12l1102t1511r1226b1581],
2	did	VBD	O	do	aux	4	SENT_164	[p12l1260t1509r1382b1581],
3	not	RB	O	not	neg	4	SENT_164	[p12l1422t1516r1553b1581],
4	find	VB	O	find	conj_or	4	SENT_164	[p12l1588t1509r1743b1581],
5	evidence	NN	O	evidence	dobj	4	SENT_164	[p12l1780t1509r2151b1581],
6	for	IN	O	for	_	0	SENT_164	[p12l8t1623r126b1694],
7	a	DT	O	a	det	9	SENT_164	[p12l176t1642r219b1694],
8	significant	JJ	O	significant	amod	9	SENT_164	[p12l272t1623r700b1712],
9	association	NN	O	association	prep_for	4	SENT_164	[p12l753t1624r1205b1694],
10	between	IN	O	between	_	0	SENT_164	[p12l1263t1623r1615b1694],
11	these	DT	O	these	det	12	SENT_164	[p12l1671t1623r1893b1694],
12	polymorphisms	NNS	O	polymorphism	prep_between	9	SENT_164	[p12l1948t1623r2145b1712, p12l11t1735r449b1825],
13	and	CC	O	and	_	0	SENT_164	[p12l484t1735r627b1807],
14	the	DT	O	the	det	15	SENT_164	[p12l665t1735r799b1807],
15	response	NN	O	response	conj_and	12	SENT_164	[p12l838t1755r1194b1825],
16	to	TO	O	to	_	0	SENT_164	[p12l1230t1743r1311b1807],
17	aspirin	NN	O	aspirin	prep_to	4	SENT_164	[p12l1346t1737r1617b1825],
18	or	CC	O	or	_	0	SENT_164	[p12l1654t1755r1738b1807],
19	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_164	[p12l1769t1735r2145b1825, p12l12t1848r153b1935],
20	,	,	O	,	_	0	SENT_164	[p12l1769t1735r2145b1825, p12l12t1848r153b1935],
21	as	IN	O	as	mark	22	SENT_164	[p12l232t1867r316b1919],
22	assessed	VBN	O	assess	dep	17	SENT_164	[p12l387t1848r751b1919],
23	by	IN	O	by	_	0	SENT_164	[p12l827t1848r923b1937],
24	platelet	NN	O	platelet	nn	25	SENT_164	[p12l994t1848r1341b1938],
25	aggregation	NN	O	aggregation	prep_by	22	SENT_164	[p12l1411t1850r1924b1938],
26	and	CC	O	and	_	0	SENT_164	[p12l1998t1848r2147b1919],
27	activation	NN	O	activation	nn	28	SENT_164	[p12l9t1963r419b2033],
28	markers	NNS	O	marker	conj_and	25	SENT_164	[p12l460t1962r787b2033],
29	or	CC	O	or	_	0	SENT_164	[p12l820t1981r904b2033],
30	by	IN	O	by	_	0	SENT_164	[p12l938t1962r1030b2051],
31	grouping	VBG	O	group	prepc_by	4	SENT_164	[p12l1062t1963r1419b2051],
32	the	DT	O	the	det	33	SENT_164	[p12l1453t1962r1586b2033],
33	patients	NNS	O	patient	dobj	31	SENT_164	[p12l1623t1963r1958b2051],
34	into	IN	O	into	_	0	SENT_164	[p12l1992t1963r2151b2033],
35	drug-insensitive	JJ	O	drug-insensitive	prep_into	31	SENT_164	[p12l8t2074r667b2164],
36	vs.	CC	O	vs.	prep	35	SENT_164	[p12l698t2094r804b2146],
37	drug-sensitive	JJ	O	drug-sensitive	amod	38	SENT_164	[p12l848t2074r1428b2164],
38	groups	NNS	O	group	dep	36	SENT_164	[p12l1462t2092r1756b2164],
39	.	.	O	.	_	0	SENT_164	[p12l1462t2092r1756b2164],

1	The	DT	O	the	det	3	SENT_165	[p12l1797t2074r1950b2146],
2	four	CD	NUMBER	four	num	3	SENT_165	[p12l1984t2074r2153b2146],
3	groups	NNS	O	group	_	0	SENT_165	[p12l9t2205r277b2277],
4	of	IN	O	of	_	0	SENT_165	[p12l321t2187r404b2258],
5	patients	NNS	O	patient	prep_of	3	SENT_165	[p12l449t2189r782b2277],
6	(	IN	O	(	_	0	SENT_165	[p12l833t2187r1520b2277],
7	drug-insensitive	JJ	O	drug-insensitive	amod	8	SENT_165	[p12l833t2187r1520b2277],
8	vs.	NN	O	v.	prep_(	5	SENT_165	[p12l1563t2206r1669b2258],
9	-	:	O	-	_	0	SENT_165	[p12l1726t2189r2147b2277],
10	sensitive	JJ	O	sensitive	amod	11	SENT_165	[p12l1726t2189r2147b2277],
11	)	NN	O	)	dep	12	SENT_165	[p12l1726t2189r2147b2277],
12	had	VBD	O	have	dep	3	SENT_165	[p12l11t2301r152b2372],
13	similar	JJ	O	similar	amod	15	SENT_165	[p12l212t2301r490b2372],
14	clinical	JJ	O	clinical	amod	15	SENT_165	[p12l545t2301r839b2372],
15	characteristics	NNS	O	characteristic	dobj	12	SENT_165	[p12l898t2301r1532b2387],
16	,	,	O	,	_	0	SENT_165	[p12l898t2301r1532b2387],
17	except	IN	O	except	_	0	SENT_165	[p12l1598t2308r1877b2390],
18	for	IN	O	for	prepc_except_for	24	SENT_165	[p12l1934t2301r2052b2372],
19	a	DT	O	a	det	21	SENT_165	[p12l2107t2320r2150b2372],
20	higher	JJR	O	higher	amod	21	SENT_165	[p12l11t2413r269b2503],
21	proportion	NN	O	proportion	pobj	24	SENT_165	[p12l305t2415r737b2503],
22	of	IN	O	of	_	0	SENT_165	[p12l775t2413r857b2485],
23	women	NNS	O	woman	prep_of	21	SENT_165	[p12l889t2433r1181b2485],
24	among	IN	O	among	rcmod	15	SENT_165	[p12l1221t2431r1491b2503],
25	aspirininsensitive	JJ	O	aspirininsensitive	pobj	24	SENT_165	[p12l1528t2415r2145b2503, p12l8t2528r190b2613],
26	,	,	O	,	_	0	SENT_165	[p12l1528t2415r2145b2503, p12l8t2528r190b2613],
27	compared	VBN	O	compare	_	0	SENT_165	[p12l246t2527r652b2616],
28	with	IN	O	with	prepc_compared_with	15	SENT_165	[p12l701t2527r880b2598],
29	aspirin-sensitive	JJ	O	aspirin-sensitive	amod	30	SENT_165	[p12l931t2528r1603b2616],
30	patients	NNS	O	patient	pobj	15	SENT_165	[p12l1653t2528r2014b2616],
31	,	,	O	,	_	0	SENT_165	[p12l1653t2528r2014b2616],
32	as	IN	O	as	_	0	SENT_165	[p12l2070t2546r2151b2598],
33	previously	RB	DATE	previously	advmod	34	SENT_165	[p12l11t2639r429b2729],
34	reported	VBN	O	report	amod	35	SENT_165	[p12l468t2639r823b2729],
35	[	NN	O	[	prep_as	15	SENT_165	[p12l869t2639r1050b2729],
36	21	CD	NUMBER	21	num	37	SENT_165	[p12l869t2639r1050b2729],
37	]	NN	O	]	nsubj	12	SENT_165	[p12l869t2639r1050b2729],
38	.	.	O	.	_	0	SENT_165	[p12l869t2639r1050b2729],

1	Contrary	JJ	O	contrary	_	0	SENT_166	[p12l122t2753r481b2842],
2	to	TO	O	to	_	0	SENT_166	[p12l517t2759r599b2823],
3	previous	JJ	O	previous	amod	4	SENT_166	[p12l640t2754r984b2842],
4	studies	NNS	O	study	prep_contrary_to	5	SENT_166	[p12l1021t2752r1310b2823],
5	[	VBP	O	[	_	0	SENT_166	[p12l1354t2752r1654b2842],
6	9	CD	NUMBER	9	number	7	SENT_166	[p12l1354t2752r1654b2842],
7	—	CD	NUMBER	—	dobj	5	SENT_166	[p12l1354t2752r1654b2842],
8	11	CD	NUMBER	11	num	9	SENT_166	[p12l1354t2752r1654b2842],
9	]	NN	O	]	nsubj	5	SENT_166	[p12l1354t2752r1654b2842],
10	,	,	O	,	_	0	SENT_166	[p12l1354t2752r1654b2842],
11	we	PRP	O	we	nsubj	14	SENT_166	[p12l1698t2771r1816b2823],
12	did	VBD	O	do	aux	14	SENT_166	[p12l1854t2752r1976b2823],
13	not	RB	O	not	neg	14	SENT_166	[p12l2020t2759r2151b2823],
14	find	VB	O	find	ccomp	5	SENT_166	[p12l8t2866r164b2937],
15	an	DT	O	a	det	16	SENT_166	[p12l202t2885r293b2937],
16	association	NN	O	association	dobj	14	SENT_166	[p12l330t2867r782b2937],
17	between	IN	O	between	_	0	SENT_166	[p12l823t2866r1174b2937],
18	a	DT	O	a	det	19	SENT_166	[p12l1212t2885r1255b2937],
19	polymorphism	NN	O	polymorphism	prep_between	16	SENT_166	[p12l1293t2866r1866b2955],
20	of	IN	O	of	_	0	SENT_166	[p12l1903t2866r1985b2937],
21	the	DT	O	the	det	26	SENT_166	[p12l2017t2866r2150b2937],
22	Pl	NN	O	pl	nn	26	SENT_166	[p12l12t2978r81b3050],
23	(	CD	NUMBER	(	num	26	SENT_166	[p12l131t2979r418b3068],
24	A1/A2	NN	O	a1/a2	nn	26	SENT_166	[p12l131t2979r418b3068],
25	)	NN	O	)	nn	26	SENT_166	[p12l131t2979r418b3068],
26	gene	NN	O	gene	prep_of	19	SENT_166	[p12l464t2996r658b3068],
27	and	CC	O	and	_	0	SENT_166	[p12l702t2978r845b3050],
28	aspirin	NN	O	aspirin	nn	29	SENT_166	[p12l891t2980r1160b3068],
29	insensitivity	NN	O	insensitivity	conj_and	26	SENT_166	[p12l1208t2980r1718b3068],
30	.	.	O	.	_	0	SENT_166	[p12l1208t2980r1718b3068],

1	However	RB	O	however	advmod	5	SENT_167	[p12l1773t2980r2143b3065],
2	,	,	O	,	_	0	SENT_167	[p12l1773t2980r2143b3065],
3	our	PRP$	O	we	poss	4	SENT_167	[p12l8t3110r143b3162],
4	study	NN	O	study	nsubj	5	SENT_167	[p12l184t3091r404b3181],
5	differs	VBZ	O	differ	_	0	SENT_167	[p12l447t3091r713b3162],
6	from	IN	O	from	_	0	SENT_167	[p12l757t3091r947b3162],
7	the	DT	O	the	det	9	SENT_167	[p12l994t3091r1128b3162],
8	previous	JJ	O	previous	amod	9	SENT_167	[p12l1175t3093r1518b3181],
9	reports	NNS	O	report	prep_from	5	SENT_167	[p12l1565t3098r1857b3181],
10	in	IN	O	in	_	0	SENT_167	[p12l1901t3093r1970b3162],
11	the	DT	O	the	det	12	SENT_167	[p12l2017t3091r2150b3162],
12	population	NN	O	population	prep_in	9	SENT_167	[p12l11t3205r447b3294],
13	studied	VBN	O	study	partmod	12	SENT_167	[p12l483t3205r782b3276],
14	and	CC	O	and	_	0	SENT_167	[p12l818t3205r962b3276],
15	the	DT	O	the	det	16	SENT_167	[p12l999t3205r1132b3276],
16	definition	NN	O	definition	prep_from	5	SENT_167	[p12l1165t3205r1563b3276],
17	employed	VBN	O	employ	partmod	16	SENT_167	[p12l1600t3205r2000b3294],
18	for	IN	O	for	_	0	SENT_167	[p12l2035t3205r2153b3276],
19	aspirin	NN	O	aspirin	nn	20	SENT_167	[p12l9t3319r279b3407],
20	insensitivity	NN	O	insensitivity	prep_for	17	SENT_167	[p12l311t3319r822b3407],
21	.	.	O	.	_	0	SENT_167	[p12l311t3319r822b3407],

1	The	DT	O	the	det	3	SENT_168	[p12l857t3317r1010b3389],
2	current	JJ	DATE	current	amod	3	SENT_168	[p12l1040t3324r1345b3389],
3	study	NN	O	study	nsubj	6	SENT_168	[p12l1373t3317r1594b3407],
4	is	VBZ	O	be	cop	6	SENT_168	[p12l1622t3319r1681b3389],
5	the	DT	O	the	det	6	SENT_168	[p12l1709t3317r1843b3389],
6	first	JJ	ORDINAL	first	_	0	SENT_168	[p12l1872t3317r2040b3389],
7	to	TO	O	to	aux	8	SENT_168	[p12l2069t3324r2151b3389],
8	evaluate	VB	O	evaluate	dep	6	SENT_168	[p12l8t3431r366b3502],
9	this	DT	O	this	det	10	SENT_168	[p12l396t3431r543b3502],
10	polymorphism	NN	O	polymorphism	dobj	8	SENT_168	[p12l575t3431r1149b3520],
11	and	CC	O	and	_	0	SENT_168	[p12l1183t3431r1326b3502],
12	its	PRP$	O	its	poss	13	SENT_168	[p12l1360t3432r1456b3502],
13	association	NN	O	association	conj_and	10	SENT_168	[p12l1486t3432r1938b3502],
14	with	IN	O	with	_	0	SENT_168	[p12l1969t3431r2147b3502],
15	aspirin	NN	O	aspirin	nn	16	SENT_168	[p12l9t3545r285b3633],
16	response	NN	O	response	prep_with	8	SENT_168	[p12l354t3563r719b3633],
17	in	IN	O	in	_	0	SENT_168	[p12l781t3545r850b3614],
18	patients	NNS	O	patient	prep_in	16	SENT_168	[p12l918t3545r1260b3633],
19	undergoing	VBG	O	undergo	partmod	18	SENT_168	[p12l1323t3543r1790b3633],
20	PCI	NN	O	pcus	dobj	19	SENT_168	[p12l1854t3544r2009b3615],
21	.	.	O	.	_	0	SENT_168	[p12l1854t3544r2009b3615],

1	In	IN	O	in	_	0	SENT_169	[p12l2083t3545r2148b3614],
2	previous	JJ	O	previous	amod	3	SENT_169	[p12l11t3658r354b3746],
3	studies	NNS	O	study	prep_in	11	SENT_169	[p12l377t3656r666b3727],
4	other	JJ	O	other	amod	6	SENT_169	[p12l689t3656r912b3727],
5	patient	NN	O	patient	nn	6	SENT_169	[p12l936t3658r1233b3746],
6	populations	NNS	O	population	nsubjpass	11	SENT_169	[p12l1259t3656r1736b3746],
7	or	CC	O	or	_	0	SENT_169	[p12l1759t3675r1843b3727],
8	normal	JJ	O	normal	amod	9	SENT_169	[p12l1867t3656r2150b3727],
9	volunteers	NNS	O	volunteer	conj_or	6	SENT_169	[p13l6t19r443b90],
10	were	VBD	O	be	auxpass	11	SENT_169	[p13l469t38r674b90],
11	examined	VBN	O	examine	_	0	SENT_169	[p13l703t19r1129b90],
12	.	.	O	.	_	0	SENT_169	[p13l703t19r1129b90],

1	Aspirin	NN	O	aspirin	nn	2	SENT_170	[p13l1164t20r1443b108],
2	insensitivity	NN	O	insensitivity	nsubjpass	4	SENT_170	[p13l1475t20r1973b108],
3	was	VBD	O	be	auxpass	4	SENT_170	[p13l1997t38r2151b90],
4	defined	VBN	O	define	_	0	SENT_170	[p13l8t131r318b203],
5	in	IN	O	in	_	0	SENT_170	[p13l352t133r420b202],
6	our	PRP$	O	we	poss	7	SENT_170	[p13l453t151r588b203],
7	study	NN	O	study	prep_in	4	SENT_170	[p13l616t131r850b221],
8	,	,	O	,	_	0	SENT_170	[p13l616t131r850b221],
9	based	VBN	O	base	_	0	SENT_170	[p13l891t131r1121b203],
10	on	IN	O	on	prepc_based_on	4	SENT_170	[p13l1154t151r1248b203],
11	AA	NN	O	aa	nn	12	SENT_170	[p13l1278t132r1415b202],
12	—	NN	O	—	pobj	4	SENT_170	[p13l1278t132r1415b202],
13	and	CC	O	and	_	0	SENT_170	[p13l1451t131r1594b203],
14	ADP	NN	O	adp	nn	15	SENT_170	[p13l1624t131r2148b203],
15	—	NN	O	—	nsubj	16	SENT_170	[p13l1624t131r2148b203],
16	induced	VBD	O	induce	conj_and	4	SENT_170	[p13l1624t131r2148b203],
17	platelet	NN	O	platelet	nn	18	SENT_170	[p13l11t244r336b334],
18	aggregation	NN	O	aggregation	dobj	16	SENT_170	[p13l380t246r894b334],
19	,	,	O	,	_	0	SENT_170	[p13l380t246r894b334],
20	because	IN	O	because	mark	27	SENT_170	[p13l948t244r1277b315],
21	use	NN	O	use	nsubjpass	27	SENT_170	[p13l1324t263r1455b315],
22	of	IN	O	of	_	0	SENT_170	[p13l1499t244r1582b315],
23	such	JJ	O	such	amod	24	SENT_170	[p13l1622t244r1799b315],
24	criteria	NNS	O	criterion	prep_of	21	SENT_170	[p13l1846t246r2150b315],
25	has	VBZ	O	have	aux	27	SENT_170	[p13l11t358r141b429],
26	been	VBN	O	be	auxpass	27	SENT_170	[p13l167t358r361b429],
27	shown	VBN	O	show	advcl	16	SENT_170	[p13l389t358r639b429],
28	to	TO	O	to	aux	29	SENT_170	[p13l667t365r748b429],
29	predict	VB	O	predict	xcomp	27	SENT_170	[p13l775t358r1070b447],
30	adverse	JJ	O	adverse	amod	32	SENT_170	[p13l1094t358r1411b429],
31	clinical	JJ	O	clinical	amod	32	SENT_170	[p13l1435t358r1730b429],
32	outcomes	NNS	O	outcome	nsubj	33	SENT_170	[p13l1755t365r2151b429],
33	[	VBP	O	[	ccomp	29	SENT_170	[p13l14t470r147b560],
34	5	CD	NUMBER	5	number	35	SENT_170	[p13l14t470r147b560],
35	]	CD	NUMBER	]	dobj	33	SENT_170	[p13l14t470r147b560],
36	.	.	O	.	_	0	SENT_170	[p13l14t470r147b560],

1	Although	IN	O	although	mark	5	SENT_171	[p13l190t470r554b560],
2	we	PRP	O	we	nsubj	5	SENT_171	[p13l594t490r711b542],
3	did	VBD	O	do	aux	5	SENT_171	[p13l749t470r871b542],
4	not	RB	O	not	neg	5	SENT_171	[p13l915t478r1045b542],
5	find	VB	O	find	advcl	17	SENT_171	[p13l1083t470r1238b542],
6	an	DT	O	a	det	7	SENT_171	[p13l1279t490r1370b542],
7	association	NN	O	association	dobj	5	SENT_171	[p13l1412t472r1864b542],
8	of	IN	O	of	_	0	SENT_171	[p13l1904t470r1987b542],
9	PlA	NN	O	plum	nn	10	SENT_171	[p13l2025t470r2153b542],
10	genotype	NN	O	genotype	prep_of	7	SENT_171	[p13l9t591r388b673],
11	with	IN	O	with	_	0	SENT_171	[p13l431t584r609b655],
12	aspirin	NN	O	aspirin	nn	13	SENT_171	[p13l657t585r927b673],
13	response	NN	O	response	prep_with	5	SENT_171	[p13l978t603r1362b673],
14	,	,	O	,	_	0	SENT_171	[p13l978t603r1362b673],
15	we	PRP	O	we	nsubj	17	SENT_171	[p13l1413t603r1530b655],
16	did	VBD	O	do	aux	17	SENT_171	[p13l1574t584r1696b655],
17	observe	VB	O	observe	_	0	SENT_171	[p13l1743t584r2062b655],
18	a	DT	O	a	det	19	SENT_171	[p13l2107t603r2150b655],
19	trend	NN	O	trend	dobj	17	SENT_171	[p13l10t696r228b768],
20	toward	IN	O	toward	_	0	SENT_171	[p13l266t696r551b768],
21	lower	JJR	O	lower	amod	22	SENT_171	[p13l592t696r820b768],
22	inhibition	NN	O	inhibition	prep_toward	17	SENT_171	[p13l851t696r1241b768],
23	of	IN	O	of	_	0	SENT_171	[p13l1278t696r1360b768],
24	platelet	NN	O	platelet	nn	25	SENT_171	[p13l1394t696r1718b786],
25	reactivity	NN	O	reactivity	prep_of	22	SENT_171	[p13l1755t698r2151b786],
26	(	CD	NUMBER	(	num	25	SENT_171	[p13l15t810r152b899],
27	GP	NN	O	gp	dep	17	SENT_171	[p13l15t810r152b899],
28	|	CD	NUMBER	|	num	30	SENT_171	[p13l209t809r474b880],
29	|	NN	O	|	nn	30	SENT_171	[p13l209t809r474b880],
30	b	NN	O	b	dobj	27	SENT_171	[p13l209t809r474b880],
31	/	:	O	/	punct	34	SENT_171	[p13l209t809r474b880],
32	|	CD	NUMBER	|	num	33	SENT_171	[p13l209t809r474b880],
33	|	CD	NUMBER	|	nsubj	34	SENT_171	[p13l209t809r474b880],
34	|	VBD	O	|	parataxis	27	SENT_171	[p13l209t809r474b880],
35	a	DT	O	a	det	37	SENT_171	[p13l209t809r474b880],
36	activation	NN	O	activation	nn	37	SENT_171	[p13l526t811r970b899],
37	)	NN	O	)	dobj	34	SENT_171	[p13l526t811r970b899],
38	in	IN	O	in	_	0	SENT_171	[p13l1024t811r1093b880],
39	response	NN	O	response	prep_in	34	SENT_171	[p13l1149t828r1506b899],
40	to	TO	O	to	_	0	SENT_171	[p13l1557t816r1638b880],
41	clopidogrel	NN	O	clopidogrel	prep_to	34	SENT_171	[p13l1687t809r2148b899],
42	among	IN	O	among	_	0	SENT_171	[p13l10t939r284b1010],
43	carriers	NNS	O	carrier	prep_among	27	SENT_171	[p13l345t923r668b992],
44	of	IN	O	of	_	0	SENT_171	[p13l728t922r812b992],
45	the	DT	O	the	det	47	SENT_171	[p13l870t922r1007b992],
46	PlA2	NN	O	pla2	nn	47	SENT_171	[p13l1072t922r1237b1007],
47	allele	NN	O	allele	prep_of	43	SENT_171	[p13l1300t922r1560b992],
48	.	.	O	.	_	0	SENT_171	[p13l1300t922r1560b992],

1	This	DT	O	this	det	2	SENT_172	[p13l1627t922r1798b992],
2	finding	NN	O	finding	nsubj	3	SENT_172	[p13l1858t922r2150b1010],
3	supports	VBZ	O	support	_	0	SENT_172	[p13l10t1042r358b1124],
4	the	DT	O	the	det	5	SENT_172	[p13l414t1034r547b1106],
5	report	NN	O	report	nsubj	9	SENT_172	[p13l606t1042r861b1124],
6	by	IN	O	by	_	0	SENT_172	[p13l919t1034r1011b1124],
7	Angiolillo	NNP	PERSON	Angiolillo	prep_by	5	SENT_172	[p13l1062t1034r1448b1124],
8	et	FW	O	et	nn	9	SENT_172	[p13l1504t1042r1587b1106],
9	al	FW	O	al	xcomp	3	SENT_172	[p13l1643t1034r1713b1106],
10	who	WP	O	who	nsubj	12	SENT_172	[p13l1767t1034r1935b1106],
11	also	RB	O	also	advmod	12	SENT_172	[p13l1991t1034r2149b1106],
12	found	VBD	O	find	rcmod	9	SENT_172	[p13l9t1147r239b1217],
13	that	IN	O	that	complm	16	SENT_172	[p13l288t1147r457b1217],
14	PlA2	NN	O	pla2	nn	15	SENT_172	[p13l504t1147r667b1232],
15	carriers	NNS	O	carrier	nsubj	16	SENT_172	[p13l711t1148r1026b1217],
16	had	VBD	O	have	ccomp	12	SENT_172	[p13l1073t1147r1213b1217],
17	a	DT	O	a	det	20	SENT_172	[p13l1261t1166r1304b1217],
18	lower	JJR	O	lower	amod	20	SENT_172	[p13l1353t1147r1581b1217],
19	anti-platelet	JJ	O	anti-platelet	amod	20	SENT_172	[p13l1624t1147r2150b1235],
20	response	NN	O	response	dobj	16	SENT_172	[p13l14t1279r370b1349],
21	to	TO	O	to	_	0	SENT_172	[p13l401t1266r483b1331],
22	a	DT	O	a	det	24	SENT_172	[p13l513t1279r556b1331],
23	300-mg	JJ	O	300-mg	amod	24	SENT_172	[p13l589t1260r887b1349],
24	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_172	[p13l918t1259r1378b1349],
25	loading	VBG	O	load	partmod	24	SENT_172	[p13l1413t1259r1708b1349],
26	dose	NN	O	dose	nn	27	SENT_172	[p13l1738t1259r1923b1331],
27	[	NN	O	[	dobj	25	SENT_172	[p13l1959t1259r2140b1349],
28	22	CD	NUMBER	22	num	29	SENT_172	[p13l1959t1259r2140b1349],
29	]	NN	O	]	dep	27	SENT_172	[p13l1959t1259r2140b1349],
30	.	.	O	.	_	0	SENT_172	[p13l1959t1259r2140b1349],

1	The	DT	O	the	det	3	SENT_173	[p13l7t1373r160b1444],
2	lower	JJR	O	lower	amod	3	SENT_173	[p13l197t1373r425b1444],
3	degree	NN	O	degree	_	0	SENT_173	[p13l456t1373r739b1463],
4	of	IN	O	of	_	0	SENT_173	[p13l772t1373r854b1444],
5	reduction	NN	O	reduction	prep_of	3	SENT_173	[p13l887t1373r1277b1444],
6	in	IN	O	in	_	0	SENT_173	[p13l1313t1375r1382b1443],
7	GP	NN	O	gp	nn	10	SENT_173	[p13l1419t1374r1527b1444],
8	|	CD	NUMBER	|	num	10	SENT_173	[p13l1566t1373r1831b1444],
9	|	NN	O	|	nn	10	SENT_173	[p13l1566t1373r1831b1444],
10	b	NN	O	b	prep_in	3	SENT_173	[p13l1566t1373r1831b1444],
11	/	:	O	/	punct	3	SENT_173	[p13l1566t1373r1831b1444],
12	|	CD	NUMBER	|	num	13	SENT_173	[p13l1566t1373r1831b1444],
13	|	CD	NUMBER	|	nsubj	14	SENT_173	[p13l1566t1373r1831b1444],
14	|	VBD	O	|	dep	3	SENT_173	[p13l1566t1373r1831b1444],
15	a	DT	O	a	det	16	SENT_173	[p13l1566t1373r1831b1444],
16	activation	NN	O	activation	nsubj	21	SENT_173	[p13l1866t1375r2144b1444, p13l10t1486r166b1555],
17	in	IN	O	in	_	0	SENT_173	[p13l200t1486r269b1554],
18	response	NN	O	response	prep_in	16	SENT_173	[p13l305t1504r662b1573],
19	to	TO	O	to	_	0	SENT_173	[p13l693t1492r775b1555],
20	clopidogrel	NN	O	clopidogrel	prep_to	18	SENT_173	[p13l806t1485r1266b1573],
21	is	VBZ	O	be	ccomp	14	SENT_173	[p13l1297t1486r1356b1555],
22	also	RB	O	also	advmod	21	SENT_173	[p13l1387t1485r1544b1555],
23	in	IN	O	in	_	0	SENT_173	[p13l1575t1486r1644b1554],
24	accordance	NN	O	accordance	prep_in	21	SENT_173	[p13l1678t1485r2149b1555],
25	with	IN	O	with	mark	39	SENT_173	[p13l7t1597r189b1669],
26	the	DT	O	the	det	30	SENT_173	[p13l253t1597r388b1669],
27	reported	VBN	O	report	amod	30	SENT_173	[p13l453t1597r813b1687],
28	lower	JJR	O	lower	dep	29	SENT_173	[p13l880t1597r1113b1669],
29	inhibitory	JJ	O	inhibitory	amod	30	SENT_173	[p13l1172t1597r1580b1687],
30	response	NN	O	response	nsubj	39	SENT_173	[p13l1642t1617r2006b1687],
31	to	TO	O	to	_	0	SENT_173	[p13l2067t1604r2150b1669],
32	abciximab	NN	O	abciximab	prep_to	30	SENT_173	[p13l10t1710r430b1781],
33	observed	VBN	O	observe	partmod	30	SENT_173	[p13l468t1710r835b1781],
34	in	IN	O	in	_	0	SENT_173	[p13l877t1712r945b1781],
35	platelets	NNS	O	platelet	prep_in	33	SENT_173	[p13l989t1710r1351b1800],
36	from	IN	O	from	_	0	SENT_173	[p13l1388t1710r1578b1781],
37	PlA1/A2	NN	O	pla1/a2	nn	38	SENT_173	[p13l1623t1710r1926b1796],
38	individuals	NNS	O	individual	prep_from	35	SENT_173	[p13l1965t1710r2144b1781, p13l7t1823r294b1893],
39	[	VBP	O	[	advcl	21	SENT_173	[p13l331t1823r513b1911],
40	23	CD	NUMBER	23	num	41	SENT_173	[p13l331t1823r513b1911],
41	]	CD	NUMBER	]	dobj	39	SENT_173	[p13l331t1823r513b1911],
42	.	.	O	.	_	0	SENT_173	[p13l331t1823r513b1911],

1	The	DT	O	the	det	3	SENT_174	[p13l551t1823r703b1893],
2	different	JJ	O	different	amod	3	SENT_174	[p13l735t1823r1104b1893],
3	response	NN	O	response	nsubjpass	14	SENT_174	[p13l1139t1842r1495b1911],
4	of	IN	O	of	_	0	SENT_174	[p13l1527t1823r1609b1893],
5	PlA2	NN	O	pla2	nn	6	SENT_174	[p13l1642t1823r1803b1908],
6	carriers	NNS	O	carrier	prep_of	3	SENT_174	[p13l1836t1824r2149b1893],
7	and	CC	O	and	_	0	SENT_174	[p13l10t1935r156b2007],
8	non-carriers	NNS	O	non-carrier	prep_of	3	SENT_174	[p13l222t1937r731b2007],
9	to	TO	O	to	_	0	SENT_174	[p13l792t1942r875b2007],
10	anti-platelet	JJ	O	anti-platelet	amod	11	SENT_174	[p13l936t1935r1475b2025],
11	drugs	NNS	O	drug	prep_to	6	SENT_174	[p13l1536t1935r1759b2025],
12	may	MD	O	may	aux	14	SENT_174	[p13l1823t1955r1991b2025],
13	be	VB	O	be	auxpass	14	SENT_174	[p13l2053t1935r2149b2007],
14	related	VBN	O	relate	_	0	SENT_174	[p13l14t2048r304b2118],
15	to	TO	O	to	_	0	SENT_174	[p13l343t2054r425b2118],
16	a	DT	O	a	det	18	SENT_174	[p13l460t2067r502b2118],
17	lower	JJR	O	lower	amod	18	SENT_174	[p13l541t2048r769b2118],
18	threshold	NN	O	threshold	prep_to	14	SENT_174	[p13l801t2048r1186b2118],
19	for	IN	O	for	mark	25	SENT_174	[p13l1224t2048r1341b2118],
20	platelet	NN	O	platelet	nn	21	SENT_174	[p13l1377t2048r1701b2136],
21	activation	NN	O	activation	nsubj	25	SENT_174	[p13l1736t2049r2145b2118],
22	among	IN	O	among	_	0	SENT_174	[p13l10t2178r278b2250],
23	PlA2	NN	O	pla2	nn	24	SENT_174	[p13l314t2160r475b2247],
24	carriers	NNS	O	carrier	prep_among	21	SENT_174	[p13l506t2162r821b2232],
25	[	VBP	O	[	advcl	14	SENT_174	[p13l857t2160r1006b2250],
26	12	CD	NUMBER	12	num	27	SENT_174	[p13l857t2160r1006b2250],
27	]	CD	NUMBER	]	nsubj	41	SENT_174	[p13l857t2160r1006b2250],
28	as	RB	O	as	_	0	SENT_174	[p13l1044t2180r1124b2232],
29	well	RB	O	well	_	0	SENT_174	[p13l1153t2160r1324b2232],
30	as	IN	O	as	_	0	SENT_174	[p13l1357t2180r1438b2232],
31	fewer	JJR	O	fewer	amod	34	SENT_174	[p13l1468t2160r1707b2232],
32	GP	NN	O	gp	nn	34	SENT_174	[p13l1737t2161r1845b2232],
33	Ilb/Illa	NN	O	ilb/illa	nn	34	SENT_174	[p13l1882t2160r2148b2232],
34	receptors	NNS	O	receptor	conj_and	27	SENT_174	[p13l14t2280r402b2363],
35	on	IN	O	on	_	0	SENT_174	[p13l432t2292r525b2344],
36	the	DT	O	the	det	37	SENT_174	[p13l560t2273r693b2344],
37	surface	NN	O	surface	prep_on	34	SENT_174	[p13l724t2273r1024b2344],
38	of	IN	O	of	_	0	SENT_174	[p13l1054t2273r1137b2344],
39	the	DT	O	the	det	40	SENT_174	[p13l1165t2273r1298b2344],
40	platelets	NNS	O	platelet	prep_of	37	SENT_174	[p13l1332t2273r1694b2363],
41	[	VBP	O	[	ccomp	25	SENT_174	[p13l1731t2273r1912b2363],
42	23	CD	NUMBER	23	num	43	SENT_174	[p13l1731t2273r1912b2363],
43	]	CD	NUMBER	]	dobj	41	SENT_174	[p13l1731t2273r1912b2363],
44	.	.	O	.	_	0	SENT_174	[p13l1731t2273r1912b2363],

1	The	DT	O	the	det	2	SENT_175	[p13l120t2386r273b2456],
2	lack	NN	O	lack	nsubj	14	SENT_175	[p13l307t2386r470b2457],
3	of	IN	O	of	_	0	SENT_175	[p13l497t2386r580b2456],
4	association	NN	O	association	prep_of	2	SENT_175	[p13l607t2387r1059b2456],
5	between	IN	O	between	_	0	SENT_175	[p13l1096t2386r1447b2457],
6	the	DT	O	the	det	9	SENT_175	[p13l1481t2386r1614b2456],
7	P2Y12	NN	O	p2y12	nn	9	SENT_175	[p13l1648t2387r1866b2471],
8	T744C	NN	O	t744c	nn	9	SENT_175	[p13l1895t2387r2148b2457],
9	polymorphism	NN	O	polymorphism	prep_between	4	SENT_175	[p13l12t2498r585b2588],
10	and	CC	O	and	_	0	SENT_175	[p13l620t2498r763b2570],
11	response	NN	O	response	conj_and	4	SENT_175	[p13l801t2518r1158b2588],
12	to	TO	O	to	_	0	SENT_175	[p13l1190t2505r1272b2570],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_175	[p13l1303t2498r1763b2588],
14	confirms	VBZ	O	confirm	_	0	SENT_175	[p13l1795t2498r2149b2570],
15	recent	JJ	O	recent	amod	16	SENT_175	[p13l14t2618r277b2682],
16	studies	NNS	O	study	dobj	14	SENT_175	[p13l332t2611r619b2682],
17	in	IN	O	in	_	0	SENT_175	[p13l674t2613r743b2682],
18	which	WDT	O	which	rel	25	SENT_175	[p13l799t2611r1036b2682],
19	various	JJ	O	various	nsubjpass	25	SENT_175	[p13l1091t2613r1386b2682],
20	loading	VBG	O	load	partmod	19	SENT_175	[p13l1444t2611r1738b2701],
21	doses	NNS	O	dose	dobj	20	SENT_175	[p13l1793t2611r2016b2682],
22	of	IN	O	of	_	0	SENT_175	[p13l2070t2611r2152b2682],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_175	[p13l9t2724r470b2812],
24	were	VBD	O	be	auxpass	25	SENT_175	[p13l503t2743r708b2794],
25	used	VBN	O	use	rcmod	16	SENT_175	[p13l746t2724r927b2794],
26	(	NN	O	(	dobj	25	SENT_175	[p13l970t2725r1357b2812],
27	300	CD	NUMBER	300	number	28	SENT_175	[p13l970t2725r1357b2812],
28	—	CD	NUMBER	—	nsubjpass	39	SENT_175	[p13l970t2725r1357b2812],
29	6OO	NN	O	6oo	nn	31	SENT_175	[p13l970t2725r1357b2812],
30	mg	NN	O	mg	nn	31	SENT_175	[p13l1375t2726r1522b2812],
31	)	NN	O	)	dep	28	SENT_175	[p13l1375t2726r1522b2812],
32	and	CC	O	and	_	0	SENT_175	[p13l1561t2724r1705b2794],
33	no	DT	O	no	det	34	SENT_175	[p13l1746t2743r1838b2794],
34	association	NN	O	association	conj_and	28	SENT_175	[p13l1874t2725r2144b2794, p13l10t2838r215b2908],
35	with	IN	O	with	_	0	SENT_175	[p13l249t2836r428b2908],
36	P2Y12	NN	O	p2y12	nn	37	SENT_175	[p13l468t2837r686b2923],
37	polymorphisms	NNS	O	polymorphism	prep_with	34	SENT_175	[p13l723t2836r1336b2926],
38	was	VBD	O	be	auxpass	39	SENT_175	[p13l1368t2856r1521b2908],
39	found	VBN	O	find	rcmod	26	SENT_175	[p13l1554t2836r1784b2908],
40	[	CD	NUMBER	[	number	41	SENT_175	[p13l1827t2836r2140b2926],
41	24,25	CD	NUMBER	24,25	num	42	SENT_175	[p13l1827t2836r2140b2926],
42	]	NN	O	]	dobj	39	SENT_175	[p13l1827t2836r2140b2926],
43	.	.	O	.	_	0	SENT_175	[p13l1827t2836r2140b2926],

1	We	PRP	O	we	nsubj	5	SENT_176	[p13l7t2950r131b3019],
2	also	RB	O	also	advmod	5	SENT_176	[p13l178t2949r336b3019],
3	did	VBD	O	do	aux	5	SENT_176	[p13l383t2949r505b3019],
4	not	RB	O	not	neg	5	SENT_176	[p13l559t2956r689b3019],
5	observe	VB	O	observe	_	0	SENT_176	[p13l735t2949r1054b3019],
6	any	DT	O	any	det	7	SENT_176	[p13l1101t2968r1243b3037],
7	association	NN	O	association	dobj	5	SENT_176	[p13l1289t2950r1741b3019],
8	between	IN	O	between	_	0	SENT_176	[p13l1794t2949r2146b3019],
9	the	DT	O	the	det	11	SENT_176	[p13l10t3061r143b3133],
10	P2Y1	NN	O	p2y1	nn	11	SENT_176	[p13l191t3062r363b3148],
11	1622A	NN	O	1622a	prep_between	7	SENT_176	[p13l424t3062r799b3133],
12	>	JJR	O	>	amod	14	SENT_176	[p13l424t3062r799b3133],
13	G	NN	O	g	nn	14	SENT_176	[p13l424t3062r799b3133],
14	polymorphism	NN	O	polymorphism	dep	11	SENT_176	[p13l850t3061r1423b3151],
15	and	CC	O	and	_	0	SENT_176	[p13l1471t3061r1614b3133],
16	response	NN	O	response	conj_and	11	SENT_176	[p13l1665t3081r2022b3151],
17	to	TO	O	to	_	0	SENT_176	[p13l2067t3068r2149b3133],
18	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_176	[p13l9t3175r496b3265],
19	.	.	O	.	_	0	SENT_176	[p13l9t3175r496b3265],

1	Therefore	RB	O	therefore	advmod	24	SENT_177	[p13l550t3175r988b3262],
2	,	,	O	,	_	0	SENT_177	[p13l550t3175r988b3262],
3	although	IN	O	although	mark	10	SENT_177	[p13l1045t3175r1400b3265],
4	both	DT	O	both	predet	7	SENT_177	[p13l1454t3175r1633b3246],
5	these	DT	O	these	det	7	SENT_177	[p13l1684t3175r1906b3246],
6	gene	NN	O	gene	nn	7	SENT_177	[p13l1955t3192r2149b3265],
7	polymorphisms	NNS	O	polymorphism	nsubjpass	10	SENT_177	[p13l12t3287r653b3375],
8	have	VBP	O	have	aux	10	SENT_177	[p13l724t3287r920b3357],
9	been	VBN	O	be	auxpass	10	SENT_177	[p13l993t3287r1193b3357],
10	associated	VBN	O	associate	advcl	24	SENT_177	[p13l1265t3287r1711b3357],
11	with	IN	O	with	_	0	SENT_177	[p13l1781t3287r1966b3357],
12	increased	VBN	O	increase	amod	15	SENT_177	[p13l2039t3288r2145b3356, p13l9t3399r323b3471],
13	ADP-induced	JJ	MISC	adp-induced	amod	15	SENT_177	[p13l364t3399r886b3471],
14	platelet	NN	O	platelet	nn	15	SENT_177	[p13l931t3399r1256b3489],
15	aggregation	NN	O	aggregation	prep_with	10	SENT_177	[p13l1295t3401r1778b3489],
16	[	CD	NUMBER	[	num	18	SENT_177	[p13l1827t3399r2141b3489],
17	15,17	CD	NUMBER	15,17	num	18	SENT_177	[p13l1827t3399r2141b3489],
18	]	NN	O	]	dep	15	SENT_177	[p13l1827t3399r2141b3489],
19	,	,	O	,	_	0	SENT_177	[p13l1827t3399r2141b3489],
20	this	DT	O	this	det	21	SENT_177	[p13l10t3512r163b3583],
21	association	NN	O	association	nsubj	24	SENT_177	[p13l232t3514r704b3583],
22	does	VBZ	O	do	aux	24	SENT_177	[p13l777t3512r969b3583],
23	not	RB	O	not	neg	24	SENT_177	[p13l1041t3519r1175b3583],
24	appear	VB	O	appear	_	0	SENT_177	[p13l1244t3531r1542b3602],
25	to	TO	O	to	aux	26	SENT_177	[p13l1609t3519r1693b3583],
26	translate	VB	O	translate	xcomp	24	SENT_177	[p13l1762t3512r2149b3583],
27	directly	RB	O	directly	advmod	26	SENT_177	[p13l10t3625r329b3713],
28	to	TO	O	to	_	0	SENT_177	[p13l366t3632r448b3695],
29	differential	JJ	O	differential	amod	30	SENT_177	[p13l486t3625r956b3695],
30	response	NN	O	response	prep_to	26	SENT_177	[p13l999t3644r1356b3713],
31	to	TO	O	to	_	0	SENT_177	[p13l1395t3632r1476b3695],
32	the	DT	O	the	det	34	SENT_177	[p13l1515t3625r1648b3695],
33	ADP	NN	O	adp	nn	34	SENT_177	[p13l1684t3626r1844b3694],
34	receptor	NN	O	receptor	prep_to	26	SENT_177	[p13l1887t3644r2144b3713, p14l10t26r130b91],

1	inhibitor	NN	O	inhibitor	nn	2	SENT_178	[p14l161t19r516b91],
2	clopidogrel	NN	O	clopidogrel	nsubjpass	10	SENT_178	[p14l546t19r1033b109],
3	,	,	O	,	_	0	SENT_178	[p14l546t19r1033b109],
4	The	DT	O	the	det	5	SENT_178	[p14l1072t19r1226b91],
5	response	NN	O	response	appos	2	SENT_178	[p14l1262t39r1620b109],
6	to	TO	O	to	_	0	SENT_178	[p14l1653t26r1735b91],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_178	[p14l1769t19r2144b109, p14l14t132r118b202],
8	has	VBZ	O	have	aux	10	SENT_178	[p14l174t132r304b202],
9	been	VBN	O	be	auxpass	10	SENT_178	[p14l360t132r553b202],
10	shown	VBN	O	show	_	0	SENT_178	[p14l610t132r859b202],
11	to	TO	O	to	aux	12	SENT_178	[p14l917t139r998b202],
12	depend	VB	O	depend	xcomp	10	SENT_178	[p14l1051t132r1352b220],
13	on	IN	O	on	_	0	SENT_178	[p14l1407t151r1501b202],
14	other	JJ	O	other	amod	15	SENT_178	[p14l1556t132r1778b202],
15	factors	NNS	O	factor	prep_on	12	SENT_178	[p14l1829t132r2140b218],
16	,	,	O	,	_	0	SENT_178	[p14l1829t132r2140b218],
17	such	JJ	O	such	_	0	SENT_178	[p14l10t244r190b316],
18	as	IN	O	as	_	0	SENT_178	[p14l261t264r343b316],
19	the	DT	O	the	det	21	SENT_178	[p14l409t244r545b316],
20	metabolic	JJ	O	metabolic	amod	21	SENT_178	[p14l615t244r1033b316],
21	activity	NN	O	activity	prep_such_as	15	SENT_178	[p14l1100t246r1419b334],
22	of	IN	O	of	_	0	SENT_178	[p14l1484t244r1567b316],
23	the	DT	O	the	det	26	SENT_178	[p14l1632t244r1768b316],
24	hepatic	JJ	O	hepatic	amod	26	SENT_178	[p14l1837t244r2149b334],
25	cytochrome	NN	O	cytochrome	nn	26	SENT_178	[p14l9t357r496b447],
26	P450	NN	O	p450	prep_of	21	SENT_178	[p14l558t358r756b428],
27	(	CD	NUMBER	(	num	28	SENT_178	[p14l823t358r1038b446],
28	CYP	NN	O	cyp	dep	15	SENT_178	[p14l823t358r1038b446],
29	)	CD	NUMBER	)	num	30	SENT_178	[p14l823t358r1038b446],
30	3A4	NN	O	3a4	dep	28	SENT_178	[p14l1106t358r1252b428],
31	[	CD	NUMBER	[	number	32	SENT_178	[p14l1320t357r1468b447],
32	26	CD	NUMBER	26	num	33	SENT_178	[p14l1320t357r1468b447],
33	]	NN	O	]	dobj	12	SENT_178	[p14l1320t357r1468b447],
34	and	CC	O	and	_	0	SENT_178	[p14l1538t357r1681b428],
35	individual	JJ	O	individual	amod	36	SENT_178	[p14l1746t357r2148b428],
36	differences	NNS	O	difference	dobj	12	SENT_178	[p14l10t470r475b540],
37	in	IN	O	in	_	0	SENT_178	[p14l531t471r600b539],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_178	[p14l657t470r1118b558],
39	absorption	NN	O	absorption	prep_in	12	SENT_178	[p14l1174t470r1607b558],
40	[	CD	NUMBER	[	num	42	SENT_178	[p14l1672t470r1853b558],
41	27	CD	NUMBER	27	num	42	SENT_178	[p14l1672t470r1853b558],
42	]	NN	O	]	dobj	12	SENT_178	[p14l1672t470r1853b558],
43	.	.	O	.	_	0	SENT_178	[p14l1672t470r1853b558],

1	Given	VBN	O	give	prep	16	SENT_179	[p14l1917t471r2145b540],
2	the	DT	O	the	det	5	SENT_179	[p14l10t582r143b654],
3	wide	JJ	O	wide	amod	5	SENT_179	[p14l172t582r369b654],
4	individual	JJ	O	individual	amod	5	SENT_179	[p14l400t582r801b654],
5	differences	NNS	O	difference	dep	1	SENT_179	[p14l834t582r1299b654],
6	in	IN	O	in	_	0	SENT_179	[p14l1331t584r1400b653],
7	cytochrome	NN	O	cytochrome	nn	9	SENT_179	[p14l1434t582r1920b672],
8	P450	NN	O	p450	nn	9	SENT_179	[p14l1950t583r2149b654],
9	activity	NN	O	activity	prep_in	5	SENT_179	[p14l10t697r321b785],
10	and	CC	O	and	_	0	SENT_179	[p14l364t695r506b766],
11	clopidorel	NN	O	clopidorel	nn	12	SENT_179	[p14l553t695r966b785],
12	absorption	NN	O	absorption	prep_in	5	SENT_179	[p14l1012t695r1444b785],
13	it	PRP	O	it	nsubj	16	SENT_179	[p14l1492t697r1550b766],
14	may	MD	O	may	aux	16	SENT_179	[p14l1597t714r1762b785],
15	be	VB	O	be	cop	16	SENT_179	[p14l1808t695r1903b766],
16	difficult	JJ	O	difficult	_	0	SENT_179	[p14l1947t695r2144b766, p14l9t808r166b878],
17	to	TO	O	to	aux	18	SENT_179	[p14l219t815r301b878],
18	isolate	VB	O	isolate	xcomp	16	SENT_179	[p14l352t808r625b878],
19	the	DT	O	the	det	20	SENT_179	[p14l678t808r812b878],
20	effects	NNS	O	effect	dobj	18	SENT_179	[p14l863t808r1150b878],
21	of	IN	O	of	_	0	SENT_179	[p14l1201t808r1284b878],
22	P2Y	NN	O	p2y	nn	24	SENT_179	[p14l1337t809r1484b877],
23	gene	NN	O	gene	nn	24	SENT_179	[p14l1534t825r1728b896],
24	polymorphisms	NNS	O	polymorphism	prep_of	20	SENT_179	[p14l1783t808r2144b896, p14l12t920r287b1010],
25	on	IN	O	on	_	0	SENT_179	[p14l322t940r415b992],
26	response	NN	O	response	prep_on	18	SENT_179	[p14l459t940r815b1010],
27	to	TO	O	to	_	0	SENT_179	[p14l853t927r935b992],
28	clopidogrel	NN	O	clopidogrel	prep_to	18	SENT_179	[p14l971t920r1459b1010],
29	.	.	O	.	_	0	SENT_179	[p14l971t920r1459b1010],

1	Our	PRP$	O	we	poss	2	SENT_180	[p14l123t1033r271b1103],
2	study	NN	O	study	poss	5	SENT_180	[p14l333t1033r626b1121],
3	’s	POS	O	’s	_	0	SENT_180	[p14l333t1033r626b1121],
4	main	JJ	O	main	amod	5	SENT_180	[p14l694t1034r888b1103],
5	limitation	NN	O	limitation	nsubj	11	SENT_180	[p14l960t1033r1360b1103],
6	is	VBZ	O	be	cop	11	SENT_180	[p14l1429t1034r1487b1103],
7	the	DT	O	the	det	11	SENT_180	[p14l1553t1033r1688b1103],
8	relatively	RB	O	relatively	advmod	9	SENT_180	[p14l1757t1033r2150b1121],
9	limited	JJ	O	limited	amod	11	SENT_180	[p14l14t1145r298b1217],
10	sample	NN	O	sample	nn	11	SENT_180	[p14l344t1145r634b1235],
11	size	NN	O	size	_	0	SENT_180	[p14l675t1147r829b1217],
12	(	CD	NUMBER	(	num	13	SENT_180	[p14l877t1146r1459b1235],
13	120patients	NNS	O	120patient	dep	11	SENT_180	[p14l877t1146r1459b1235],
14	)	CD	NUMBER	)	dep	13	SENT_180	[p14l877t1146r1459b1235],
15	.	.	O	.	_	0	SENT_180	[p14l877t1146r1459b1235],

1	However	RB	O	however	advmod	24	SENT_181	[p14l1513t1147r1883b1232],
2	,	,	O	,	_	0	SENT_181	[p14l1513t1147r1883b1232],
3	given	VBN	O	give	prep	24	SENT_181	[p14l1933t1147r2145b1235],
4	a	DT	O	a	det	6	SENT_181	[p14l10t1277r53b1329],
5	genotype	NN	O	genotype	nn	6	SENT_181	[p14l90t1265r469b1348],
6	frequency	NN	O	frequency	dep	3	SENT_181	[p14l505t1258r922b1348],
7	of	IN	O	of	prep	6	SENT_181	[p14l955t1258r1038b1329],
8	about	IN	O	about	pcomp	7	SENT_181	[p14l1071t1258r1305b1329],
9	30	CD	PERCENT	30	num	10	SENT_181	[p14l1343t1259r1489b1329],
10	%	NN	PERCENT	%	pobj	8	SENT_181	[p14l1343t1259r1489b1329],
11	for	IN	O	for	_	0	SENT_181	[p14l1525t1258r1643b1329],
12	the	DT	O	the	det	14	SENT_181	[p14l1677t1258r1811b1329],
13	studied	VBN	O	study	amod	14	SENT_181	[p14l1847t1258r2145b1329],
14	polymorphisms	NNS	O	polymorphism	prep_for	10	SENT_181	[p14l12t1371r651b1459],
15	,	,	O	,	_	0	SENT_181	[p14l12t1371r651b1459],
16	a	DT	O	a	det	18	SENT_181	[p14l688t1390r731b1441],
17	sample	NN	O	sample	nn	18	SENT_181	[p14l759t1371r1049b1459],
18	size	NN	O	size	nsubj	24	SENT_181	[p14l1076t1372r1230b1441],
19	of	IN	O	of	_	0	SENT_181	[p14l1258t1371r1341b1441],
20	120	CD	NUMBER	120	num	21	SENT_181	[p14l1371t1372r1506b1441],
21	subjects	NNS	O	subject	prep_of	18	SENT_181	[p14l1534t1371r1876b1459],
22	would	MD	O	would	aux	24	SENT_181	[p14l1902t1371r2145b1441],
23	have	VB	O	have	aux	24	SENT_181	[p14l12t1482r201b1553],
24	detected	VBN	O	detect	conj_and	24	SENT_181	[p14l231t1482r601b1553],
25	a	DT	O	a	det	26	SENT_181	[p14l635t1502r677b1553],
26	difference	NN	O	difference	dobj	24	SENT_181	[p14l708t1482r1136b1553],
27	of	IN	O	of	_	0	SENT_181	[p14l1166t1482r1248b1553],
28	at	IN	O	at	quantmod	30	SENT_181	[p14l1276t1490r1357b1553],
29	least	JJS	O	least	mwe	28	SENT_181	[p14l1389t1482r1582b1553],
30	20	CD	PERCENT	20	num	31	SENT_181	[p14l1612t1483r1761b1553],
31	%	NN	PERCENT	%	prep_of	26	SENT_181	[p14l1612t1483r1761b1553],
32	between	IN	O	between	_	0	SENT_181	[p14l1794t1482r2146b1553],
33	the	DT	O	the	det	35	SENT_181	[p14l10t1595r143b1666],
34	genotype	NN	O	genotype	nn	35	SENT_181	[p14l182t1602r561b1685],
35	groups	NNS	O	group	prep_between	31	SENT_181	[p14l601t1613r870b1685],
36	in	IN	O	in	_	0	SENT_181	[p14l908t1597r977b1666],
37	the	DT	O	the	det	38	SENT_181	[p14l1019t1595r1152b1666],
38	indices	NNS	O	index	prep_in	24	SENT_181	[p14l1191t1595r1476b1666],
39	for	IN	O	for	_	0	SENT_181	[p14l1514t1595r1632b1666],
40	response	NN	O	response	prep_for	38	SENT_181	[p14l1672t1614r2028b1685],
41	to	TO	O	to	_	0	SENT_181	[p14l2067t1602r2149b1666],
42	aspirin	NN	O	aspirin	prep_to	24	SENT_181	[p14l10t1709r279b1796],
43	or	CC	O	or	_	0	SENT_181	[p14l338t1727r421b1778],
44	clopidogrel	NN	O	clopidogrel	prep_to	24	SENT_181	[p14l473t1708r960b1796],
45	,	,	O	,	_	0	SENT_181	[p14l473t1708r960b1796],
46	with	IN	O	with	_	0	SENT_181	[p14l1021t1708r1199b1778],
47	80	CD	PERCENT	80	number	48	SENT_181	[p14l1258t1709r1405b1778],
48	%	NN	PERCENT	%	amod	49	SENT_181	[p14l1258t1709r1405b1778],
49	power	NN	O	power	prep_with	24	SENT_181	[p14l1463t1727r1717b1796],
50	and	CC	O	and	_	0	SENT_181	[p14l1769t1708r1912b1778],
51	at	IN	O	at	_	0	SENT_181	[p14l1970t1715r2051b1778],
52	a	DT	O	a	det	54	SENT_181	[p14l2106t1727r2149b1778],
53	significance	NN	O	significance	nn	54	SENT_181	[p14l10t1820r497b1910],
54	level	NN	O	level	prep_at	24	SENT_181	[p14l550t1820r743b1892],
55	of	IN	O	of	_	0	SENT_181	[p14l793t1820r876b1892],
56	0.05	CD	NUMBER	0.05	prep_of	54	SENT_181	[p14l922t1821r1124b1892],
57	.	.	O	.	_	0	SENT_181	[p14l922t1821r1124b1892],

1	Based	VBN	O	base	_	0	SENT_182	[p14l1185t1820r1416b1892],
2	on	IN	O	on	prepc_based_on	15	SENT_182	[p14l1468t1840r1561b1892],
3	our	PRP$	O	we	poss	5	SENT_182	[p14l1613t1840r1748b1892],
4	negative	JJ	O	negative	amod	5	SENT_182	[p14l1797t1822r2149b1910],
5	findings	NNS	O	finding	pobj	15	SENT_182	[p14l9t1933r330b2021],
6	and	CC	O	and	_	0	SENT_182	[p14l383t1933r526b2003],
7	previous	JJ	O	previous	amod	8	SENT_182	[p14l584t1934r927b2021],
8	reports	NNS	O	report	pobj	15	SENT_182	[p14l982t1939r1274b2021],
9	[	VBP	O	[	rcmod	8	SENT_182	[p14l1333t1933r1647b2021],
10	24,25	CD	NUMBER	24,25	number	11	SENT_182	[p14l1333t1933r1647b2021],
11	]	CD	NUMBER	]	dobj	9	SENT_182	[p14l1333t1933r1647b2021],
12	,	,	O	,	_	0	SENT_182	[p14l1333t1933r1647b2021],
13	it	PRP	O	it	nsubj	15	SENT_182	[p14l1708t1934r1766b2003],
14	is	VBZ	O	be	cop	15	SENT_182	[p14l1819t1934r1877b2003],
15	likely	JJ	O	likely	_	0	SENT_182	[p14l1932t1933r2151b2021],

1	360	CD	NUMBER	360	_	0	SENT_183	[p14l99t2096r160b2128],
2	E.	NNP	O	E.	nn	3	SENT_183	[p14l1810t2097r1866b2128],
3	|	NNP	O	|	dep	1	SENT_183	[p14l1810t2097r1866b2128],
4	.	.	O	.	_	0	SENT_183	[p14l1810t2097r1866b2128],

1	Lev	NNP	O	Lev	_	0	SENT_184	[p14l1888t2097r1948b2128],
2	et	FW	O	et	nn	3	SENT_184	[p14l1963t2099r2000b2128],
3	al.	FW	O	al.	dep	1	SENT_184	[p14l2017t2096r2059b2128],
4	.	.	O	.	_	0	SENT_184	[p14l2017t2096r2059b2128],

1	that	IN	O	that	dep	23	SENT_185	[p14l10t2300r183b2372],
2	the	DT	O	the	det	3	SENT_185	[p14l249t2300r385b2372],
3	phenomenon	NN	O	phenomenon	nsubj	23	SENT_185	[p14l455t2300r990b2390],
4	of	IN	O	of	_	0	SENT_185	[p14l1059t2300r1143b2372],
5	“	NN	O	“	nn	6	SENT_185	[p14l1207t2302r1709b2372],
6	resistance	NN	O	resistance	prep_of	3	SENT_185	[p14l1207t2302r1709b2372],
7	”	CD	NUMBER	”	dep	3	SENT_185	[p14l1207t2302r1709b2372],
8	to	TO	O	to	_	0	SENT_185	[p14l1773t2307r1855b2372],
9	these	DT	O	these	det	10	SENT_185	[p14l1923t2300r2150b2372],
10	drugs	NNS	O	drug	prep_to	7	SENT_185	[p14l9t2413r254b2503],
11	,	,	O	,	_	0	SENT_185	[p14l9t2413r254b2503],
12	as	RB	O	as	_	0	SENT_185	[p14l304t2432r385b2484],
13	well	RB	O	well	_	0	SENT_185	[p14l424t2413r595b2484],
14	as	IN	O	as	_	0	SENT_185	[p14l639t2432r720b2484],
15	the	DT	O	the	det	17	SENT_185	[p14l761t2413r895b2484],
16	inter-individual	JJ	O	inter-individual	amod	17	SENT_185	[p14l937t2413r1574b2484],
17	variability	NN	O	variability	conj_and	7	SENT_185	[p14l1615t2413r2038b2503],
18	in	IN	O	in	_	0	SENT_185	[p14l2077t2415r2146b2484],
19	drug	NN	O	drug	nn	20	SENT_185	[p14l9t2526r191b2614],
20	response	NN	O	response	prep_in	17	SENT_185	[p14l234t2545r618b2614],
21	,	,	O	,	_	0	SENT_185	[p14l234t2545r618b2614],
22	is	VBZ	O	be	cop	23	SENT_185	[p14l666t2527r725b2596],
23	multi-factorial	JJ	O	multi-factorial	_	0	SENT_185	[p14l767t2526r1369b2596],
24	and	CC	O	and	_	0	SENT_185	[p14l1411t2526r1553b2596],
25	is	VBZ	O	be	auxpass	27	SENT_185	[p14l1597t2527r1655b2596],
26	not	RB	O	not	neg	27	SENT_185	[p14l1697t2533r1828b2596],
27	caused	VBN	O	cause	conj_and	23	SENT_185	[p14l1867t2526r2146b2596],
28	only	RB	O	only	advmod	27	SENT_185	[p14l9t2638r182b2728],
29	by	IN	O	by	_	0	SENT_185	[p14l245t2638r337b2728],
30	single	JJ	O	single	amod	32	SENT_185	[p14l398t2638r632b2728],
31	gene	NN	O	gene	nn	32	SENT_185	[p14l696t2656r890b2728],
32	mutations	NNS	O	mutation	agent	27	SENT_185	[p14l956t2640r1391b2710],
33	.	.	O	.	_	0	SENT_185	[p14l956t2640r1391b2710],

1	Factors	NNS	O	factor	nsubj	15	SENT_186	[p14l1466t2640r1763b2710],
2	such	JJ	O	such	_	0	SENT_186	[p14l1825t2638r2002b2710],
3	as	IN	O	as	_	0	SENT_186	[p14l2069t2658r2150b2710],
4	absorption	NN	O	absorption	nn	9	SENT_186	[p14l10t2751r489b2841],
5	,	,	O	,	_	0	SENT_186	[p14l10t2751r489b2841],
6	metabolism	NN	O	metabolism	dep	9	SENT_186	[p14l568t2751r1088b2838],
7	,	,	O	,	_	0	SENT_186	[p14l568t2751r1088b2838],
8	drug	NN	O	drug	dep	9	SENT_186	[p14l1165t2751r1351b2841],
9	interactions	NNS	O	interaction	prep_such_as	1	SENT_186	[p14l1419t2753r1932b2822],
10	and	CC	O	and	_	0	SENT_186	[p14l2000t2751r2147b2822],
11	platelet	NN	O	platelet	nn	12	SENT_186	[p14l12t2864r337b2952],
12	turnover	NN	O	turnover	conj_and	9	SENT_186	[p14l382t2871r738b2934],
13	probably	RB	O	probably	advmod	15	SENT_186	[p14l782t2864r1141b2952],
14	also	RB	O	also	advmod	15	SENT_186	[p14l1183t2864r1341b2934],
15	play	VB	O	play	_	0	SENT_186	[p14l1388t2864r1556b2952],
16	an	DT	O	a	det	18	SENT_186	[p14l1599t2883r1690b2934],
17	important	JJ	O	important	amod	18	SENT_186	[p14l1738t2865r2149b2952],
18	role	NN	O	role	dobj	15	SENT_186	[p14l13t2976r195b3048],
19	.	.	O	.	_	0	SENT_186	[p14l13t2976r195b3048],

1	Further	JJ	O	further	amod	2	SENT_187	[p14l238t2976r544b3048],
2	studies	NNS	O	study	nsubj	4	SENT_187	[p14l572t2976r860b3048],
3	should	MD	O	should	aux	4	SENT_187	[p14l890t2976r1151b3048],
4	provide	VB	O	provide	_	0	SENT_187	[p14l1187t2976r1494b3066],
5	more	JJR	O	more	amod	6	SENT_187	[p14l1527t2996r1734b3048],
6	insight	NN	O	insight	dobj	4	SENT_187	[p14l1765t2976r2037b3066],
7	to	TO	O	to	_	0	SENT_187	[p14l2068t2984r2149b3048],
8	whether	IN	O	whether	complm	13	SENT_187	[p14l7t3089r354b3159],
9	the	DT	O	the	det	12	SENT_187	[p14l398t3089r531b3159],
10	specific	JJ	O	specific	amod	12	SENT_187	[p14l577t3089r891b3177],
11	genetic	JJ	O	genetic	amod	12	SENT_187	[p14l937t3090r1241b3177],
12	profile	NN	O	profile	nsubj	13	SENT_187	[p14l1289t3089r1558b3177],
13	has	VBZ	O	have	prepc_to	4	SENT_187	[p14l1607t3089r1736b3159],
14	a	DT	O	a	det	16	SENT_187	[p14l1782t3108r1825b3159],
15	significant	JJ	O	significant	amod	16	SENT_187	[p14l1871t3089r2144b3177, p14l9t3208r191b3273],
16	role	NN	O	role	dobj	13	SENT_187	[p14l261t3201r420b3273],
17	in	IN	O	in	_	0	SENT_187	[p14l487t3203r557b3272],
18	modulating	VBG	O	modulate	prepc_in	16	SENT_187	[p14l629t3201r1099b3291],
19	the	DT	O	the	det	20	SENT_187	[p14l1166t3201r1302b3273],
20	response	NN	O	response	dobj	18	SENT_187	[p14l1372t3221r1736b3291],
21	to	TO	O	to	_	0	SENT_187	[p14l1803t3208r1886b3273],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_187	[p14l1953t3203r2145b3273, p14l12t3314r337b3404],
23	medications	NNS	O	medication	prep_to	18	SENT_187	[p14l377t3314r899b3385],
24	.	.	O	.	_	0	SENT_187	[p14l377t3314r899b3385],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_188	[p14l7t3574r1014b3682],

1	We	PRP	O	we	nsubj	3	SENT_189	[p15l7t75r131b144],
2	would	MD	O	would	aux	3	SENT_189	[p15l160t73r405b144],
3	like	VB	O	like	_	0	SENT_189	[p15l443t73r586b144],
4	to	TO	O	to	aux	5	SENT_189	[p15l619t80r700b144],
5	thank	VB	O	thank	xcomp	3	SENT_189	[p15l732t73r964b144],
6	Ms.	NNP	O	Ms.	nn	8	SENT_189	[p15l993t75r1119b144],
7	Angela	NNP	PERSON	Angela	nn	8	SENT_189	[p15l1157t73r1434b163],
8	Bergeron	NNP	PERSON	Bergeron	dobj	5	SENT_189	[p15l1470t74r1834b163],
9	for	IN	O	for	_	0	SENT_189	[p15l1868t73r1987b144],
10	her	PRP$	O	she	poss	13	SENT_189	[p15l2019t73r2151b144],
11	invaluable	JJ	O	invaluable	amod	13	SENT_189	[p15l10t185r435b255],
12	technical	JJ	O	technical	amod	13	SENT_189	[p15l472t185r851b255],
13	assistance	NN	O	assistance	prep_for	8	SENT_189	[p15l890t186r1331b255],
14	.	.	O	.	_	0	SENT_189	[p15l890t186r1331b255],

1	References	NNS	O	reference	_	0	SENT_190	[p15l15t425r592b509],

1	[	NN	O	[	_	0	SENT_191	[p15l51t658r132b729],
2	1	CD	NUMBER	1	num	1	SENT_191	[p15l51t658r132b729],
3	]	CD	NUMBER	]	num	5	SENT_191	[p15l51t658r132b729],
4	Buchanan	NNP	PERSON	Buchanan	nn	5	SENT_191	[p15l181t658r492b715],
5	MR	NN	PERSON	mr	dep	1	SENT_191	[p15l519t659r635b727],
6	,	,	O	,	_	0	SENT_191	[p15l519t659r635b727],
7	Brister	NNP	O	Brister	nn	8	SENT_191	[p15l671t660r888b715],
8	SJ	NNP	O	SJ	appos	5	SENT_191	[p15l913t659r1001b715],
9	.	.	O	.	_	0	SENT_191	[p15l913t659r1001b715],

1	Individual	JJ	O	individual	amod	2	SENT_192	[p15l1039t658r1355b715],
2	variation	NN	O	variation	_	0	SENT_192	[p15l1380t660r1673b715],
3	in	IN	O	in	_	0	SENT_192	[p15l1702t660r1758b714],
4	the	DT	O	the	det	5	SENT_192	[p15l1787t658r1894b715],
5	effects	NNS	O	effect	prep_in	2	SENT_192	[p15l1921t658r2151b715],
6	of	IN	O	of	_	0	SENT_192	[p15l178t752r244b808],
7	ASA	NN	O	asa	prep_of	5	SENT_192	[p15l265t752r389b808],
8	on	IN	O	on	_	0	SENT_192	[p15l413t767r488b808],
9	platelet	NN	O	platelet	nn	10	SENT_192	[p15l519t752r778b823],
10	function	NN	O	function	prep_on	7	SENT_192	[p15l803t752r1097b808],
11	:	:	O	:	_	0	SENT_192	[p15l803t752r1097b808],
12	implications	NNS	O	implication	dep	2	SENT_192	[p15l1130t752r1530b823],
13	for	IN	O	for	_	0	SENT_192	[p15l1556t752r1650b808],
14	the	DT	O	the	det	15	SENT_192	[p15l1675t752r1782b808],
15	use	NN	O	use	prep_for	12	SENT_192	[p15l1810t767r1914b808],
16	of	IN	O	of	_	0	SENT_192	[p15l1940t752r2007b808],
17	ASA	NN	O	asa	prep_of	15	SENT_192	[p15l2028t752r2152b808],
18	clinically	RB	O	clinically	advmod	15	SENT_192	[p15l178t845r489b916],
19	.	.	O	.	_	0	SENT_192	[p15l178t845r489b916],

1	Can	MD	O	can	aux	3	SENT_193	[p15l527t846r645b901],
2	J	NNP	O	J	nn	3	SENT_193	[p15l671t846r707b901],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_193	[p15l737t845r972b901],
4	1995	CD	DATE	1995	num	3	SENT_193	[p15l1011t845r1406b913],
5	;	:	O	;	_	0	SENT_193	[p15l1011t845r1406b913],
6	11:221	CD	NUMBER	11:221	num	7	SENT_193	[p15l1011t845r1406b913],
7	-7	CD	NUMBER	-7	dep	3	SENT_193	[p15l1431t846r1523b901],
8	.	.	O	.	_	0	SENT_193	[p15l1431t846r1523b901],

1	[	NN	O	[	nn	5	SENT_194	[p15l51t938r132b1009],
2	2	CD	NUMBER	2	num	5	SENT_194	[p15l51t938r132b1009],
3	]	CD	NUMBER	]	num	5	SENT_194	[p15l51t938r132b1009],
4	Eikelboom	NNP	O	Eikelboom	nn	5	SENT_194	[p15l181t938r517b994],
5	JW	NNP	O	JW	_	0	SENT_194	[p15l545t939r655b1007],
6	,	,	O	,	_	0	SENT_194	[p15l545t939r655b1007],
7	Hirsh	NNP	PERSON	Hirsh	nn	8	SENT_194	[p15l691t938r851b994],
8	J	NNP	PERSON	J	conj_or	5	SENT_194	[p15l881t939r934b1006],
9	,	,	O	,	_	0	SENT_194	[p15l881t939r934b1006],
10	Weitz	NNP	PERSON	Weitz	nn	11	SENT_194	[p15l965t939r1152b994],
11	JI	NNP	PERSON	JI	conj_or	5	SENT_194	[p15l1177t939r1250b1007],
12	,	,	O	,	_	0	SENT_194	[p15l1177t939r1250b1007],
13	Johnston	NNP	PERSON	Johnston	nn	14	SENT_194	[p15l1283t938r1574b994],
14	M	NNP	O	M	conj_or	5	SENT_194	[p15l1602t939r1674b1006],
15	,	,	O	,	_	0	SENT_194	[p15l1602t939r1674b1006],
16	Yi	NNP	O	Yi	nn	17	SENT_194	[p15l1707t939r1761b993],
17	Q	NNP	O	Q	conj_or	5	SENT_194	[p15l1791t938r1858b1006],
18	,	,	O	,	_	0	SENT_194	[p15l1791t938r1858b1006],
19	Yusuf	NNP	PERSON	Yusuf	nn	23	SENT_194	[p15l1890t938r2066b994],
20	S.	NNP	O	S.	nn	23	SENT_194	[p15l2091t939r2143b994],
21	Aspirin-resistant	JJ	O	aspirin-resistant	amod	23	SENT_194	[p15l176t1031r718b1102],
22	thromboxane	NN	O	thromboxane	nn	23	SENT_194	[p15l750t1031r1187b1087],
23	biosynthesis	NN	O	biosynthesis	conj_and	8	SENT_194	[p15l1222t1031r1617b1102],
24	and	CC	O	and	_	0	SENT_194	[p15l1650t1031r1765b1087],
25	the	DT	O	the	det	26	SENT_194	[p15l1800t1031r1907b1087],
26	risk	NN	O	risk	conj_and	8	SENT_194	[p15l1943t1031r2056b1087],
27	of	IN	O	of	_	0	SENT_194	[p15l2086t1031r2152b1087],
28	myocardial	JJ	O	myocardial	amod	29	SENT_194	[p15l180t1124r541b1195],
29	infarction	NN	O	infarction	prep_of	26	SENT_194	[p15l582t1124r924b1192],
30	,	,	O	,	_	0	SENT_194	[p15l582t1124r924b1192],
31	stroke	NN	O	stroke	conj_or	5	SENT_194	[p15l971t1124r1195b1193],
32	,	,	O	,	_	0	SENT_194	[p15l971t1124r1195b1193],
33	or	CC	O	or	_	0	SENT_194	[p15l1241t1139r1309b1180],
34	cardiovascular	JJ	O	cardiovascular	amod	35	SENT_194	[p15l1347t1124r1825b1180],
35	death	NN	O	death	conj_or	5	SENT_194	[p15l1864t1124r2049b1180],
36	in	IN	O	in	_	0	SENT_194	[p15l2093t1125r2148b1179],
37	patients	NNS	O	patient	prep_in	35	SENT_194	[p15l180t1218r447b1288],
38	at	IN	O	at	_	0	SENT_194	[p15l476t1222r540b1273],
39	high	JJ	O	high	amod	40	SENT_194	[p15l571t1217r703b1288],
40	risk	NN	O	risk	prep_at	37	SENT_194	[p15l737t1217r850b1273],
41	for	IN	O	for	_	0	SENT_194	[p15l876t1217r971b1273],
42	cardiovascular	JJ	O	cardiovascular	amod	43	SENT_194	[p15l998t1217r1477b1273],
43	events	NNS	O	event	prep_for	40	SENT_194	[p15l1503t1222r1743b1273],
44	.	.	O	.	_	0	SENT_194	[p15l1503t1222r1743b1273],

1	Circulation	NN	O	circulation	_	0	SENT_195	[p15l1781t1217r2146b1273],
2	2002	CD	DATE	2002	num	1	SENT_195	[p15l178t1311r779b1379],
3	;	:	O	;	_	0	SENT_195	[p15l178t1311r779b1379],
4	105:1650	CD	NUMBER	105:1650	number	5	SENT_195	[p15l178t1311r779b1379],
5	—	CD	NUMBER	—	dep	1	SENT_195	[p15l178t1311r779b1379],
6	5	CD	NUMBER	5	dep	5	SENT_195	[p15l178t1311r779b1379],
7	.	.	O	.	_	0	SENT_195	[p15l178t1311r779b1379],

1	[	NN	O	[	nn	3	SENT_196	[p15l52t1403r132b1474],
2	3	CD	NUMBER	3	num	3	SENT_196	[p15l52t1403r132b1474],
3	]	NN	O	]	_	0	SENT_196	[p15l52t1403r132b1474],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_196	[p15l178t1403r397b1459],
5	PA	NN	ORGANIZATION	pa	dep	3	SENT_196	[p15l435t1404r527b1472],
6	,	,	O	,	_	0	SENT_196	[p15l435t1404r527b1472],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_196	[p15l572t1403r771b1459],
8	KP	NNP	O	KP	appos	5	SENT_196	[p15l811t1404r896b1472],
9	,	,	O	,	_	0	SENT_196	[p15l811t1404r896b1472],
10	Hiatt	NNP	PERSON	Hiatt	nn	11	SENT_196	[p15l941t1404r1102b1459],
11	BL	NN	O	bl	appos	5	SENT_196	[p15l1140t1404r1233b1471],
12	,	,	O	,	_	0	SENT_196	[p15l1140t1404r1233b1471],
13	O'Connor	NNP	PERSON	O'Connor	nn	14	SENT_196	[p15l1276t1403r1585b1459],
14	CM	NN	O	cm	appos	5	SENT_196	[p15l1619t1404r1733b1459],
15	.	.	O	.	_	0	SENT_196	[p15l1619t1404r1733b1459],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_197	[p15l1775t1403r2149b1474],
2	for	IN	O	for	_	0	SENT_197	[p15l178t1496r272b1552],
3	coronary	JJ	O	coronary	amod	4	SENT_197	[p15l296t1511r585b1567],
4	stenting	NN	O	stenting	prep_for	1	SENT_197	[p15l609t1497r896b1567],
5	:	:	O	:	_	0	SENT_197	[p15l609t1497r896b1567],
6	response	NN	O	response	nn	7	SENT_197	[p15l931t1511r1216b1567],
7	variability	NN	O	variability	conj_and	1	SENT_197	[p15l1240t1496r1587b1567],
8	,	,	O	,	_	0	SENT_197	[p15l1240t1496r1587b1567],
9	drug	NN	O	drug	nn	10	SENT_197	[p15l1619t1496r1764b1567],
10	resistance	NN	O	resistance	appos	7	SENT_197	[p15l1793t1497r2143b1564],
11	,	,	O	,	_	0	SENT_197	[p15l1793t1497r2143b1564],
12	and	CC	O	and	_	0	SENT_197	[p15l178t1589r293b1646],
13	the	DT	O	the	det	14	SENT_197	[p15l330t1589r437b1645],
14	effect	NN	O	effect	conj_and	1	SENT_197	[p15l470t1589r670b1645],
15	of	IN	O	of	_	0	SENT_197	[p15l704t1589r770b1645],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_197	[p15l803t1594r1250b1660],
17	platelet	NN	O	platelet	nn	18	SENT_197	[p15l1286t1589r1545b1660],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_197	[p15l1582t1590r1912b1660],
19	.	.	O	.	_	0	SENT_197	[p15l1582t1590r1912b1660],

1	Circulation	NN	O	circulation	_	0	SENT_198	[p15l1956t1590r2147b1646, p15l181t1682r372b1738],
2	2003	CD	DATE	2003	num	1	SENT_198	[p15l405t1682r899b1750],
3	;	:	O	;	_	0	SENT_198	[p15l405t1682r899b1750],
4	107:2908	CD	NUMBER	107:2908	number	5	SENT_198	[p15l405t1682r899b1750],
5	—	CD	NUMBER	—	dep	1	SENT_198	[p15l914t1714r934b1718],
6	29013	CD	NUMBER	29013	dep	5	SENT_198	[p15l950t1682r1162b1738],
7	.	.	O	.	_	0	SENT_198	[p15l950t1682r1162b1738],

1	[	NN	O	[	nn	5	SENT_199	[p15l52t1775r132b1846],
2	4	CD	NUMBER	4	num	5	SENT_199	[p15l52t1775r132b1846],
3	]	CD	NUMBER	]	num	5	SENT_199	[p15l52t1775r132b1846],
4	Serebruany	NNP	O	Serebruany	nn	5	SENT_199	[p15l178t1775r550b1846],
5	VL	NNP	O	VL	_	0	SENT_199	[p15l564t1776r664b1844],
6	,	,	O	,	_	0	SENT_199	[p15l564t1776r664b1844],
7	Steinhubl	NNP	O	Steinhubl	nn	8	SENT_199	[p15l689t1775r996b1831],
8	SR	NN	O	sr	appos	5	SENT_199	[p15l1014t1776r1110b1843],
9	,	,	O	,	_	0	SENT_199	[p15l1014t1776r1110b1843],
10	Berger	NNP	PERSON	Berger	nn	11	SENT_199	[p15l1138t1776r1352b1846],
11	PB	NN	O	pb	appos	8	SENT_199	[p15l1370t1776r1468b1844],
12	,	,	O	,	_	0	SENT_199	[p15l1370t1776r1468b1844],
13	Malinin	NNP	PERSON	Malinin	nn	14	SENT_199	[p15l1490t1775r1723b1831],
14	AI	NNP	O	AI	appos	8	SENT_199	[p15l1741t1776r1825b1844],
15	,	,	O	,	_	0	SENT_199	[p15l1741t1776r1825b1844],
16	Bhatt	NNP	PERSON	Bhatt	nn	17	SENT_199	[p15l1852t1775r2026b1831],
17	DL	NNP	O	DL	appos	8	SENT_199	[p15l2046t1776r2143b1843],
18	,	,	O	,	_	0	SENT_199	[p15l2046t1776r2143b1843],
19	Topol	NNP	PERSON	Topol	nn	20	SENT_199	[p15l176t1868r351b1939],
20	EJ	NNP	O	EJ	appos	8	SENT_199	[p15l373t1869r461b1924],
21	.	.	O	.	_	0	SENT_199	[p15l373t1869r461b1924],

1	Variability	NN	O	variability	_	0	SENT_200	[p15l484t1868r823b1939],
2	in	IN	O	in	_	0	SENT_200	[p15l840t1869r894b1924],
3	platelet	NN	O	platelet	nn	4	SENT_200	[p15l917t1868r1177b1939],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_200	[p15l1198t1869r1681b1939],
5	to	TO	O	to	_	0	SENT_200	[p15l1699t1873r1765b1924],
6	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_200	[p15l1782t1868r2150b1939],
7	among	IN	O	among	_	0	SENT_200	[p15l178t1974r393b2031],
8	544	CD	NUMBER	544	num	9	SENT_200	[p15l420t1962r532b2017],
9	individuals	NNS	O	individual	prep_among	1	SENT_200	[p15l555t1960r931b2017],
10	.	.	O	.	_	0	SENT_200	[p15l555t1960r931b2017],

1	J	NNP	O	J	nn	4	SENT_201	[p15l959t1962r996b2017],
2	Am	NNP	O	Am	nn	4	SENT_201	[p15l1014t1961r1121b2016],
3	Coll	NNP	O	Coll	nn	4	SENT_201	[p15l1148t1960r1272b2017],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_201	[p15l1300t1960r1535b2017],
5	2005	CD	DATE	2005	num	4	SENT_201	[p15l1563t1961r2009b2029],
6	;	:	O	;	_	0	SENT_201	[p15l1563t1961r2009b2029],
7	45:246	CD	NUMBER	45:246	num	9	SENT_201	[p15l1563t1961r2009b2029],
8	-	:	O	-	_	0	SENT_201	[p15l1563t1961r2009b2029],
9	51	CD	DATE	51	dep	4	SENT_201	[p15l2028t1962r2120b2017],
10	.	.	O	.	_	0	SENT_201	[p15l2028t1962r2120b2017],

1	[	NN	O	[	_	0	SENT_202	[p15l51t2054r132b2125],
2	5	CD	NUMBER	5	num	1	SENT_202	[p15l51t2054r132b2125],
3	]	CD	NUMBER	]	num	5	SENT_202	[p15l51t2054r132b2125],
4	Gum	NN	O	gum	nn	5	SENT_202	[p15l178t2055r324b2110],
5	PA	NN	O	pa	dep	1	SENT_202	[p15l355t2055r447b2123],
6	,	,	O	,	_	0	SENT_202	[p15l355t2055r447b2123],
7	Kottke-Marchant	JJ	O	kottke-marchant	amod	8	SENT_202	[p15l481t2054r1028b2110],
8	K	NN	O	k	appos	5	SENT_202	[p15l1056t2055r1113b2122],
9	,	,	O	,	_	0	SENT_202	[p15l1056t2055r1113b2122],
10	Welsh	NNP	ORGANIZATION	Welsh	nn	11	SENT_202	[p15l1143t2054r1332b2110],
11	PA	NN	ORGANIZATION	pa	appos	5	SENT_202	[p15l1363t2055r1454b2122],
12	,	,	O	,	_	0	SENT_202	[p15l1363t2055r1454b2122],
13	White	NNP	O	White	nn	14	SENT_202	[p15l1485t2054r1678b2110],
14	J	NNP	O	J	appos	5	SENT_202	[p15l1702t2055r1755b2123],
15	,	,	O	,	_	0	SENT_202	[p15l1702t2055r1755b2123],
16	Topol	NNP	O	Topol	nn	17	SENT_202	[p15l1785t2054r1960b2125],
17	EJ	NNP	O	EJ	appos	5	SENT_202	[p15l1989t2055r2078b2110],
18	.	.	O	.	_	0	SENT_202	[p15l1989t2055r2078b2110],

1	A	DT	O	a	det	5	SENT_203	[p15l2108t2055r2152b2109],
2	prospective	JJ	O	prospective	amod	5	SENT_203	[p15l180t2148r583b2218],
3	,	,	O	,	_	0	SENT_203	[p15l180t2148r583b2218],
4	blinded	JJ	O	blinded	amod	5	SENT_203	[p15l613t2147r853b2203],
5	determination	NN	O	determination	_	0	SENT_203	[p15l877t2147r1345b2203],
6	of	IN	O	of	_	0	SENT_203	[p15l1370t2147r1436b2203],
7	the	DT	O	the	det	9	SENT_203	[p15l1455t2147r1563b2203],
8	natural	JJ	O	natural	amod	9	SENT_203	[p15l1586t2147r1820b2204],
9	history	NN	O	history	prep_of	5	SENT_203	[p15l1845t2147r2067b2218],
10	of	IN	O	of	_	0	SENT_203	[p15l2086t2147r2152b2203],
11	aspirin	NN	O	aspirin	nn	12	SENT_203	[p15l178t2240r394b2310],
12	resistance	NN	O	resistance	prep_of	9	SENT_203	[p15l429t2240r760b2296],
13	among	IN	O	among	_	0	SENT_203	[p15l790t2253r1005b2310],
14	stable	JJ	O	stable	amod	15	SENT_203	[p15l1036t2239r1234b2296],
15	patients	NNS	O	patient	prep_among	5	SENT_203	[p15l1267t2240r1534b2310],
16	with	IN	O	with	_	0	SENT_203	[p15l1561t2239r1703b2296],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_203	[p15l1736t2239r2147b2296, p15l181t2332r266b2389],
18	disease	NN	O	disease	prep_with	5	SENT_203	[p15l293t2332r557b2389],
19	.	.	O	.	_	0	SENT_203	[p15l293t2332r557b2389],

1	J	NNP	O	J	nn	4	SENT_204	[p15l589t2334r626b2389],
2	Am	NNP	O	Am	nn	4	SENT_204	[p15l650t2333r756b2388],
3	Coll	NNP	O	Coll	nn	4	SENT_204	[p15l788t2332r913b2389],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_204	[p15l944t2332r1180b2389],
5	2003	CD	DATE	2003	num	4	SENT_204	[p15l1213t2333r1614b2401],
6	;	:	O	;	_	0	SENT_204	[p15l1213t2333r1614b2401],
7	41:961	CD	NUMBER	41:961	number	8	SENT_204	[p15l1213t2333r1614b2401],
8	-5	CD	NUMBER	-5	dep	4	SENT_204	[p15l1639t2334r1731b2389],
9	.	.	O	.	_	0	SENT_204	[p15l1639t2334r1731b2389],

1	[	NN	O	[	dep	5	SENT_205	[p15l52t2426r132b2497],
2	6	CD	NUMBER	6	num	3	SENT_205	[p15l52t2426r132b2497],
3	]	CD	NUMBER	]	dep	1	SENT_205	[p15l52t2426r132b2497],
4	Muller	NNP	O	Muller	dep	5	SENT_205	[p15l176t2426r383b2483],
5	I	PRP	O	I	dep	21	SENT_205	[p15l407t2428r440b2495],
6	,	,	O	,	_	0	SENT_205	[p15l407t2428r440b2495],
7	Besta	NNP	O	Besta	nn	8	SENT_205	[p15l471t2427r646b2482],
8	F	NN	O	f	appos	5	SENT_205	[p15l671t2427r711b2495],
9	,	,	O	,	_	0	SENT_205	[p15l671t2427r711b2495],
10	Schulz	NNP	PERSON	Schulz	nn	11	SENT_205	[p15l739t2426r947b2483],
11	C	NNP	O	C	appos	5	SENT_205	[p15l968t2427r1029b2495],
12	,	,	O	,	_	0	SENT_205	[p15l968t2427r1029b2495],
13	Massberg	NNP	LOCATION	Massberg	nn	14	SENT_205	[p15l1056t2426r1353b2497],
14	S	NNP	LOCATION	S	appos	5	SENT_205	[p15l1375t2427r1428b2495],
15	,	,	O	,	_	0	SENT_205	[p15l1375t2427r1428b2495],
16	Schomig	NNP	O	Schomig	nn	17	SENT_205	[p15l1457t2426r1726b2497],
17	A	NNP	O	A	appos	5	SENT_205	[p15l1745t2427r1809b2495],
18	,	,	O	,	_	0	SENT_205	[p15l1745t2427r1809b2495],
19	Gawaz	NNP	PERSON	Gawaz	nn	20	SENT_205	[p15l1837t2427r2054b2483],
20	M.	NNP	PERSON	M.	appos	5	SENT_205	[p15l2072t2427r2143b2482],
21	Prevalence	NN	PERSON	prevalence	dep	25	SENT_205	[p15l181t2519r539b2576],
22	of	IN	O	of	_	0	SENT_205	[p15l577t2519r643b2575],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_205	[p15l678t2519r1045b2590],
24	non-responders	NNS	O	non-responder	prep_of	21	SENT_205	[p15l1086t2519r1591b2590],
25	among	IN	O	among	_	0	SENT_205	[p15l1629t2533r1844b2590],
26	patients	NNS	O	patient	pobj	25	SENT_205	[p15l1884t2520r2151b2590],
27	with	IN	O	with	_	0	SENT_205	[p15l177t2611r319b2668],
28	stable	JJ	O	stable	amod	30	SENT_205	[p15l347t2611r545b2668],
29	angina	NN	O	angina	nn	30	SENT_205	[p15l571t2612r785b2682],
30	pectoris	NN	O	pectoris	prep_with	26	SENT_205	[p15l812t2612r1075b2682],
31	scheduled	VBN	O	schedule	partmod	30	SENT_205	[p15l1100t2611r1428b2668],
32	for	IN	O	for	_	0	SENT_205	[p15l1455t2611r1550b2668],
33	elective	JJ	O	elective	amod	36	SENT_205	[p15l1573t2611r1838b2668],
34	coronary	JJ	O	coronary	amod	36	SENT_205	[p15l1863t2627r2152b2682],
35	stent	NN	O	stent	nn	36	SENT_205	[p15l178t2710r345b2761],
36	placement	NN	O	placement	prep_for	31	SENT_205	[p15l376t2705r747b2776],
37	.	.	O	.	_	0	SENT_205	[p15l376t2705r747b2776],

1	Thromb	NNP	O	Thromb	nn	2	SENT_206	[p15l787t2705r1038b2762],
2	Haemost	NNP	O	Haemost	_	0	SENT_206	[p15l1066t2706r1354b2761],
3	2003	CD	DATE	2003	num	2	SENT_206	[p15l1386t2706r1904b2774],
4	;	:	O	;	_	0	SENT_206	[p15l1386t2706r1904b2774],
5	89:783	CD	NUMBER	89:783	num	6	SENT_206	[p15l1386t2706r1904b2774],
6	—	NN	O	—	dep	2	SENT_206	[p15l1386t2706r1904b2774],
7	7	CD	NUMBER	7	dep	6	SENT_206	[p15l1386t2706r1904b2774],
8	.	.	O	.	_	0	SENT_206	[p15l1386t2706r1904b2774],

1	[	NN	O	[	_	0	SENT_207	[p15l52t2798r132b2869],
2	7	CD	NUMBER	7	number	3	SENT_207	[p15l52t2798r132b2869],
3	]	CD	NUMBER	]	dep	1	SENT_207	[p15l52t2798r132b2869],
4	Bhatt	NNP	O	Bhatt	nn	5	SENT_207	[p15l181t2798r356b2854],
5	DL	NNP	O	DL	dep	3	SENT_207	[p15l395t2799r492b2854],
6	.	.	O	.	_	0	SENT_207	[p15l395t2799r492b2854],

1	Aspirin	NN	O	aspirin	nn	2	SENT_208	[p15l532t2799r755b2869],
2	resistance	NN	O	resistance	_	0	SENT_208	[p15l797t2799r1147b2854],
3	:	:	O	:	_	0	SENT_208	[p15l797t2799r1147b2854],
4	more	JJR	O	more	quantmod	5	SENT_208	[p15l1193t2813r1358b2854],
5	than	IN	O	than	num	9	SENT_208	[p15l1394t2798r1538b2854],
6	just	RB	O	just	quantmod	5	SENT_208	[p15l1575t2799r1701b2869],
7	a	DT	O	a	det	9	SENT_208	[p15l1737t2813r1771b2854],
8	laboratory	NN	O	laboratory	nn	9	SENT_208	[p15l1812t2798r2151b2869],
9	curiosity	NN	O	curiosity	dep	2	SENT_208	[p15l178t2891r475b2961],
10	.	.	O	.	_	0	SENT_208	[p15l178t2891r475b2961],

1	J	NNP	O	J	nn	4	SENT_209	[p15l508t2892r544b2947],
2	Am	NNP	O	Am	nn	4	SENT_209	[p15l568t2891r675b2946],
3	Coll	NNP	O	Coll	nn	4	SENT_209	[p15l706t2890r831b2947],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_209	[p15l862t2890r1098b2947],
5	2004	CD	DATE	2004	num	4	SENT_209	[p15l1131t2891r1688b2959],
6	;	:	O	;	_	0	SENT_209	[p15l1131t2891r1688b2959],
7	43:1127	CD	NUMBER	43:1127	number	8	SENT_209	[p15l1131t2891r1688b2959],
8	—	CD	NUMBER	—	dep	4	SENT_209	[p15l1131t2891r1688b2959],
9	9	CD	NUMBER	9	dep	8	SENT_209	[p15l1131t2891r1688b2959],
10	.	.	O	.	_	0	SENT_209	[p15l1131t2891r1688b2959],

1	[	NN	O	[	nn	5	SENT_210	[p15l51t2983r132b3054],
2	8	CD	NUMBER	8	num	5	SENT_210	[p15l51t2983r132b3054],
3	]	CD	NUMBER	]	num	5	SENT_210	[p15l51t2983r132b3054],
4	Nguyen	NNP	ORGANIZATION	Nguyen	nn	5	SENT_210	[p15l181t2985r416b3054],
5	TA	NNP	ORGANIZATION	TA	_	0	SENT_210	[p15l446t2984r545b3052],
6	,	,	O	,	_	0	SENT_210	[p15l446t2984r545b3052],
7	Diodati	NNP	O	Diodati	nn	8	SENT_210	[p15l585t2983r813b3040],
8	JG	NNP	O	JG	appos	5	SENT_210	[p15l844t2984r948b3052],
9	,	,	O	,	_	0	SENT_210	[p15l844t2984r948b3052],
10	Pharand	NNP	O	Pharand	nn	12	SENT_210	[p15l987t2983r1246b3040],
11	C.	NNP	O	C.	nn	12	SENT_210	[p15l1278t2984r1339b3040],
12	Resistance	NNP	O	Resistance	appos	5	SENT_210	[p15l1379t2984r1721b3040],
13	to	TO	O	to	_	0	SENT_210	[p15l1751t2989r1817b3040],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_210	[p15l1846t2983r2147b3054, p15l181t3077r286b3134],
15	:	:	O	:	_	0	SENT_210	[p15l1846t2983r2147b3054, p15l181t3077r286b3134],
16	a	DT	O	a	det	17	SENT_210	[p15l336t3093r370b3134],
17	review	NN	O	review	dep	5	SENT_210	[p15l415t3078r634b3134],
18	of	IN	O	of	_	0	SENT_210	[p15l674t3077r740b3134],
19	the	DT	O	the	det	20	SENT_210	[p15l780t3077r887b3134],
20	evidence	NN	O	evidence	prep_of	17	SENT_210	[p15l928t3077r1249b3134],
21	.	.	O	.	_	0	SENT_210	[p15l928t3077r1249b3134],

1	J	NNP	O	J	nn	4	SENT_211	[p15l1294t3078r1331b3134],
2	Am	NNP	O	Am	nn	4	SENT_211	[p15l1368t3078r1475b3133],
3	Coll	NNP	O	Coll	nn	4	SENT_211	[p15l1519t3077r1644b3134],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_211	[p15l1688t3077r1924b3134],
5	2005	CD	DATE	2005	num	4	SENT_211	[p15l1970t3078r2144b3146],
6	;	:	O	;	_	0	SENT_211	[p15l1970t3078r2144b3146],
7	45:1157	CD	NUMBER	45:1157	number	8	SENT_211	[p15l178t3170r590b3227],
8	—	CD	NUMBER	—	dep	4	SENT_211	[p15l178t3170r590b3227],
9	64	CD	NUMBER	64	dep	8	SENT_211	[p15l178t3170r590b3227],
10	.	.	O	.	_	0	SENT_211	[p15l178t3170r590b3227],

1	[	NN	O	[	nn	3	SENT_212	[p15l51t3263r132b3334],
2	9	CD	NUMBER	9	num	3	SENT_212	[p15l51t3263r132b3334],
3	]	NN	O	]	_	0	SENT_212	[p15l51t3263r132b3334],
4	Szczeklik	NNP	MISC	Szczeklik	nn	5	SENT_212	[p15l178t3263r478b3320],
5	A	NNP	MISC	A	dep	3	SENT_212	[p15l521t3264r584b3332],
6	,	,	O	,	_	0	SENT_212	[p15l521t3264r584b3332],
7	Undas	NNP	O	Undas	nn	8	SENT_212	[p15l641t3263r834b3320],
8	A	NNP	O	A	appos	5	SENT_212	[p15l878t3264r941b3332],
9	,	,	O	,	_	0	SENT_212	[p15l878t3264r941b3332],
10	Sanak	NNP	O	Sanak	nn	11	SENT_212	[p15l995t3263r1185b3320],
11	M	NNP	O	M	appos	5	SENT_212	[p15l1229t3265r1301b3332],
12	,	,	O	,	_	0	SENT_212	[p15l1229t3265r1301b3332],
13	Frolow	NNP	O	Frolow	nn	14	SENT_212	[p15l1357t3263r1577b3320],
14	M	NNP	O	M	appos	5	SENT_212	[p15l1621t3265r1692b3332],
15	,	,	O	,	_	0	SENT_212	[p15l1621t3265r1692b3332],
16	Wegrzyn	NNP	PERSON	Wegrzyn	nn	18	SENT_212	[p15l1745t3265r2020b3334],
17	W.	NNP	O	W.	nn	18	SENT_212	[p15l2067t3265r2143b3320],
18	Relationship	NN	O	relationship	appos	5	SENT_212	[p15l181t3356r581b3427],
19	between	IN	O	between	_	0	SENT_212	[p15l613t3356r894b3413],
20	bleeding	JJ	O	bleeding	amod	21	SENT_212	[p15l929t3356r1208b3427],
21	time	NN	O	time	prep_between	3	SENT_212	[p15l1238t3358r1409b3425],
22	,	,	O	,	_	0	SENT_212	[p15l1238t3358r1409b3425],
23	aspirin	NN	O	aspirin	conj_and	21	SENT_212	[p15l1446t3358r1661b3427],
24	and	CC	O	and	_	0	SENT_212	[p15l1694t3356r1808b3413],
25	the	DT	O	the	det	26	SENT_212	[p15l1841t3356r1948b3413],
26	PlA1	NN	O	pla1	conj_and	21	SENT_212	[p15l1981t3356r2145b3425],
27	/	:	O	/	punct	3	SENT_212	[p15l1981t3356r2145b3425],
28	A2	NN	O	a2	nn	29	SENT_212	[p15l176t3450r246b3518],
29	polymorphism	NN	O	polymorphism	dep	3	SENT_212	[p15l278t3449r735b3520],
30	of	IN	O	of	_	0	SENT_212	[p15l765t3449r831b3506],
31	platelet	NN	O	platelet	nn	33	SENT_212	[p15l859t3449r1119b3520],
32	glycoprotein	NN	O	glycoprotein	nn	33	SENT_212	[p15l1146t3449r1555b3520],
33	Illa	NN	PERSON	illum	prep_of	29	SENT_212	[p15l1590t3451r1707b3506],
34	.	.	O	.	_	0	SENT_212	[p15l1590t3451r1707b3506],

1	Br	NN	O	br	nn	3	SENT_213	[p15l1743t3450r1814b3505],
2	J	NN	O	j	nn	3	SENT_213	[p15l1836t3451r1872b3506],
3	Haematol	NN	O	haematol	_	0	SENT_213	[p15l1899t3451r2147b3506, p15l182t3542r269b3599],
4	2000	CD	DATE	2000	dep	3	SENT_213	[p15l303t3543r864b3611],
5	;	:	O	;	_	0	SENT_213	[p15l303t3543r864b3611],
6	110:965	CD	NUMBER	110:965	num	7	SENT_213	[p15l303t3543r864b3611],
7	—	NN	O	—	dep	3	SENT_213	[p15l303t3543r864b3611],
8	7	CD	NUMBER	7	dep	7	SENT_213	[p15l303t3543r864b3611],
9	.	.	O	.	_	0	SENT_213	[p15l303t3543r864b3611],

1	[	NN	O	[	nn	5	SENT_214	[p15l14t3635r133b3706],
2	10	CD	NUMBER	10	num	5	SENT_214	[p15l14t3635r133b3706],
3	]	CD	NUMBER	]	num	5	SENT_214	[p15l14t3635r133b3706],
4	Papp	NNP	O	Papp	nn	5	SENT_214	[p15l182t3637r336b3706],
5	E	NNP	O	E	_	0	SENT_214	[p15l367t3637r421b3704],
6	,	,	O	,	_	0	SENT_214	[p15l367t3637r421b3704],
7	Havasi	NNP	O	Havasi	nn	8	SENT_214	[p15l459t3637r664b3692],
8	V	NNP	O	V	appos	5	SENT_214	[p15l693t3637r745b3704],
9	,	,	O	,	_	0	SENT_214	[p15l693t3637r745b3704],
10	Bene	NNP	PERSON	Bene	nn	11	SENT_214	[p15l783t3637r940b3692],
11	J	NNP	PERSON	J	appos	8	SENT_214	[p15l968t3637r1021b3704],
12	,	,	O	,	_	0	SENT_214	[p15l968t3637r1021b3704],
13	Komlosi	NNP	PERSON	Komlosi	nn	14	SENT_214	[p15l1059t3635r1305b3692],
14	K	NNP	PERSON	K	appos	8	SENT_214	[p15l1338t3637r1395b3704],
15	,	,	O	,	_	0	SENT_214	[p15l1338t3637r1395b3704],
16	Czopf	NNP	O	Czopf	nn	17	SENT_214	[p15l1430t3635r1617b3706],
17	L	NNP	O	L	appos	8	SENT_214	[p15l1646t3637r1698b3704],
18	,	,	O	,	_	0	SENT_214	[p15l1646t3637r1698b3704],
19	Magyar	NNP	ORGANIZATION	Magyar	nn	20	SENT_214	[p15l1731t3637r1965b3706],
20	E	NNP	ORGANIZATION	E	appos	8	SENT_214	[p15l1994t3637r2049b3704],
21	,	,	O	,	_	0	SENT_214	[p15l1994t3637r2049b3704],
22	et	FW	O	et	nn	23	SENT_214	[p15l2084t3641r2151b3692],
23	al.	FW	O	al.	appos	8	SENT_214	[p15l180t3728r257b3785],
24	.	.	O	.	_	0	SENT_214	[p15l180t3728r257b3785],

1	Glycoprotein	NN	O	glycoprotein	dep	7	SENT_215	[p15l300t3728r721b3799],
2	IIIA	NN	O	iium	nn	3	SENT_215	[p15l764t3729r862b3784],
3	gene	NN	O	gene	dep	1	SENT_215	[p15l897t3742r1052b3799],
4	(	CD	NUMBER	(	num	5	SENT_215	[p15l1092t3728r1243b3799],
5	PlA	NN	O	plum	dep	7	SENT_215	[p15l1092t3728r1243b3799],
6	)	CD	NUMBER	)	num	7	SENT_215	[p15l1092t3728r1243b3799],
7	polymorphism	NN	O	polymorphism	dep	12	SENT_215	[p15l1284t3728r1741b3799],
8	and	CC	O	and	_	0	SENT_215	[p15l1779t3728r1894b3785],
9	aspirin	NN	O	aspirin	nn	10	SENT_215	[p15l1932t3729r2148b3799],
10	resistance	NN	O	resistance	dep	12	SENT_215	[p16l182t19r533b75],
11	:	:	O	:	_	0	SENT_215	[p16l182t19r533b75],
12	is	VBZ	O	be	_	0	SENT_215	[p16l588t19r635b75],
13	there	EX	O	there	expl	15	SENT_215	[p16l682t18r858b75],
14	any	DT	O	any	det	15	SENT_215	[p16l906t34r1020b89],
15	correlation	NN	O	correlation	xcomp	12	SENT_215	[p16l1066t18r1457b75],
16	?	.	O	?	_	0	SENT_215	[p16l1066t18r1457b75],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_216	[p16l1506t19r1632b74],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_216	[p16l1679t18r2150b75],
3	2005	CD	DATE	2005	num	2	SENT_216	[p16l179t111r737b179],
4	;	:	O	;	_	0	SENT_216	[p16l179t111r737b179],
5	39:1013	CD	NUMBER	39:1013	number	6	SENT_216	[p16l179t111r737b179],
6	—	CD	NUMBER	—	dep	2	SENT_216	[p16l179t111r737b179],
7	8	CD	NUMBER	8	dep	6	SENT_216	[p16l179t111r737b179],
8	.	.	O	.	_	0	SENT_216	[p16l179t111r737b179],

1	[	NN	O	[	nn	5	SENT_217	[p16l14t204r133b275],
2	11	CD	NUMBER	11	num	5	SENT_217	[p16l14t204r133b275],
3	]	CD	NUMBER	]	num	5	SENT_217	[p16l14t204r133b275],
4	Macchi	NNP	PERSON	Macchi	nn	5	SENT_217	[p16l178t204r401b260],
5	L	NNP	PERSON	L	_	0	SENT_217	[p16l430t205r482b272],
6	,	,	O	,	_	0	SENT_217	[p16l430t205r482b272],
7	Christiaens	NNP	ORGANIZATION	Christiaens	nn	8	SENT_217	[p16l512t204r875b260],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_217	[p16l901t205r952b272],
9	,	,	O	,	_	0	SENT_217	[p16l901t205r952b272],
10	Brabant	NNP	LOCATION	Brabant	nn	11	SENT_217	[p16l986t204r1241b260],
11	S	NNP	O	S	appos	8	SENT_217	[p16l1265t204r1317b272],
12	,	,	O	,	_	0	SENT_217	[p16l1265t204r1317b272],
13	Sorel	NNP	ORGANIZATION	Sorel	nn	14	SENT_217	[p16l1348t204r1511b260],
14	N	NNP	ORGANIZATION	N	appos	8	SENT_217	[p16l1538t205r1600b272],
15	,	,	O	,	_	0	SENT_217	[p16l1538t205r1600b272],
16	Ragot	NNP	O	Ragot	nn	17	SENT_217	[p16l1634t205r1816b275],
17	S	NNP	O	S	appos	8	SENT_217	[p16l1839t204r1892b272],
18	,	,	O	,	_	0	SENT_217	[p16l1839t204r1892b272],
19	Allal	NNP	PERSON	Allal	nn	20	SENT_217	[p16l1921t204r2066b260],
20	J	NNP	PERSON	J	appos	8	SENT_217	[p16l2091t205r2143b272],
21	,	,	O	,	_	0	SENT_217	[p16l2091t205r2143b272],
22	et	FW	O	et	nn	23	SENT_217	[p16l179t302r246b353],
23	al.	FW	O	al.	appos	8	SENT_217	[p16l280t296r357b353],
24	.	.	O	.	_	0	SENT_217	[p16l280t296r357b353],

1	Resistance	NN	O	resistance	nsubjpass	8	SENT_218	[p16l400t297r741b353],
2	in	FW	O	in	nn	3	SENT_218	[p16l775t297r830b352],
3	vitro	FW	O	vitro	rcmod	1	SENT_218	[p16l863t297r1018b353],
4	to	TO	O	to	dep	3	SENT_218	[p16l1051t301r1117b353],
5	low-dose	JJ	O	low-dose	amod	6	SENT_218	[p16l1153t296r1443b353],
6	aspirin	NN	O	aspirin	pobj	4	SENT_218	[p16l1476t297r1691b367],
7	is	VBZ	O	be	auxpass	8	SENT_218	[p16l1727t297r1774b353],
8	associated	VBN	O	associate	_	0	SENT_218	[p16l1807t296r2148b353],
9	with	IN	O	with	_	0	SENT_218	[p16l178t389r320b446],
10	platelet	NN	O	platelet	nn	11	SENT_218	[p16l372t389r631b460],
11	PlA1	NN	O	pla1	prep_with	8	SENT_218	[p16l681t389r802b458],
12	(	CD	NUMBER	(	num	14	SENT_218	[p16l862t390r972b460],
13	GP	NN	O	gp	nn	14	SENT_218	[p16l862t390r972b460],
14	Illa	NN	O	illum	nn	24	SENT_218	[p16l1024t391r1140b460],
15	)	CD	NUMBER	)	num	16	SENT_218	[p16l1024t391r1140b460],
16	polymorphism	NN	O	polymorphism	dep	14	SENT_218	[p16l1193t389r1649b460],
17	but	CC	O	but	_	0	SENT_218	[p16l1701t389r1807b446],
18	not	RB	O	not	neg	19	SENT_218	[p16l1856t395r1960b446],
19	with	IN	O	with	nn	24	SENT_218	[p16l2005t389r2148b446],
20	C807T	NN	O	c807t	nn	23	SENT_218	[p16l180t483r383b539],
21	(	CD	NUMBER	(	num	23	SENT_218	[p16l425t483r535b554],
22	GP	NN	O	gp	nn	23	SENT_218	[p16l425t483r535b554],
23	Ia/Ila	NN	O	ia/ila	pobj	19	SENT_218	[p16l580t484r775b553],
24	)	NN	O	)	dep	11	SENT_218	[p16l580t484r775b553],
25	and	CC	O	and	_	0	SENT_218	[p16l818t483r933b539],
26	C-5T	NN	O	c-5t	nn	27	SENT_218	[p16l976t483r1127b539],
27	Kozak	NN	PERSON	kozak	prep_with	8	SENT_218	[p16l1168t483r1356b539],
28	(	CD	NUMBER	(	num	32	SENT_218	[p16l1398t483r1508b553],
29	GP	NN	O	gp	nn	32	SENT_218	[p16l1398t483r1508b553],
30	Ibalpha	NN	O	ibalpha	nn	32	SENT_218	[p16l1553t483r1813b554],
31	)	CD	NUMBER	)	num	32	SENT_218	[p16l1553t483r1813b554],
32	polymorphisms	NNS	O	polymorphism	dep	27	SENT_218	[p16l1858t483r2147b554, p16l182t576r425b647],
33	.	.	O	.	_	0	SENT_218	[p16l1858t483r2147b554, p16l182t576r425b647],

1	J	NNP	O	J	nn	4	SENT_219	[p16l458t577r494b632],
2	Am	NNP	O	Am	nn	4	SENT_219	[p16l518t577r625b631],
3	Coll	NNP	O	Coll	nn	4	SENT_219	[p16l656t576r781b632],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_219	[p16l812t576r1048b632],
5	2003	CD	DATE	2003	num	4	SENT_219	[p16l1081t576r1638b645],
6	;	:	O	;	_	0	SENT_219	[p16l1081t576r1638b645],
7	42:1115	CD	NUMBER	42:1115	number	8	SENT_219	[p16l1081t576r1638b645],
8	—	CD	NUMBER	—	dep	4	SENT_219	[p16l1081t576r1638b645],
9	9	CD	NUMBER	9	dep	8	SENT_219	[p16l1081t576r1638b645],
10	.	.	O	.	_	0	SENT_219	[p16l1081t576r1638b645],

1	[	NN	O	[	_	0	SENT_220	[p16l7t669r126b741],
2	12	CD	NUMBER	12	num	1	SENT_220	[p16l7t669r126b741],
3	]	CD	NUMBER	]	num	5	SENT_220	[p16l7t669r126b741],
4	Michelson	NNP	PERSON	Michelson	nn	5	SENT_220	[p16l172t669r493b726],
5	AD	NN	O	ad	dep	1	SENT_220	[p16l515t670r623b739],
6	,	,	O	,	_	0	SENT_220	[p16l515t670r623b739],
7	Furman	NNP	ORGANIZATION	Furman	nn	8	SENT_220	[p16l656t671r897b726],
8	MI	NNP	ORGANIZATION	MI	appos	5	SENT_220	[p16l921t670r1013b739],
9	,	,	O	,	_	0	SENT_220	[p16l921t670r1013b739],
10	Goldschmidt-Clermont	NNP	O	Goldschmidt-Clermont	nn	11	SENT_220	[p16l1043t669r1790b726],
11	P	NN	O	p	appos	5	SENT_220	[p16l1816t670r1857b739],
12	,	,	O	,	_	0	SENT_220	[p16l1816t670r1857b739],
13	Mascelli	NNP	ORGANIZATION	Mascelli	nn	14	SENT_220	[p16l1884t669r2144b726],
14	MA	NNP	ORGANIZATION	MA	appos	5	SENT_220	[p16l172t763r288b832],
15	,	,	O	,	_	0	SENT_220	[p16l172t763r288b832],
16	Hendrix	NNP	PERSON	Hendrix	nn	17	SENT_220	[p16l340t762r594b819],
17	C	NNP	PERSON	C	appos	5	SENT_220	[p16l636t763r697b832],
18	,	,	O	,	_	0	SENT_220	[p16l636t763r697b832],
19	Coleman	NNP	PERSON	Coleman	nn	20	SENT_220	[p16l747t762r1029b819],
20	L	NNP	O	L	appos	5	SENT_220	[p16l1077t764r1128b832],
21	,	,	O	,	_	0	SENT_220	[p16l1077t764r1128b832],
22	et	FW	O	et	nn	23	SENT_220	[p16l1178t768r1245b819],
23	al.	FW	O	al.	appos	5	SENT_220	[p16l1287t762r1365b819],
24	.	.	O	.	_	0	SENT_220	[p16l1287t762r1365b819],

1	Platelet	NN	O	platelet	nn	3	SENT_221	[p16l1418t762r1677b819],
2	GP	NN	O	gp	nn	3	SENT_221	[p16l1720t763r1807b819],
3	Illa	NN	PERSON	illum	nsubj	9	SENT_221	[p16l1854t764r1946b819],
4	Pl	NN	PERSON	pl	dep	3	SENT_221	[p16l1992t762r2144b834],
5	(	CD	NUMBER	(	num	4	SENT_221	[p16l1992t762r2144b834],
6	A	DT	O	a	det	7	SENT_221	[p16l1992t762r2144b834],
7	)	NN	O	)	dep	3	SENT_221	[p16l1992t762r2144b834],
8	polymorphisms	NNS	O	polymorphism	dep	7	SENT_221	[p16l176t856r665b928],
9	display	VBP	O	display	_	0	SENT_221	[p16l707t856r937b928],
10	different	JJ	O	different	amod	11	SENT_221	[p16l977t856r1272b913],
11	sensitivities	NNS	O	sensitivity	dobj	9	SENT_221	[p16l1313t857r1702b913],
12	to	TO	O	to	_	0	SENT_221	[p16l1743t862r1809b913],
13	agonists	NNS	O	agonist	prep_to	9	SENT_221	[p16l1852t857r2140b928],
14	.	.	O	.	_	0	SENT_221	[p16l1852t857r2140b928],

1	Circulation	NN	O	circulation	_	0	SENT_222	[p16l176t951r542b1008],
2	2000	CD	DATE	2000	num	1	SENT_222	[p16l574t952r1176b1020],
3	;	:	O	;	_	0	SENT_222	[p16l574t952r1176b1020],
4	101:1013	CD	NUMBER	101:1013	number	5	SENT_222	[p16l574t952r1176b1020],
5	—	CD	NUMBER	—	dep	1	SENT_222	[p16l574t952r1176b1020],
6	8	CD	NUMBER	8	dep	5	SENT_222	[p16l574t952r1176b1020],
7	.	.	O	.	_	0	SENT_222	[p16l574t952r1176b1020],

1	[	RB	O	[	advmod	2	SENT_223	[p16l7t1043r130b1115],
2	13	CD	NUMBER	13	_	0	SENT_223	[p16l7t1043r130b1115],
3	]	CD	NUMBER	]	num	5	SENT_223	[p16l7t1043r130b1115],
4	Andrioli	JJ	O	andrioli	amod	5	SENT_223	[p16l175t1043r436b1100],
5	G	NN	O	g	dep	2	SENT_223	[p16l494t1044r561b1113],
6	,	,	O	,	_	0	SENT_223	[p16l494t1044r561b1113],
7	Minuz	NNP	PERSON	Minuz	nn	8	SENT_223	[p16l619t1044r813b1100],
8	P	NN	PERSON	p	appos	5	SENT_223	[p16l868t1044r911b1113],
9	,	,	O	,	_	0	SENT_223	[p16l868t1044r911b1113],
10	Solero	NNP	PERSON	Solero	nn	11	SENT_223	[p16l971t1043r1180b1101],
11	P	NN	PERSON	p	appos	5	SENT_223	[p16l1236t1044r1278b1113],
12	,	,	O	,	_	0	SENT_223	[p16l1236t1044r1278b1113],
13	Pincelli	NNP	PERSON	Pincelli	nn	14	SENT_223	[p16l1341t1043r1581b1100],
14	S	NNP	PERSON	S	appos	5	SENT_223	[p16l1638t1044r1691b1113],
15	,	,	O	,	_	0	SENT_223	[p16l1638t1044r1691b1113],
16	Ortolani	NNP	PERSON	Ortolani	nn	17	SENT_223	[p16l1752t1043r2023b1100],
17	R	NNP	PERSON	R	appos	5	SENT_223	[p16l2083t1044r2141b1113],
18	,	,	O	,	_	0	SENT_223	[p16l2083t1044r2141b1113],
19	Lussignoli	NNP	LOCATION	Lussignoli	nn	20	SENT_223	[p16l180t1137r492b1209],
20	S	NNP	LOCATION	S	appos	5	SENT_223	[p16l532t1138r585b1207],
21	,	,	O	,	_	0	SENT_223	[p16l532t1138r585b1207],
22	et	FW	O	et	nn	23	SENT_223	[p16l629t1143r696b1194],
23	al.	FW	O	al.	appos	5	SENT_223	[p16l734t1137r811b1194],
24	.	.	O	.	_	0	SENT_223	[p16l734t1137r811b1194],

1	Defective	JJ	O	defective	amod	2	SENT_224	[p16l859t1137r1172b1194],
2	platelet	NN	O	platelet	_	0	SENT_224	[p16l1211t1137r1471b1209],
3	response	NN	O	response	dep	2	SENT_224	[p16l1512t1153r1797b1209],
4	to	TO	O	to	_	0	SENT_224	[p16l1835t1143r1901b1194],
5	arachidonic	JJ	O	arachidonic	amod	6	SENT_224	[p16l1939t1137r2143b1194, p16l177t1231r375b1288],
6	acid	NN	O	acid	prep_to	3	SENT_224	[p16l411t1231r543b1288],
7	and	CC	O	and	_	0	SENT_224	[p16l582t1231r697b1288],
8	thromboxane	NN	O	thromboxane	prep_to	3	SENT_224	[p16l735t1231r1172b1289],
9	A	DT	O	a	det	12	SENT_224	[p16l1205t1232r1339b1303],
10	(	NN	O	(	nn	12	SENT_224	[p16l1205t1232r1339b1303],
11	2	CD	NUMBER	2	num	12	SENT_224	[p16l1205t1232r1339b1303],
12	)	NN	O	)	dep	2	SENT_224	[p16l1205t1232r1339b1303],
13	in	IN	O	in	_	0	SENT_224	[p16l1378t1233r1433b1288],
14	subjects	NNS	O	subject	prep_in	12	SENT_224	[p16l1471t1231r1745b1303],
15	with	IN	O	with	_	0	SENT_224	[p16l1778t1231r1921b1288],
16	Pl	NN	O	pl	nn	18	SENT_224	[p16l1962t1231r2144b1303],
17	(	CD	NUMBER	(	num	18	SENT_224	[p16l1962t1231r2144b1303],
18	A2	NN	O	a2	prep_with	14	SENT_224	[p16l1962t1231r2144b1303],
19	)	CD	NUMBER	)	num	20	SENT_224	[p16l1962t1231r2144b1303],
20	polymorphism	NN	O	polymorphism	dep	2	SENT_224	[p16l179t1325r638b1397],
21	of	IN	O	of	_	0	SENT_224	[p16l677t1325r744b1382],
22	beta	NN	O	beta	prep_of	20	SENT_224	[p16l781t1325r1017b1397],
23	(	CD	NUMBER	(	number	24	SENT_224	[p16l781t1325r1017b1397],
24	3	CD	NUMBER	3	num	29	SENT_224	[p16l781t1325r1017b1397],
25	)	NN	O	)	nn	29	SENT_224	[p16l781t1325r1017b1397],
26	subunit	NN	O	subunit	nn	29	SENT_224	[p16l1058t1325r1299b1382],
27	(	CD	NUMBER	(	num	29	SENT_224	[p16l1341t1325r1774b1397],
28	glycoprotein	NN	O	glycoprotein	nn	29	SENT_224	[p16l1341t1325r1774b1397],
29	Illa	NN	O	illum	dep	2	SENT_224	[p16l1819t1327r1963b1397],
30	)	NN	O	)	dep	29	SENT_224	[p16l1819t1327r1963b1397],
31	.	.	O	.	_	0	SENT_224	[p16l1819t1327r1963b1397],

1	Br	NN	O	br	nn	3	SENT_225	[p16l2009t1326r2081b1382],
2	J	NN	O	j	nn	3	SENT_225	[p16l2112t1327r2149b1382],
3	Haematol	NN	O	haematol	_	0	SENT_225	[p16l177t1419r497b1476],
4	2000	CD	DATE	2000	dep	3	SENT_225	[p16l530t1420r975b1488],
5	;	:	O	;	_	0	SENT_225	[p16l530t1420r975b1488],
6	110:911	CD	NUMBER	110:911	number	7	SENT_225	[p16l530t1420r975b1488],
7	—	CD	NUMBER	—	dep	3	SENT_225	[p16l1001t1452r1021b1456],
8	8	CD	NUMBER	8	dep	7	SENT_225	[p16l1038t1420r1093b1476],
9	.	.	O	.	_	0	SENT_225	[p16l1038t1420r1093b1476],

1	[	RB	O	[	advmod	2	SENT_226	[p16l7t1512r129b1584],
2	14	CD	NUMBER	14	_	0	SENT_226	[p16l7t1512r129b1584],
3	]	CD	NUMBER	]	num	5	SENT_226	[p16l7t1512r129b1584],
4	Kunapuli	NNP	O	Kunapuli	nn	5	SENT_226	[p16l179t1512r460b1584],
5	SP	NN	O	sp	dep	2	SENT_226	[p16l516t1513r597b1582],
6	,	,	O	,	_	0	SENT_226	[p16l516t1513r597b1582],
7	Dorsam	NNP	ORGANIZATION	Dorsam	nn	8	SENT_226	[p16l660t1514r899b1569],
8	RT	NN	ORGANIZATION	rt	appos	5	SENT_226	[p16l958t1513r1045b1582],
9	,	,	O	,	_	0	SENT_226	[p16l958t1513r1045b1582],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_226	[p16l1107t1514r1223b1569],
11	S	NNP	O	S	appos	5	SENT_226	[p16l1278t1513r1331b1582],
12	,	,	O	,	_	0	SENT_226	[p16l1278t1513r1331b1582],
13	Quinton	NNP	PERSON	Quinton	nn	14	SENT_226	[p16l1391t1513r1652b1580],
14	TM	NNP	O	TM	appos	5	SENT_226	[p16l1705t1514r1821b1570],
15	.	.	O	.	_	0	SENT_226	[p16l1705t1514r1821b1570],

1	Platelet	NN	O	platelet	_	0	SENT_227	[p16l1884t1512r2147b1569],
2	purinergic	JJ	O	purinergic	amod	3	SENT_227	[p16l178t1608r510b1679],
3	receptors	NNS	O	receptor	dep	1	SENT_227	[p16l538t1613r873b1679],
4	.	.	O	.	_	0	SENT_227	[p16l538t1613r873b1679],

1	Curr	NNP	O	Curr	nn	3	SENT_228	[p16l908t1608r1053b1664],
2	Opin	NNP	O	Opin	nn	3	SENT_228	[p16l1075t1608r1225b1679],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_228	[p16l1249t1607r1597b1664],
4	2003	CD	DATE	2003	num	3	SENT_228	[p16l1626t1608r2140b1677],
5	;	:	O	;	_	0	SENT_228	[p16l1626t1608r2140b1677],
6	3:175	CD	NUMBER	3:175	number	7	SENT_228	[p16l1626t1608r2140b1677],
7	—	CD	NUMBER	—	dep	3	SENT_228	[p16l1626t1608r2140b1677],
8	80	CD	NUMBER	80	dep	7	SENT_228	[p16l1626t1608r2140b1677],
9	.	.	O	.	_	0	SENT_228	[p16l1626t1608r2140b1677],

1	[	RB	O	[	advmod	2	SENT_229	[p16l7t1700r126b1772],
2	15	CD	NUMBER	15	_	0	SENT_229	[p16l7t1700r126b1772],
3	]	CD	NUMBER	]	num	5	SENT_229	[p16l7t1700r126b1772],
4	Fontana	NNP	PERSON	Fontana	nn	5	SENT_229	[p16l176t1702r438b1757],
5	P	NN	PERSON	p	dep	2	SENT_229	[p16l464t1701r506b1770],
6	,	,	O	,	_	0	SENT_229	[p16l464t1701r506b1770],
7	Dupont	NNP	ORGANIZATION	Dupont	nn	8	SENT_229	[p16l538t1701r770b1772],
8	A	NNP	O	A	appos	5	SENT_229	[p16l791t1701r854b1770],
9	,	,	O	,	_	0	SENT_229	[p16l791t1701r854b1770],
10	Gandrille	NNP	O	Gandrille	nn	11	SENT_229	[p16l884t1700r1186b1757],
11	S	NNP	O	S	appos	5	SENT_229	[p16l1209t1701r1262b1770],
12	,	,	O	,	_	0	SENT_229	[p16l1209t1701r1262b1770],
13	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	14	SENT_229	[p16l1294t1700r1758b1757],
14	C	NNP	O	C	appos	5	SENT_229	[p16l1781t1701r1842b1770],
15	,	,	O	,	_	0	SENT_229	[p16l1781t1701r1842b1770],
16	Reny	NNP	PERSON	Reny	nn	17	SENT_229	[p16l1876t1701r2030b1772],
17	JL	NNP	PERSON	JL	appos	5	SENT_229	[p16l2050t1702r2141b1770],
18	,	,	O	,	_	0	SENT_229	[p16l2050t1702r2141b1770],
19	Aiach	NNP	O	Aiach	nn	20	SENT_229	[p16l171t1794r349b1851],
20	M	NNP	O	M	appos	5	SENT_229	[p16l396t1796r468b1864],
21	,	,	O	,	_	0	SENT_229	[p16l396t1796r468b1864],
22	et	FW	O	et	nn	23	SENT_229	[p16l521t1800r588b1851],
23	al.	FW	O	al.	appos	5	SENT_229	[p16l634t1794r711b1851],
24	.	.	O	.	_	0	SENT_229	[p16l634t1794r711b1851],

1	Adenosine	NN	LOCATION	adenosine	nsubjpass	6	SENT_230	[p16l763t1794r1100b1851],
2	diphosphate-induced	JJ	O	diphosphate-induced	amod	4	SENT_230	[p16l1146t1794r1837b1866],
3	platelet	NN	O	platelet	nn	4	SENT_230	[p16l1888t1794r2148b1866],
4	aggregation	NN	O	aggregation	dep	1	SENT_230	[p16l174t1890r560b1961],
5	is	VBZ	O	be	auxpass	6	SENT_230	[p16l594t1890r640b1946],
6	associated	VBN	O	associate	_	0	SENT_230	[p16l672t1889r1014b1946],
7	with	IN	O	with	_	0	SENT_230	[p16l1045t1889r1189b1946],
8	P2Y12	NN	O	p2y12	nn	11	SENT_230	[p16l1225t1889r1400b1958],
9	gene	NN	O	gene	nn	11	SENT_230	[p16l1432t1903r1587b1961],
10	sequence	NN	O	sequence	nn	11	SENT_230	[p16l1619t1904r1927b1961],
11	variations	NNS	O	variation	prep_with	6	SENT_230	[p16l1956t1890r2143b1946, p16l174t1984r332b2039],
12	in	IN	O	in	_	0	SENT_230	[p16l361t1983r416b2039],
13	healthy	JJ	O	healthy	amod	14	SENT_230	[p16l449t1982r695b2054],
14	subjects	NNS	O	subject	prep_in	6	SENT_230	[p16l722t1982r1020b2054],
15	.	.	O	.	_	0	SENT_230	[p16l722t1982r1020b2054],

1	Circulation	NN	O	circulation	_	0	SENT_231	[p16l1058t1982r1422b2039],
2	2003	CD	DATE	2003	num	1	SENT_231	[p16l1456t1983r2058b2052],
3	;	:	O	;	_	0	SENT_231	[p16l1456t1983r2058b2052],
4	108:989	CD	NUMBER	108:989	number	5	SENT_231	[p16l1456t1983r2058b2052],
5	—	CD	NUMBER	—	dep	1	SENT_231	[p16l1456t1983r2058b2052],
6	95	CD	NUMBER	95	dep	5	SENT_231	[p16l1456t1983r2058b2052],
7	.	.	O	.	_	0	SENT_231	[p16l1456t1983r2058b2052],

1	[	RB	O	[	advmod	2	SENT_232	[p16l7t2076r126b2148],
2	16	CD	NUMBER	16	_	0	SENT_232	[p16l7t2076r126b2148],
3	]	CD	NUMBER	]	num	5	SENT_232	[p16l7t2076r126b2148],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_232	[p16l176t2078r438b2133],
5	P	NN	ORGANIZATION	p	dep	2	SENT_232	[p16l468t2078r510b2146],
6	,	,	O	,	_	0	SENT_232	[p16l468t2078r510b2146],
7	Gaussem	NNP	ORGANIZATION	Gaussem	nn	8	SENT_232	[p16l544t2077r830b2134],
8	P	NN	ORGANIZATION	p	appos	5	SENT_232	[p16l861t2078r904b2146],
9	,	,	O	,	_	0	SENT_232	[p16l861t2078r904b2146],
10	Aiach	NNP	O	Aiach	nn	11	SENT_232	[p16l935t2076r1113b2133],
11	M	NNP	O	M	appos	5	SENT_232	[p16l1141t2078r1213b2146],
12	,	,	O	,	_	0	SENT_232	[p16l1141t2078r1213b2146],
13	Fiessinger	NNP	O	Fiessinger	nn	14	SENT_232	[p16l1249t2078r1573b2148],
14	JN	NN	O	jn	appos	5	SENT_232	[p16l1598t2078r1699b2146],
15	,	,	O	,	_	0	SENT_232	[p16l1598t2078r1699b2146],
16	Emmerich	NNP	PERSON	Emmerich	nn	17	SENT_232	[p16l1735t2076r2059b2133],
17	J	NNP	PERSON	J	appos	5	SENT_232	[p16l2087t2078r2140b2146],
18	,	,	O	,	_	0	SENT_232	[p16l2087t2078r2140b2146],
19	Reny	NNP	PERSON	Reny	nn	20	SENT_232	[p16l177t2172r331b2243],
20	JL	NNP	O	JL	appos	5	SENT_232	[p16l361t2172r451b2228],
21	.	.	O	.	_	0	SENT_232	[p16l361t2172r451b2228],

1	P2Y12	NN	O	p2y12	nn	3	SENT_233	[p16l494t2171r669b2240],
2	H2	NN	O	h2	nn	3	SENT_233	[p16l706t2172r777b2240],
3	haplotype	NN	O	haplotype	nsubjpass	5	SENT_233	[p16l812t2171r1139b2243],
4	is	VBZ	O	be	auxpass	5	SENT_233	[p16l1172t2172r1219b2228],
5	associated	VBN	O	associate	_	0	SENT_233	[p16l1252t2171r1594b2228],
6	with	IN	O	with	_	0	SENT_233	[p16l1627t2171r1770b2228],
7	peripheral	JJ	O	peripheral	amod	9	SENT_233	[p16l1808t2171r2147b2243],
8	arterial	JJ	O	arterial	amod	9	SENT_233	[p16l174t2265r419b2322],
9	disease	NN	O	disease	prep_with	5	SENT_233	[p16l460t2265r719b2322],
10	:	:	O	:	_	0	SENT_233	[p16l460t2265r719b2322],
11	a	DT	O	a	det	15	SENT_233	[p16l766t2280r801b2322],
12	case	NN	O	case	nn	15	SENT_233	[p16l841t2265r1276b2322],
13	—	CD	NUMBER	—	num	15	SENT_233	[p16l841t2265r1276b2322],
14	control	NN	O	control	nn	15	SENT_233	[p16l841t2265r1276b2322],
15	study	NN	O	study	dep	9	SENT_233	[p16l1317t2265r1508b2337],
16	.	.	O	.	_	0	SENT_233	[p16l1317t2265r1508b2337],

1	Circulation	NN	O	circulation	_	0	SENT_234	[p16l1557t2265r1923b2322],
2	2003	CD	DATE	2003	num	1	SENT_234	[p16l1967t2265r2141b2334],
3	;	:	O	;	_	0	SENT_234	[p16l1967t2265r2141b2334],
4	108:2971	CD	NUMBER	108:2971	number	5	SENT_234	[p16l181t2359r474b2416],
5	-3	CD	NUMBER	-3	dep	1	SENT_234	[p16l499t2359r591b2415],
6	.	.	O	.	_	0	SENT_234	[p16l499t2359r591b2415],

1	[	NN	O	[	nn	5	SENT_235	[p16l7t2452r128b2524],
2	17	CD	NUMBER	17	num	5	SENT_235	[p16l7t2452r128b2524],
3	]	CD	NUMBER	]	num	5	SENT_235	[p16l7t2452r128b2524],
4	Hetherington	NNP	PERSON	Hetherington	nn	5	SENT_235	[p16l178t2452r614b2524],
5	SL	NNP	O	SL	_	0	SENT_235	[p16l669t2453r761b2522],
6	,	,	O	,	_	0	SENT_235	[p16l669t2453r761b2522],
7	Singh	NNP	PERSON	Singh	nn	8	SENT_235	[p16l821t2452r991b2524],
8	RK	NNP	PERSON	RK	appos	5	SENT_235	[p16l1050t2453r1151b2522],
9	,	,	O	,	_	0	SENT_235	[p16l1050t2453r1151b2522],
10	Lodwick	NNP	PERSON	Lodwick	nn	11	SENT_235	[p16l1213t2452r1481b2510],
11	D	NNP	O	D	appos	8	SENT_235	[p16l1535t2454r1595b2522],
12	,	,	O	,	_	0	SENT_235	[p16l1535t2454r1595b2522],
13	Thompson	NNP	PERSON	Thompson	nn	14	SENT_235	[p16l1652t2452r1989b2524],
14	JR	NNP	O	JR	appos	8	SENT_235	[p16l2043t2453r2141b2522],
15	,	,	O	,	_	0	SENT_235	[p16l2043t2453r2141b2522],
16	Goodall	NNP	PERSON	Goodall	nn	17	SENT_235	[p16l176t2547r427b2604],
17	AH	NNP	O	AH	appos	8	SENT_235	[p16l479t2547r592b2616],
18	,	,	O	,	_	0	SENT_235	[p16l479t2547r592b2616],
19	Samani	NNP	PERSON	Samani	nn	20	SENT_235	[p16l651t2547r884b2604],
20	NJ	NNP	O	NJ	appos	8	SENT_235	[p16l942t2548r1040b2604],
21	.	.	O	.	_	0	SENT_235	[p16l942t2548r1040b2604],

1	Dimorphism	NN	O	dimorphism	nsubjpass	9	SENT_236	[p16l1103t2547r1490b2619],
2	in	IN	O	in	_	0	SENT_236	[p16l1546t2548r1601b2603],
3	the	DT	O	the	det	7	SENT_236	[p16l1656t2547r1764b2604],
4	P2Y1	NN	O	p2y1	nn	7	SENT_236	[p16l1820t2547r1959b2616],
5	ADP	NN	ORGANIZATION	adp	nn	7	SENT_236	[p16l2017t2547r2147b2603],
6	receptor	NN	O	receptor	nn	7	SENT_236	[p16l178t2646r461b2712],
7	gene	NN	O	gene	prep_in	1	SENT_236	[p16l487t2655r643b2712],
8	is	VBZ	O	be	auxpass	9	SENT_236	[p16l671t2642r718b2697],
9	associated	VBN	O	associate	_	0	SENT_236	[p16l746t2640r1087b2697],
10	with	IN	O	with	_	0	SENT_236	[p16l1115t2640r1258b2697],
11	increased	VBN	O	increase	amod	14	SENT_236	[p16l1288t2640r1602b2697],
12	platelet	NN	O	platelet	nn	14	SENT_236	[p16l1633t2640r1893b2712],
13	activation	NN	O	activation	nn	14	SENT_236	[p16l1921t2642r2143b2698, p16l176t2736r305b2791],
14	response	NN	O	response	prep_with	9	SENT_236	[p16l364t2750r659b2806],
15	to	TO	O	to	_	0	SENT_236	[p16l714t2740r781b2791],
16	ADP	NN	O	adp	prep_to	14	SENT_236	[p16l832t2735r976b2791],
17	.	.	O	.	_	0	SENT_236	[p16l832t2735r976b2791],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_237	[p16l1034t2734r1452b2791],
2	Thromb	NNP	O	Thromb	nn	4	SENT_237	[p16l1505t2734r1763b2792],
3	Vasc	NNP	O	Vasc	nn	4	SENT_237	[p16l1821t2736r1961b2792],
4	Biol	NNP	O	Biol	_	0	SENT_237	[p16l2014t2734r2142b2792],
5	2005	CD	DATE	2005	num	4	SENT_237	[p16l175t2829r812b2897],
6	;	:	O	;	_	0	SENT_237	[p16l175t2829r812b2897],
7	25:252	CD	NUMBER	25:252	number	8	SENT_237	[p16l175t2829r812b2897],
8	—	CD	NUMBER	—	dep	4	SENT_237	[p16l175t2829r812b2897],
9	2527	CD	DATE	2527	dep	8	SENT_237	[p16l175t2829r812b2897],
10	.	.	O	.	_	0	SENT_237	[p16l175t2829r812b2897],

1	[	NN	O	[	nn	5	SENT_238	[p16l7t2922r126b2994],
2	18	CD	NUMBER	18	num	5	SENT_238	[p16l7t2922r126b2994],
3	]	CD	NUMBER	]	num	5	SENT_238	[p16l7t2922r126b2994],
4	Jefferson	NNP	ORGANIZATION	Jefferson	nn	5	SENT_238	[p16l173t2922r478b2979],
5	BK	NNP	ORGANIZATION	BK	_	0	SENT_238	[p16l506t2923r606b2992],
6	,	,	O	,	_	0	SENT_238	[p16l506t2923r606b2992],
7	Foster	NNP	O	Foster	nn	8	SENT_238	[p16l639t2923r842b2979],
8	JH	NNP	O	JH	appos	5	SENT_238	[p16l862t2923r964b2991],
9	,	,	O	,	_	0	SENT_238	[p16l862t2923r964b2991],
10	McCarthy	NNP	PERSON	McCarthy	nn	11	SENT_238	[p16l992t2922r1301b2994],
11	JJ	NN	PERSON	jj	appos	8	SENT_238	[p16l1322t2923r1411b2991],
12	,	,	O	,	_	0	SENT_238	[p16l1322t2923r1411b2991],
13	Ginsburg	NNP	PERSON	Ginsburg	nn	14	SENT_238	[p16l1440t2922r1727b2994],
14	G	NNP	PERSON	G	appos	8	SENT_238	[p16l1750t2923r1817b2992],
15	,	,	O	,	_	0	SENT_238	[p16l1750t2923r1817b2992],
16	Parker	NNP	PERSON	Parker	nn	17	SENT_238	[p16l1850t2922r2059b2979],
17	A	NNP	O	A	appos	8	SENT_238	[p16l2077t2923r2140b2991],
18	,	,	O	,	_	0	SENT_238	[p16l2077t2923r2140b2991],
19	Kottke-Marchant	NNP	O	Kottke-Marchant	nn	20	SENT_238	[p16l176t3015r724b3073],
20	K	NNP	O	K	appos	8	SENT_238	[p16l765t3017r822b3085],
21	,	,	O	,	_	0	SENT_238	[p16l765t3017r822b3085],
22	et	FW	O	et	nn	23	SENT_238	[p16l867t3021r934b3072],
23	al.	FW	O	al.	appos	8	SENT_238	[p16l973t3015r1050b3072],
24	.	.	O	.	_	0	SENT_238	[p16l973t3015r1050b3072],

1	Aspirin	NN	O	aspirin	_	0	SENT_239	[p16l1093t3016r1317b3087],
2	resistance	NN	O	resistance	dep	1	SENT_239	[p16l1360t3017r1690b3073],
3	and	CC	O	and	_	0	SENT_239	[p16l1730t3015r1845b3072],
4	a	DT	O	a	det	6	SENT_239	[p16l1886t3031r1920b3072],
5	single	JJ	O	single	amod	6	SENT_239	[p16l1959t3015r2147b3087],
6	gene	NN	O	gene	dep	1	SENT_239	[p16l174t3124r355b3182],
7	.	.	O	.	_	0	SENT_239	[p16l174t3124r355b3182],

1	Am	NNP	O	Am	nn	3	SENT_240	[p16l387t3110r494b3166],
2	J	NNP	O	J	nn	3	SENT_240	[p16l520t3111r556b3167],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_240	[p16l586t3110r822b3167],
4	2005	CD	DATE	2005	num	3	SENT_240	[p16l855t3110r1374b3179],
5	;	:	O	;	_	0	SENT_240	[p16l855t3110r1374b3179],
6	95:805	CD	NUMBER	95:805	number	7	SENT_240	[p16l855t3110r1374b3179],
7	—	CD	NUMBER	—	dep	3	SENT_240	[p16l855t3110r1374b3179],
8	8	CD	NUMBER	8	dep	7	SENT_240	[p16l855t3110r1374b3179],
9	.	.	O	.	_	0	SENT_240	[p16l855t3110r1374b3179],

1	[	NN	O	[	nn	5	SENT_241	[p16l7t3204r126b3276],
2	19	CD	NUMBER	19	num	5	SENT_241	[p16l7t3204r126b3276],
3	]	CD	NUMBER	]	num	5	SENT_241	[p16l7t3204r126b3276],
4	Kleiman	NNP	ORGANIZATION	Kleiman	nn	5	SENT_241	[p16l176t3204r436b3261],
5	NS	NNP	ORGANIZATION	NS	_	0	SENT_241	[p16l488t3205r586b3273],
6	,	,	O	,	_	0	SENT_241	[p16l488t3205r586b3273],
7	Klem	NNP	PERSON	Klem	nn	8	SENT_241	[p16l643t3204r802b3261],
8	J	NNP	PERSON	J	appos	5	SENT_241	[p16l851t3205r904b3274],
9	,	,	O	,	_	0	SENT_241	[p16l851t3205r904b3274],
10	Fernandes	NNP	O	Fernandes	nn	11	SENT_241	[p16l960t3204r1296b3261],
11	LS	NN	O	l	appos	8	SENT_241	[p16l1346t3205r1434b3274],
12	,	,	O	,	_	0	SENT_241	[p16l1346t3205r1434b3274],
13	Rubin	NNP	PERSON	Rubin	nn	14	SENT_241	[p16l1491t3204r1667b3261],
14	H	NNP	PERSON	H	appos	8	SENT_241	[p16l1719t3205r1782b3274],
15	,	,	O	,	_	0	SENT_241	[p16l1719t3205r1782b3274],
16	Challa	NNP	PERSON	Challa	nn	17	SENT_241	[p16l1836t3204r2040b3261],
17	S	NNP	O	S	appos	8	SENT_241	[p16l2088t3205r2141b3273],
18	,	,	O	,	_	0	SENT_241	[p16l2088t3205r2141b3273],
19	Solomon	NNP	PERSON	Solomon	nn	20	SENT_241	[p16l174t3298r448b3355],
20	S	NNP	O	S	appos	8	SENT_241	[p16l488t3299r541b3368],
21	,	,	O	,	_	0	SENT_241	[p16l488t3299r541b3368],
22	et	FW	O	et	nn	23	SENT_241	[p16l585t3303r652b3355],
23	al.	FW	O	al.	appos	8	SENT_241	[p16l690t3298r768b3355],
24	.	.	O	.	_	0	SENT_241	[p16l690t3298r768b3355],

1	Pharmacodynamic	JJ	MISC	pharmacodynamic	amod	2	SENT_242	[p16l815t3298r1411b3370],
2	profile	NN	O	profile	nsubj	9	SENT_242	[p16l1452t3298r1668b3370],
3	of	IN	O	of	_	0	SENT_242	[p16l1705t3298r1771b3355],
4	the	DT	O	the	det	8	SENT_242	[p16l1807t3298r1914b3355],
5	direct	JJ	O	direct	amod	8	SENT_242	[p16l1952t3298r2148b3355],
6	thrombin	NN	O	thrombin	nn	8	SENT_242	[p16l174t3392r472b3449],
7	antagonist	NN	O	antagonist	nn	8	SENT_242	[p16l507t3393r851b3464],
8	bivalirudin	NN	O	bivalirudin	prep_of	2	SENT_242	[p16l885t3392r1232b3449],
9	given	VBN	O	give	_	0	SENT_242	[p16l1267t3393r1437b3464],
10	in	IN	O	in	_	0	SENT_242	[p16l1472t3393r1528b3448],
11	combination	NN	O	combination	prep_in	9	SENT_242	[p16l1562t3392r1969b3449],
12	with	IN	O	with	_	0	SENT_242	[p16l2001t3392r2144b3449],
13	the	DT	O	the	det	15	SENT_242	[p16l174t3486r281b3543],
14	glycoprotein	NN	O	glycoprotein	nn	15	SENT_242	[p16l311t3486r721b3558],
15	IIb	NN	O	iib	prep_with	11	SENT_242	[p16l757t3486r865b3543],
16	/	:	O	/	punct	17	SENT_242	[p16l757t3486r865b3543],
17	Illa	NN	PERSON	illum	dep	9	SENT_242	[p16l878t3487r970b3543],
18	antagonist	NN	O	antagonist	nn	19	SENT_242	[p16l1001t3487r1345b3558],
19	eptifibatide	NN	O	eptifibatide	dep	17	SENT_242	[p16l1374t3486r1791b3558],
20	.	.	O	.	_	0	SENT_242	[p16l1374t3486r1791b3558],

1	Am	VBP	O	be	dep	3	SENT_243	[p16l1825t3487r1932b3542],
2	Heart	NNP	O	Heart	nn	3	SENT_243	[p16l1961t3487r2149b3543],
3	J	NNP	O	J	_	0	SENT_243	[p16l170t3581r207b3637],
4	2002	CD	DATE	2002	num	3	SENT_243	[p16l238t3580r840b3649],
5	;	:	O	;	_	0	SENT_243	[p16l238t3580r840b3649],
6	143:585	CD	NUMBER	143:585	dep	3	SENT_243	[p16l238t3580r840b3649],
7	—	CD	NUMBER	—	num	8	SENT_243	[p16l238t3580r840b3649],
8	93	CD	NUMBER	93	dep	6	SENT_243	[p16l238t3580r840b3649],
9	.	.	O	.	_	0	SENT_243	[p16l238t3580r840b3649],

1	[	RB	O	[	dep	2	SENT_244	[p16l7t3673r126b3745],
2	20	CD	NUMBER	20	dep	5	SENT_244	[p16l7t3673r126b3745],
3	]	CD	NUMBER	]	num	5	SENT_244	[p16l7t3673r126b3745],
4	Michelson	NNP	PERSON	Michelson	nn	5	SENT_244	[p16l172t3673r493b3730],
5	AD	NN	O	ad	_	0	SENT_244	[p16l535t3674r644b3743],
6	,	,	O	,	_	0	SENT_244	[p16l535t3674r644b3743],
7	Barnard	NNP	ORGANIZATION	Barnard	nn	8	SENT_244	[p16l696t3673r948b3730],
8	MR	NN	ORGANIZATION	mr	appos	5	SENT_244	[p16l991t3674r1106b3743],
9	,	,	O	,	_	0	SENT_244	[p16l991t3674r1106b3743],
10	Krueger	NNP	ORGANIZATION	Krueger	nn	11	SENT_244	[p16l1159t3674r1415b3745],
11	LA	NNP	ORGANIZATION	LA	appos	5	SENT_244	[p16l1458t3674r1554b3743],
12	,	,	O	,	_	0	SENT_244	[p16l1458t3674r1554b3743],
13	Frelinger	NNP	PERSON	Frelinger	nn	15	SENT_244	[p16l1606t3673r1901b3745],
14	III	NNP	PERSON	III	nn	15	SENT_244	[p16l1946t3674r1995b3729],
15	AL	NNP	O	AL	appos	5	SENT_244	[p16l2040t3674r2141b3743],
16	,	,	O	,	_	0	SENT_244	[p16l2040t3674r2141b3743],

1	Furman	NNP	O	Furman	nn	2	SENT_245	[p17l176t19r418b75],
2	MI	NNP	O	MI	_	0	SENT_245	[p17l448t19r540b75],
3	.	.	O	.	_	0	SENT_245	[p17l448t19r540b75],

1	Evaluation	NN	O	evaluation	_	0	SENT_246	[p17l581t18r921b75],
2	of	IN	O	of	_	0	SENT_246	[p17l953t18r1019b75],
3	platelet	NN	O	platelet	nn	4	SENT_246	[p17l1049t18r1309b90],
4	function	NN	O	function	prep_of	1	SENT_246	[p17l1339t18r1610b75],
5	by	IN	O	by	_	0	SENT_246	[p17l1645t18r1719b90],
6	flow	NN	O	flow	nn	7	SENT_246	[p17l1747t18r1890b75],
7	cytometry	NN	O	cytometry	prep_by	1	SENT_246	[p17l1918t23r2143b90, p17l174t117r323b184],
8	.	.	O	.	_	0	SENT_246	[p17l1918t23r2143b90, p17l174t117r323b184],

1	Methods	NNS	O	method	_	0	SENT_247	[p17l356t112r638b169],
2	2000	CD	DATE	2000	num	1	SENT_247	[p17l669t112r1116b182],
3	;	:	O	;	_	0	SENT_247	[p17l669t112r1116b182],
4	21:259	CD	NUMBER	21:259	num	6	SENT_247	[p17l669t112r1116b182],
5	-	:	O	-	_	0	SENT_247	[p17l669t112r1116b182],
6	70	CD	DATE	70	dep	1	SENT_247	[p17l1133t112r1227b169],
7	.	.	O	.	_	0	SENT_247	[p17l1133t112r1227b169],

1	[	NN	O	[	nn	5	SENT_248	[p17l7t206r126b278],
2	21	CD	NUMBER	21	num	5	SENT_248	[p17l7t206r126b278],
3	]	CD	NUMBER	]	num	5	SENT_248	[p17l7t206r126b278],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_248	[p17l176t208r289b263],
5	PY	NNP	PERSON	PY	_	0	SENT_248	[p17l344t207r430b276],
6	,	,	O	,	_	0	SENT_248	[p17l344t207r430b276],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_248	[p17l490t206r650b263],
8	WH	NNP	PERSON	WH	appos	5	SENT_248	[p17l703t208r834b276],
9	,	,	O	,	_	0	SENT_248	[p17l703t208r834b276],
10	Ng	NNP	O	Ng	nn	11	SENT_248	[p17l896t207r974b278],
11	W	NNP	O	W	appos	8	SENT_248	[p17l1025t208r1101b276],
12	,	,	O	,	_	0	SENT_248	[p17l1025t208r1101b276],
13	Cheng	NNP	PERSON	Cheng	nn	14	SENT_248	[p17l1160t206r1361b278],
14	X	NNP	PERSON	X	appos	8	SENT_248	[p17l1412t208r1471b276],
15	,	,	O	,	_	0	SENT_248	[p17l1412t208r1471b276],
16	Kwok	NNP	PERSON	Kwok	nn	17	SENT_248	[p17l1534t206r1703b263],
17	JY	NN	PERSON	jy	appos	8	SENT_248	[p17l1753t208r1837b276],
18	,	,	O	,	_	0	SENT_248	[p17l1753t208r1837b276],
19	Tse	NNP	O	Tse	nn	20	SENT_248	[p17l1894t208r1997b263],
20	HF	NN	O	hf	appos	8	SENT_248	[p17l2052t207r2141b276],
21	,	,	O	,	_	0	SENT_248	[p17l2052t207r2141b276],
22	et	FW	O	et	nn	23	SENT_248	[p17l174t305r240b357],
23	al.	FW	O	al.	appos	8	SENT_248	[p17l295t300r372b357],
24	.	.	O	.	_	0	SENT_248	[p17l295t300r372b357],

1	Low-dose	JJ	O	low-dose	amod	2	SENT_249	[p17l436t300r743b357],
2	aspirin	NN	O	aspirin	nsubj	3	SENT_249	[p17l797t301r1013b372],
3	increases	VBZ	O	increase	_	0	SENT_249	[p17l1070t301r1374b357],
4	aspirin	NN	O	aspirin	nn	5	SENT_249	[p17l1429t301r1645b372],
5	resistance	NN	O	resistance	dobj	3	SENT_249	[p17l1704t301r2034b357],
6	in	IN	O	in	_	0	SENT_249	[p17l2089t301r2145b356],
7	patients	NNS	O	patient	prep_in	3	SENT_249	[p17l176t395r443b466],
8	with	IN	O	with	_	0	SENT_249	[p17l483t394r627b451],
9	coronary	JJ	O	coronary	amod	11	SENT_249	[p17l673t409r962b466],
10	artery	NN	O	artery	nn	11	SENT_249	[p17l1004t399r1206b466],
11	disease	NN	O	disease	prep_with	7	SENT_249	[p17l1247t394r1512b451],
12	.	.	O	.	_	0	SENT_249	[p17l1247t394r1512b451],

1	Am	VBP	O	be	_	0	SENT_250	[p17l1559t395r1665b450],
2	J	NN	O	j	nsubj	3	SENT_250	[p17l1706t395r1743b451],
3	Med	VBD	O	med	ccomp	1	SENT_250	[p17l1782t394r1923b451],
4	2005	CD	DATE	2005	dobj	3	SENT_250	[p17l1967t394r2141b464],
5	;	:	O	;	_	0	SENT_250	[p17l1967t394r2141b464],
6	118:723	CD	NUMBER	118:723	num	7	SENT_250	[p17l181t489r552b546],
7	—	NN	O	—	dep	4	SENT_250	[p17l181t489r552b546],
8	7	CD	NUMBER	7	dep	7	SENT_250	[p17l181t489r552b546],
9	.	.	O	.	_	0	SENT_250	[p17l181t489r552b546],

1	[	NN	O	[	nn	5	SENT_251	[p17l7t581r126b653],
2	22	CD	NUMBER	22	num	5	SENT_251	[p17l7t581r126b653],
3	]	CD	NUMBER	]	num	5	SENT_251	[p17l7t581r126b653],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_251	[p17l171t581r480b653],
5	DJ	NNP	O	DJ	_	0	SENT_251	[p17l527t582r621b651],
6	,	,	O	,	_	0	SENT_251	[p17l527t582r621b651],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_251	[p17l675t581r1209b638],
8	A	NNP	O	A	appos	5	SENT_251	[p17l1250t582r1312b651],
9	,	,	O	,	_	0	SENT_251	[p17l1250t582r1312b651],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_251	[p17l1366t581r1663b638],
11	E	NNP	PERSON	E	appos	8	SENT_251	[p17l1708t583r1763b651],
12	,	,	O	,	_	0	SENT_251	[p17l1708t583r1763b651],
13	Alfonso	NNP	PERSON	Alfonso	nn	14	SENT_251	[p17l1811t581r2053b638],
14	F	NN	PERSON	f	appos	8	SENT_251	[p17l2101t583r2141b651],
15	,	,	O	,	_	0	SENT_251	[p17l2101t583r2141b651],
16	Sabate	NN	O	sabate	nn	17	SENT_251	[p17l174t676r397b733],
17	M	NN	O	m	appos	8	SENT_251	[p17l448t677r520b746],
18	,	,	O	,	_	0	SENT_251	[p17l448t677r520b746],
19	Fernandez	NNP	PERSON	Fernandez	nn	20	SENT_251	[p17l582t676r925b733],
20	C	NNP	O	C	appos	8	SENT_251	[p17l977t677r1039b746],
21	,	,	O	,	_	0	SENT_251	[p17l977t677r1039b746],
22	et	FW	O	et	nn	23	SENT_251	[p17l1098t681r1165b733],
23	al.	FW	O	al.	appos	8	SENT_251	[p17l1217t676r1294b733],
24	.	.	O	.	_	0	SENT_251	[p17l1217t676r1294b733],

1	PlA	NN	O	plum	nn	2	SENT_252	[p17l1357t676r1460b733],
2	polymorphism	NN	O	polymorphism	_	0	SENT_252	[p17l1513t676r1974b748],
3	and	CC	O	and	_	0	SENT_252	[p17l2029t676r2144b733],
4	platelet	NN	O	platelet	nn	5	SENT_252	[p17l176t770r436b842],
5	reactivity	NN	O	reactivity	conj_and	2	SENT_252	[p17l485t771r801b842],
6	following	VBG	O	follow	_	0	SENT_252	[p17l846t770r1148b842],
7	clopidogrel	NN	O	clopidogrel	prep_following	2	SENT_252	[p17l1195t770r1562b842],
8	loading	VBG	O	load	partmod	7	SENT_252	[p17l1612t770r1848b842],
9	dose	NN	O	dose	dobj	8	SENT_252	[p17l1894t770r2042b827],
10	in	IN	O	in	_	0	SENT_252	[p17l2089t771r2145b826],
11	patients	NNS	O	patient	prep_in	8	SENT_252	[p17l176t865r443b936],
12	undergoing	VBG	O	undergo	partmod	11	SENT_252	[p17l494t864r858b936],
13	coronary	JJ	O	coronary	amod	15	SENT_252	[p17l906t880r1196b936],
14	stent	NN	O	stent	nn	15	SENT_252	[p17l1243t869r1411b921],
15	implantation	NN	O	implantation	dobj	12	SENT_252	[p17l1460t864r1907b936],
16	.	.	O	.	_	0	SENT_252	[p17l1460t864r1907b936],

1	Blood	NN	O	blood	nn	3	SENT_253	[p17l1965t864r2152b921],
2	Coagul	NN	O	coagul	nn	3	SENT_253	[p17l176t957r396b1029],
3	F	NN	O	f	nsubj	4	SENT_253	[p17l424t959r468b1014],
4	ibrinolysis	VBZ	O	ibrinolysis	_	0	SENT_253	[p17l467t957r803b1029],
5	2004	CD	DATE	2004	dobj	4	SENT_253	[p17l834t958r1008b1027],
6	;	:	O	;	_	0	SENT_253	[p17l834t958r1008b1027],
7	1	CD	NUMBER	1	number	8	SENT_253	[p17l1026t959r1047b1014],
8	5:89	CD	NUMBER	5:89	dep	5	SENT_253	[p17l1066t958r1207b1015],
9	-	:	O	-	_	0	SENT_253	[p17l1222t990r1242b994],
10	93	CD	DATE	93	dep	5	SENT_253	[p17l1258t958r1353b1014],
11	.	.	O	.	_	0	SENT_253	[p17l1258t958r1353b1014],

1	[	NN	O	[	_	0	SENT_254	[p17l7t1052r126b1124],
2	23	CD	NUMBER	23	num	1	SENT_254	[p17l7t1052r126b1124],
3	]	NNP	O	]	nn	5	SENT_254	[p17l7t1052r126b1124],
4	Wheeler	NNP	O	Wheeler	nn	5	SENT_254	[p17l171t1052r449b1109],
5	GL	NNP	O	GL	dep	1	SENT_254	[p17l471t1053r576b1122],
6	,	,	O	,	_	0	SENT_254	[p17l471t1053r576b1122],
7	Braden	NNP	ORGANIZATION	Braden	nn	8	SENT_254	[p17l609t1052r833b1109],
8	GA	NNP	ORGANIZATION	GA	appos	5	SENT_254	[p17l860t1053r971b1122],
9	,	,	O	,	_	0	SENT_254	[p17l860t1053r971b1122],
10	Bray	NNP	ORGANIZATION	Bray	nn	11	SENT_254	[p17l1005t1053r1147b1124],
11	PF	NNP	ORGANIZATION	PF	appos	5	SENT_254	[p17l1172t1053r1254b1122],
12	,	,	O	,	_	0	SENT_254	[p17l1172t1053r1254b1122],
13	Marciniak	NNP	PERSON	Marciniak	nn	14	SENT_254	[p17l1282t1052r1600b1109],
14	SJ	NNP	O	SJ	appos	5	SENT_254	[p17l1623t1053r1711b1122],
15	,	,	O	,	_	0	SENT_254	[p17l1623t1053r1711b1122],
16	Mascelli	NNP	PERSON	Mascelli	nn	17	SENT_254	[p17l1739t1052r2000b1109],
17	MA	NNP	PERSON	MA	appos	5	SENT_254	[p17l2025t1053r2141b1122],
18	,	,	O	,	_	0	SENT_254	[p17l2025t1053r2141b1122],
19	Sane	NNP	O	Sane	nn	20	SENT_254	[p17l174t1147r326b1203],
20	DC	NNP	O	DC	appos	5	SENT_254	[p17l355t1147r459b1203],
21	.	.	O	.	_	0	SENT_254	[p17l355t1147r459b1203],

1	Reduced	VBN	O	reduce	_	0	SENT_255	[p17l496t1146r769b1203],
2	inhibition	NN	O	inhibition	dobj	1	SENT_255	[p17l798t1146r1109b1203],
3	by	IN	O	by	_	0	SENT_255	[p17l1141t1146r1214b1218],
4	abciximab	NN	O	abciximab	prep_by	1	SENT_255	[p17l1240t1146r1576b1203],
5	in	IN	O	in	_	0	SENT_255	[p17l1601t1147r1657b1202],
6	platelets	NNS	O	platelet	prep_in	1	SENT_255	[p17l1688t1146r1978b1218],
7	with	IN	O	with	_	0	SENT_255	[p17l2002t1146r2145b1203],
8	the	DT	O	the	det	10	SENT_255	[p17l174t1239r281b1296],
9	PlA2	NN	O	pla2	nn	10	SENT_255	[p17l313t1239r442b1308],
10	polymorphism	NN	O	polymorphism	prep_with	6	SENT_255	[p17l474t1239r958b1311],
11	.	.	O	.	_	0	SENT_255	[p17l474t1239r958b1311],

1	Am	VBP	O	be	dep	3	SENT_256	[p17l991t1240r1098b1296],
2	Heart	NNP	O	Heart	nn	3	SENT_256	[p17l1127t1241r1314b1296],
3	J	NNP	O	J	_	0	SENT_256	[p17l1339t1241r1376b1296],
4	2002	CD	DATE	2002	num	3	SENT_256	[p17l1406t1240r1969b1309],
5	;	:	O	;	_	0	SENT_256	[p17l1406t1240r1969b1309],
6	143:76	CD	NUMBER	143:76	dep	3	SENT_256	[p17l1406t1240r1969b1309],
7	—	CD	NUMBER	—	num	8	SENT_256	[p17l1406t1240r1969b1309],
8	82	CD	NUMBER	82	dep	6	SENT_256	[p17l1406t1240r1969b1309],
9	.	.	O	.	_	0	SENT_256	[p17l1406t1240r1969b1309],

1	[	NN	O	[	nn	6	SENT_257	[p17l7t1334r126b1406],
2	24	CD	NUMBER	24	num	6	SENT_257	[p17l7t1334r126b1406],
3	]	CD	NUMBER	]	num	6	SENT_257	[p17l7t1334r126b1406],
4	von	NNP	PERSON	von	nn	6	SENT_257	[p17l172t1350r285b1391],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_257	[p17l326t1334r653b1391],
6	N	NNP	PERSON	N	nsubjpass	29	SENT_257	[p17l694t1335r756b1404],
7	,	,	O	,	_	0	SENT_257	[p17l694t1335r756b1404],
8	von	NNP	PERSON	von	nn	10	SENT_257	[p17l796t1350r909b1391],
9	Beckerath	NNP	PERSON	Beckerath	nn	10	SENT_257	[p17l950t1334r1278b1391],
10	O	NNP	PERSON	O	appos	6	SENT_257	[p17l1316t1335r1383b1404],
11	,	,	O	,	_	0	SENT_257	[p17l1316t1335r1383b1404],
12	Koch	NNP	PERSON	Koch	nn	13	SENT_257	[p17l1428t1334r1577b1391],
13	W	NNP	O	W	appos	6	SENT_257	[p17l1613t1335r1688b1404],
14	,	,	O	,	_	0	SENT_257	[p17l1613t1335r1688b1404],
15	Eichinger	NNP	PERSON	Eichinger	nn	16	SENT_257	[p17l1734t1334r2036b1406],
16	M	NNP	O	M	appos	6	SENT_257	[p17l2069t1336r2141b1404],
17	,	,	O	,	_	0	SENT_257	[p17l2069t1336r2141b1404],
18	Schomig	NNP	O	Schomig	nn	19	SENT_257	[p17l174t1428r444b1500],
19	A	NNP	O	A	appos	6	SENT_257	[p17l488t1429r551b1498],
20	,	,	O	,	_	0	SENT_257	[p17l488t1429r551b1498],
21	Kastrati	NNP	PERSON	Kastrati	nn	26	SENT_257	[p17l607t1429r859b1485],
22	A.	NNP	O	A.	nn	26	SENT_257	[p17l906t1429r969b1485],
23	P2Y12	NNP	O	P2Y12	nn	26	SENT_257	[p17l1026t1429r1200b1498],
24	gene	NN	O	gene	nn	26	SENT_257	[p17l1248t1442r1403b1500],
25	H2	NN	O	h2	nn	26	SENT_257	[p17l1454t1429r1524b1498],
26	haplotype	NN	O	haplotype	appos	6	SENT_257	[p17l1574t1428r1900b1500],
27	is	VBZ	O	be	auxpass	29	SENT_257	[p17l1947t1429r1994b1485],
28	not	RB	O	not	neg	29	SENT_257	[p17l2043t1434r2148b1485],
29	associated	VBN	O	associate	_	0	SENT_257	[p17l174t1521r515b1578],
30	with	IN	O	with	_	0	SENT_257	[p17l553t1521r695b1578],
31	increased	VBN	O	increase	amod	32	SENT_257	[p17l734t1521r1048b1578],
32	adenosine	NN	O	adenosine	prep_with	29	SENT_257	[p17l1087t1521r1418b1578],
33	diphosphate-induced	JJ	O	diphosphate-induced	amod	35	SENT_257	[p17l1454t1521r2145b1593],
34	platelet	NN	O	platelet	nn	35	SENT_257	[p17l176t1615r435b1687],
35	aggregation	NN	O	aggregation	npadvmod	32	SENT_257	[p17l464t1617r851b1687],
36	after	IN	O	after	_	0	SENT_257	[p17l882t1615r1046b1673],
37	initiation	NN	O	initiation	prep_after	32	SENT_257	[p17l1074t1617r1372b1672],
38	of	IN	O	of	_	0	SENT_257	[p17l1403t1615r1469b1672],
39	clopidogrel	NN	O	clopidogrel	nn	40	SENT_257	[p17l1496t1615r1863b1687],
40	therapy	NN	O	therapy	prep_of	37	SENT_257	[p17l1894t1615r2149b1687],
41	with	IN	O	with	_	0	SENT_257	[p17l172t1710r320b1767],
42	a	DT	O	a	det	45	SENT_257	[p17l378t1726r412b1767],
43	high	JJ	O	high	amod	45	SENT_257	[p17l471t1710r608b1782],
44	loading	NN	O	loading	nn	45	SENT_257	[p17l668t1710r914b1782],
45	dose	NN	O	dose	prep_with	32	SENT_257	[p17l970t1710r1150b1767],
46	.	.	O	.	_	0	SENT_257	[p17l970t1710r1150b1767],

1	Blood	NNP	O	Blood	nn	3	SENT_258	[p17l1214t1710r1408b1767],
2	Coagul	NNP	O	Coagul	nn	3	SENT_258	[p17l1462t1710r1691b1782],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_258	[p17l1746t1710r2145b1782],
4	2005	CD	DATE	2005	num	3	SENT_258	[p17l174t1804r770b1872],
5	;	:	O	;	_	0	SENT_258	[p17l174t1804r770b1872],
6	16:199	CD	NUMBER	16:199	number	7	SENT_258	[p17l174t1804r770b1872],
7	-204	CD	NUMBER	-204	dep	3	SENT_258	[p17l174t1804r770b1872],
8	.	.	O	.	_	0	SENT_258	[p17l174t1804r770b1872],

1	[	NN	O	[	nn	5	SENT_259	[p17l7t1896r126b1968],
2	25	CD	NUMBER	25	num	5	SENT_259	[p17l7t1896r126b1968],
3	]	CD	NUMBER	]	num	5	SENT_259	[p17l7t1896r126b1968],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_259	[p17l171t1896r480b1968],
5	DJ	NNP	O	DJ	_	0	SENT_259	[p17l520t1898r615b1966],
6	,	,	O	,	_	0	SENT_259	[p17l520t1898r615b1966],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_259	[p17l662t1896r1195b1954],
8	A	NNP	O	A	appos	5	SENT_259	[p17l1230t1897r1293b1966],
9	,	,	O	,	_	0	SENT_259	[p17l1230t1897r1293b1966],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_259	[p17l1340t1896r1636b1953],
11	E	NNP	PERSON	E	appos	8	SENT_259	[p17l1676t1898r1731b1966],
12	,	,	O	,	_	0	SENT_259	[p17l1676t1898r1731b1966],
13	Ramirez	NNP	PERSON	Ramirez	nn	14	SENT_259	[p17l1778t1897r2043b1953],
14	C	NNP	O	C	appos	8	SENT_259	[p17l2079t1897r2141b1966],
15	,	,	O	,	_	0	SENT_259	[p17l2079t1897r2141b1966],
16	Cavallari	NNP	PERSON	Cavallari	nn	17	SENT_259	[p17l174t1990r460b2047],
17	U	NNP	O	U	appos	8	SENT_259	[p17l496t1992r559b2059],
18	,	,	O	,	_	0	SENT_259	[p17l496t1992r559b2059],
19	Trabetti	NNP	O	Trabetti	nn	20	SENT_259	[p17l594t1990r855b2047],
20	E	NNP	O	E	appos	8	SENT_259	[p17l892t1992r946b2059],
21	,	,	O	,	_	0	SENT_259	[p17l892t1992r946b2059],
22	et	FW	O	et	nn	23	SENT_259	[p17l982t1996r1049b2047],
23	al.	FW	O	al.	appos	8	SENT_259	[p17l1080t1990r1158b2047],
24	.	.	O	.	_	0	SENT_259	[p17l1080t1990r1158b2047],

1	Lack	NN	O	lack	_	0	SENT_260	[p17l1198t1990r1345b2047],
2	of	IN	O	of	_	0	SENT_260	[p17l1373t1990r1439b2047],
3	association	NN	O	association	prep_of	1	SENT_260	[p17l1468t1992r1829b2047],
4	between	IN	O	between	_	0	SENT_260	[p17l1864t1990r2145b2047],
5	the	DT	O	the	det	9	SENT_260	[p17l174t2083r281b2140],
6	P2Y12	NN	O	p2y12	nn	9	SENT_260	[p17l328t2084r503b2153],
7	receptor	NN	O	receptor	nn	9	SENT_260	[p17l552t2089r833b2155],
8	gene	NN	O	gene	nn	9	SENT_260	[p17l877t2097r1033b2155],
9	polymorphism	NN	O	polymorphism	prep_between	1	SENT_260	[p17l1080t2083r1538b2155],
10	and	CC	O	and	_	0	SENT_260	[p17l1585t2083r1700b2140],
11	platelet	NN	O	platelet	nn	12	SENT_260	[p17l1749t2083r2009b2155],
12	response	NN	O	response	conj_and	9	SENT_260	[p17l2057t2099r2143b2140, p17l174t2193r392b2249],
13	to	TO	O	to	_	0	SENT_260	[p17l444t2183r510b2234],
14	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_260	[p17l561t2177r929b2249],
15	in	IN	O	in	_	0	SENT_260	[p17l982t2179r1037b2234],
16	patients	NNS	O	patient	prep_in	1	SENT_260	[p17l1094t2179r1361b2249],
17	with	IN	O	with	_	0	SENT_260	[p17l1410t2177r1553b2235],
18	coronary	JJ	O	coronary	amod	20	SENT_260	[p17l1607t2193r1896b2249],
19	artery	NN	O	artery	nn	20	SENT_260	[p17l1946t2183r2149b2249],
20	disease	NN	O	disease	prep_with	16	SENT_260	[p17l174t2271r437b2328],
21	.	.	O	.	_	0	SENT_260	[p17l174t2271r437b2328],

1	Thromb	NNP	O	Thromb	nn	2	SENT_261	[p17l477t2271r729b2328],
2	Res	NNP	O	Res	_	0	SENT_261	[p17l757t2272r868b2328],
3	2005	CD	DATE	2005	num	2	SENT_261	[p17l899t2272r1344b2340],
4	;	:	O	;	_	0	SENT_261	[p17l899t2272r1344b2340],
5	116:491	CD	NUMBER	116:491	number	6	SENT_261	[p17l899t2272r1344b2340],
6	-7	CD	NUMBER	-7	dep	2	SENT_261	[p17l1370t2273r1462b2328],
7	.	.	O	.	_	0	SENT_261	[p17l1370t2273r1462b2328],

1	[	NN	O	[	nn	5	SENT_262	[p17l7t2365r126b2437],
2	26	CD	NUMBER	26	num	5	SENT_262	[p17l7t2365r126b2437],
3	]	CD	NUMBER	]	num	5	SENT_262	[p17l7t2365r126b2437],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_262	[p17l176t2366r285b2422],
5	WC	NNP	O	WC	_	0	SENT_262	[p17l311t2365r438b2434],
6	,	,	O	,	_	0	SENT_262	[p17l311t2365r438b2434],
7	Gurbel	NNP	ORGANIZATION	Gurbel	nn	8	SENT_262	[p17l472t2365r691b2422],
8	PA	NN	ORGANIZATION	pa	appos	5	SENT_262	[p17l722t2365r813b2434],
9	,	,	O	,	_	0	SENT_262	[p17l722t2365r813b2434],
10	Watkins	NNP	ORGANIZATION	Watkins	nn	11	SENT_262	[p17l844t2365r1101b2422],
11	PB	NN	ORGANIZATION	pb	appos	8	SENT_262	[p17l1129t2366r1227b2434],
12	,	,	O	,	_	0	SENT_262	[p17l1129t2366r1227b2434],
13	Neer	NNP	PERSON	Neer	nn	14	SENT_262	[p17l1263t2366r1417b2422],
14	CJ	NNP	O	CJ	appos	8	SENT_262	[p17l1442t2365r1538b2434],
15	,	,	O	,	_	0	SENT_262	[p17l1442t2365r1538b2434],
16	Hopp	NNP	PERSON	Hopp	nn	17	SENT_262	[p17l1574t2366r1739b2437],
17	AS	NNP	O	AS	appos	8	SENT_262	[p17l1763t2365r1862b2434],
18	,	,	O	,	_	0	SENT_262	[p17l1763t2365r1862b2434],
19	Carville	NNP	ORGANIZATION	Carville	nn	20	SENT_262	[p17l1896t2365r2147b2422],
20	DG	NNS	ORGANIZATION	dg	appos	8	SENT_262	[p17l176t2459r286b2528],
21	,	,	O	,	_	0	SENT_262	[p17l176t2459r286b2528],
22	et	FW	O	et	nn	23	SENT_262	[p17l331t2464r399b2515],
23	al.	FW	O	al.	appos	8	SENT_262	[p17l438t2458r515b2515],
24	.	.	O	.	_	0	SENT_262	[p17l438t2458r515b2515],

1	Contribution	NN	O	contribution	_	0	SENT_263	[p17l562t2458r973b2515],
2	of	IN	O	of	_	0	SENT_263	[p17l1015t2458r1081b2515],
3	hepatic	JJ	O	hepatic	amod	6	SENT_263	[p17l1120t2458r1364b2530],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_263	[p17l1403t2458r1792b2530],
5	P450	NN	O	p450	nn	6	SENT_263	[p17l1830t2459r1990b2515],
6	3A4	NN	O	3a4	prep_of	1	SENT_263	[p17l2030t2459r2148b2515],
7	metabolic	JJ	O	metabolic	amod	8	SENT_263	[p17l176t2552r512b2610],
8	activity	NN	O	activity	dep	1	SENT_263	[p17l566t2554r823b2624],
9	to	TO	O	to	_	0	SENT_263	[p17l875t2558r942b2609],
10	the	DT	O	the	det	11	SENT_263	[p17l996t2552r1106b2609],
11	phenomenon	NN	O	phenomenon	prep_to	8	SENT_263	[p17l1162t2552r1592b2624],
12	of	IN	O	of	_	0	SENT_263	[p17l1648t2552r1716b2609],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_263	[p17l1767t2552r2146b2624],
14	resistance	NN	O	resistance	prep_of	11	SENT_263	[p17l176t2648r532b2703],
15	.	.	O	.	_	0	SENT_263	[p17l176t2648r532b2703],

1	Circulation	NN	O	circulation	_	0	SENT_264	[p17l571t2647r936b2704],
2	2004	CD	DATE	2004	num	1	SENT_264	[p17l969t2647r1571b2715],
3	;	:	O	;	_	0	SENT_264	[p17l969t2647r1571b2715],
4	109:166	CD	NUMBER	109:166	number	5	SENT_264	[p17l969t2647r1571b2715],
5	-71	CD	NUMBER	-71	dep	1	SENT_264	[p17l969t2647r1571b2715],
6	.	.	O	.	_	0	SENT_264	[p17l969t2647r1571b2715],

1	[	NN	O	[	_	0	SENT_265	[p17l7t2739r126b2811],
2	27	CD	NUMBER	27	num	1	SENT_265	[p17l7t2739r126b2811],
3	]	CD	NUMBER	]	num	5	SENT_265	[p17l7t2739r126b2811],
4	Taubert	NN	PERSON	taubert	nn	5	SENT_265	[p17l171t2739r425b2796],
5	D	NN	PERSON	d	dep	1	SENT_265	[p17l454t2740r514b2809],
6	,	,	O	,	_	0	SENT_265	[p17l454t2740r514b2809],
7	Kastrati	NNP	PERSON	Kastrati	nn	8	SENT_265	[p17l549t2740r800b2796],
8	A	NNP	O	A	appos	5	SENT_265	[p17l827t2740r890b2809],
9	,	,	O	,	_	0	SENT_265	[p17l827t2740r890b2809],
10	Harlfinger	NNP	O	Harlfinger	nn	11	SENT_265	[p17l925t2739r1256b2811],
11	S	NNP	O	S	appos	5	SENT_265	[p17l1280t2740r1333b2809],
12	,	,	O	,	_	0	SENT_265	[p17l1280t2740r1333b2809],
13	Gorchakova	NNP	PERSON	Gorchakova	nn	14	SENT_265	[p17l1366t2739r1751b2796],
14	O	NNP	PERSON	O	appos	5	SENT_265	[p17l1777t2740r1845b2809],
15	,	,	O	,	_	0	SENT_265	[p17l1777t2740r1845b2809],
16	Lazar	NNP	PERSON	Lazar	nn	17	SENT_265	[p17l1880t2741r2056b2796],
17	A	NNP	O	A	appos	5	SENT_265	[p17l2077t2740r2141b2809],
18	,	,	O	,	_	0	SENT_265	[p17l2077t2740r2141b2809],
19	von	NNP	PERSON	von	nn	21	SENT_265	[p17l171t2849r284b2891],
20	Beckerath	NNP	PERSON	Beckerath	nn	21	SENT_265	[p17l332t2833r660b2890],
21	N	NNP	O	N	appos	5	SENT_265	[p17l707t2835r769b2903],
22	,	,	O	,	_	0	SENT_265	[p17l707t2835r769b2903],
23	et	FW	O	et	nn	24	SENT_265	[p17l817t2839r884b2890],
24	al.	FW	O	al.	appos	5	SENT_265	[p17l927t2833r1004b2890],
25	.	.	O	.	_	0	SENT_265	[p17l927t2833r1004b2890],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_266	[p17l1056t2833r1631b2890],
2	of	IN	O	of	_	0	SENT_266	[p17l1673t2833r1740b2890],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_266	[p17l1779t2833r2147b2905],
4	after	IN	O	after	_	0	SENT_266	[p17l174t2928r338b2985],
5	administration	NN	O	administration	prep_after	1	SENT_266	[p17l370t2928r848b2985],
6	of	IN	O	of	_	0	SENT_266	[p17l884t2928r950b2985],
7	a	DT	O	a	det	10	SENT_266	[p17l982t2943r1016b2985],
8	high	JJ	O	high	amod	10	SENT_266	[p17l1053t2928r1185b3000],
9	loading	NN	O	loading	nn	10	SENT_266	[p17l1224t2928r1460b3000],
10	dose	NN	O	dose	prep_of	1	SENT_266	[p17l1493t2928r1666b2985],
11	.	.	O	.	_	0	SENT_266	[p17l1493t2928r1666b2985],

1	Thromb	NNP	O	Thromb	nn	2	SENT_267	[p17l1711t2928r1963b2985],
2	Haemost	NNP	O	Haemost	_	0	SENT_267	[p17l1996t2929r2144b2985, p17l174t3027r334b3079],
3	2004	CD	DATE	2004	num	2	SENT_267	[p17l366t3022r884b3090],
4	;	:	O	;	_	0	SENT_267	[p17l366t3022r884b3090],
5	92:311	CD	NUMBER	92:311	number	6	SENT_267	[p17l366t3022r884b3090],
6	-6	CD	NUMBER	-6	dep	2	SENT_267	[p17l366t3022r884b3090],
7	.	.	O	.	_	0	SENT_267	[p17l366t3022r884b3090],

